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Transcriptome characterisation of the intra-mammalian 
stage of male and female Schistosoma mansoni 
 
Andreas Florian Sessler 
 
Schistosoma mansoni is a member of a genus of platyhelminths whose members 
cause the disease schistosomiasis. Particularly prevalent in sub-Saharan Africa, it 
is thought to be directly responsible for approximately 5500 deaths per year, as 
well as contributing significantly to morbidity, being responsible for 3.3 million 
lost disability-adjusted life years. Schistosomes are dioecious and male and 
female worms find one another and pair in the blood vessels of the host’s liver. 
This sets in motion a unique feature of schistosome biology, the pairing-
dependent sexual maturation of the female worms. Over the course of the next 
three weeks, the females fully develop their reproductive organs, especially 
ovaries and vitellarian tissue, to allow for the production of large quantities of 
eggs, which not only play a crucial role in the transmission of the parasites but 
are also responsible for much of the pathology associated with schistosomiasis.  
 
This thesis aims to explore the changes in gene expression which take place 
following pairing and result in the sexual maturation of females. To do so, RNA-
Seq data was produced from male and female worms from mixed sex as well as 
single sex infections at 18, 21, 28, 35, 38 and 49 days post infection and analysed 
to understand when and how gene expression changes in paired worms. Then 
gene expression was examined in worms that had been removed from their 
partner to examine the process of regression, where female worms lose much of 
their reproductive tissue. The last experiments describe examine gene 
expression in the testes and ovaries of schistosomes, to reveal differences 
between the gonads of worms from mixed and single sex infections and 
understand in more detail how these worms may regulate the growth of their 
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Schistosomiasis is caused by a genus of platyhelminths called Schistosoma; an 
estimated 200 million people require treatment for the disease annually, 
approximately 90% of whom live in sub-Saharan Africa (WHO, 2018). According 
to the Global Burden of Disease Study the death of 5500 people was directly 
caused by schistosomiasis in 2013 (Naghavi et al., 2015). However the precise 
number is difficult to estimate because of the difficulties of measuring the 
contribution of chronic schistosomiasis to conditions such as kidney failure and 
bladder cancer and estimates are as high as 200,000 deaths per year globally 
WHO (2018). 
 
1.2 Biology of schistosomes 
Schistosoma mansoni as well as several other species of schistosomes, notably S. 
japonicum and Schistosoma haematobium, are responsible for schistosomiasis. 
Schistosomes belong to the class Trematoda, which usually have a flattened, oval 
body shape ranging in length from around 0.1 cm to 7 cm with a ventral as well 
as an oral sucker (Barnes and Robert, 1982). Schistosomes are around 0.6-1.1 cm 
long and 0.1 cm wide, with a long, slim body (Machado-Silva et al., 1997). The 
morphology of male and female worms differs considerably (Loker & Brant, 
2006). Male worms maintain the typical flattened body shape of trematodes but 
curled up to form the gynecophoral canal, whereas the female worms have a 





Figure 1.1: Scanning electron microscopy of adult Schistosoma mansoni 
couples. After pairing, the female worm resides inside the gynecophoral canal 
(GC) of the male. Both worms have an oral (OS) as well as a ventral sucker (VS). 
The tegument of male worms is covered with tegumental tubercles (TT).  These 
images were taken in collaboration with Dave Goulding, WTSI, Hinxton. 
 
1.2.1 Life cycle 
The S. mansoni life cycle (see Figure 1.2) is similar to that of other trematodes 
and involves a mollusc and a mammalian host (Tucker et al., 2013). However, 
unlike most trematodes, the members of the Schistosomatidae, the family S. 
mansoni belongs to, are dioecious (Loker & Brant, 2006). This means that there 
are distinct male and female worms instead of hermaphrodites. The life cycle of 
S. mansoni features two hosts, a molluscan intermediate host, in which the 
parasites undergo asexual reproduction, and the vertebrate definitive host, in 
which the adult worms reproduce sexually and lay eggs (Tucker et al., 2013). 
When the eggs are placed in fresh water, ciliated larvae called miracidia (136 ± 3 
µm in length and 54 ± 1 µm in width (Eklu-Natey et al., 1985) are released.  S. 
mansoni miracidia invade the intermediate host – fresh water snails of the genus 
Biomphalaria – by burrowing through the skin of its foot (Cosseau et al., 2009). 








which in turn produce secondary (or daughter) sporocysts by asexual 




Figure 1.2: Life cycle of Schistosoma species. 1) Eggs are excreted via faeces or 
in the case of S. haematobium in the urine and reach fresh water. 2) Miracidia 
hatch from the eggs and seek a snail host. 3) The miracidia penetrate a snail host 
(in the case of S. mansoni a snail of the genus Biomphalaria) and 4) two 
generations of sporocysts develop from the miracidia inside the host. 5)  
Cercariae are produced and released into the water. 6) Cercariae penetrate the 
human skin, 7) shedding their tail and transforming into schistosomulae. 8) After 
moving through the circulation and lungs for several weeks, 9) male and female 
adult worms pair in the liver and 10) relocate to the mesenteric system of the 
bowel (or the venous plexus of the bladder in the case of S. haematobium). The 
couples then start egg-laying, thereby continuing the life cycle. Reproduced 





Each daughter sporocyst produces a clonal population of cercariae, the life cycle 
stage infecting humans (McKerrow & Salter, 2002). By shedding during daylight 
hours, S. mansoni maximise the chances of the cercariae being released when a 
suitable mammalian host might be nearby (Fingerut et al., 2003). The cercariae 
use their forked tail for locomotion and use changes in light and the presence of 
medium-chain fatty acids in the skin to detect a host (McKerrow & Salter, 2002). 
When a cercaria comes into contact with a suitable host, it attaches to the skin 
and uses proteases to break into the skin, migrating into the subcutaneous 
tissue, losing its tail in the process (Salter et al., 2000).  
 
Following host invasion, the parasites transform into schistosomules. They 
spend around days traveling through the skin and circulation, migrate through 
the lungs (peaking here around 5-6 d.p.i.), then continuing over the course of the 
next two weeks until they enter the portal vessel of the liver (P. Miller & Wilson, 
1980). There, they begin to feed on blood as the gut develops and they begin to 
grow. At this stage the male worms become visibly larger than the females 
(Basch, 1991) From around 21 day post infection (d.p.i.) onward the parasites 
mature and males and females commence pairing around 28 d.p.i. Basch, 1991). 
It is well established that female worms require pairing with a male partner to 
develop mature gonads and vitellaria to become sexually mature (Kunz, 2001). 
Without pairing, female worms remain stunted and infertile (Collins & Newmark, 
2013). Around 35 d.p.i., S. mansoni pairs have usually migrated into the 
mesenteric blood vessels and maturing females produce the first eggs (Basch, 
1991). However, there is considerable variation in the time it takes worms to 
migrate through different parts of their hosts’ bodies, depending on the species 
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of worm in question as well as the host species – mice, rats, hamsters and 
humans – varying by as much as 20 days (Yolles et al., 1949; Wilson, 1978; 
Crabtree & Wilson, 1986; Miller & Wilson, 1980). 
 
After S. mansoni pairs have migrated to the mesentery and commenced egg 
production, they will often continue to produce eggs for years if left untreated 
(Harris et al., 1984) Approximately half of the eggs get trapped in various organs 
(LoVerde et al., 2005), where they cause considerable damage (see Chapter 
1.3.2). The remaining eggs cross through the wall of the intestine into the lumen 
of the gut from where they are excreted with faeces (deWalick et al., 2011) If 
eggs wash into fresh water, miracidia hatch, ready to invade the snail 
intermediate host, and the cycle repeats. 
 
Aside from the migration through the host, another critical aspect of worm 
development is the morphological changes that take place during the first 6-7 
weeks after infection. Cort (1921) describes the development of male and female 
schistosomes from mixed sex (MS) infections beginning at the lung stage (around 
7 d.p.i) until the worms have matured fully and commence oviposition (around 
35 d.p.i.). The author notes that at 7 d.p.i. the young worms remain at 
approximately the same size as schistosomules with the gut starting to develop. 
The first differences between male and female worms are described at 15 d.p.i., 
when the worms reach the portal vessel of the liver, commence feeding on blood 
and begin to grow. Males are larger and have more developed oral and ventral 
suckers at this time. At around 21 d.p.i. organogeny begins: male worms develop 
testes and in females a uterus becomes visible. After another week of maturation, 
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at around 28 d.p.i., gametogeny is thought to take place. Males have been shown 
to possess 8 testes at 28 d.p.i., some of which contain sperm, and females to have 
developed ovaries. At 28 d.p.i., Cort (1921) first observed pairing of worms, but 
also showed that maturation of the vitellarium in particular requires a further 
week. At 30 d.p.i., the author demonstrated the presence of vitelline globes, but 
found that oviposition generally begins to occur at 35 d.p.i. At this point, females 
have well-developed vitelline glands to provide a steady supply of egg shell 
proteins, whilst male worms produce large quantities of sperm for fertilisation. 
Very similar observations were made by Biolchini et al. (2006), but technological 
improvements over the 85 years that separated these two studies, most notably 
confocal microscopy, allowed them to study the development of the worm 
organs in more detail. Indeed, the latter authors noticed that at week three 47-
59% of males had developed the gynecophoral canal, 5% of females had 
developed an ootype, and 33% of females had developed ovaries, whereas Cort 
(1921) did not observe ovaries at this time and made no mention of the 
gynecophoral canal development. At week four, Biolchini et al. (2006) found that 
15-26% of male worms began to develop tegumental tubercles (Figure 1.1). Also, 
69% of females were found to have ovaries and 12-75% an ootype, with a single 
female presenting with a fertilised egg. In addition, Biolchini et al. (2006) found 
the oral suckers of male worms to be significantly larger in size than that of 
females at 21-28 d.p.i., an important difference at 21 d.p.i. for distinguishing 
worms morphologically. Both papers noted the significance of pairing in the 
development of the females, which, unlike male worms, do not mature sexually 
until paired. In particular, development of the vitellarium and maturation of the 
ovaries was observed only following pairing (Biolchini et al., 2006; Cort, 1921). 
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Notably, the development of S. japonicum appears to occur at a slightly faster 
pace, as most worms were found to be paired by 22 d.p.i. and the first sperm and 
mature oocytes are first observed at the same time, presumably in worms that 
paired particularly early, and sexually mature worms are found at 28 d.p.i. 
(Wang et al., 2017).  
 
The induced maturation of the reproductive organs of a paired female worm 
culminates in the production of eggs. The function of the ovary is to produce 
viable, fertilised oocytes, the vitellarium, on the other hand, produces eggshell 
precursor proteins and provides nutrient reserves for the developing embryo in 
the form of lipid droplets (LoVerde et al., 2005). After oocytes have become 
fertilised with the male sperm inside the female oviduct, the fertilised cells move 
to the vitello-oviduct, where they are surrounded by approximately 38 
vitellocytes (Loverde & Chen, 1991) (Figure 1.3). The maturation of vitellocytes 
is commonly divided into four stages (Erasmus, 1975): The first is a stem cell 
stage of undifferentiated, small cells near the periphery of the vitelline lobes 
(S1). Then the cell begins to differentiate and grow in size (S2). The cells then 
begin to synthesise large amounts of proteins and form vitelline droplets; while 
the rate of protein synthesis increases the vitelline droplets begin to form 
clusters. Subsequently, lipid droplets and a small number of β-glycogen particles 
accumulate to provide energy to the embryo (S3). The final stages of 
development, mature vitellocytes (S4), leave through the vitelline duct to reach 
the ootype (Figure 1.3) (Wang & Collins, 2016). Approximately 11,000 S4 
vitellocytes are produced daily by mature females (LoVerde et al., 2005) and to 
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satisfy this demand the vitellarium takes up a large portion of the female worm’s 
body (Galanti et al., 2012).  
Figure 1.3: Diagram of the female reproductive organs, reproduced from 
Wang & Collins (2016).  Left: The relative positions are shown for the 
gonopore, ootype, Mehlis’ gland, oviduct, vitelline duct, ovary, vitellaria and 
seminal receptacle. Right: vitellocytes move towards the central vitelline duct as 
they mature through a sequence of stages (S1-S4); stem cell-like S1 cells, 
proliferating S2 cells, larger S3 vitellocytes accumulating granules, and finally 
mature S4 vitellocytes. 
 
Each paired female has been estimated to lay around 300 eggs per day for 
several years (Loverde & Chen, 1991). Schistosome are estimated to live for 2.7-
4.5 years (3.3 on average) (Goddard & Jordan, 1980) although there are reports 
of worms surviving and continuing to produce viable eggs for up to 47 years 
(Harris et al., 1984; Markel et al., 1978; Warren et al., 1974). Adult S. mansoni 
cannot reproduce asexually and female reproductive maturity is critically 
dependent on pairing with a male worm. Not only does transmission rely on 
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efficient egg production but also the pathology caused by schistosomes is in large 
parts driven by the host immune reaction against the eggs of these parasites and 
the resulting inflammation and formation of granulomas in the liver and spleen 
(Gryseels et al., 2006). For these reasons, the process of pairing-induced 
maturation is an attractive target for intervention and an intensely studied 
aspect of schistosome biology (Loverde & Chen, 1991). 
 
1.3 Impact on human welfare 
According to the WHO (2018) Approximately 200 million people required 
treatment for schistosomiasis in 2016, of which only about 90 million receive it. 
Furthermore, the WHO (2018) estimates that approximately 90% of those 
infected live in Africa, with limited access to medical care. Hence the number of 
schistosomiasis-related deaths is considerable, but much of it impact is related to 
chronic morbidity (WHO, 2016). To accurately reflect the impact of a disease not 
just in terms of lives lost but also taking into account the morbidity caused by 
diseases such as schistosomiasis a disability weight is used. This is a weight 
factor reflecting the magnitude of the health loss associated with the5 disease on 
a scale from 0-1, representing full health and death respectively (Salomon et al., 
2015). As part of the Global Burden of Disease Study, schistosomiasis was 
attributed a disability weight of 0.6% for the year 1990 (Murray & Lopez, 1997), 
although other studies put the disability weight as high as 2-15% (King et al., 
2005). In the most recent Global Burden of Disease Study, the estimate of total 
disability-adjusted life years (DALYs) lost due to schistosomiasis was raised from 
2.125 million to 3.309 million DALYs (Murray et al., 2012), reflecting the higher 
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estimates of disease prevalence as well as revised estimates of mortality and 
morbidity as measured by DALYs. Schistosomiasis transmission has been 
reported in 78 countries, including European countries such as Portugal and 
more recently France (Berry et al., 2014). Schistosomiasis is considered to be 
endemic in 52 out of 78 countries (WHO, 2018). Although sub-Saharan Africa is 
most affected, schistosomiasis is also found in countries along the Atlantic coast 
of South America and the Caribbean as well as several Southeast Asian countries 
(Gryseels et al., 2006).  
 
1.3.1 Chemotherapy and control of schistosomiasis 
Currently the only drug available to fight schistosomiasis effectively is 
praziquantel, which is used heavily in large parts of Africa with the declared aim 
of morbidity control (WHO, 2018). That means that rather than aiming to 
eradicate the disease in these areas, the aim is to reduce the intensity of the 
infection in the population and thereby lower the frequency of complications 
associated with schistosomiasis. The WHO considers schoolchildren to be target 
populations for these mass treatment programs, as well as at-risk adults such as 
fishermen or farmers who work in irrigation ditches and communities who 
heavily depend on water in endemic regions (WHO, 2018). Evidence has shown 
that pre-school children can also carry high intensity infections. For example, 
Dabo et al. (2011) found between 15.7% of preschool children in different 
villages in Mali to have high intensity infections, determined by an egg count of 
≥50eggs/ml in their urine. However, there are concerns about the safety of 
praziquantel in very young children due to a lack of reliable safety data (Stothard 
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et al., 2013). This mass treatment strategy, although representing the most cost-
effective method in high-prevalence settings (WHO, 2018), has major limitations: 
Firstly, it does not eradicate schistosomiasis in the regions covered but, as stated 
above, aims to control morbidity. Secondly, it leaves the vector population 
unaffected, including infected snails. For this reason, there is a risk of reinfection 
and so mass treatment needs to be repeated regularly to provide long-term 
benefit, which puts further strain on limited resources (WHO, 2018). Thirdly, 
due to mass drug administration, there is an increased pressure on parasite 
populations to become resistant to praziquantel - indeed reports of reduced 
sensitivity to praziquantel have been published in recent years (Crellen et al., 
2016; Wang et al., 2014). 
 
Unfortunately, despite decades of research into the development of a 
schistosomiasis vaccine, no successful formulation has been yet found (Hagan & 
Sharaf, 2003; McManus & Loukas, 2008). There is evidence that protective 
immunity against percutaneous infection with schistosomes can be raised with 
radiation-attenuated cercariae (Bickle, 2009; El Ridi & Tallima, 2015). 
Reductions in worm burdens up to 40-60% in treated mice were observed 
(Bickle et al., 1979). However, no single- or multi-valent vaccine tested to date 
has been able to advance from clinical trials. As a result, the search for viable 
vaccine targets continues including “–omics” approaches such as 
transcriptomics, proteomics but also glycomics and immunomics for candidate 
generation (Loukas et al., 2011) and several promising candidates are being 
investigated (Merrifield et al., 2016). These include a fatty acid binding protein 
(Sm14), tetraspanin-2 (SmTSP-2), glutathione S-transferase (Sh28GST) and 
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calpain (Sm80) (Tebeje et al., 2016).  While vaccines using Sm14, Sh28GST and 
SmTSP-2 have already been tested in humans (Bourke et al., 2014; Merrifield et 
al., 2016; Santini-Oliveira et al., 2016) the vaccine using calpain has been tested 
in mice and baboons (Ahmad et al., 2010; Ahmad et al., 2011) and is now 
undergoing preparations for human trials (Rojo et al., 2017). 
 
1.3.2 Pathology of schistosomiasis 
Acute pathology 
Individuals who are exposed to schistosomal cercariae for the first time, such as 
travelers or migrants are prone to developing acute symptoms in response to 
infection (Paris & Caumes, 2010; Ross et al., 2007). It has been suggested that the 
low rate of acute schistosomiasis in exposed populations, especially children, is 
due to a combination of underdiagnoses and in-utero sensitization (Gryseels et 
al., 2006). Within the first hours or days after penetration of the skin by 
cercariae, some may develop a temporary rash or lesions at the site of 
penetration (Gryseels et al., 2006). Over the weeks or sometimes months 
following the infection, some individuals may experience an acute systemic 
hypersensitivity to the developing worms also known as Katayama fever (Ross et 
al., 2007); symptoms include fever, fatigue, myalgia, malaise, cough, eosinophilia, 
and lung lesions (Gryseels et al., 2006). Although most patients recover within 2-
10 weeks, some go on to develop abdominal symptoms as well, including weight 





Chronic pathology  
As is the case for many infectious diseases, the severity of symptoms is 
determined by a combination of several factors: the intensity of infection, the 
host immune response and environmental factors. The symptoms of chronic 
schistosomiasis include abdominal pain, diarrhea and rectal bleeding (or 
haematuria in the case of an S. haematobium infection). Over the course of the 
infection the patients can develop anaemia, hepatosplenomegaly, an 
enlargement of liver and spleen as the result of fibrosis, and periportal fibrosis. 
 
Most of the chronic pathology caused by the infection is not inflicted by the adult 
worms. Instead it results from the host immune response against the eggs during 
their perivesicular or periintestinal migration or once they have become trapped 
in organs such as liver, spleen and lung (Gryseels et al., 2006). The human 
immune system responds to S. mansoni infections in a T helper 2-associated 
manner (Colley & Secor, 2014). This includes the use of parasite-specific 
antibodies, eosinophils and alternatively activated macrophages (Barron & 
Wynn, 2011; Colley & Secor, 2014), driven by the release of interleukins 4 and 13 
(Pagán & Ramakrishnan, 2018). These interleukins help to modulate the immune 
repose to a state of chronic inflammation and the formation of granulomas 
around S. mansoni eggs (Colley & Secor, 2013). The eggs play an active role in 
this process through the secretion of proteolytic enzymes that provoke an 
eosinophilic pro-inflammatory and granulomatous response (Cass et al., 2007; 
Jenkins et al., 2007; Everts et al., 2009). In the case of S. haematobium, the 
deposition of eggs around the bladder can also result in squamous cell carcinoma 
of the bladder (Nesi et al., 2015). In the liver, this immune response can lead to 
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fibrosis and later cirrhosis (Wynn, 2015). This, in turn, can result in potentially 
lethal pulmonary hypertension and oesophageal varices (Colley & Secor, 2013). 
In other parts of the body this immune response can cause genital, urinary, 
intestinal and pulmonary schistosomiasis as well as neuroschistosomiasis 
(Gryseels et al., 2006). Individuals with genital schistosomiasis may have 
symptoms including inflammatory lesions in reproductive organs that can lead 
to infertility as well as increasing the transmission of sexually transmitted 
infections, such as HIV (Gryseels, 2012).  
 
Apart from the potentially irreversible damage to the internal organs, 
schistosomiasis can have a range of more subtle effects. These effects include, 
but are not limited to, fatigue, stunted physical and cognitive development of 
young children, as well as anaemia and exacerbation of malnutrition (Mcgarvey, 
2000; Sousa-Figueiredo et al., 2012). As these conditions affect large numbers of 
people in endemic areas, it becomes clear that successful intervention would be 
of great benefit to these communities (Gryseels et al., 2006).  
 
 
1.4 Male-female interaction 
The dependence of female S. mansoni on pairing with a male for sexual 
maturation is long established (Kunz, 2001). Mating usually occurs in a parallel 
fashion (anterior to anterior), but about 12% of S. mansoni pairs are found to be 
paired in a reverse orientation (Faust et al., 1934). Although it is usual for S. 
mansoni females to pair with one male only, it has been observed, both with 
freshly perfused worms as well as in vitro, that multiple males will clasp onto a 
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single female. (Basch, 1991). In other members of the family Schistosomatidae, 
the number of females paired with a single male can be greater. For example, 
Chu & Cutress (1954) found male Austrobilharzia variglandis to be paired with 3 
to 8 females at once. Furthermore, Armstrong (1965) found a male 
Heterobilharzia americana to be paired simultaneously with 29 female S. 
mansoni, all of which appeared to be sexually mature. Male S. mansoni have a 
propensity to pair and in the absence of females will clasp onto objects of similar 
shape and size to female worms, e.g. made from cotton or agar (Basch & Nicolas, 
1989). Even in vitro, worms pair or re-pair quickly: Michaels & Prata (1968) 
observed that when keeping male and a female worm together in vitro, the 
proportion of paired worms increased steadily. Out of a total of 140 potential 
pairs, after 1 day in culture 20.7% of worms were paired, 84.2% after 2 days, 
94.5% after 3 days and 100% after 5 days. 
 
When trying to determine the nature of the stimulus that leads to female sexual 
maturation, the first processes to be examined were insemination as well as the 
transfer of metabolites, such as carbohydrates, cholesterol, lipids, amino acids 
and polypeptides, to the female (Basch, 1991). Shaw (1977) demonstrated that 
pairing alone is enough to induce some development of vitelline tissue and 
occasionally even formation of an egg, without insemination. To do so, he 
allowed females from single sex (SS) infection and males from MS infections to 
pair, noting changes in female morphology within 5-6 days, whilst showing that 
~85% of females remained unfertilised up to this point. Michaels (1969) also 
showed that males irradiated with X-rays readily paired and induced female 
maturation. Even without intact testes, this lead to successful female sexual 
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development and egg laying. The male stimulus was also shown not to be under 
the control of the cerebral ganglia of the nervous system, as decapitated males 
are still able to induce female maturation (Popiel & Basch, 1984); however, as 
the authors stated, this does not unequivocally rule out involvement of the 
central nervous system, as parts of the nervous system in the rest of the body 
were found to remain functional (Popiel & Basch, 1984). Furthermore, the 
stimulus is also not species-specific as females paired with males of other species 
(heterospecific pairing) will produce eggs, albeit at a reduced rate (Kunz, 2001).  
 
Although the nature of the stimulation of female worms is unclear, it requires 
contact, occurs along the whole gynecophoral canal and is local, i.e. is not 
propagated longitudinally through the body of the female worm (Basch, 1991). 
The nature of the stimulus has been speculated to be physical, for example 
tactile, or involve transfer of hormones, nutrients and other signalling molecules 
(LoVerde et al., 2005). Several studies have provided evidence for nutrients 
playing a key role in supporting female fertility (Pearce & Huang, 2015), 
especially the availability of red blood cells (Wang et al., 2015) and fatty acids 
(Huang et al., 2012). S. mansoni cannot synthesise fatty acids, relying instead on 
their host to provide them (Meyer et al., 1970). Metabolites such as glucose 
(Cornford & Huot, 1981) and cholesterol (Popiel & Basch, 1986) can be 
transferred through the gynecophoral canal to the female which may help to 






1.5 Molecular biology of male-female interaction 
Several signalling pathways thought to be involved in stimulating the growth and 
maturation of female S. mansoni have been characterised, including the 
transforming growth factor (TGF)-β/SMAD and the MAPK pathway (Beckmann 
et al., 2010). In the context of female maturation they serve to transmit growth-
inducing stimuli from the male worm to the nuclei of cells in the vitellarium and 
ovaries (Beckmann et al., 2010).  
 
The TGF-β pathway plays an important role in the development of multicellular 
organisms (Osman et al., 2006). TGF-β is a polypeptide and a cytokine that helps 
to regulate cell proliferation, differentiation and apoptosis (Massagué, 2012). 
Signalling is initiated by transmembrane serine/threonine kinase receptors, the 
TGF-β receptors I & II (TβRI & TβRII) (Osman et al., 2006). TGF-β signalling also 
relies on SMAD proteins, which were first detected in Drosophila melanogaster 
(Sekelsky et al., 1995) and Caenorhabditis elegans (Savage et al., 1996) where 
they were termed “mothers against decapentaplegic” (MAD) and “small body 
size” (SMA), respectively. Proteins found to be homologues of these two are now 
called SMAD by merging the two names. SMADs form trimers of two R-SMAD and 
one co-SMAD molecule. These act as transcription factors to activate expression 
of downstream genes (Shi & Massagué, 2003). Homologues of TβRs, SMADs, as 
well as of several other proteins that form part of the intracellular TGF-β 
signalling pathway, have been discovered in schistosomes (Loverde et al., 2007). 
These include the TβRI-regulating protein FKBP12 as well as the proteins 
SMAD2, a receptor regulated SMAD (R-SMAD) (Wu et al., 2001) and SMAD4, a 
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common-mediator-SMAD (co-SMAD) (Shi et al., 1997). Many of these genes have 
been shown to be expressed in the ovaries and vitellarium of female and in the 
testis of male worms (Beckmann et al., 2010).  
 
To demonstrate the importance of TGF-β signalling for female reproductive 
activity, Knobloch et al. (2007) exposed  S. mansoni pairs in vitro to the synthetic 
TβR-I inhibitor TRIKI and demonstrated a reduction in mitotic activity the 
vitelline cells of females by 46%, as well as a 28% reduction of laid eggs. 
However, as higher concentrations of TRIKI did not lead to a greater reduction in 
mitosis and egg laying, the authors concluded that alternative signalling 
pathways must be involved in the development of the vitellarium (Knobloch et 
al., 2007).  
 
Using another inhibitor, the Src-kinase specific herbimycin A, Knobloch et al. 
(2007, 2006) found egg laying in vitro to be reduced by 40-60% and mitotic 
activity in females (but not males) reduced by 25-75% in a dose-dependent 
manner. Src kinases are cytoplasmic tyrosine kinases (CTK) and hence belong to 
the superfamily of protein tyrosine kinases (Beckmann et al., 2010). CTKs are 
divided into eight subcategories based on the presence or absence of domains as 
well as their structural arrangements and several members of the CTKs have 
been discovered and found to be expressed in schistosome reproductive tissues 
(Beckmann et al., 2010). 
 
The Src kinases SmTK3 (Kapp et al., 2004) and SmTK6 (Beckmann et al., 2011) 
have been localised to the gonads of S. mansoni, however, SmTK6 expression was 
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found to be absent from the vitellarian tissue (Beckmann et al., 2011). The Fyn-
type Src kinase SmTK5 is expressed in the gonads and vitellarium, and SmTK4, 
which belongs to the class of Syk kinases, is also expressed in the gonads but not 
the vitellarium (Knobloch et al., 2002).. SmTK3, SmTK4 and SmTK6 were shown 
to interact directly with one another to regulate downstream signalling using 
yeast-2-hybrid screening (Beckmann et al., 2010; Kapp et al., 2004). Syk kinases 
regulate cell proliferation and progression through the cell cycle by activating 
expression of mitotic genes (Beckmann et al., 2010) but also by regulating 
cytokinesis and the cytoskeleton rearrangements (Mócsai et al., 2010). Syk 
kinases are activated by receptor tyrosine kinases (RTK), such as the epidermal 
growth factor receptor (EGFR) (Vicogne et al., 2004) or venus kinase receptors ( 
Vicogne et al., 2003). Sky kinase activation leads to the activation of a cascade of 
mitogen activating protein kinases, known as the MAPK signalling pathway (Qi & 
Elion, 2005). At least 15 RTKs have been identified in the S. mansoni genome: 
This includes four EGFRs, two insulin receptors, two fibroblast growth factor 
receptors (FGFR), an Ephrin receptor, a RTK-like orphan receptor, a muscle-
specific kinase receptor, a cholecystokinin tetrapeptide receptor families as well 
as an unknown receptor (Andrade et al., 2011; Avelar et al., 2011). A variety of 
extracellular stimuli can activate the MAPK pathway through RTKs in the cell 
membrane. Through a series of kinases activating one another, a MAPK such as 
the extracellular responsive kinase (ERK) is activated (Qi, 2005). ERK 
translocates into the nucleus where it phosphorylates the transcription factor 
ELK-1, thereby allowing it to form a heterodimer with the serum response factor 
and activate transcription by binding to the promoter of target genes such as c-
Fos in humans (Cavigelli et al., 1995).  
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Several components of the MAPK signalling cascade were discovered in the S. 
mansoni genome by in silico analysis (Andrade et al., 2011) and their biological 
role has been further characterised since then: In planarians, ERK is now known 
to play a central role in the regeneration of tissue by stem cells (Tasaki et al., 
2011), a process thought to be similar to the growth of the female reproductive 
organs in S. mansoni in response to pairing (Collins & Newmark, 2013), whereas 
in C. elegans the MAPK pathway is known to be important in several 
developmental events as well as establishing meiosis in the germ line 
(Sundaram, 2006). Andrade et al. (2014) demonstrated that RNAi using long 
dsRNA molecules can be used in vivo in S. mansoni to investigate the role of the 
MAPK pathway. They successfully knocked down ERK and found no effect on 
worm survival but a 44% reduction in hepatic egg count relative to a negative 
control, suggesting that MAPK may play a role in female fertility.   
 
Other proteins involved in regulation of the MAPK pathway for which 
homologues have been found in S. mansoni include the adapter proteins SHC and 
growth factor receptor-bound protein 2, which act by binding to the cytoplasmic 
portion of RTKs, and control recruitment of “Son of sevenless” (SOS), a guanine 
nucleotide exchange factor protein (Knobloch et al., 2007). This in turn activates 
the membrane associated GTPase called Ras by catalysing the exchange of GDP 
with GTP, thereby activating Ras which goes on to activate the MAPK cascade 
(Beckmann et al., 2010). Another protein, the GTPase-activating protein (GAP), 
promotes the exchange of GTP with GDP, thereby leading to deactivation of Ras, 
causing deactivation of the MAPK pathway (Beckmann et al., 2010).  However, 
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activated Src kinases can phosphorylate GAP to down-regulate its inhibitory 
effect on the MAPK pathway (Downward, 1997; Qi, 2005). 
 
In addition to RTKs, the integrin receptors α and β have been found to activate 
focal adhesion kinase (FAK), another CTK (Guan, 1997; Mitra & Schlaepfer, 
2006). Integrins are composed of two non-covalently associated transmembrane 
glycoprotein subunits, α and β, and primarily serve to attach the cytoskeleton to 
the extracellular matrix (Alberts et al., 2007). They also play an important role in 
signalling by passing on extracellular stimuli to the FAK and often cooperate to 
promote cell growth, survival and proliferation (Alberts et al., 2007).  S. mansoni 
integrin receptors and their role in reproduction were described by Beckmann et 
al. (2012) who found that integrin-β-1 was expressed in the reproductive organs 
of S. mansoni, co-localising with SmTK3, SmTK4 and SmTK6. Using a yeast-2-
hybrid screen the same authors showed that integrin-β-1 interacts with the SH2 
domain of SmTK4 and with the SH3 domain of SmTK3 and SmTK6 (Beckmann et 
al., 2012). Recently, the interaction between integrins and the Venus Kinase 
Receptor 1, a RTK, was shown to regulate proliferation of oocytes by apoptosis in 
S. mansoni (Gelmedin et al., 2017). 
 
Integrins often occur in complexes with tetraspanins (Tugues et al., 2013). These 
are a group of proteins characterised by four transmembrane domains, which 
form so called tetraspanin enriched microdomains which allow other molecules 
to assemble into signalling complexes (Tugues et al., 2013).  Several tetraspanin 
homologues have been identified in S. mansoni, including members of the CD63 
family of tetraspanins (Cogswell et al., 2012; Tran et al., 2010). One of the CD63 
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homologues is known to be expressed in a female-specific manner (Cogswell et 
al., 2012). In humans, CD63 has been shown to down-regulate apoptosis by 
interacting with the protein “tissue inhibitor of metalloprotease-1” (Jung et al., 
2006). 
 
Another group of kinases found in S. mansoni are polo like kinases (Long et al., 
2010), also known as Cdc5, which have been shown to regulate cell cycle 
progression in a wide range of organisms such as Saccharomyces cerevisiae, D. 
melanogaster, C. elegans and humans (Chase et al., 2000; Llamazares et al., 1991; 
Toczyski et al., 1997). Polo-like kinases have a serine/threonine kinase domain 
as well as two signature motifs, known as polo boxes (Barr et al., 2004). In model 
organisms they have been found to tightly control the G2/M transition in the cell 
cycle by phosphorylation of Cdc25 which in turn activates CDKs by 
dephosphorylation (Roshak et al., 2000). This process drives the activation of 
mitotic events including centrosome maturation, bipolar spindle formation, 
activation of the anaphase promoting complex, chromosome segregation and 
actin ring formation in preparation for cytokinesis (Van De Weerdt & Medema, 
2006). Polo-like kinases themselves are regulated by a group called polo-like 
kinase kinases, one member of which has been found in S. mansoni and is a 
homologue of human protein Ste20 (Yan et al., 2007). Ste20-like kinases belong 
to the germinal center kinase subfamily and their function, like that of the 
integrin receptors, relates to the regulation of actin-mediated processes 





1.6 Genomics & Transcriptomics 
1.6.1 Genome 
S. mansoni is a diploid organism with seven pairs of autosomes, a pair of sex 
chromosomes and a mitochondrial genome (Swain et al., 2011). Schistosomes 
have a ZW determination, meaning that the male is homogametic (ZZ) and the 
female heterogametic (ZW) (Short & Grossman, 1981).  
 
Berriman et al. (2009) found the nuclear genome to be 30% larger than 
previously estimated, around 374.9 Mb, approximately one ninth of the human 
genome but considerably larger than the genome of C. elegans (~98 Mbp) (C. 
elegans Sequencing Consortium, 1998) or D. melanogaster (~120 Mbp) (Adams 
et al., 2000). 40% of the S. mansoni genome is made up of repetitive sequences, 
including 72 families of long-terminal repeat (LTR) and non-LTR transposons 
each, comprising 15% and 5% respectively of the whole genome. In the most 
recently published version of the genome its size was revised down to 364.5 Mb 
and the number of genes now stands at 10,852, having been revised down from 
11,807 in the original genome paper, after more than 45% of gene models were 
modified (Protasio et al., 2012). These advances were due in part to RNA-Seq 
evidence that allowed for improved gene predictions and due to a less 
fragmented genome with fewer duplicated sequences that had resulted from 
polymorphism (Protasio et al., 2012). The current genome assembly consists of 
9203 contigs with an average length of 39.4 kb, a N50 length of 78.3 kb – a 
measure of assembly quality indicating that 50% of the genome sequence was 
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contained on contigs greater or equal to 78.3 kb – and 885 scaffolds with an 
average length of 411.9 kb and a N50 length of 32.1 Mb (Protasio et al., 2012).  
 
Assembly of the Z and W chromosomes proved to be difficult as there are large 
regions of homology where the chromosomes are indistinguishable the Z and W 
chromosomes assembled together in 34 scaffolds with 59 Mb in total (Protasio et 
al., 2012). The same authors used differences in coverage of male and female 
DNA to identify female-specific regions of the W chromosome. Overall, 30% of 
the Z/W chromosome sequence was unique to the Z chromosome, and 23 Z-
specific genetic markers were identified in the assembled Z/W scaffolds 
(Protasio et al., 2012). 114 unplaced scaffolds, totalling approximately 1.1 Mb, 
were found to be W-specific but contained approximately 90% repetitive 
sequence including known female-specific repeats (Portela et al., 2010).  
 
1.6.2 Transcriptomics of sex-specific schistosome biology 
Due to its relevance for pathology and transmission, understanding the sexual 
dimorphism of schistosomes is critically important. This aspect of schistosome 
biology was and continues to be studied using different methods of 
transcriptome analysis (for example (Fitzpatrick et al., 2005; Lu et al., 2017)). In 
recent decades, several new methods of transcriptome analysis have become 
available, including methods based on quantitative real time PCR (qRT-PCR), 
expressed sequence tags (EST), serial analysis of gene expression (SAGE), cDNA 
microarrays and later RNA–Seq as well as variations of these methods (Lowe et 
al., 2017). In the following paragraphs, I will summarise schistosome 
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transcriptomics, the development of methods and their use to address 
increasingly detailed biological questions. 
 
Early papers to examine the differential expression of genes in male and female 
S. mansoni examined individual genes such as actin (Davis et al., 1985) or small 
groups of genes, due to a lack of high-throughput methods. In this case, Davis et 
al. (1985) used northern blot analysis to compare mRNA levels. The authors 
showed that two actin transcripts were more abundant in male worms than in 
females, cercariae and eggs. Using the same methodology the transcription of the 
gene coding for the egg shell protein p48 was studied (Chen et al., 1992). The 
authors found it to be exclusively expressed in paired female worms. 
Furthermore Grevelding et al. (1997) identified three more genes, encoding egg 
shell protein p14, ferritin-1, and mucin-like protein A11, which they showed to 
only be expressed the vitelline tissue of paired female worms. 
 
Thanks to the progress in human transcriptomics (Adams et al., 1991, 1992, 
1993; Hoog, 1991), increasing availability of genomic data (Franco et al., 1995), 
programs and resources such as the WHO/UNDP/World Bank Schistosoma 
Genome Network (http://www.nhm.ac.uk/hosted_sites/schisto), the 
Schistosoma mansoni EST Genome Project (http://verjo18.iq.usp.br/schisto/) 
and the Institute for Genomic Research Schistosoma mansoni genome project 
(http://www.tigr.org/tdb/e2k1/sma1/index.shtml), it became feasible to design 
S. mansoni specific microarrays. This allowed scientists to examine hundreds of 
genes at the same time (Lowe et al., 2017). Hoffmann et al. (2002) used a cDNA 
microarray with 576 probes and were able to double the number of genes 
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known to be differentially expressed between male and female schistosomes, 
identifying sex-specific expression for twelve female- and four new male-specific 
transcripts. 
 
One year later, 16000 ESTs and 163 full-length cDNA had been sequenced, when 
Verjovski-Almeida et al. (2003) generated ten times more ESTs and provided the 
first sequencing-based comprehensive overview of a schistosome transcriptome. 
However most transcripts were still not sequenced along their full length, 
instead rather small, unique nucleotide sequences (tags) were sequenced, which 
allowed the corresponding genes to be identified (Lowe et al., 2017)l. 
 
Many of the subsequent publications that examined differences between male 
and female worms as well as paired and single worms used microarray or tag 
sequencing methods: Between 2004 and 2014 several such papers were 
published (Fitzpatrick et al., 2004; Fitzpatrick et al., 2005; Fitzpatrick & 
Hoffmann, 2006; Leutner et al., 2013; Moertel et al., 2006; Sun et al., 2014) 
leading to a further expansion of genes known to be gender- or pairing-
associated. When examining differences between male and female worms from 
the genus Schistosoma, the number of gender-associated genes discovered by 
such undertakings thus increased from 16 (four male- and twelve female-specific 
genes (Hoffmann et al., 2002) to 30 (eight male- and 22 female- associated 
genes) in S. japonicum (Fitzpatrick et al., 2004), then later 227 (86 male- and 141 
female-specific genes) in S. mansoni (Fitzpatrick et al., 2005) and finally 2179 
(1163 male- and 1016 female-specific genes in S. japonicum (Moertel et al., 2006) 
genes, an 136-fold increase of genes known to be differentially expressed 
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between male and female worms within four years.  
 
Due to these investigations, we now know the transcripts most differentially 
expressed between sexually mature male and female worms. These differences 
closely reflect the biology of this parasite, with sexually mature females up-
regulating transcription of genes associated with egg production, such as the 
major egg antigens other eggshell proteins, p48 (chorion), as well as tyrosinases 
(Fitzpatrick & Hoffmann, 2006). Male-specific genes on the other hand are 
dominated by tegument and muscle genes (e.g. tetraspanin genes, tegumental 
antigen as well as actin, dynein light chain 3, myosin and tropomyosin) 
(Fitzpatrick et al., 2005, 2004; Moertel et al., 2006). These may reflect the role of 
the male worm in anchoring the female inside blood vessels, moving her to 
suitable egg deposition sites (Fitzpatrick et al., 2005). 
 
The role of pairing on gene expression and the resulting sexual maturation has 
also generated considerable interest (Fitzpatrick & Hoffmann, 2006; Leutner et 
al., 2013; Sun et al., 2014).  A number of different comparisons have been made: 
first Fitzpatrick & Hoffmann (2006) used a cDNA microarray to examine 
differential gene expression in seven week old adult males and sexually mature 
female from mixed sex (MS) and females from single sex (SS) infections. This 
allowed the author to identify 245 genes differentially expressed between 
females from MS infections (64 genes) and SS infections (181 genes), and 138 
138 genes differentially expressed between males from equivalent infections 
(104 genes up-regulated in males from SS and 34 in males from MS infections). 
In 2013, Leutner et al. used a combination of oligonucleotide microarray and 
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SuperSAGE (a form of Serial Analysis of Gene Expression using high-throughput 
sequencing (Lowe et al., 2017)) to examine males from MS and SS infections 
(using the terms pairing-experienced and inexperienced). Their microarray 
analysis allowed them to discover a total of 526 genes, which were differentially 
expressed in MS (229 genes) and SS males (297 genes) whereas their SuperSAGE 
analysis only detected 288 genes (253 genes in MS males and 35 in SS males). 
The discrepancy was explained partially by the fact that expression for over 
4000 (out of a total 6326 examined) genes was only detected by one of the two 
methods as well as the use of stringent significance thresholds (Leutner et al., 
2013). The intersection of those two data sets contains a total of 29 genes, 21 of 
which had functional annotation at the time, from which 16 genes were up-
regulated in males from SS, and 5 in males from MS infections (Leutner et al., 
2013). Sun et al. (2014) examined S. japonicum at 18 and 23 d.p.i. to get an 
insight into the early changes induced by pairing, as well as the changes taking 
place in females from SS and MS infections between 18 and 23 d.p.i. At 18 d.p.i. 
they found a total of 318 differentially expressed genes (241 in females from SS 
and 77 in females from MS infections). However, at 23 d.p.i. the number of 
differentially expressed genes had risen to 3446 genes (533 in females from MS 
and 2913 in females from SS infections) (Sun et al., 2014). The numbers of genes 
differentially expressed between females from 18 and 23 d.p.i. are also large: for 
females from SS infections, 2545 genes were found to be differentially expressed 
(2193 up-regulated in females from 18 d.p.i. and 352 up-regulated in females 
from 23 d.p.i.) and for females from MS infections, 1998 genes were found to be 
differentially expressed (740 up-regulated in females at 18 d.p.i. and 1258 up-
regulated at 23 d.p.i.) (Sun et al., 2014). Due to an apparent lack of replicates in 
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this study, it is hard to estimate how much biological variability there is, but a 
general trend can be seen clearly: The transcriptome of paired female worms 
(MS infections) becomes increasingly divergent from females that remain 
unpaired (SS infections) (Sun et al., 2014). As paired females mature sexually the 
differences between them and females from single sex females become more 
noticeable both morphologically (Fitzpatrick & Hoffmann, 2006), but also at the 
transcriptome level and these differences increase as pairing continues until the 
paired female reaches complete sexual maturity around 5 weeks p.i. (Basch, 
1991). 
 
Recently, Wang et al. (2017) published a large RNA-Seq study in which they 
presented evidence that biogenic amines serve as the male stimulus for female 
sexual maturation. Having sequenced 48 S. japonicum transcriptomes from eight 
time points in the intra-mammalian stage (between 14-28 d.p.i.) and both sexes, 
with three biological replicates each, these authors found the expression of an 
aromatic-L-amino acid decarboxylase (AADC) to increase leading up to pairing, 
and showed the expression of AADC to be located in the gynecophoral canal by 
using whole mount in situ hybridisation (Wang et al., 2017). Furthermore the 
authors found an allatostatin-A receptor-like gene (AlstR), coding for an insect-
like hormone receptor, to be involved in the maturation of female reproductive 
organs (Wang et al., 2017). Indeed, when AlstR was knocked down using RNAi, 
ovaries and vitelline glands failed to mature, in contrast to control females 
(Wang et al., 2017). Another study found evidence that histone modifications 
(H3K27me3) are different between male and female S. mansoni (Picard et al., 
2016). The authors found these epigenetic modifications to correlate with gene 
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expression showed there to be a sex-biased dynamic of histone methylation, in 
particular a depletion of H3K27me3 along the transcription unit in male worms 
(Picard et al., 2016). However, as all RNA-Seq data in this study was derived from 
worms of SS infections, it remains to be seen if these results hold true for 






























































































































































































































































































































































































































































































































































































































































































































































































































Table 1.1: Summary of the published literature on schistosome 
transcriptomic discussed in this chapter. The table provides the name of the 
first author and year of publication, the methods of transcriptomics used, the 
Schistosoma species examined in a given publication, the number of probes used 
(in the case of microarrays) or DNA reads sequenced (in the case of RNA-Seq), 
the samples which were compared and finally the number of differentially 
expressed genes (DEGs) observed. *) Including positive controls; **) Results for 




1.6.3 Methods of transcriptomics 
This thesis relies heavily on gene expression data, including RNA sequencing 
(RNA-Seq) first and foremost, but also used quantitative reverse transcription 
polymerase chain reaction (qRT-PCR) data, which is often considered the gold 
standard for comparing gene expression, for validation of RNA-Seq data. 
Microarray data is only used to briefly, by correlating previously published 
microarray data to RNA-Seq data. The following section introduces these 
methods for measuring changes in the transcriptome as well as their strengths 
and weaknesses.  
 
Quantitative reverse transcription PCR 
qRT-PCR is used frequently to compare expression of small numbers of genes 
between different samples. After reverse transcription of mRNA, the cDNA is 
used as template for a PCR reaction where, over the course of several rounds of 
amplification, the quantity of target cDNA is measured. This can for example be 
done using SYBR Green, a compound that fluoresces when bound to DNA. Over 
successive rounds of PCR this results in stronger fluorescence as more DNA has 
been produced. The quantities of DNA in the sample and control can then be 
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compared to determine the relative abundances of the target sequence in the 
cDNA. The method most commonly used for inferring differences in expression 
between samples is called ΔΔCt Calculation Method, and it makes use of one or 
more internal reference (IR) genes thought to be expressed at identical levels 
across all samples, to control for differences in the quantity of input cDNA 
(Kubista et al., 2006). The IR is used for normalisation of the amount of input 
cDNA between different samples, so that any differences between target gene 
expression observed after normalisation represents the treatment effect (see 
Chapter 2.2.5). qRT-PCR has been widely used to measure gene expression in 
schistosomes. For example it has been used to identify or validate gender-
specific gene expression by comparing male and female samples (Hoffmann et 
al., 2002), pairing-induced gene expression by comparing cDNA samples from 
paired to those of virginal females (Fitzpatrick & Hoffmann, 2006). Another 
example is the use of qRT-PCR to compare gene expression in different organs 
(Hahnel et al., 2014) and in RNAi knock-down experiments (Tran et al., 2010). 
 
Microarray 
cDNA microarrays are a collection of DNA probes which are immobilised on a 
small chip to allow sample RNA (after reverse transcription to cDNA) to be 
bound by hybridisation with the complementary probe sequences. When 
applying sample cDNA to the microarray, the relative abundance of sample cDNA 
molecules is usually measured using fluorophore- or chemiluminescence-
labelled probes (M. B. Miller & Tang, 2009). It is worth noting that reference 
sequences have to be known prior to the production of the microarray probes 
(Lowe et al., 2017). This allows comparisons of transcript abundances of two or 
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more experimental conditions. As in the case of qRT-PCR, stringent 
normalisation is necessary to obtain accurate results. This includes measuring 
technical as well as biological variation across the transcriptome. Microarrays 
can be performed at very high throughput, due to the relatively low labour 
intensity (compared to RNA-Seq), but they require a relatively large amount of 
mRNA input (about 1 µg of mRNA) (Lowe et al., 2017). This can limit the 
application of microarray, if the biological samples are difficult to obtain and 
very small in size. 
 
RNA sequencing 
RNA-Seq relies on high-throughput sequencing technology that can provide the 
sequences of vast numbers of short cDNA fragments to determine the abundance 
of cDNA molecules in each sample. Depending on the precise method used to 
make the cDNA library to be sequenced, the data may include information on the 
expression of not just messenger RNA (mRNA) but also non-coding RNAs such as 
ribosomal RNA (rRNA), transfer RNA (tRNA) and others. Careful normalisation is 
required for accurate results. The normalisation needs to correct for within-
sample biases, caused by factors such as transcript length and GC-content, as 
well as between-sample biases, especially amount of sequenced cDNA. To correct 
within-sample biases RPKM (reads per kilobase of transcript per million mapped 
reads) or FPKM (fragments per kilobase of transcript per million mapped reads) 
are often chosen. This method scales the number of reads for a given gene to the 
length the given transcript as well as the overall number of reads across the 
whole transcriptome (Verk et al., 2013). However, it has been demonstrated that 
this method skews calls for differential expression in favour of longer transcripts 
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as the number of reads mapping to a gene will be proportional to its length and 
higher read counts give more statistical power to determine significant 
differences (Oshlack & Wakefield, 2009). In cases where expression of a gene is 
compared across different samples (rather than different genes within one 
sample), only between-sample normalisation is necessary (Verk et al., 2013). In 
such cases sequencing yield is the most important variable to take into account. 
The sequencing yield, i.e. the total number of transcript reads generated during 
sequencing, has to be considered during the normalisation as it often differs 
between replicates and treatment groups. Rather than dividing the read count 
per gene by the total number of reads for a given sample, more robust methods 
are used that can take extreme expression values into account (Love et al., 2014). 
Such methods include the median-of-ratios (Love et al., 2014) and the trimmed 
mean of M-values method (Robinson et al., 2009). However, in this context it is 
also important to consider the effect of relative abundances of mRNAs in a 
transcriptome. If the real expression of a target gene is identical in two samples, 
but its relative abundance is higher in one sample (for example due to a large 
number of other genes becoming down-regulated) the target gene will appear to 
be differentially expressed. Technical variation in transcriptome analysis is the 
measured differences introduced by the method or transcriptome analysis and 
sample handling, rather than differences in the underlying biology. Technical 
variation is thought to be smaller in RNA-Seq than in microarray technology 
(Marioni et al., 2008), biological variation has to be measured carefully to allow 
statistical inference of differential expression of a gene between two samples 
(Love et al., 2014). Furthermore, during the final steps of RNA-Seq library 
production, the cDNA is usually amplified using PCR. During this process some 
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biases may be introduced as some GC-rich cDNA molecules don’t become 
amplified at the same rate as other molecules (Aird et al., 2011). However, this 
effect should be negligible when comparing expression of the same gene across 
different samples, as these samples should experience the same amplification 
biases at that locus. 
 
RNA-Seq offers several advantages over microarrays. Firstly, microarrays rely on 
a library of probes that is pre-determined and based on existing genome 
annotations (Lowe et al., 2017). Thus, genes that have not yet been discovered 
will be excluded from the analysis. Unlike microarrays, RNA-Seq data can be 
used to discover new transcripts and genes. This information can then be used to 
validate predicted gene models in the genome and contribute to improving the 
quality of genome annotation (Lowe et al., 2017). Secondly, RNA-Seq allows to 
detect splice variants, which can remain undiscovered in microarrays as, in many 
cases, different variants will hybridise with the same probe. Another advantage 
of RNA-Seq over microarray data is a larger dynamic range, which means 
accurate quantification of genes with very low or high expression (Zhao et al., 
2014). In the absence of expression microarrays will often measure non-zero 
expression levels due to background noise such as non-specific hybridisation. 
Conversely at the high expression levels micro arrays can become saturated and 
unable resolve different expression levels anymore (Zhao et al., 2014). This 
allows for a more quantitative measurement of low and very high abundance 





Comparison of RNA-Seq and proteomics 
A discrepancy between mRNA and protein levels is to be expected in any 
organism as there are many mechanisms regulating the abundance of proteins in 
a cell (Maier et al., 2009). These include different efficiencies of mRNA cap 
binding proteins, the rate at which ribosomes are recruited to internal ribosome 
binding sites, codon usage, regulation by microRNAs, binding to RNA-binding 
proteins and mRNA stability which is mainly controlled by the mRNA poly-A tail 
(Vogel & Marcotte, 2012).  Protein abundance is also regulated further down-
stream of translation by degradation signals leading to ubiquitination and 
proteolysis (Vogel & Marcotte, 2012). All these factors combined mean that there 
is not a perfect correlation between mRNA and protein levels (Maier et al., 
2009). Schwanhaeusser et al. (2011) examined the correlation of steady-state 
mRNA and protein abundance in mouse fibroblasts, finding that, across 5028 
genes, mRNA levels only explain between one and two thirds of the variation in 
protein levels observed (R2=0.41). In human medulloblastoma cells, Vogel et al. 
(2010) reported that 66% of variation in protein levels could be explained by 
factors including mRNA concentration, UTR sequences and the coding sequence. 
However, these authors showed that mRNA concentration only explained 27% of 
the variance, 3’ UTRs 8% and that 31% was explained by the coding sequence. 
Nonetheless, Vogel & Marcotte (2012) conclude that mRNA is a suitable proxy 
for the presence of a protein as mRNA levels detected by RNA-Seq directly 
correlated to the corresponding proteins in a proteomics experiment. However, 
work by Li et al. (2014) showed that due to problems with the normalisation of 
proteomics data in the aforementioned studies, mRNA concentrations predict 
around 84% of protein abundances (instead of 27%). Furthermore, the mRNA 
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and protein abundance were shown to correlate more strongly after when cells 
responded to a stimulus (as opposed to a being in a steady state) (Koussounadis 
et al. 2015). In such situations the mRNA abundance of differentially expressed 
genes is even better correlated to their protein products (Koussounadis et al. 
2015).  
 
1.7 Aims of my project 
The aim of this thesis is to explore and characterise the differences between 
male and female worms during their intra-mammalian development at the 
transcriptome level. Using the vast quantities of expression data that can be 
generated using RNA-Seq and the unprecedented detail it affords, what factors 
involved in the process of female maturation can be identified from the 
transcriptome? How does this change our understanding of the role that the 
male-female interaction plays in the transmission and pathology of the disease? 
In particular, this thesis addresses the differential expression of genes between 
male and female schistosomes during their intra-mammalian development 
including the changes in gene expression induced by the male-female 
interaction. Three main topics are examined in this thesis.  
 
The first is the development of male and female worms inside the mammalian 
host. Particularly, when and how do male and female worms start to diverge at 
the transcriptome level? And similarly, what are the early differences of female 
worms in MS infections compared to SS infections at the transcriptome level? 
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Furthermore, what roles do some of the genes identified play in the female 
fertility? These results are presented in Chapter 3. 
 
Next, I wanted to discover the effect of cell proliferation and apoptosis on the 
maintenance of sexual maturity as well as regression of female reproductive 
tissues. Furthermore, how does pairing regulate these processes? Using an in 
vitro culture system of female worms in the presence or absence of male worms, 
the changes in expression of fertility-related genes were examined as well as 
genes that control apoptosis and cell proliferation. Results from this work 
comprise Chapter 4. 
 
In Chapter 5, the transcriptomes of S. mansoni testes and ovaries were examined.  
This work was performed to learn how gene expression changed in the gonads in 
response to pairing. As pairing induces proliferation of the ovaries, it was of 
particular interest to us which transcriptome changes allowed for this 
proliferation to take place. These changes are obscured in the whole worms’ 
transcriptome by the larger vitellaria but can be better resolved by examining 
the gonad transcriptomes. 
  
Finally, Chapter 6 provides a summary of the findings in this thesis and places 












2.1 Parasite and snail maintenance 
2.1.1 Parasites and snail origin 
The species of schistosome used throughout this thesis was S. mansoni. For 
Chapter 3 & 4 a parasite strain originally recovered from Puerto Rico were used. 
The parasites used in Chapter 5 originate from Liberia. Biomphalaria glabrata 
were used to maintain the S. mansoni life cycle throughout. 
 
2.1.2 Miracidia infection of snails 
Livers from S. mansoni infected (6-7 weeks p.i.) mice were soaked in sterile 1.2% 
NaCl solution with Penicillin/Streptomycin (100 U/ml; 0.05 mg/ml) at room 
temperature (RT) for 10 min. Livers were then transferred to a plastic beaker, 
and about 20 ml of sterile 1.2% NaCl solution added. A blender (Bosch MSM 
6B150) was used to homogenise the livers for 3 min at the lowest speed and the 
resulting liquid then filtered through two sieves with a pore size of 180 µm, to 
remove larger liver particles, and then 45 µm to collect eggs. Eggs were collected 
in the lower sieve and further washed with 1.2% NaCl solution. The eggs were 
then transferred to a volumetric flask with a narrow neck and the flask filled 
with Lepple water (see below). After incubating for 1 hour at 28°C, all but the top 
2 cm were covered in aluminium foil and the flask incubated for another 1 hour 
period. Next, miracidia were collected from the top layer of the solution. Five to 
six miracidia were used for mixed sex snail infections. For infections small snails 
(0.5 cm in diameter) were placed individually in the well of a 24-well plate 
together with 1 ml of Lepple water. The miracidia were then carefully added to 
each well and left to infect the snail for 2 hours. Next the snails were placed back 
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into an aquarium for 5 weeks when snails were ready to be used to obtain 
cercariae. 
 
Lepple water (1x) 
 
0.378 mM calcium chloride dihydrate 
0.500 mM magnesium sulphate heptahydrate 
0.025 mM potassium sulphate 
0.500 mM sodium carbonate anhydrous 
0.0002 mM ferric chloride 
 
Lepple water was usually prepared as a 10x concentrated solution and diluted 
with water prior to use. 
 
To obtain mice infected with male or female schistosomes only, 50 snails were 
infected with single miracidia. In the four weeks following infection, the snails 
were exposed to light for two hours to shed clonal, single sex, cercariae (Tucker 
et al., 2013). Approximately 500 cercariae from each snail, as well as single male 
and a single female adult worm (positive controls) were processed for DNA 
extraction with a DNA Mini kit (Qiagen, 51304) PCR was used to identify sex-
specific W2 regions on the (female-specific) W-chromosome using the rhodopsin 




FWD: CTGTTTCGAATTTCACACTTCA  (Tm = 61.7°C) 




FWD: GACGGCCACACTAAAG  (Tm = 54.7°C) 
REV: AGTAAAATGGTCACTGCTAT (Tm = 52.8°C) 
 
PCR reactions were assembled using 10 µl of HiFi Ready Mix (Kapa, KK2602), 2.5 
µl of genomic DNA solution, 1.0 µl of the primer mix (10 µM) and 6.5 µl of ddH20 
for a total of 20 µl. After denaturing the DNA for 5 min at 95°C the samples then 
underwent 35 cycles of amplification (95°C, 5 sec; 55°C, 5 sec; 68°C, 10 sec). 
Finally, the samples were kept ay 72°C for 1 min. 
 
The PCR products were run on an 1% agarose gel in TBE buffer at 80 V and 100 
mA for 50 min. Female samples showed amplification in both the Rhodopsin- as 
well as W2-specific PCR reaction, whereas male samples only had an amplicon in 





Figure 2.1: The sex of cercariae from single-miracidium infections was determined by PCR. 
Male S. mansoni samples do not have an amplicon in the W chromosome specific region, whereas 
female S. mansoni samples do have an amplicon for the W specific reaction. The Rho reactions 
serve as a positive control and should have an amplicon regardless of sex. The cercariae from 
four snails (Cerc 1, 3, 4 and 5) were found to be female, the other (Cerc 2 and 6) male. 
 
2.1.3 Detecting eggs in mouse livers 
To determine whether single sex infections with only male or only female worms 
had been achieved, the livers of sacrificed mice were blended as described above. 
Livers were transferred to a plastic beaker and homogenised using a blender 
(Bosch MSM 6B150) for 3 min at the lowest speed. The resulting liquid was then 
filtered through two sieves with a pore size of 180 µm, to remove larger liver 
particles, and then 45 µm to collect eggs. If any eggs were found, the 
corresponding mouse was classed as having had a mixed sex infection, otherwise 
(if any worms had been recovered from the mouse by perfusion) the mouse was 




2.1.4 Collection of cercariae 
Infected snails were kept in a dark cabinet until cercariae were required. Then 
they were moved into small glass beakers with enough Lepple water to cover all 
snails and left under a bright light for one hour allowing the cercariae to emerge 
from the snails. After one hour, the water was carefully poured into 50 ml falcon 
tubes and the snails transferred back into their tanks in the dark cabinet. 
Cercariae numbers were estimated by taking the average count from five 10 µl 
aliquots of the cercariae. The cercariae were killed with Lugol’s iodine solution 
(Sigma, L6146) and then counted under a dissection microscope. 
 
2.1.5 Infections and perfusions 
All animal experiments were conducted under Home Office Project Licence No. 
80/2596. All protocols were presented and approved by the Animal Welfare and 
Ethical Review Body (AWERB) of the Wellcome Trust Sanger Institute. The 
AWERB is constituted as required by the UK Animals (Scientific Procedures) Act 
1986 Amendment Regulations 2012. 
 
BALB/c mice were infected with about 250 mixed sex or single sex cercariae via 
intraperitoneal injection. After 18 to 49 d.p.i., the mice were euthanised by 
injection with an overdose of sodium pentothal and perfused to recover adult 
worms residing in the blood system. The worms used in Chapter 5 were grown 
in Syrian hamsters (Mesocricetus auratus); all animal work associated with 
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Chapter 5 was performed by the group of Prof. Dr. Christoph Grevelding (Justus-
Liebig-University, BFS, Institute for Parasitology, Gießen, Germany). 
 
2.1.6 In vitro culture 
In Chapter 3 (RNAi experiments), worms were maintained in vitro. Two 
experiments were set up, one with a total duration of seven days, and one with a 
48 h incubation. For this latter experiment parasites were kept in supplemented 
DMEM media (see below) in a dark incubator at 37°C with 5% CO2. In the case of 
the seven day incubation, the media was replaced every two days (see RNAi 
methods (2.2.2) for details). Furthermore, in Chapter 4, the effect of culture in 
DMEM media and Basch media on worm fertility was tested. The following 
recipes were used to prepare these media. 
 
Supplemented DMEM 
0.02 M Hepes buffer (Sigma, 83264) 
2 mM L-glutamine (Sigma, G7513) 
10% Foetal calf serum* (Sigma, F3297)  
1x Antibiotic-Anitimycotic (ThermoFisher, 15240062) 
DMEM media** (ThermoFisher, 10270106) 
 
*) Foetal calf serum was heat-deactivated before use. 







In Chapter 4 worms were kept in vitro for seven days and Basch media (Basch, 
1981). This media was used to was used to maintain female maturity as much as 
possible, as the female reproductive system usually regressed in culture. Worms 
were again maintained in an incubator at 37°C with 5% CO2 and half the media 
was replaced every two days. Modified Basch media was prepared as described 
by Bhardwaj et al. (2011). 
 
Directly prior to use, 1% (by volume) horse red blood cells (RBCs) were added to 
the media. For this whole blood (ThermoFisher, SR0050) was first centrifuged at 
4°C and 500 g for 10 min, then serum and the upper layer of blood were 
removed. The remaining RBCs were then suspended in BME (ThermoFisher, 
41010-109) to produce a 50% stock solution of RBCs.  
 
2.1.7 Isolation of S. mansoni gonads 
The isolation of gonads was performed by the Dr. Zhigang Lu from the group of 
Prof. Dr. Christoph Grevelding (Justus-Liebig-University, BFS, Institute for 
Parasitology, Gießen, Germany) on worms from both MS and SS infections. It was 
performed as previously described by Hahnel et al. (2013), first using detergents 
(Brij35, Nonidet P40-Substitute, Tween80 and TritonX-405) to dissolve the 







2.2 Molecular biology techniques 
2.2.1 Cloning 
If a transcripts was 1300 bp or shorter, primers were designed to clone the 
whole transcripts. Otherwise, a fragment of the transcript around 1000 bp in 
length was chosen and primers designed manually to clone that fragment. The 
primer pairs were designed to have similar melting temperatures to facilitate 
PCR reactions. Total RNA was isolated from adult worms using the Trizol 
reagents (Invitrogen, 15596026) (see 2.2.3). cDNA was synthesised using the 
SuperScript® III First-Strand Synthesis System (ThermoFisher, 18080051) using 
the manufacturer’s protocol, with slight alterations. Firstly, reagents were 
incubated for 2 min at 25°C before 1 µl of SuperScript® III was added. Secondly, 
samples were incubated at 25°C, 10min; 50°C, 60 min; 70°C, 15min. cDNAs were 
amplified using the ReadyMix Taq (Sigma, P4600) following manufacturer’s 
instructions. The following primers were used:  
 
CD63 receptor (Smp_155310) primers: 
FWD: ATGTGTACTGTCGTATTGAGATTAAC (TM = 59.0°C) 
REV: TTAAGGATATCCAGTGGTTAGTATC (TM = 58.2°C) 
CD63 antigen (Smp_173150) primers: 
FWD: ATGGCCTCTTTAAGCTGTGG  (TM = 63.1°C) 
REV: TTAGTCAGAATCGCCAGATTTG  (TM = 63.0°C) 
TSP-2 (Smp_181530) primers: 
FWD: TTCTTCTTCGTTTCAGGGATGT  (TM = 63.7°C) 




Boule (Smp_144860) primers: 
FWD: GCCTTGGGGCATCTAAAGGT  (TM = 66.1°C) 
REV: TGCTGCAGTGGATGCTGTTA  (TM = 65.7°C) 
MXRA8b (Danio rerio; negative control) primers: 
FWD: TCTTTCATGCAGGCCACAGT   (TM = 65.8°C) 
REV: CCGGAACCAACCCGATTACA   (TM = 68.8°C) 
 
Target genes were amplified from the cDNA using 35 cycles of PCR (95°C, 5 sec; 
variable temperature, 5 sec; 72°C, 30 sec) and finally 1 min at 72°C. The 
annealing temperature was generally set to be 5°C lower than the higher melting 
temperature of the two primers (see above). 
   
PCR products were then run on a 1% agarose gel in TBE buffer for 40 min at 100 
V and 120 mA to confirm product size. The PCR reaction was then cleaned up 
using the QIAquick PCR Purification Kit (Qiagen, 28104) following 
manufacturer’s instructions. 
 
The required volumes of insert and vector (3000 bp; 50 ng/µl) necessary for 
ligation at a 1:1 and 3:1 ratio were determined using Promega’s Bio calculator. 
http://www.promega.com/a/apps/biomath/index.html?calc=ratio 





The reactions were then incubated for 1.5 h at RT (rather than 1 h according to 
the protocol). Luria-Bertani (LB) Ampicillin (0.1 mg/mL) agar plates were 
prepared by using 0.1M Isopropyl β-D-1-thiogalactopyranoside (IPTG) 
(ThermoFisher, R1171) and 20 mg/µl 5-bromo-4-chloro-3-indolyl-β-D-
galactopyranoside (X-gal) (ThermoFisher, R0941) per plate which was spread 
with a sterile plate spreader. 50 µl of competent cells (Invitrogen, C4-04003) 
were used for cloning, following the manufacturer’s instructions.  
 
Next, 950 µl Super Optimal broth with Catabolite repression (SOC) medium 
(ThermoFisher, 15544034) were added to each tube of transformed bacteria; the 
samples were then placed in large 50 ml Falcon tubes and incubated at 37°C 
(shaking at 200 RPM) for 75 min. Transformed bacteria were removed from the 
incubator and centrifuged for 2 min at 1000 x g. 900 µl of clear supernatant was 
removed and the remainder used to resuspend the cells. Approximately 50 µl of 
suspended cells were plated onto the prepared LB agar plates and incubated at 
37°C overnight. 
 
2.2.2 RNA interference 
This method relies on RNA molecules that are complementary to the target 
mRNA sequences. RNAi exploits a cellular mechanism to defend against RNA 
viruses to target specific mRNAs for degradation by the RNA-induced silencing 





The genes of interest, CD63a (Smp_173150) and CD63R (Smp_155310), as well 
as a positive control, TSP-2 (Smp_181530), were cloned (see 2.2.1) into the 
pGEM-T easy vector (Promega, A1360). The zebrafish (Danio rerio) gene 
encoding the matrix-remodelling associated protein 8b, with no homology to S. 
mansoni proteins, was chosen as a negative control.  
 
To create a linear template with T7 polymerase promoters on either end, 
primers were designed that had both a gene specific sequence (same as the 
original cloning primers) as well as the T7 promoter sequence.  
 
CD63 receptor primers (Tm = 54°C): 
FWD: TAATACGACTCACTATAGGGATGTGTACTGTCGTATTGAGATTAAC  
REV: TAATACGACTCACTATAGGGGAACAACAAATTTGGCATC  
CD63 antigen primers (Tm = 58°C): 
FDW: TAATACGACTCACTATAGGGATGGCCTCTTTAAGCTGTGG  
REV: TAATACGACTCACTATAGGGCAGGGATTGTTTGTCCACTC  
TSP-2 primers (Tran et al., 2010) (Tm = 59°C): 
FWD: TAATACGACTCACTATAGGGTGATTGTGGTTGGTGCACTT   
REV: TAATACGACTCACTATAGGGGACCAATGCGAACAGAAACA  
Negative control (MXRA8b) primers (Tm = 60°C): 
FWD: TAATACGACTCACTATAGGGTCTTTCATGCAGGCCACAGT  
REV: TAATACGACTCACTATAGGGCCGGAACCAACCCGATTACA   
 
All primers contain a T7 binding site (underlined). The PCR was performed 
following the instructions of the “MEGAscript T7 dsRNA” kit (ThermoFisher, 
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AM1626), first using the annealing temperatures (see above) of the gene-specific 
region of the primers for 5 cycles and then increasing the annealing temperature 
by 5°C for a further 30 cycles. The template was purified using a PCR clean up kit 
(Qiagen, 28104) following the manufacturer’s instructions and was then used as 
input for the “MEGAscript T7 dsRNA” kit. Incubation of the in vitro transcription 
reaction was performed for 4 hours, and then the dsRNA was isolated from the 
reactions using the manufacturer’s instructions. The kit used a column based 
method were the dsRNA is first precipitated with salts and ethanol, then bound 
to a column, washed several times and finally eluted. Length and concentration 




Soaking was performed as described by Tran et al. (2010) with slight 
modifications. Briefly, worms were perfused from mice at 49 d.p.i. and paired 
couples cultured in Basch media while being soaked for seven days in 10 µg/ml 
dsRNA. The following four dsRNA treatment groups were used: CD63R, CD63a, 
TSP-2 (positive control) and a negative control RNA (see above). Media was 
replaced every two days and new dsRNA added. After seven days worms were 
transferred into Trizol (Invitrogen, 15596026) for RNA extractions and the laid 
eggs counted in the plates. 
 
dsRNA electroporation 
For electroporation, worms were washed carefully in DMEM (ThermoFisher, 
10270106) following perfusions, placed in a microcentrifuge tube in 100 µl 
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DMEM. Then, 20 µl of dsRNA solution (1 µg/ml) was added to the tube and 
incubated for 15 min at RT. The worms and the dsRNA solution were then 
transferred into 4 mm electroporation cuvettes (Bio-Rad). 
 
20 milliseconds square wave pulse was delivered to the worms using the Bio-
Rad Gene Pulser Xcell system at 125 V; worms were then transferred into pre-
warmed Basch medium (37°C) and cultured in vitro for 48 h. After 48 h the 
worms were transferred into Trizol (Invitrogen, 15596026) for RNA extractions 
and their eggs counted on the plates. 
 
2.2.3 RNA extractions 
Samples were placed in 500 µl of Trizol (Invitrogen, 15596026) and stored at -
80°C until further processing. Once ready, the samples were left to thaw on ice 
and then transferred to MagNA Lyser Green Beads tubes (Roche, 03358941001), 
containing small ceramic beads for mechanical homogenisation of tissue 
samples. The tubes were then placed in a FastPrep-24 instrument (MP 
Biomedicals) and homogenised three times for 20 sec at intensity 5, with 5 min 
rest on ice between runs. Following homogenisation, samples were incubated for 
5 min at RT to allow dissociation of nucleoprotein complexes. Approximately 0.2 
volumes of chloroform:isoamyl alcohol (24:1) (Sigma, C0549) was added and the 
samples shaken vigorously. After a further 3 min incubation at RT the samples 
were centrifuged at 14000 g for 15 min at 4°C. 
 
Following centrifugation, the aqueous phase was transferred into a fresh RNase 
free micro centrifuge tube. Total RNA was isolated from the aqueous phase using 
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the RNA Clean & Concentrator kit (Cambridge Bioscience, R1019) following 
manufacturer’s instructions. Samples for qPCR were treated with DNase in the 
isolation columns as described in the kit protocol. Total RNA was eluted in 22 µl 
of elution buffer and checked for degradation using a Nano Chip (Agilent, 5067-
1512) on an Agilent 2100 Bioanalyzer. The RNA was deemed to be of good 
quality if one sharp ribosomal RNA peak could be seen. Samples were then 
stored at -80°C until further processing.  
 
 
Figure 2.1: Example of good quality extracted total RNA. The sharp peak of 
RNA at 2000 nucleotides (nt) is the ribosomal RNA peak. 
 
 
2.2.4 cDNA synthesis 
cDNA was used for cloning as well as qPCR. 11 µl of DNase treated, full length 
total RNA was used as input. 1 µl dNTPs (10 mM for each nucleotide) (NEB, 
N0447S) was added as well as 1 µl oligo-dT18 primers (100 µM) (ThermoFisher, 
SO131). Samples were denatured for 5 min at 65°C and then cooled on ice. Then, 
4 µl 5x First Strand buffer (ThermoFisher), 1 µl dithiothreitol (0.1 M; Sigma) and 
1 µl SuperScript® III (ThermoFisher) were added.  Samples were incubated at 
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Primer3 (http://bioinfo.ut.ee/primer3/) was used to design qPCR primers (see 
Table 2.1) for the target genes cd63r, cd63a and tsp-2. Settings were chosen to 
return primers providing approximately 100 bp long amplicons that did not 
overlap with the dsRNA probes used for RNAi (2.2.2). psmd4 (Smp_090340) was 
used as reference gene in all qPCR reactions. For quantification of RNAi 
efficiency, two more genes were used as internal reference, ndufv2 
(Smp_069770) and gapdh (Smp_056970). Liu et al. (2012) found the house 
keeping genes psdm4 and ndufv2 to be particularly suitable as qPCR reference 
genes due to their stable expression.  
 
Target FWD REV Efficiency 
cd63r 
Smp_155310 
CCCCTGTTGTAAAATGGATGCC CCTGGACATGTTGGATCGAGA 106% 
cd63a 
Smp_173150 
GTTGCCGTTTTAGTAGCGGC CTCGGATAACACAGACAGCGA 95% 
tsp-2 
Smp_181530 
CGAAATTGAACCCCCACTAC CATGCTCCAAACATCCCTAAA 97% 
psdm4 
Smp_000740 
CAAAGTTACAACGAGTTTCTGGCTCT TGGCGTTTGCGATTTGCCAT 104% 
ndufv2 
Smp_069770 
TGGAATGCCTTGGAGCTTGTG TCCGCTTTGTGGACCAGGTT 98% 
gapdh 
Smp_056970 
TGTGAAAGAGATCCAGCAAAC GATATTACCTGAGCTTTATCAATGG 101% 
 
Table 2.1: List of qPCR targets and their forward and reverse primers. tsp-2 
primer sequences were first described by Tran et al. (2010). Primer efficiencies 




Primer efficiencies were determined using a dilution series of primer 
concentrations as described by the manufacturer (Applied Biosystems, 2010). All 
primer pairs were found to have an efficiency between 90-110%. 
 
The qPCR was performed using KAPA SYBR FAST universal qPCR kit (KAPA 
Biosystems), following the manufacturer instructions. All cDNA samples were 
run in triplicates, as well as a triplicate negative control without cDNA template 
and a control with total RNA instead of cDNA to detect genomic DNA 
contamination. If genomic DNA has also been extracted during the RNA 
extraction, it could cause a false positive signal; the total RNA used in this control 
was not reverse transcribed and therefore should not allow for PCR 
amplification. 
 
All reactions were 20 µl in volume and performed in sealed MicroAmp 48-Well 
skirted PCR plates (ThermoFisher, 4375816) and briefly centrifuged to remove 
bubbles. qPCR reactions were performed in an Applied Biosystems StepOnePlus 
machine using the thermocycling conditions recommended by the manufacturer 
(KAPA Biosystems, 2016) (denaturation: 95°C, 3 min; then 40 cycles of: 95°C, 1 
sec; 60°C, 20 sec). The amplification data was analysed and plotted manually in 
Microsoft EXCEL (v14.2.3) using the ΔΔCt method (Livak & Schmittgen, 2001). 
 
Initially the relative difference in expression between the internal reference and 
target gene was measured for both treated and control samples: 
ΔCttreated = CtInternal reference, treated – Cttarget gene, treated 




For multiple reference genes the average Ct value was calculated: 
Ctreference gene = (CtGAPDH + CtPSMD4 + CtNDUFV2) / 3 
 
Finally, to find the relative difference in gene expression: 
ΔΔCq = mean(ΔCttreated) – mean(ΔCtcontrol) 
 
The fold-change was then calculated as follows: 
Fold-change = 2 ^ ΔΔCt 
 
2.2.6 Dot blot 
To measure the efficiency of DIG labelling in the RNA probe, I used a dot blot 
assay, as described by Zimmerman et al. (2013). Briefly, serially diluted RNA 
probes were applied to a nylon membrane (Sigma, 11209272001) and cross-
linked using UV light. The membrane was washed with maleic acid buffer, 
treated with blocking buffer and exposed to an anti-DIG antibody (Sigma, 
11093274910) with a conjugated alkaline phosphatase enzyme (150 mU/ml) in 
blocking buffer. Samples were developed until the desired signal was reached. 
 
2.2.7 Whole mount in situ hybridisation 
Whole mount in situ hybridisations (WISH) were performed using a protocol 
provided by Dr. James Collins, (UTSouthwestern, Department of Pharmacology, 
Dallas, Texas). For the in vitro synthesis of DIG-labelled RNA probes, the insert of 
the pGEM-T easy plasmid (Promega, A1360) was amplified using M13 primers 
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(Sigma, P3098; Sigma, P2973).  The amplicon included the insert flanked by a T7 
and a SP6 promoter on either side to allow synthesis of a sense (negative 
control) and an anti-sense probe (95°C, 5 sec; 50°C 5 sec; 72°C, 30 sec for 35 
cycles, then 72°C, 1 min). 
 
The amplicon was then purified using a PCR purification Kit (Qiagen, 28104) and 
the DNA template concentration was measured using the Qubit 2.0 system 
(ThermoFisher). 
 
A DIG RNA labelling KIT (Roche, 11175025910) was then used to synthesise 
DIG-labelled probes from the amplicons according to the manufacturer’s 
protocol. 
 
The solution was then cleaned up using the Cambridge Bioscience RNA clean and 
concentrator kit following manufacturer’s instructions. Probe quality and 
concentration were determined using the Agilent Tapestation and the NanoDrop 
1000 (ThermoFisher). DIG-labeling efficiency was tested using a dot blot test 
(see 2.2.9). 
 
1) Preserving specimens 
Parasites were collected by perfusion from mice seven weeks after infection with 
250 mixed sex cercariae. The worms were then washed with DMEM to remove 
host material. Once clean, worms were killed using 0.6 M magnesium chloride 
for about 1 min and fixed for 4 h at room temperature in solution of 4% 
formaldehyde and 0.3% Triton-X 100 in phosphate buffered saline (PBSTx). 
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Next, the worms were rinsed with PBSTx, placed in 50% methanol in PBSTx for 5 
min on a gentle shaker and then transferred to 50 ml tube with 100% methanol 
and stored at -20°C until needed. 
 
The protocol for whole mount in situ hybridisation was run over 3 days; on day 1 
the DIG-RNA probe is hybridised to the target RNA, on day 2 the DIG label is 
bound by the antibody and on day 3, the alkaline phosphatase on the antibody is 
used for detection. 
 
2) Permeabilisation & hybridisation with probe 
Samples were rehydrated in 50% methanol in PBSTx for 5min on a gentle shaker 
and then for 5 min in PBSTx at RT. Pigments were removed, especially from the 
guts and the vitellarian tissue of female worms by placing the worms in 
bleaching solution for 1 hour at RT under bright light. Next, samples were placed 
in small baskets, transferred to 24-well plates and rinsed in PBSTx. The baskets 
were used throughout the protocol to allow quicker and less damaging transfer 
of specimens between different buffers and solutions. The worms were 
permeabilised with proteinase K (5ug/ml) in PBSTx for 30 min at RT, without 
shaking. Following proteinase K treatment, the worms were rinsed in PBSTx and 
then fixed again in 4% formaldehyde in PBSTx for 10 min at RT. Then, the worms 
were transferred briefly to PBSTx and washed in a 50% PBSTx:50% PreHyb 
buffer solution for 5 min at RT while being gently shaken. The washing solution 
was then replaced with pre-warmed 100% PreHyb buffer and samples incubated 
at 52°C for 2 h while gently shaking. 1 h prior to adding the probe, 1000ng of 
DIG-RNA probe was mixed with 500 µl of hybridisation buffer and heated to 
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72°C for 5 min to denature the RNA probe using a heat block (Stuart scientific, 
SBH130D). The probe was then allowed to cool slowly to 52°C in the heat block 
and was held at that temperature until needed. The PreHyb buffer was then 
replaced with the hybridisation buffer with the probe. Next, the samples and 
probes were allowed to hybridise overnight at 52°C while being gently shaken. 
 
 
3) Removal of excess probe & incubation with antibody 
The hybridisation buffer was removed and samples washed at 52°C with the 
preheated solutions of wash hybridisation buffer (2 x 30 min), 2 x saline sodium 
citrate (SSC) buffer and 0.1% triton-X (2 x 30 min), and 0.2 x SSC buffer and 0.1% 
triton-X (2 x 30 min); finally, worms were washed twice in Tris-NaCl-Tween 
(TNT) buffer at RT while gently shaking. Samples were transferred to blocking 
solution for 2 h at RT, still shaking. Next, samples were transferred to blocking 
solution with anti-DIG-alkaline phosphatase antibody (1:2000 dilution) and 
incubated at 4°C overnight whilst gently shaking. 
 
4) Removal of excess antibody & developing AP staining 
Next, the samples were washed six times for 10 min at RT in TNT buffer. 
Then, samples were developed in alkaline phosphatase (AP) buffer with nitro 
blue tetrazolium and 5-bromo-4-chloro-3-indolyl-phosphate (NBT/BCIP, Sigma, 
11681451001) until the desired signal intensity had been reached. To stop the 
reaction, samples were transferred to PBSTx and placed in 100% ethanol for 10-
20 min at RT. Samples were then removed from the ethanol, placed back in 




2.2.8 Imaging of WISH specimen – light microscopy 
A Leica M205 FA dissection microscope was used to examine the prepared 




2.3 RNA-Seq library preparation & sequencing 
cDNA libraries were produced from pools of male or female worms, with the 
exception of the libraries in Chapter 4, where individual worms of both sexes 
were used, each representing a biological replicate. In the case of pooled worms, 
all worms originated from the same mouse, forming a biological replicate.  
 
2.3.1 mRNA selection 
100 ng of total RNA was used for each RNA-Seq libraries made from pooled 
worms (Chapter 3 & 5). For the cDNA libraries produced from single worms  
(Chapter 4) only 50 ng of total RNA was available per sample. Oligo dT beads 
(ThermoFisher, 61002) were used to increase the mRNA content of the samples, 
following the manufacturer’s instruction. The method makes use of magnetic 
beads covered in oligo dT molecules, to capture the mRNA by binding to the 






2.3.2 mRNA fragmentation 
mRNA was made up to 200 µl and sheared to around 200 bases using a AFA 
Covaris focused sonicator (Settings: Duty cycle – 10%; Intensity – 5; time – 60 
sec; NB: Duty cycle refers to the proportion of treatment time during which the 
acoustic burst is active). 
 
2.3.3 Reverse transcription 
Similarly, to the cDNA synthesis step in the cloning section (2.2.1), RNA was used 
to create cDNA in this step. However, in this step the mRNA had been isolated 
(2.3.1) as well as fragmented (2.3.2) and rather than using oligo-dT primers, 
random hexamer primers (NEB, S1330S) were used to reverse transcribe all 
fragments. 1 µl random primers (3 µg/ml) and 1 µl dNTPs (10 mM for each 
dNTP) (NEB, N0446S) were added to11 µl of fragmented RNA. The mixture was 
denatured at 65°C for 5 min and chilled on ice. Next, 4 µl of 5x First Strand buffer 
(NEB, E6114), 1 µl of dithiothreitol (0.1 M; Sigma, D0632) and 1 µl of RNase 
inhibitor (40 U/µl; ThermoFischer, 10777019) were added. The sample was 
incubated at RT for 2 min following which 1 µl of SuperScript® III (200 U/µl; 
ThermoFischer, 18080093) enzyme was added, to a total volume of 20 µl. The 
sample was then incubated in a thermocycler (25°C, 10 min; 50°C, 60 min; 70°C, 
15 min). This denatures the SuperScript® III enzyme but leaves the RNA/DNA 
duplex intact. After this step, the RNA/DNA duplex was cleaned using the 
RNAClean XP beads (Beckman Coulter, A63987) following manufacturer’s 




2.3.4 Second strand DNA synthesis 
Second strand synthesis was performed with dUTP rather than dTTP allowing 
the two DNA strands to be differentiated into the sense strand (mRNA sequence 
– dUTP labelled) and antisense strand (complementary to mRNA – dTTP 
labelled). 22.6 µl of RNA/DNA duplex from the last step were mixed with 3 µl of 
buffer 2 (NEB, B7002S), 2 µl dNTP mix (dUTP, dATP; dGTP; dCTP at 10 mM each) 
(NEB, E6114), 0.4 µl RNase H (5000 U/ml) (NEB, M0297S) to nick (i.e. create a 
break in) the RNA strand, allowing the remaining RNA fragments to act as 
primers) and 2 µl of DNA pol I (5000 U/ml) (NEB, M0210S). The sample was 
incubated at 16°C for 2.5 h, then held at 4°C. After second strand synthesis, the 
sample was cleaned using AMPure XP beads (Agencourt, AQ 60050) (at a ratio of 
1 volume of sample to 1.8 volumes of beads). The sample was resuspended in 40 
µl of water at the end of the bead purification protocol. 
 
2.3.5 End repair, dA tailing, adapter ligation, size selection 
The Sanger Sequencing Kit I (NEB, E6000B-SS) was used to perform end repair, 
dA tailing, adapter ligation and size selection of the cDNA. All steps were 
performed following the manufacturer’s instructions. 
 
In the next step, the Uracil-specific excision reagent (USER) enzyme (NEB, 
M5505S) was used to digest the second strand of all DNA molecules in the 
sample. For this, 1 µl of USER enzyme was added to 10 µl of library. The sample 
was then incubated in a thermocycler for 15 min at 37°C, then for 10 min at 95°C, 
and finally held at 4°C.  
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2.3.6 PCR amplification 
After removal of primer dimers and digestion with the USER enzyme, the sample 
was amplified to reach a sufficiently high DNA concentration for sequencing. For 
this, 25 µl of 2x KAPA HIFI HS Master mix was added to 22 µl of cDNA as well as 
1 µl each of PE 1.0 Illumina primer (10mM), Illumina index primer (10 mM), and 
water. A unique barcode sequence was added to the cDNAs of each sample using 
the PCR primer. This allowed DNA sequences to be assigned to one sample in 
silico once sequencing was complete. This tagging allowed for mixing of libraries 
before sequencing, helping to control for biases, which could otherwise be 
introduced by differences across sequencing lane and runs. The sample was then 
amplified using a thermocycler (denaturation 95°C, 5min; 10 cycles of 95°C, 20 
sec; 60°C, 15 sec; 72°C, 60 sec; and next 72°C, 5 min). Following the PCR, the 
samples were size selected, using 0.8x sample volume of Agencourt AMPure XP 
beads following manufacturer’s instructions to remove adapter dimers, which 
were amplified by the PCR reaction.  
 
2.3.7 Sequencing 
All samples were sequenced on an Illumina HiSeq 2500 platform. Samples in 
Chapter 3 & 4 (60 and 70 samples respectively) were sequenced in three 
sequencing runs (six lanes in total). The biological replicates for each condition 
were distributed as evenly as possible across the runs. The 24 samples in 
Chapter 5 on the other hand were all sequenced together in one run (two lanes 





2.4.1 Aligning RNA-Seq reads to the genome 
Tophat2 (v2.0.8b) was used to map RNA-Seq data to version 5.2 of the S. mansoni 
genome (Protasio et al., 2012). RNA-Seq reads span splice junctions where 
introns have been removed from the transcript. Many mapping tools do not take 
splicing into account when mapping reads to the genome as they are specialised 
for mapping genomic DNA reads. Tophat2 was specifically designed for RNA-Seq 
data to allow for optimal mapping of RNA-Seq data to the genome several 
parameters had to be set manually. By default, Tophat2 distributes a read that 
maps to multiple locations in the genome randomly to one of those locations. In 
this case this is undesirable as it could create the appearance of expression in 
loci that are not expressed, therefore the parameter was set to allow only for 
uniquely matching reads to be mapped (-g 1). Next, the appropriate library type 
was specified (--library-type fr-firststrand), based on the preparation method 
using dUTP. Also based on the method of library preparation, the expected 
(mean) inner distance between mate pairs was set to 200 (-r 200) and the mate 
standard deviation was set to 100 (--mate-std-dev 100). To accurately map 
spliced reads the minimum length of sequence on either side of the splice 
junction was set to be at least six bases long (-a 6). Finally, the minimum and 
maximum lengths of introns were also specified as 10 and 40,000 bases 
respectively (-i 10 -I 40000) and microexons, exons as short as 3 base pairs 
which are difficult to detect without specialised algorithms (Volfovsky et al., 
2003), were allowed for (--microexon-search). The output of this mapping of 
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RNA-Seq data to the S. mansoni genome was provided in Binary sequence 
Aligned Map (BAM) format. 
 
 
2.4.2 Sorting and merging of BAM files 
SAMtools (v0.1.19) was used for the processing of mapped RNA-Seq data in BAM 
format (Li et al., 2009). All BAM files were sorted, and the two BAM files (one for 
each lane of Illumina HiSeq 2500) corresponding to each sample merged, 
generating a single BAM file per sample. 
 
2.4.3 Counting reads  
HTSeq (v0.5.4) was used to summarise the mapped data and produce a list of 
read counts per gene for each sample (Anders et al., 2015). Using a file in Gene 
Transfer Format (GTF) as reference for gene boundaries, HTSeq takes into 
account the strandedness of the data, only counting reads in the orientation of 
the mRNA and not of antisense RNA. Reads were also only counted for the 
longest splice variant of each gene to avoid complications in regions where the 
splice variants overlap and reads could not be unambiguously assigned. 
 
2.4.4 Differential gene expression analysis 
RNA-Seq data was analysed in all three results Chapter (3, 4 & 5) to identify 
differentially expressed genes across groups of samples in R (v3.2.2) (R Core 
Team, 2015) using DESeq2 Love et al. (2014). DESeq2 was created specifically to 
address the challenges, i.e.  small numbers of replicates, large dynamic range and 
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the presence of outliers within the replicates (Love et al., 2014), that arise when 
analysing high throughput sequencing data, such as RNA-Seq data.  
 
Model and normalisation 
Using the output of HTSeq, the number of unambiguously mapped reads per 
gene, a count matrix is created containing the read count for each gene in each 
sample. DESeq2 fits a Generalised Linear Model (GLM) for each gene. It models 
the read counts to follow a negative binomial distribution and calculates a size 
factor using the median-of-ratios method described in DESeq (Love et al., 2014). 
This corrects for the depth of sequencing across the different samples, allowing 
them to be compared against one another.  
 
Empirical Bayes shrinkage for dispersion estimation 
To model the variability between replicates, DESeq2 estimates a dispersion 
parameter, which is critical for proper statistical inference of differential 
expression. To do so, first the gene-wise dispersion is estimated using maximum-
likelihood, then DESeq2 uses this information to estimate the expected 
dispersion value for genes of a given expression strength by fitting a smooth 
curve through the distribution of dispersion. DESeq2 then “shrinks the gene-
wise dispersion estimates toward the values predicted” to obtain final dispersion 
values. 
 
Empirical Bayes shrinkage for fold-change estimation 
One of the biggest challenges when calculating fold changes using HTS data is the 
strong variance especially for genes with low read counts where the signal to 
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noise ratio is less favourable. DESeq2 shrinks log fold-change (LFC) estimates 
towards zero so that shrinkage is stronger for genes with low read counts, high 
dispersion, or fewer degrees of freedom. This is achieved by fitting each of the 
GLMs to obtain a maximum-likelihood estimation of the LFC and then fitting a 
zero-centred normalised distribution of all LFC. This distribution is then used in 
another round of GLM fitting, and the corrected estimates are kept as final LFC 
estimates.  
 
Automatic independent filtering 
As differential expression of over 10,000 S. mansoni genes were examined in 
each RNA-Seq experiment, multiple testing adjustments were performed to 
reduce false positive results using the Benjamini and Hochberg method 
(Benjamini & Hochberg, 1995). The automatic independent filtering method 
used by DESeq2 was designed to remove genes from the analysis that have little 
or no change of being differentially expressed. Importantly, these genes were 
excluded from further analysis using criteria independent of the statistics used 
to determine differential expression. The filtering relies on average expression 
strength for filtering, removing lowly expressed genes first. By default, DESeq2 
removes as many genes from the analysis as necessary to maximise the number 
of genes found to be differentially expressed at the specified false discovery rate 
(FDR) value (default 10%). In this thesis the automatic independent filtering was 
most prominently used in Chapter 4 where high dispersion of gene expression 





Detection of count outliers 
To reduce the impact of outliers on the average distribution of dispersion and log 
fold change, DESeq2 detects and removes individual outliers that do not fit the 
assumptions of the model such as a replicate with a read count several orders of 
magnitude higher than all other samples. To achieve this, DESeq2 uses a 
standard outlier diagnostic called Cook’s distance. It measures how much the 
GLM for a given gene would be affected, if a particular sample was removed. 
However, this could only be done were three or more replicates were available 
for a given condition, as outlier status cannot be determined otherwise. 
 
2.4.5 Correlation of RNA-Seq data with microarray data 
To give an estimate of the reproducibility of the RNA-Seq data from Chapter 5 – 
whole male and female worms as well as isolated S. mansoni gonads - sequencing 
data were compared to the microarray signal intensity of comparable samples 
published by Nawaratna et al. (2011). Microarray probe sequences were 
obtained from the Gene Expression Omnibus public database (accession 
numbers: GPL10875 & GSE23942). Probe sequences were mapped to the S. 
mansoni genome (version 5.2) using bowtie (v1.1.0), a fast and memory-efficient 
mapping tool for short reads (Langmead et al., 2009), using default settings. A 
GTF file that contained the location of each mapped probe in the genome was 
created using the genome coordinates for each sequence from the BAM file and a 
custom python script. The number of RNA-Seq reads mapped to the microarray 
probe sequences was then counted as described in “Counting reads (HTSeq-
count)“ (2.4.3), using the newly created GTF file as reference. The number of 
RNA-Seq reads mapped to the probes was then compared to the normalised 
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signal intensity measured for the probe as reported by Nawaratna et al. (2011). 
The correlation coefficient was calculated for the RNA-Seq and microarray signal 
using the correlation function in R (R Core Team, 2015). 
 
2.4.6 Principal component analysis (PCA) 
PCA plots are used here to visualise data, especially the differences between 
experimental conditions or detect batch effects. The principal components are 
variables underlying the data set that explain the maximum amount of data 
variance with as few principal components as possible, with the aim to visualise 
multi-dimensional expression data in a two-dimensional plot. To create a PCA 
plot, the matrix of normalised counts created in DESeq2 was used. A regularised 
log transformation was performed on the data matrix. This has a variance 
stabilising effect, especially helping to minimize the differences between samples 
for rows with small counts. DESeq2 then provided a function to create the PCA 
plot based on the transformed data (Love et al., 2014). 
 
2.4.7 Heatmaps 
The R package “pheatmaps” (V1.0.8) was used to draw heatmaps (Kolde, 2015). 
This software uses count data after regularised logarithmic transformation 
(performed by DESeq2) as input to draw heatmaps of a specified subset of genes. 
To produce a heatmap, the program then calculates a Z-score, i.e. the number of 
standard deviations a data point is from the mean, which allows for better 
scaling across all samples than for example plotting the log-fold change. K-means 
clustering is used by pheatmaps. 
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2.4.8 Gene Ontology (GO) term enrichment 
To perform GO term enrichment analysis on the sets of differentially expressed 
genes, topGO (Alexa et al., 2006) was used. GO terms provide a hierarchical 
structure to classify genes according to their molecular function, localisation and 
the biological process in which they are involved (GO Consortium, 2004). The 
analysis of GO terms in this thesis was restricted to those in the category 
“Biological Process”. Genes significantly up or down-regulated (usually with an 
adjusted p-value of < 0.01) in a particular condition were used as input for topGO 
and GO terms were considered significantly enriched if their p-value was < 0.05. 
 
2.4.9 InterProScan & Pfam enrichment 
The program InterProScan 5.0.7 (Quevillon et al., 2005; Zdobnov & Apweiler, 
2001) was used to identify conserved protein domains. The sequences of all 
annotated Schistosoma mansoni proteins were used as input. This produces a list 
of all matches between the provided sequences and annotated protein domains, 
including Pfam matches. From the output, all Pfam (Finn et al., 2014) domains 
were used that were identified with high confidence (p-value < 0.01). Duplicate 
domains were also removed, i.e. those that occurred more than once in a protein, 
to prevent the enrichment statistics to be skewed by such proteins. Furthermore, 
all domains, only found in a single S. mansoni protein were removed because no 
meaningful enrichment analysis could be performed on them. In total 1479 




Using a custom python script this information was combined with the results of 
differential expression analysis from DESeq2 to determine if the differentially 
expressed genes (DEGs) were enriched for proteins containing particular 
domains. The script created a table as output that was opened using Microsoft 
Excel to calculate if a domain was significantly more or less abundant than 
expected by change using a two-sided hypergeometric test. Domains were 
accepted to be significantly enriched if p < 0.05 and if the domain in question 
was found more frequently than the average domain. This resulted in excluding 
domains which were actually depleted in a sample, rather than enriched. For 
examples it might exclude the egg shell synthesis domains from being shown as 
significantly depleted in male worms; however, this domains would be shown as 
significantly enriched in female worms. 
 
2.4.10 KEGG pathway enrichment 
The Kyoto Encyclopedia of Genes and Genomes (KEGG) database online resource 
(Kanehisa & Goto, 2000) was used to provide pathway information, as they have 
reference pathways from hundreds of metabolic and signalling pathways. The 
html files of all KEGG entries of S. mansoni genes were downloaded and the 
corresponding GeneDB IDs as well as KEGG pathways associated with the gene in 
question were extracted from the files. Using this information, a table containing 
all S. mansoni genes and all pathways that the given gene belongs to was created. 
In total 2046 genes with KEGG pathway annotation were identified. In total 




After DESeq2 analysis of RNA-Seq data, a python script was used to count the 
number of DEGs found to belong to each pathway. The script would create a 
table that can be opened by Microsoft Excel to calculate if the number of genes 
belonging to a given pathway was significantly higher than expected by chance 
using a two-sided hypergeometric test. Pathways were accepted to be 
significantly enriched if p < 0.05 and if it was found more frequently that the 
average pathway. As in the case of domain enrichment, pathways which were 
actually depleted, rather than enriched were excluded from the analysis, as they 
would usually be found to be significantly enriched in the other condition of the 
DESeq2 analysis. 
 
For example, in Chapter 5, in a comparison of female worms from SS and MS 
infections, 2726 DEGs were identified, of which 787 were up-regulated in MS 
females. Of the 787 DEGs in MS females, 365 were annotated as members of a 
KEGG pathway.  Across all pathways, about 37% of annotated genes were up-
regulated in MS females, including 75 of 110 (68%) genes associated with the 
Ribosome KEGG pathway (smm03010); a greater proportion of DEGs in this 
pathway are upregulated than expected by chance as was determined using a 
hypergeometric test, demonstrating that the genes up-regulated in MS females 
are significantly enriched with ribosome related genes (p = 8.47E-12).  
 
On the other hand, in SS females, 1939 DEGs were identified, but none of the 110 
ribosome-associated genes were found to be up-regulated. On average only 
about 14% of the genes associated with KEGG pathways were up-regulated in SS 
females. As a result, expression of ribosomal genes was also found to be 
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significantly different from the expected (14%) DEGs in SS females (p-value = 
6.67E-08). However, in this case the proportion of DEGs in the Ribosome 
pathway is lower than expected by change (it is in fact 0). As a result, the 
hypergeometric test demonstrated that the genes up-regulated in SS females are 
significantly depleted of ribosome related genes.  
 
Because the depletion of a pathway in one sample usually mirrored the 
enrichment of that same pathway in the other sample in a gene expression 
comparison, only significantly enriched pathways were considered in the results 
of the following chapters. 
 
2.4.11 Cluster analysis of RNA-Seq data 
Two R packages were used to cluster RNA-Seq data by the pattern of gene 
expression across different samples: MBCluster (Si et al., 2013) and Kohonen 
(Wehrens, 2015). The MBCluster analysis was performed in R using counts 
normalised for library size as input; the size factors used to correct for library 
size were provided by DESeq2 (see 2.4.4). MBCluster models the data to follow a 
negative binomial distribution and uses an Expectation-Maximisation algorithm 
to estimate model parameters and divides genes into groups, or clusters, with 
similar expression patters across the different samples. Importantly, MBCluster 
was designed to cluster genes according to their expression profile (i.e. the 
relative changes in expression) but not absolute expression levels. Kohonen is 
also an R package used to group genes by their expression across different 
samples. Unlike MBCluster, Kohonen is based on a heuristic method designed to 
produce self-organising maps (SOM), a type of artificial neural network, from 
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data sets using unsupervised learning. It uses data that has undergone 
regularised logarithmic transformation as input (provided by DESeq2). The data 
was then processed to have a mean expression of zero for each gene. This allows 
Kohonen to cluster the genes by the magnitude of changes in their expression, 
not absolute expression. Kohonen initially uses a random distribution of data 
point across the map, but then trains the map until it reaches an optimal 
distribution of data point across the SOM. 
 
2.4.12 Gene models & annotation 
The annotation of DEGs was checked using a combination of BLAST, against gene 
sequences of model organisms, as well as Pfam to identify relevant domains in 
the predicted protein sequences. For Chapters 3 and 4 a list of putative 
apoptosis-related genes was compiled. These genes were identified from the 
literature (Lee et al., 2011; Lee et al., 2014; Peng et al., 2010), as well as by using 
BLAST to identify S. mansoni homologues of genes annotated in the KEGG 
database as apoptosis-related genes. Especially Homo sapiens and Caenorhabditis 
elegans gene sequences were used to BLAST against all S. mansoni genes on the 
GeneDB database. An e-value of 1.00E-05 was used as significance cut-off. 
Additionally, Pfam was used to confirm the presence of conserved domains, 
important to the function of protein product. Using the Artemis Comparison 
Tool, RNA-Seq evidence was used to improve predicted gene models of the 
apoptosis-related genes. Using the RNA-Seq data mapped by Tophat2, both 
exons that had not been previously annotated, as well as the exon-intron 




2.5 Scanning Electron Microscopy 
Freshly perfused worms were washed in PBS and then fixed in 2.5% 
glutaraldehyde and 2% Paraformaldehyde in PBS for 1 h. Specimens were then 
prepared for scanning electron microscopy using the osmium 
tetroxide/thiocarbohydrazide method (Malick & Wilson, 1975). The following 
steps were performed by Dave Goulding, WTSI, Hinxton. The samples were 
rinsed in 0.1 M sodium cacodylate buffer and then alternated between 
incubation in 1% osmium tetroxide and incubation in 1% thiocarbohydrazide for 
a total of 5 incubations. Following these incubations, the specimens were 
dehydrated in an ethanol series (30%, 50%, 70%, 90% and 100%). Then a 
critical point drying was performed in a Bal-Tec CPD030 and specimens were 
mounted on aluminium stubs with silver dag. Finally, samples were coated with 
a 2 nm gold layer in a Bal-Tec SCD050 and examined in a Hitachi S-4800 











Transcriptome analysis of male and female  







The aim of this Chapter is to explore the transcriptome changes that occur 
during the development of male and female schistosomes inside the mammalian 
host, with a particular emphasis on sexual maturation taking place after pairing. 
As discussed in detail in the introduction to this thesis, female maturation is 
dependent on stimulation by a male partner. Here, I examined the 
transcriptomes of female and male worms in the days leading up to pairing as 
well as the weeks following pairing. In particular, I wanted to explore how the 
male and female transcriptomes change over time and how the gene expression 
of worms from mixed sex (MS) infections differs from that of single sex (SS) 
infections. 
 
In this Chapter, a variety of functional genomic tools and databases were used to 
investigate differentially expressed genes. Using a combination of different tools, 
such as GO terms, KEGG pathway and Pfam domain enrichment, I was able to get 
a more thorough understanding of the processes taking place in the developing 
worms.  
 
While many previous studies on pairing-induced changes in gene expression 
used microarrays (Fitzpatrick & Hoffmann, 2006; Leutner et al., 2013), a recent 
study used RNA-Seq (Sun et al., 2014). An analysis of female worms at 18 and 23 
d.p.i. from both SS and MS infections was performed, to study female gene 
expression in the presence or absence of male worms, but also the changes that 
take place between the two time points. Although almost 3000 differentially 
expressed genes (DEGs) were identified in some of their comparisons, their 
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approach left room for improvement. Their method of RNA-Seq relied on 
sequencing tags, which are short, 17 base-pair sub-region of a whole cDNA 
sequence. As result the tags do not cover transcripts along their entire lengths 
which can make gene expression less quantifiable (Wang et al., 2009). More 
importantly, the authors did not sequence any biological replicates for any of 
their samples for their conditions, although this has now become standard 
practice as it allows for a more robust statistical analysis by making it possible 
for the variation within treatment groups to be measured accurately (Schurch et 
al., 2016). This is because variability between biological replicates is often higher 
than expected, so without biological replicates real differences in expression 
between treatment groups cannot be reliably distinguished from random 
fluctuations in expression (Schurch et al., 2016). The method of determining 
differentially expressed genes is not described in detail in the methods (the 
authors refer to “a rigorous algorithm [that] was adopted to screen genes that 
were differentially expressed between samples”), making it difficult to replicate 
their analysis and their results (Sun et al., 2014). Finally, the authors performed 
a pathway analysis using the identified DEGs (Sun et al., 2014). However, in their 
analysis Sun et al. (2014) did not evaluate the proportion of genes that were 
differentially expressed in each pathway and therefore did not examine the 
statistical significance of the up- or down-regulated pathways that they reported. 
For example, Sun et al. (2014) report that “pathways, such as cell adhesion 
molecules (CAMs), ribosome biogenesis in eukaryotes, the Notch signalling 
pathway” were up-regulated. However, it is not clear if what percentage of genes 
of a particular pathway were differentially expressed. A low proportion of DEGs 
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in a pathway could be the result of random chance, whereas a larger proportion 
could give greater confidence in the result.  
 
Another study examining the development of S. mansoni from cercaria to adult 
worm (Picard et al., 2016). However, the results were limited by the fact that 
female specimens did not experience pairing and thus did not commence sexual 
maturation over the course of the experiment (Picard et al., 2016). Most recently, 
Wang et al. (2017) published a RNA-Seq time course of the intra-mammalian 
development of male and female S. japonicum from 14 to 28 d.p.i.. The results 
suggested that biogenic amines and insect-hormone-like receptors play crucial 
roles in male-female signalling and sexual maturation of ovaries and vitelline 
glands in female worms (see Chapter 1.6.2). Using RNAi targeted at the insect-
hormone-like receptor, the authors provided evidence of a role of the insect-
hormone-like receptor in the development of these reproductive tissues (Wang 
et al., 2017). However, no RNAi results were reported for the AADC gene 
involved in the production of amines. The authors only analysed the 
transcriptomes of worms from MS infections. This makes it more difficult to 
distinguish the changes in expression linked to pairing from those that occur 
independently of pairing as the worms develop without the opposite sex. 
Notably, the development of S. japonicum as described by Wang et al. (2017) 
appears to be accelerated when compared to S. mansoni (see Chapter 1.2.1), as 
the worms were observed to pair and reach sexual maturity consistently earlier 
than in equivalent studies on S. mansoni (Biolchini et al, 2006). Differences in the 
speed of development, even between strains of the same species of schistosome, 




In my experiment, male and female S. mansoni from MS and SS infections were 
collected and processed for RNA-Seq at six time points: days 18, 21, 28, 35, 38 
and 49 d.p.i.. My analysis included not just the transcriptome changes taking 
place in female worms but also those of male worms. Robust statistical analyses 
were used to determine differentially expressed genes and pathway enrichment 
analysis. Additional bioinformatics tools were used, including Pfam domain 
analysis, GO terms and cluster analysis (see Chapter 2.4), to infer the potential 
roles of differentially expressed genes in the development and sexual 
maturation. Finally, I used whole mount in situ hybridisation and RNAi to 
characterised two genes found to be involved in female sexual maturity. This was 
done to explore the site of expression as well as the function of these genes in S. 
mansoni using respectively. 
 
3.2 Results 
3.2.1 Egg laying  
The livers of infected mice were examined for the presence of S. mansoni eggs 
(Figure 3.1), as described in Chapter 2.1.3. Schistosome eggs were found 
exclusively in livers of mice infected with MS parasites at 35 and 38 d.p.i. As 
expected, eggs were not observed in the livers of mice with the SS infections. 
Although paired worms were recovered at 28 d.p.i. from mice with MS infections, 
no eggs could be recovered from the livers of these mice. Since pairing is thought 
to take place from around 28 d.p.i. (Basch, 1991) most female worms would not 
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Figure 3.1: Eggs were only detected in the livers of mice with mixed sex 
infections. Single sex infections with male or female worms were found not to 
yield eggs at any time point, whereas mixed sex infections were found to yield 
eggs from 35 d.p.i., but not 21 and 28 d.p.i. At 18 and 49 d.p.i. no mixed sex 
infections were available (“-“). 
 
3.2.2 Sequencing and sample clustering 
The RNA-Seq data was prepared as described in Chapter 2.4, yielding over 20 
million reads for each of the 70 samples (see Appendix A.1 for details). On 
average, 79% of the reads could be mapped to the S. mansoni genome (v5.2) 
(Appendix A.1), with the remainder mostly comprising PCR artefacts, especially 
primer dimers, created during the amplification of the sequencing library. 
Samples were then analysed using DESeq2. First, a principal component analysis 
(PCA) plot (Figure 3.2) was created of all samples. This gives a simplified 
overview of how developing male and female worms differ at the transcriptome 
level across the time course from 18 to 49 d.p.i. in MS and SS infections. While 
male worms from SS and MS infections develop at a similar rate, females from SS 
infections are known to become arrested at an early developmental stage 
(Popiel, 1986). This was reflected at the transcriptome level by the PCA plot as 
well as the following differential expression analysis (see Chapters 3.2.4 and 
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3.2.5). From 21 d.p.i. the gene expression of SS females remained almost 
unchanged, developmentally arrested, and most similar to MS females at 21 d.p.i. 
Females from MS infections became very distinct from all other samples from 28 
to 38 d.p.i. at the transcriptome level.  
 
Figure 3.2: Samples group into male, as well as mixed and single sex female 
clusters. Principle Component Analysis (PCA) plot of gene expression in 
developing male and female S. mansoni from single sex (SS) and mixed sex (MS) 
infections at 18 – 49 days post infection (d.p.i.) PC1 explains 57% of the variance 
observed in the data set and broadly correlates with female sexual maturity over 
time, whereas PC2 explains only 17% of the variance and broadly correlates to 
male maturity. Together 74% of variance across the data set is captured by the 




These findings reflected that female sexual development depends on pairing 
with a male whereas male maturation is largely independent of the female, as 
has been noted in the literature (Basch, 1991). In this context, it was also 
interesting to note that female worms from MS and SS infections were 
transcriptomically very similar at 21 d.p.i., but diverged significantly after 28 
d.p.i., when pairing is thought to take place (Basch, 1991). It should also be noted 
that male and female samples from MS infections separate very well at all 
available time points (it should be noted that the males and females from SS 
infections at 18 d.p.i. did not separate). This shows that males and females were 
correctly identified even at 21 d.p.i. using morphological differences outlined by 
Basch (1991). 
 
3.2.3 Gender-specific gene expression 
During their intra-mammalian development, male and female worms grow from 
morphologically similar immature stages to distinct male and female worms that 
are usually reproductively active by 35 d.p.i. (Biolchini et al., 2006). Pearce and 
Huang (2015) suggested that the sexual dimorphism of male and female worms 
can be explained by adaptations for different biological roles. This allows for a 
unique co-dependency that maximises egg production. The male, for instance, is 








Figure 3.3: The male and female transcriptome becomes increasingly 
different, especially from 28 to 35 days post infection. A) Number of 
differentially expressed genes between male and female worms from mixed sex 
infections at 21 to 38 days post infection. Genes were considered to be 
differentially expressed if the adjusted p-value of < 0.01 and fold-change > 2. B) 
Log ratio vs mean (MA) plots of pair-wise comparisons of gene expression in 
male and female worms from MS infections from 21 to 38 d.p.i. Genes with an 
adjusted p-value of < 0.01 are highlighted in red, the others are grey. The black 
lines represent the fold change cut-off (log-fold change = ± 1). Triangles indicate 
genes outside the boundaries of the plots; like other genes, they are red if they 
are statistically significant, grey if they are not. 
 
 
In order to identify genes differentially expressed between male and female 
worms from MS infections at 21, 28, 35 and 38 d.p.i. DESeq2 was used. The 
threshold for differential expression was an adjusted p-value of < 0.01 and a 
fold-change in expression > 2 throughout this Chapter. Pairwise comparisons of 
males and females at each time point showed that there was an increase from 38 
DEGs at 21 d.p.i. to over 3600 DEGs at 38 d.p.i. (of 10828 genes in total). The 
biggest absolute increase occurred from 28 to 35 d.p.i., approximately 1270% 
(Figure 3.3), as males and females diverge transcriptomically. These changes are 
responsible for the development of sex-specific features and the increasing 
proportion of reproductive tissues such as ovaries and vitellaria in female 
worms. 
 
At 21 d.p.i., male and female worms from MS infections were very similar at the 
transcriptome level. Of the 38 DEGs (see Figure 3.3a), 22 were up-regulated in 
females and 16 in males (see Appendix A.2 and A.3 for full lists of DEGs). In 
female worms several genes involved in cell division and cell fate determination 
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could be identified (Table 3.1). First, the gene coding for MutS, a protein 
implicated in mismatch DNA repair, was up-regulated (Table 3.1). Second, 
female worms express higher levels of the gene coding for Delta-like protein 
(Table 3.1), which is a ligand of Notch receptors involved in cell fate 
determination (Zhou et al., 2010). Third, a gene coding for a single minded-like 
protein was up-regulated in female worms (Table 3.1). In Drosophila, single 
minded is required for the proper development of midline cells (Nambu et 
al.,1991). At 21 d.p.i. both male and female worms are in the process of 
developing their reproductive organs (Biolchini et al., 2006) as well as their gut 
(Basch, 1991) and these gene may be involved in regulating these processes. 
 
Gene ID Product Fold Change Adjusted p-value 
Smp_213480 MutS protein 6.54 9.36E-06 
Smp_178780 Single minded 4.78 0.00160 
Smp_141250 Jagged 1 2.59 0.00874 
 
Table 3.1: Cell division related genes up-regulated in females from mixed 
sex infections at 21 days post infection. Fold changes are relative to 
expression in male worms from mixed sex infections at 21 d.p.i. (see Appendix 
A.3 for full list). The p-value has been adjusted for multiple hypothesis testing. 
 
In males, two nervous system related genes were found to be up-regulated at 21 
d.p.i. (Appendix A.3). One of the two genes encoded a sodium chloride dependent 
neurotransmitter (Smp_160360, 3.54-fold change, adjusted p-value = 3.36E-07). 
The other encoded a neuropeptide receptor (Smp_133550, 2.0-fold change, 
adjusted p-value = 0.0067). Collins et al. (2010) showed that neuropeptide Y is 
involved in the development and maintenance of the germline in planarians and 
identified peptide homologues in S. mansoni. This evidence suggests the 
differential use of neuropeptide receptors in male and female S. mansoni in the 
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mammalian stage of their life cycle. Smp_133550 remains significantly up-
regulated in males at 38 d.p.i. ( 7.1-fold change, adjusted p-value = 2.79E-21) 
(Appendix A.4). Together, the differentially expressed genes suggest that the 
development of male and female worms including that of the nervous system has 
begun to diverge by 21 d.p.i., priming the otherwise transcriptomically very 
similar males and females for their sex-specific development.  
 
At 38 d.p.i. approximately 33.4% (3616) of all genes were found to be 
differentially transcribed (Figure 3.3), revealing the extraordinary degree to 
which mature females from MS infections differ from their male counterparts. 
1377 of the 3616 DEGs were up-regulated in females (Figure 3.3). Among the 
female DEGs were several encoding well known fertility-associated proteins 
including female specific protein 800 (fs800) and other trematode egg shell 
synthesis domain containing proteins, two tyrosinases and an extracellular 
superoxide dismutase all of which were at least 80-fold up-regulated compared 
to male worms (adjusted p-value < 4.00E-22) (Appendix A.5). Another gene up-
regulated in females encodes a homologue of the human TNF receptor associated 
protein 1 (TRAP1; Smp_155740) (Appendix A.5).  
 
At 38 d.p.i., MS male worms express 2239 genes at significantly higher levels 
than females (Figure 3.3). A selection of 29 genes pre-dominantly expressed in 
males was identified in the literature (Fitzpatrick et al., 2005; Piao et al., 2011) 
and tested for male-biased expression. All 29 genes were found to be 
differentially expressed (Table 3.2), including genes coding for collagen, calpain 
and musculature related proteins.  
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Gene ID Product Fold change Adjusted p-value 
Smp_006860 PDZ & LIM protein 4.66 9.42E-23 
Smp_022340 PDZ & LIM protein 5.83 6.54E-22 
Smp_166920 PDZ & LIM protein 7.50 8.16E-22 
Smp_164590 Fibrillar collagen α 4.65 8.03E-12 
Smp_123830 Collagen α (xi) chain 4.14 6.81E-12 
Smp_196840 Collagen α 1(II) chain 2.59 7.50E-09 
Smp_170340 Collagen α 1(IV) chain 5.68 2.01E-07 
Smp_156770 Tegumental antigen Sm15 7.26 5.12E-14 
Smp_179810 Tegumental antigen Sm8 5.06 8.86E-15 
Smp_214180 Calpain 3.48 7.16E-18 
Smp_214190 Calpain 3.03 2.08E-21 
Smp_020550 Ldl receptor 3.85 1.15E-06 
Smp_161930 Actin 4.56 1.49E-18 
Smp_059170 Troponin 7.43 1.07E-22 
Smp_174520 Dynein light chain 4.08 0.0031 
Smp_176300 Dynein heavy chain 2.34 1.13E-06 
Smp_212280 Dynein heavy chain 3.11 1.17E-13 
Smp_140500 Paramyosin 2.13 0.0003 
Smp_021920 Paramyosin 6.85 9.62E-08 
 
Table 3.2: Differential expression analysis confirmed male-biased 
expression patterns of known male-specific genes from the literature 
(Fitzpatrick et al., 2005; Piao et al., 2011). This was a comparison of male and 
female worms from mixed sex infections at 38 days post infection. Fold changes 
are provided relative to female expression; all genes in this table were up-
regulated in male worms. The p-value has been adjusted for multiple hypothesis 
testing. 
 
As in MS males at 21 d.p.i., the neuropeptide receptor (Smp_133550) was found 
to be up-regulated in MS males at 38 d.p.i. (fold change = 7.1, adjusted p-value = 
2.79E-21). Additionally, another G-protein coupled receptor (Smp_170020, 9.1-
fold change, adjusted p-value = 2.54E-30) with homology to neuropeptide 
receptors was found to be up-regulated in the male worms (Table 3.3). Overall, a 
high proportion (13 out of 16) of neurotransmitter-gated ion channels 
(identified by their PFAM domain annotation) were significantly up-regulated in 
male worms compared to female worms (Table 3.3). These include three 
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glutamate-gated chloride channel subunits (2, 3 and 4) (Smp_015630, 
Smp_104890 and Smp_099500), seven out of eight nicotinic acetylcholine 
receptors and receptor subunits (Smp_031680, Smp_012000, Smp_132070, 
Smp_180570, Smp_139330, Smp_157790 and Smp_176310), as well as an 
acetylcholine receptor subunit α (Smp_101990), a neural acetylcholine receptor 
subunit α 4 (Smp_037960) and a glycine receptor subunit β (Smp_096480) 
(Table 3.3). Of the remaining three neurotransmitter receptors identified in the 
S. mansoni genome, one is up-regulated in females (Smp_142690), while 
expression of the remaining two could not be detected at this stage of the life 
cycle (Smp_175110, Smp_197600) (Table 3.3). This striking enrichment in 
neurotransmitter receptor mRNA expression in male worms over female worms 
raises questions on the role of these proteins in the male reproductive process. 
When comparing expression of these 13 genes in males to female worms from SS 
infections, no such enrichment is found (Appendix A.6); only two of the genes, 
Smp_104890 and Smp_101990, are still expressed at significantly higher levels in 
male worms than in the immature females (Appendix A.6). This suggests that the 
relative abundance of different tissue types is responsible for the up-regulation 
of neurotransmitter receptor genes in male worms.  The large proportion of 
ovarian and particularly vitellarian cells in mature females as well as the 
relatively lower proportion of muscle (Loker & Brant, 2006) may be responsible 
for the lower relative expression of neurotransmitter genes in whole females. In 
contrast, immature females are more male-like than mature females at the 





Gene ID  Product Average 
read count 
Fold change Adjusted  
p-value 
Smp_015630 Glutamate-gated chloride channel 
subunit 
353.74 4.61 1.23E-06 
Smp_104890 Glutamate-gated chloride channel 
subunit 
244.18 6.03 7.84E-24 
Smp_099500 Glutamate-gated chloride channel 
subunit 
38.57 2.75 0.0053 
Smp_031680 Nicotinic acetylcholine receptor 176.02 5.13 4.92E-08 
Smp_012000 Nicotinic acetylcholine receptor 92.58 3.52 8.81E-05 
Smp_132070 Nicotinic acetylcholine receptor subunit 3562.48 2.67 5.57E-16 
Smp_180570 Nicotinic acetylcholine receptor 132.26 4.04 9.15E-08 
Smp_139330 Nicotinic acetylcholine receptor non α 811.23 4.32 1.98E-18 
Smp_157790 Nicotinic acetylcholine receptor subunit 121.98 4.31 2.22E-06 
Smp_176310 Nicotinic acetylcholine receptor subunit 699.76 3.58 6.37E-07 
Smp_101990 Acetylcholine receptor subunit α 23.03 2.53 0.0053 
Smp_037960 Neuronal acetylcholine receptor 
subunit α 
1308.18 2.75 1.76E-05 
Smp_096480 Glycine receptor subunit β 520.33 3.44 1.93E-11 
Smp_142690 Neuronal acetylcholine receptor 
subunit α 
1875.19 0.42 2.93E-21 
Smp_175110 Neurotransmitter gated ion channel 0.00 N/A N/A 
Smp_197600 Nicotinic acetylcholine receptor 
subunit 
0.68 1.5 0.3996 
 
Table 3.3: Neurotransmitter-gated ion channels are largely up-regulated in 
male worms. The differential expression analysis compares male and female 
worms from mixed sex infections at 38 days post infection. Average read counts 
are a measure of absolute expression across all samples, and fold changes are 
provided relative to female expression (fold changes > 1 indicate up-regulation 
in males). If no expression was measured, fold change and p-value are marked as 
N/A. The p-value has been adjusted for multiple hypothesis testing. 
 
To better understand what biological processes the DEGs play a role in in 
females and males I made use of the KEGG database and performed a pathway 
enrichment analysis to identify pathways with significantly more DEGs than 
expected by chance. At 38 d.p.i., the DEGs upregulated in MS females were found 
to be enriched for 13 pathways involved in DNA replication and protein 
synthesis (Table 3.4), reflecting the proliferation of ovarian and especially 
vitellarian cells to drive egg production. In contrast, several lipid-metabolic 
pathways, developmental signalling pathways and pathways involved in 
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endocytosis were significantly enriched in males (see Table 3.5). Amongst these, 
is the TGF-β pathway that has been implicated in the male-female interaction 
and the stimulation of female fertility (LoVerde et al., 2009) (Table 3.5). Another 
up-regulated pathway is phosphatidylinositol signalling (smm04070, p-value = 
0.020) (Table 3.5). It has been proposed that female fertility is supported by lipid 
transfer from the male to the female (Popiel & Basch, 1986). Several lipid 
metabolism-related pathways were indeed significantly enriched in the DEGs 
upregulated in males at 38 d.p.i., including glycerolipid and glycerophospholipid 
metabolism (smm00564, p-value = 0.00019; smm00561, p-value = 0.00059) as 
well as ether lipid metabolism (smm00565, p-value = 0.0082) (Table 3.5). 
However, this could also simply reflect a higher rate of tegument turnover in 
male worms, which have a thicker tegument as well as a larger surface area, due 















KEGG ID Pathway Total Genes DEGs Expected p-value 
smm03010 Ribosome 110 82 42.98 7.92E-15 
smm03008 Ribosome biogenesis in eukaryotes 62 47 24.23 2.22E-09 
smm03050 Proteasome 32 27 12.50 1.34E-07 
smm03030 DNA replication 30 22 11.72 1.06E-04 
smm03040 Spliceosome 105 59 41.03 1.11E-04 
smm03060 Protein export 19 15 7.42 3.84E-04 
smm00510 N-Glycan biosynthesis 30 21 11.72 4.13E-04 
smm03440 Homologous recombination 18 14 7.03 7.83E-04 
smm00970 Aminoacyl-tRNA biosynthesis 34 21 13.29 3.79E-03 
smm03013 RNA transport 103 52 40.25 4.50E-03 
smm04141 Protein processing in endoplasmic 
reticulum 
89 45 34.78 7.02E-03 
smm03410 Base excision repair 20 12 7.82 3.00E-02 
smm00240 Pyrimidine metabolism 59 28 23.05 4.37E-02 
 
Table 3.4: Female worms up-regulated KEGG pathways playing a role in 
protein synthesis and DNA replication. At 38 days post infection, genes 
significantly upregulated in females from mixes sex infections were enriched in 
13 KEGG pathways. “Total genes” is the number of genes in the given pathway. 
“DEGs” provides the number of differentially expressed genes in that pathway. 
“Expected” provides the number of genes expected by chance to be differentially 















KEGG ID Pathway Total Genes DEGs Expected p-value 
smm04144 Endocytosis 64 26 10.82 3.15E-06 
smm04512 ECM-receptor interaction 9 8 1.52 4.71E-06 
smm04068 FoxO signalling pathway 38 18 6.43 8.63E-06 
smm04310 Wnt signalling pathway 35 17 5.92 1.02E-05 
smm04080 Neuroactive ligand-receptor 
interaction 
15 10 2.54 2.10E-05 
smm00564 Glycerophospholipid metabolism 35 15 5.92 1.88E-04 
smm00561 Glycerolipid metabolism 17 9 2.87 5.93E-04 
smm00500 Starch and sucrose metabolism 14 8 2.37 6.33E-04 
smm00380 Tryptophan metabolism 10 6 1.69 2.29E-03 
smm00340 Histidine metabolism 5 4 0.85 3.36E-03 
smm04142 Lysosome 47 15 7.95 4.96E-03 
smm00565 Ether lipid metabolism 9 5 1.52 8.19E-03 
smm04340 Hedgehog signalling pathway 9 5 1.52 8.19E-03 
smm00514 Other types of O-glycan biosynthesis 4 3 0.68 1.60E-02 
smm00010 Glycolysis / Gluconeogenesis 27 9 4.57 1.85E-02 
smm04070 Phosphatidylinositol signalling 
system 
32 10 5.41 2.05E-02 
smm04630 Jak-STAT signalling pathway 11 5 1.86 2.08E-02 
smm04320 Dorso-ventral axis formation 8 4 1.35 2.71E-02 
smm04350 TGF-β signalling pathway 16 6 2.71 2.91E-02 
 
Table 3.5 Male worms upregulated KEGG pathways involved in cellular 
metabolism and various signalling pathways. At 38 days post infection, genes 
upregulated in males from mixed sex infections were enriched in 19 KEGG 
pathways. “Total genes” is the number of genes in the given pathway. “DEGs” 
provides the number of differentially expressed genes in that pathway. 
“Expected” provides the number of genes expected by chance to be differentially 
expressed in each pathway. 
  
3.2.4 Male development 
In male worms, the greatest difference in gene expression was found between 18 
and 21 d.p.i. (1858 DEGs in total) (Figure 3.4), suggesting that this was when 
most of the male-specific developmental changes took place. The number of 
DEGs dropped sharply after that time, to 130 (21 vs 28), 59 (28 vs 35) and finally 
17 DEGs (35 vs 38), (Figure 3.4). Below, some of the results of the differential 








Figure 3.4: The largest number of differentially expressed genes was found 
between 18 and 21 days post infection (d.p.i.) in developing male worms. A) 
This plot provides the number of differentially expressed genes found by pair-
wise comparisons of males from mixed sex infections of different time points. B) 
Log ratio vs mean (MA) plots showing the mean expression and log-fold change 
of each pair-wise comparison. Genes marked as red dots have been assigned an 
adjusted p-value of < 0.01, the other are grey. Black lines represent the fold 
change cut-off (log-fold change = ±1). Triangles indicate genes outside the 
boundaries of the plots; like other genes, they are red if they are statistically 
significant, grey if they are not. 
 
Cytochrome P450-dependent drug metabolism 
Praziquantel is currently the main drug to treat schistosomiasis, especially as 
part of mass treatment programs in endemic areas (Crellen et al., 2016). 
However, immature worms are known to be less sensitive to praziquantel, 
making it difficult to clear an infection completely and stop the parasite life cycle 
in endemic areas (Sabah et al., 1986; Vimieiro et al., 2013). At 18 d.p.i., three out 
of four genes belonging to the cytochrome P450 dependent drug metabolism 
pathway were found to be up-regulated in male worms compared to male worms 
at 21 d.p.i. (Appendix A.7). The relatively high expression of genes involved in 
cytochrome P450-dependent drug metabolism at 18 d.p.i. may be the reason 
why immature worms are less susceptible to praziquantel. A Glutathione S 
transferase (GST) was not only up-regulated in males at 18 d.p.i. compared to 
males at 21 d.p.i. (Smp_024010, 5.1-fold change, adjusted p-value = 4.50E-05) 
(Appendix A.8), but also compared to males at 38 d.p.i. (21.9-fold change, 
adjusted p-value = 1.34E-14) (Appendix A.8). The same gene was also up-
regulated in female worms at 18 compared to 38 d.p.i. (18.2-fold change, 




Regulation of cell division in the testes 
Compared to 21 d.p.i., the gene coding for the cell cycle regulator Cdc25 
(Smp_152200, 6.0-fold change, adjusted p-value = 0.00061) was up-regulated at 
28 d.p.i. in male worms, as was follistatin (Smp_123300, 2.3-fold change, 
adjusted p-value = 0.00027) (Appendix A.9). Follistatin is also associated with 
the proliferation of spermatocytes and was also found to be down-regulated 
from 28 to 35 d.p.i. (2.4-fold change, adjusted p-value = 0.00082) (Appendix 
A.10). Leutner et al. (2013) demonstrated that paired male worms express lower 
levels of follistatin than unpaired males. The down-regulation of the gene 
encoding follistatin in MS males at 35 d.p.i. compared to those at 28 d.p.i. is 
probably related to this observation (Appendix A.10).  From 21 to 28 d.p.i., a 
gene encoding the homologue of basonuclin 2 (Smp_138350, 5.4-fold change, 
adjusted p-value = 1.86E-05) was up-regulated in male worms from mixed sex 
infections (Appendix A.16). 
 
Aromatic-L-amino acid decarboxylase 
Wang et al. (2017) hypothesised that the AADC gene, which they found to be 
expressed in S. japonicum males during mating (see Chapter 1.6.2), was 
responsible for inducing female sexual maturity. The AADC gene was also found 
to be up-regulated in male S. mansoni. The S. mansoni gene (Smp_135230) was 
significantly up-regulated in male worms at 38 d.p.i. compared to males at 18 
d.p.i. (8.50-fold change, adjusted p-value = 2.26E-06) (Appendix A.11). 
Additionally, it was found to be significantly up-regulated in male worms from 
MS infections compared to males in SS infections at 35 d.p.i. (8.39-fold change, 
adjusted p-value = 1.23E-03) and 38 d.p.i. (5.33-fold change, adjusted p-value = 
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1.99E-03), falling just short of the significance threshold (adjusted p-value < 
0.01) at 28 d.p.i. (2.32-fold change, adjusted p-value = 0.0359) (Appendix A.11). 
The lack of expression in males from SS infections as well as the confirmation of 
expression in mature MS males (here in S. mansoni) adds further weight to the 
hypothesis of AADC being involved the stimulation of female fertility in 
schistosomes.  
 
3.2.5 Female development 
Pairing is thought to commence between three and four weeks post infection, 
allowing female worms to reach sexual maturity around five weeks post infection 
(Biolchini et al. 2006). Accordingly, the greatest difference in gene expression in 
MS female worms was found between 28 and 35 d.p.i. (1545 DEGs) (Figure 3.5). 
By comparison, there were only 300 DEGs between 18 and 21 d.p.i., 385 between 









Figure 3.5: The largest number of differentially expressed genes (DEGs) 
was found between 28 and 35 days post (d.p.i.) infection in female worms 
from mixed sex infections. A) DEGs found by pair-wise comparisons of females 
from mixed sex infections at different time points. B) Log ratio vs mean (MA) 
plots show the mean expression and log-fold change of each pair-wise 
comparison. Genes marked as red dots have been assigned an adjusted p-value 
of < 0.01, the others are grey. Black lines represent the fold change cut-off (log-
fold change = ±1). Triangles indicate genes outside the boundaries of the plots; 




Egg production related genes 
During the maturation of paired female schistosomes, many fertility related 
genes are known to become up-regulated (Fitzpatrick & Hoffmann, 2006). This is 
largely due to the growth and maturation of the reproductive organs including 
the ovaries and the vitellarium (Fitzpatrick & Hoffmann, 2006). Many of the 
significantly up-regulated genes were also found in the comparison of male and 
female worms (Chapter 3.2.3). In this comparison of females from different time 
points, the most notable up-regulation of fertility-related genes occurred 
between days 21 and 28, where 266 DEGs were found to become up-regulated 
(Figure 3.5). The DEGs included all genes encoding trematode egg shell synthesis 
domains, a tyrosinase (Smp_050270), and the extracellular superoxide 
dismutase (Smp_095980) (Appendix A.12). Furthermore, two tetraspanins were 
up-regulated, CD63 antigen (Smp_173150) and a CD63 receptor (Smp_155310) 
(Appendix A.12). Although CD63 antigen is expressed in mature females, its 
function remains unclear (Cogswell et al., 2012). At 38 d.p.i., females from MS 
infections expressed the CD63 receptor and antigen, at 191-fold (adjusted p-
value = 5.98E-30) and 39-fold (adjusted p-value = 1.62E-42) higher levels 
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respectively, than females from SS infections (Appendix A.13). This made them 
the 21st and 51st of the most differentially expressed genes, the majority of which 
are thought to be expressed in the vitellarian tissue. Together the DEGs 
summarised in this paragraph confirmed that female schistosomes from MS 
infections have not only begun to pair by 28 d.p.i. but also that females have 
started to develop their reproductive organs at that time. As others recently 
observed (Biolchini et al., 2006), it appears that pairing takes pace somewhat 
earlier than reported by Basch (1991). These genes became further up-regulated 
at 35 d.p.i. and 38 d.p.i. and were consistently expressed at significantly higher 
levels in females from MS infections rather than SS infections (see Chapter 3.2.8). 
 
Ovary-specific gene expression 
While the most differentially expressed genes up-regulated in mature females 
are thought to be largely expressed in the vitellaria [for example Fitzpatrick et al. 
(2007), Fitzpatrick & Hoffmann (2006), Köster et al. (1988)], at 21 d.p.i. 
(compared to 18 d.p.i.), a least two of the up-regulated genes probably play an 
important role in the ovaries of mature females. The first encoded a homologue 
of human sperm associated antigen (Smp_001160, 2.2-fold change, adjusted p-
value = 2.08E-05) (Appendix A.14), which plays a role in fertility in mammals 
(Lin et al., 2001). The other encoded boule (Smp_144860, 6.6-fold change, 
adjusted p-value = 6.34E-05) (Appendix A.14), a conserved transcription factor 
found in most animals. Amongst others, it has been shown to regulate male and 
female gametogenesis in the flatworm Macrostomum ligano (Kuales et al., 2011). 





At 18 d.p.i., females express two wnt family genes (Smp_196930, 2.5-fold change, 
adjusted p-value = 0.0027; Smp_167140, 3.1-fold change, adjusted p-value = 
0.0067) that became down-regulated at 21 d.p.i. (Appendix A.15) Additionally, a 
gene (Smp_062560, 2.2-fold change, adjusted p-value = 0.0067) homologous to a 
Secreted frizzled-related protein 2, a regulator of the Wnt pathway, was up-
regulated (Appendix A.15) Frizzled proteins are G-protein coupled receptors 
that regulate the Wnt signalling pathway (Nusse, 2009). Up-regulation of these 
three genes suggests, that the Wnt signalling pathway is more active during the 
earlier parts of their development, where it could regulate the formation of a 
body axis, cell fate and cell proliferation.  
 
Differential expression of transcription factors 
Across this RNA-Seq time course, many transcription factors were found to be 
differentially regulated. In particular a large number of genes coding for proteins 
regulating transcription became down-regulated at in females worms from MS 
infections at 28 d.p.i. when compared to 21 d.p.i. (Appendix A.17). Based on their 
GO term annotations, 37 transcription factor genes were identified: about a third 
of all the DEGs down-regulated at 28 d.p.i.  (Appendix A.17). Such large-scale 
down-regulation of transcription factors in females from MS infections could 
suggest that some development processes reach their conclusion at this time. Of 
the 37 transcription factors, 22 were also expressed at significantly lower levels 





Conversely, as the worms started to pair and females began to initiate the 
proliferation of their reproductive tissues, especially ovaries and vitellaria, 
another set of transcription factors was significantly up-regulated (Appendix 
A.19). Among the 100 most differentially expressed genes at 38 d.p.i. three genes 
with zinc finger domains were identified (Smp_166560, Smp_087320 and 
Smp_095350). All three zinc finger genes were found to be up-regulated more 
than 10-fold (adjusted p-value < 9.00E-22) (Appendix A.19) and it is tempting to 
speculate that they play a role in regulating transcription of genes involved in 
female maturation. 
 
3.2.6 Male time series analysis 
The previous analysis of pair-wise comparisons made it apparent that 
differential expression of genes can be found across the time course, with more 
differential expression found between MS and SS females than males. Next, I 
wanted to define sets of genes regulated in a pairing dependent manner 
throughout the course of infection. To do so, I performed a likelihood ratio test to 
identify genes that were up- or down-regulated over the course of infection in 
worms from SS or MS infections but not in both infections. Based on this test, 39 
genes (Table 3.6) were identified as differentially expressed in males from MS 
and SS infections across the time course (adjusted p-value < 0.01) in the 
otherwise very similar male worms (Figure 3.6). These included several genes 
coding for proteins involved in signalling and signal transduction processes, such 
as the fibroblast growth factor (FGF) receptor activating protein (Smp_035730, 
adjusted p-value = 0.0053) and the epidermal growth factor (EGF) receptor 
(Smp_152680, adjusted p-value = 0.0069), which were found to be expressed at 
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higher levels in paired males (Table 3.6). These genes are shown to be expressed 
in the testes in Chapter 5 of this thesis. The FGF and the EGF signalling pathways 
regulate cell proliferation and differentiation (Eswarakumar et al., 2005; Herbst, 
2004). This suggests that paired males have a higher rate of cell proliferation in 
their testes, which could result in a greater number of spermatocytes being 
produced.  
 







Smp_005880 Phosphoenolpyruvate carboxykinase MS 1.60 3571.83 2.86E-03 
Smp_012000 Nicotinic acetylcholine receptor SS 2.77 129.19 1.10E-05 
Smp_012380 Voltage-gated potassium channel subunit β 2 SS 1.59 1174.94 6.87E-03 
Smp_013950 Solute carrier family 43 MS 1.66 1119.06 2.03E-06 
Smp_015020 Sodium potassium transporting ATPase α 
subunit 
MS 1.71 2041.50 5.04E-03 
Smp_019980 Vacuole membrane protein 1 MS 1.19 2745.53 9.17E-04 
Smp_020840 Uncharacterised protein MS 1.74 68.18 4.84E-03 
Smp_021960 Uncharacterised protein MS 1.02 318.04 1.10E-05 
Smp_028800 Uncharacterised protein SS 2.23 39.30 2.49E-04 
Smp_035730 FGF receptor activating protein MS 1.06 934.37 5.33E-03 
Smp_044800 Ankyrin repeat and E domain containing 
protein 
MS 1.15 327.46 8.81E-04 
Smp_063560 Transmembrane protein 120b MS 1.22 1080.30 5.33E-03 
Smp_114430 Uncharacterised protein MS 4.63 53.16 5.53E-03 
Smp_125210 Aquaporin 9 (Small solute channel 1) MS 1.49 119.40 6.47E-03 
Smp_126290 Uncharacterised protein SS 2.21 283.56 1.71E-03 
Smp_128010 Uncharacterised protein MS 4.10 146.98 1.10E-05 
Smp_134990 Uncharacterised protein MS 3.01 112.52 2.55E-08 
Smp_135020 Putative oxalate:formate antiporter MS 1.80 249.99 4.84E-03 
Smp_135230 Tyrosine Decarboxylase MS 3.15 440.13 1.27E-05 
Smp_147070 Sodium-coupled neutral amino acid MS 2.34 1640.36 4.29E-03 
Smp_151490 Vertebrate nebulin MS 1.87 3474.33 6.31E-03 
Smp_152680 Epidermal growth factor receptor MS 1.75 159.89 6.90E-03 
Smp_152730 Histone-lysine N-methyltransferase MS 1.83 39.41 8.32E-03 
Smp_158480 AMP binding enzyme MS 16.87 1332.34 2.12E-09 
Smp_158720 SCY1-like protein kinase SS 1.53 484.09 1.10E-05 
Smp_160040 Uncharacterised protein MS 3.44 15.31 3.10E-03 
Smp_167160 Dynamin binding protein MS 1.51 2472.35 6.90E-03 
Smp_168670 cGMP dependent protein kinase 1 MS 1.16 381.69 5.53E-03 
Smp_168940 Uncharacterised protein MS 4.09 293.32 2.72E-03 
Smp_169150 Short transient receptor potential channel 3 SS 2.00 144.97 9.86E-03 
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Smp_172960 Uncharacterised protein MS 1.36 2005.73 1.24E-03 
Smp_173290 Uncharacterised protein MS 2.22 23.87 1.10E-05 
Smp_173300 Uncharacterised protein MS 2.35 16.12 1.14E-05 
Smp_174870 Uncharacterised protein MS 2.00 487.85 6.75E-08 
Smp_176400 Uncharacterised protein MS 6.56 29.18 7.16E-03 
Smp_190210 Uncharacterised protein SS 5.51 5.27 9.96E-04 
Smp_194190 Endothelin-converting enzyme 2 MS 2.47 109.63 4.51E-03 
Smp_212750 Uncharacterised protein MS 2.43 75.40 2.64E-04 
Smp_212760 Putative kinesin SS 2.03 909.99 7.79E-04 
 
Table 3.6: Significant genes found in the time series analysis of male worms. The 
“MS/SS” column reports whether expression was up-regulated in males from 
mixed sex or single sex infections at 38 days post infection (d.p.i.). The fold 
change is provided for 38 d.p.i. The average read count is a measure of absolute 






Figure 3.6:  Male worms from mixed sex and single sex infections are very 
similar at the transcriptome levels throughout their development. Principal 
component analysis plot of male RNA-Seq samples. The first two principal 
components show 77% of the measured variance. The PC1 axis seems to broadly 
correlate with worm maturity. Time points indicate the number of days post 




3.2.7 Female time series analysis 
As for the male samples, a likelihood ratio test was used to identify pairing-
controlled genes in females and 5173 such genes were discovered (adjusted p-
value < 0.01). At 38 d.p.i.,  2670 of the genes were up-regulated in MS females 
and 2503 up-regulated in SS females. The PCA plot (Figure 3.7) shows female 
worms from MS and SS infection forming separate clusters from 28 d.p.i. 
onwards. To analyse such a  large number of genes, two different clustering 





Figure 3.7: Female from mixed sex infections diverge from the single sex 
samples from 28 d.p.i. In this PCA plot of female RNA-Seq samples, the first two 
principal components capture 89% of the measured variance. Whereas paired 
females develop along PC1 over time, with sexual maturation contributing to 
81% of the total variation, single females change primarily along PC2 (8%). Time 
points indicate the number of days post infection (d.p.i.). 
 
 
3.2.8 Fertility-related genes 
Having identified over 5000 pairing-regulated genes involved in females, I tried 
two different clustering methods, the Kohonen method (Wehrens & Buydens, 
2007) and MBCluster (Si et al., 2014) (Chapter 2.4.11), to split the genes into 
groups with similar patterns of expression. This was done to ensure the 
reproducibility of the clustering results and to define a set of putative fertility-
related genes. Similar patterns of expression across several samples, especially 
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in time course experiments, can be evidence for co-expression and suggest roles 
in the same biological processes (Si et al., 2014). Kohonen is based on a heuristic 
method designed to produce self-organising maps from data sets using 
unsupervised learning. Self-organising maps are a two-dimensional 
representation of multi-dimensional data that aim to place similar data points, 
e.g. genes close to one another thereby forming clusters of similar genes 
(Wehrens & Buydens, 2007). In contrast, MBCluster assumes the data to have a 
negative binomial distribution and uses an Expectation-Maximisation algorithm 
to estimate model parameters and cluster membership (Si et al., 2014).  
 
For both methods, genes were divided into 16 clusters (Figures 3.8 and 3.9) as 
higher numbers of clusters usually resulted only in an increasing number of 
clusters with very small number of genes, even as low as one or two genes (data 
not shown). In the MBCluster results, one cluster, containing 76 genes, was 
characterised by the largest overall fold changes and high expression levels in 
MS females at 28, 35 and 38 d.p.i. (see Figure 3.8). This group of genes included 
two of the clusters formed by the Kohonen method, which separated the genes 
further based on their relative expression (see Figure 3.9). Of the two Kohonen 
clusters, one (Cluster 13) contained genes with particularly high expression in 
mature females. The 25 genes in that cluster are among the 32 most up-
regulated genes in paired females ranging from 540-fold to over 45350-fold up-
regulation over the time course (Appendix A.20). Together, these genes account 
for over 14% of the sequencing reads in the transcriptome of mature females, 
compared to only 0.0065% of reads in immature females (Appendix A.21). 
Eleven of the genes were found by InterProScan to code for a trematode eggshell 
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synthesis domain (Appendix A.20). Also included were genes coding for two 
tyrosinases (Smp_013540 & Smp_050270) and an extracellular superoxide 
dismutase (Smp_095980) (Appendix A.20) all of which are known pairing-
regulated genes (Fitzpatrick & Hoffmann, 2006).  
 
 
Figure 3.8: Genes were divided into 16 clusters based on expression 
profiles. The MBCluster plots show gene expression across all female RNA-Seq 
samples. For each gene in a cluster the log2 fold changes (Y-axis) are plotted 
against the days post infection (X-axis). Samples from single sex (SS) infections 
have a white background; samples from mixed sex (MS) infections have a red 
background. The red lines represent the cluster average for each time point. The 




Figure 3.9: Genes were divided into 16 clusters based on their expression 
using the Kohonen method. Left – heatmap of number of genes per cluster. 
Right – Average log2-expression of genes inside each cluster for all time points 
and for mixed and single sex females. Cluster 13 is on the top left in both maps. 
The two clusters of fertility-related genes discussed in Chapter 3.2.8, Cluster 13 
and 14, are contained in red circles. 
 
 
To select gene clusters that exhibit significant changes in expression over the 
time course, genes were filtered based on their average fold changes relative to 
expression in female worms at 18 d.p.i. The expression levels of seven out of the 
16 clusters (1, 4, 7, 9, 11, 13 and 14) identified by the MBCluster method at least 
doubled or halved over the time course (see Figure 3.10). It showed that the fold 
changes in gene expression were larger in females from MS than SS infections. A 
GO term analysis was performed on the sets of genes contained in each of these 7 






Figure 3.10: The magnitude of changes in gene expression is larger in 
females from mixed sex than females from single sex infections. Average 
expression of genes in the MBCluster clusters with greater than 2-fold changes in 
gene expression across the female samples of the time course. All expression fold 
changes are measured relative to females from single sex infections at 18 days 
post infection (d.p.i.).  
 
The clusters 9, 13 and 14 were found to be enriched for genes annotated with 
developmental GO terms such as multicellular organismal development, Wnt 
signalling and sex determination (Tables 3.7, 3.8 and 3.9). From 18 d.p.i. 
onwards expression of these genes fell in females from MS as well as SS 
infections (Figure 3.10). Notably, the down-regulation of these genes was more 





GO term Description Annotated Significant Expected p-value 
GO:0007156 Homophilic cell adhesion 60 22 1.74 2.00E-19 
GO:0007275 Multicellular organismal 
development 
286 35 8.3 3.20E-13 
GO:0006355 Regulation of transcription 800 57 23.22 9.80E-12 
GO:0016055 Wnt signalling pathway 27 7 0.78 0.00026 
GO:0007155 Cell adhesion 226 35 6.56 0.00027 
GO:0030154 Cell differentiation 78 9 2.26 0.00038 
GO:0030238 Male sex determination 6 3 0.17 0.00045 
 
Table 3.7: Significant GO terms for the genes in cluster 9 of the MBCluster 
analysis. “Annotated” - total number of genes in the genome annotated with a 
given GO term. “Significant” - the number of genes annotated with that GO term 
in Cluster 9. “Expected” – the number of genes with that GO term expected by 
chance. The significance cut-off was p = 0.01. The GO terms are all in the 
“Biological Process” category. 
 
GO term Description Annotated Significant Expected p-value 
GO:0006813 Potassium ion transport 77 8 1.99 0.00076 
GO:0006941 Striated muscle contraction 145 11 3.74 0.00122 
GO:0045596 Negative regulation of cell 
differentiation 
3 2 0.08 0.00195 
GO:0030514 Negative regulation of BMP 
signalling 
3 2 0.08 0.00195 
GO:0051216 Cartilage development 5 2 0.13 0.00629 
GO:0007223 Wnt signalling pathway (Ca 
modulating) 
6 2 0.15 0.00928 
 
Table 3.8: Significant GO terms for the genes in cluster 13 of the MBCluster 
analysis. “Annotated” - total number of genes in the genome annotated with a 
given GO term. “Significant” - the number of genes annotated with that GO term 
in Cluster 13. “Expected” – the number of genes with that GO term expected by 
chance. The significance cut-off was p = 0.01. The GO terms are all in the 











GO term Description Annotated Significant Expected p-value 
GO:0007186 G-protein coupled receptor 
signalling 
161 30 8.46 2.50E-09 
GO:0007155 Cell adhesion 226 44 11.87 4.90E-08 
GO:0007156 Homophilic cell adhesion 60 14 3.15 1.70E-06 
GO:0006811 Ion transport 389 52 20.44 5.60E-06 
GO:0006813 Potassium ion transport 77 14 4.05 3.70E-05 
GO:0006468 Protein phosphorylation 337 34 17.71 0.00013 
GO:0007160 Cell-matrix adhesion 8 4 0.42 0.00044 
GO:0007229 Integrin-mediated signalling 
pathway 
9 4 0.47 0.00076 
GO:0006816 Calcium ion transport 49 9 2.57 0.00086 
GO:0007165 Signal transduction 547 67 28.74 0.00143 
GO:0030245 Cellulose catabolic process 6 3 0.32 0.00255 
GO:0007169 Transmembrane receptor 
protein tyrosine kinase signalling 
31 6 1.63 0.00483 
GO:0006865 Amino acid transport 22 5 1.16 0.00486 
GO:0006814 Sodium ion transport 64 9 3.36 0.0058 
 
Table 3.9: Significant GO terms for the genes in cluster 14 of the MBCluster 
analysis. “Annotated” - total number of genes in the genome annotated with a 
given GO term. “Significant” - the number of genes annotated with that GO term 
in Cluster 14. “Expected” – the number of genes with that GO term expected by 
chance. The significance cut-off was p = 0.01. The GO terms are all in the 
“Biological Process” category. 
 
Expression of Clusters 1, 4 and 7 increased over time in both SS and MS females.  
In all three the effect was greater in females from MS infections than females 
from SS infections (Figure 3.10). At 38 d.p.i. average expression was around 6- 
and 3.5-fold higher than at 18 d.p.i., compared with a 1.4- and 2.4-fold increase in 
SS  females for clusters 1 and 4 respectively (Figure 3.10). Cluster 1 contained 
several genes with a female-biased expression, including gene coding for 
proteins such as ferritin (Smp_087760) (Appendix A.22), whereas cluster 4 
contained several genes encoding saposins, cathepsins and a haemoglobinase, 




Cluster 7 expression displayed the greatest up-regulation of gene expression 
amongst all clusters (Figure 3.10). In MS females, expression was on average 60-
fold up-regulated at 38 d.p.i. relative to expression at 18 d.p.i. (Figure 3.10). This 
cluster contained many genes associated with female fertility, particularly egg 
production, such as genes encoding eggshell synthesis domain containing 
proteins (Smp_077900, Smp_000290, Smp_191910, Smp_000430 and 
Smp_077890), tyrosinases (Smp_050270 and Smp_013540), and a superoxide 
dismutase (Smp_095980) (Appendix A.24). Cluster 7 was found to be 
significantly enriched for several GO terms. These included tyrosine metabolic 
process (GO:0006570, p = 0.00014), phenol-containing compound biosynthetic 
process (GO:0046189, p = 0.00014) and pigment biosynthetic process 
(GO:0046148, p = 0.00128) due to the presence of the two tyrosinases in this 
cluster (Appendix A.25). Both tyrosinases are known to be expressed 
predominantly in sexually mature females and are thought to catalyse the 
oxidation of phenolic compounds contributing to egg shell formation (Fitzpatrick 
et al., 2007). This process can produce free radicals and other oxidising agents 
(Tada, Kohno, & Niwano, 2014).  Superoxide metabolic process (GO:0006801, p 
= 0.020) (Appendix A.25) was also overrepresented. Superoxide dismutases that 
are known to be expressed in female worms in a pairing dependant manner (Sun 
et al., 2014), are also found in this cluster and may serve to protect the female 
reproductive tissues from oxidative stress. Other up-regulated genes included 
genes coding for a protein kinase as well as the tetraspanin CD63 receptor 




The role of eggshell synthesis domain containing proteins as well as the 
tyrosinases in egg production has been demonstrated previously (Fitzpatrick et 
al., 2007). On the other hand, the role of the membrane receptors CD63 antigen 
(CD63a) and CD63 receptor (CD63R) is not clear and will be the focus of the rest 
of the chapter. CD63a, but not CD63R, has previously been shown to have a 
pairing-dependent pattern of expression (Cogswell et al., 2012). As revealed by 
the time course data, both genes are not only female-specific but also respond to 
pairing in their expression profiles (Cluster 7 in Figure 3.10).  
 
According to GeneDB (Logan-Klumpler et al., 2012), CD63a is a predicted 24.1 
kDa protein with 225 amino acids and CD63R is a predicted 30.6 kDa protein of 
276 amino acids. However, tetraspanins often undergo post-translational 
modifications (Termini & Gillette, 2017), so their actual mass may be 
substantially higher. Tetraspanins are a group of proteins defined by their four 
transmembrane regions, which anchor the proteins in the cell membrane 
(Termini & Gillette, 2017). They generally protrude around 3-5 nm from the cell 
membrane (Grove, 2014) with two extracellular regions and three short 
intracellular loops (Termini & Gillette, 2017). Their roles in cell biology involve 
association with other proteins, including other tetraspanins, and thereby 
enabling the formation of signalling complexes (Levy & Shoham, 2005).  
 
Next I used qRT-PCR to measure the difference in gene expression between 
males and females at different d.p.i. for CD63a and CD63R. This was done to 
confirm the findings of the RNA-Seq analysis. Then, to further investigate the role 
of CD63a and CD63R in female fertility, in situ hybridisations and RNAi 
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knockdown experiments were performed to determine in which tissues these 
genes are expressed and whether an effect of these tetraspanins on fertility could 
be demonstrated. 
 
3.2.9 qRT-PCR analysis of CD63 antigen & CD63 receptor 
Pairing-dependent expression of CD63R and CD63a in female worms was 
confirmed by qRT-PCR (Figure 3.11). Expression in female worms was measured 
relative to expression in male worms at 21 d.p.i. using PSMD4 (a proteasome 26S 
subunit) as a reference gene (Liu et al., 2012). CD63R expression in females from 
MS infections was found to increase dramatically from 21 to 28 d.p.i. and 
remained high thereafter with expression being over 800-fold higher in females 
than males at 40 d.p.i. (Figure 3.11). 
 
CD63a expression also increased significantly in females from MS infections from 
21 to 28 d.p.i compared to males and continued to be expressed highly until 40 
d.p.i. (Figure 3.12). At 21 d.p.i., females expressed CD63a  at 1.25-fold of the male 
expression, which increased to 56.6-fold at 40 d.p.i., a 45-fold increase in female 





Figure 3.11: Expression of CD63R significantly higher in female worms 
from 28 d.p.i. onwards. Expression is give as a fold change relative to male 
expression at 21 d.p.i. PSMD4 was used as internal reference gene for this qRT-
PCR analysis. Error bars are the standard error of the mean. 
 
 
Figure 3.12: Expression of CD63a is higher in female than in male worms. 
Expression is given as a fold change relative to male expression at 21 d.p.i. 
PSMD4 was used as internal reference gene for this qRT-PCR analysis. Error bars 
are the standard error of the mean. 
 
Both RNA-Seq and qPCR data show that there is a strong up-regulation of CD63R 
and CD63a expression in paired females, whereas expression in males (and, in 
the case of RNA-Seq data, females from SS infections) remains relatively constant 
at a low level (Figures 3.11 and 3.12; see Cluster 7 in Figure 3.10).  
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3.2.10 Whole mount in situ hybridisation 
The cluster analysis of RNA-Seq data suggested that CD63a and CD63R could be 
expressed in the vitellaria of MS females and play a role in egg production. In situ 
hybridisation was used to identify the tissues in which expression of the two 
genes occurs. Tetraspanin-2 (TSP-2) was used as a positive control. TSP-2 is an 
abundant tegumental protein (Castro-Borges et al., 2011) and its expression at 
the mRNA level can be demonstrated in the cell bodies of the tegument (see 
Figure 3.13). These cell bodies lie outside the light brown vitelline lobes but no 




Figure 3.13: Tetraspanin-2 is expressed in the cell bodies of the worm 
tegument. Alkaline phosphatase staining (Chapter 2.27) of digoxigenin-labelled 
tetraspanin-2 mRNA in female worms. Expression was not observed in the 
vitelline tissue. F – Sexually mature female; V – Vitellarium; T – Tegument; CB – 
Cell body. A) Whole mature female with staining located in the cell bodies of the 
tegument. The red rectangle indicates where the close-up in B) is derived from. 
B) Close-up of the female specimen in A). Stained cell bodies can be seen in the 
tegument. C) Close-up of a different female specimen. Stained cell bodies can be 





Figure 3.14: A close-up of the stained cell bodies indicates tetraspanin-2 is 
expressed in the cell bodies of the tegument. The original image is on the left; 
on the right the border of the vitellarium has been marked in red. V – vitellarium; 
T – tegument; CB – cell body. 
 
In contrast to TSP-2, CD63a expression was detected inside the vitelline tissue of 
the 12 female specimens (see Figure 3.15). No expression was detected in the 








Figure 3.15: CD63 antigen is expressed in the vitelline tissue of female 
worms. Alkaline phosphatase staining (Chapter 2.27) of digoxigenin-labelled 
CD63 antigen mRNA in female worms. F – Sexually mature female; V – 
Vitellarium; T – Tegument. A) Whole female stained for CD63 antigen. B) Close-
up female mid-section. C) No signal was found in the negative control.  
 
The pattern of staining observed for the CD63R (see Figure 3.16) was similar to 
CD63a, showing expression in the vitellaria. Particularly, 14 female specimens 
displayed CD63R expression in the outer regions of the vitellaria, but little or no 
staining in the centre of the organ (Figure 3.15). No expression was observed in 
the female negative control or male worms (Figure 3.15). Erasmus (1975) 
described the organisation of vitellocytes. The author  suggested that there is a 
gradient of maturity from the least mature (S1) cells at the periphery of the 
lobes, then S2 and S3 to the most mature (S4) cells in the centre of the female 





Figure 3.16: CD63 receptor is expressed in the vitelline tissue of female 
worms. Alkaline phosphatase staining (Chapter 2.27) of digoxigenin-labelled 
CD63 receptor mRNA in female worms. Staining was found to be most intense in 
the outer portions of the vitellaria. F – Sexually mature female; V – Vitellarium; T 
– Tegument. A) Whole female stained for CD63 receptor. A red rectangle 
indicates the section of the image that the close-up in B) was derived from. B) 
Close-up of female mid-section. C) No signal was found in the negative control. 
 
The results of the whole mount in situ hybridisation confirm expression in the 
vitellaria of mature female worms, as suggested by the cluster analysis of RNA-
Seq data of CD63a (Smp_173150) and CD63R (Smp_155310) (Appendix A.24). 
However, CD63R expression seemed to take place in the outer regions of the 
vitellaria (Figure 3.16), possibly due to expression in particular subpopulations 
of vitelline cells. 
 
3.2.11 RNA interference 
In order to determine if CD63a and CD63R play a significant role in the 
production of eggs, RNA interference (RNAi) was used (Chapter 2.2.2). Soaking 
in dsRNA was chosen, rather than electroporation, to maintain fertility as much 
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as possible and the number laid eggs was the measured phenotype. The positive 
control knockdown, TSP-2, was successful, with qRT-PCR showing a reduction of 
mRNA levels to 0.5% of those in the negative control (see Figure 3.17).  
 
In contrast, CD63R expression was found to be higher in the treated sample 




Figure 3.17: Tetraspanin-2 expression was reduced significantly to 0.5% of 
expression in negative control. Using the ‘soaking method’, an RNAi 
knockdown of tetraspanin-2 was performed in mature females. Knocked down 
tetraspanin-2 expression was measured relative to the negative control samples 
(soaked in non-specific dsRNA) using qRT-PCR. Two biological replicates were 
used for treatment and the control group. “Proteasome 26S Subunit, Non-ATPase 
4” (PSMD4) was used as internal reference gene. The difference was found to be 







Figure 3.18: An increase in CD63R expression was observed relative to the 
negative control. RNAi knockdown in mature female worms, soaked in CD63a-
specific dsRNA, was measured relative to negative control worms (soaked in 
non-specific dsRNA) using qRT-PCR. Two biological replicates were used for 
both treatment and control. “Proteasome 26S Subunit, Non-ATPase 4” (PSMD4) 
was used as internal reference gene. The difference was found to be statistically 
non-significant (p = 0.086). Error bars represent the standard error of the mean. 
 
For CD63a, a moderate knockdown of around 35% was measured (see Figure 
3.19). In negative controls, which did not undergo reverse transcription, 
amplification was only observed over six cycles after amplification in the 
samples suggesting that the DNase treatment successfully removed most 
potential gDNA contamination (Appendix A.25). In the no template control, 
amplification was only observed over 10 cycles after amplification in the sample 
showing that little non-specific amplification was taking place (Appendix A.25). 
TSP-2 is expressed in the tegumental cell bodies (Tran et al., 2010), which may 
be more accessible to the dsRNA than the vitellarian tissue deeper inside the 
worm. This may explain why the TSP-2 knockdown was successful compared to 




Figure 3.19: A moderate knock of CD63a expression of 35% was observed. 
RNAi knockdown of CD63R was measured in mature females relative to the 
negative control (worms soaked in non-specific dsRNA) using qRT-PCR. Two 
biological replicates were used for both treatment and control. “Proteasome 26S 
Subunit, Non-ATPase 4” (PSMD4) was used as internal reference gene. The 
difference was found to be just short of statistical significance (p = 0.053). Error 










Figure 3.20: Reduction in laid eggs by the CD63a & CD63R knock-down 
worms was not statistically significant. An ANOVA showed that the 
treatment groups did not differ significantly from the negative control (p = 
0.485). Egg production was measured as a phenotype of RNAi knockdown. Eggs 
were counted two days after RNAi knockdown began. The number of eggs is 
given per female. Error bars represent the standard error of the mean of the 
three biological replicates. 
 
A moderate reduction in eggs was observed in both knockdown groups relative 
to the negative control group (see Figure 3.20), although no strong reduction in 
gene expression could be demonstrated and in the case of CD63R a 50% higher 
expression was measured compared to the negative control. However, because 
only two biological replicates could be set up for each condition, an analysis of 
variance (ANOVA) found there to be no statistically significant difference 
between the groups (p = 0.485).  
 
In the RNA-Seq data, high levels of CD63R expression were observed in mature 
females. However, the qRT-PCR analysis indicated low expression of CD63R in 
the control and the treated samples. Therefore,  I investigated whether there was 
a change in mRNA expression between freshly perfused worms and those 
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cultured in vitro for seven days, as had been done for the knockdown 
experiment. From the batch of worms used for the RNAi soaking experiment 
several worms had been placed in Trizol directly following the perfusion, which 
were used as in vivo control. 
 
The qRT-PCR analysis showed that CD63R expression was 230-fold higher in 
freshly perfused worms compared to worms after seven days in vitro, whereas 
CD63a expression was only 14-fold higher in the freshly perfused worms 
compared to worms after in vitro culture (see Figure 3.21), probably due to the 
fact that CD63a is expressed at higher base levels in all worms compared to 
CD63R. Some down-regulation of these genes in vitro had been anticipated even 
in the negative control because of the regression of female fertility in culture 
(Galanti et al., 2012). However, the extent to which expression of CD63a and 
CD63R declined was unexpected. The down-regulation in mRNA expression with 
such a large effect size both in the control and RNAi treated worms is likely to 
interfere with an accurate measurement of the effect of the RNAi treatment and 







Figure 3.21: Expression of CD63 receptor (left) and CD63 antigen (right) 
was significantly higher prior to in vitro culture. Expression was measured in 
freshly perfused (ex vivo) worms and worms cultured for seven days (in vitro). 
For both qRT-PCR reactions PSMD4 was used as internal reference gene. The 
differences in expression were statistically significant for both genes (CD63R: p = 
0.016; CD63a: p = 0.036). Error bars represent the standard error of the mean. 
 
The experiment showed that TSP-2 mRNA levels could be depleted by 
approximately 99.5% by soaking worms in dsRNA (Figure 3.17). However, the 
soaking did not reduce CD63R mRNA and only resulted in a mild reduction of 
CD63a mRNA. To facilitate better access of dsRNA molecules to the deeper 
tissues such as the vitellarium, the treatment was repeated, using 
electroporation instead of simple soaking as well as a shortening of the 
experiment from one week to 48 hours. A potential disadvantage of 
electroporation is the greater level of stress caused to the female and the impact 
on their egg production this might have, which could obscure any subtle effect 
the knockdown might have on egg production. The length of the experiment was 
also shortened to lessen the effect of in vitro culturing and reduce the decline in 





In this RNAi experiment, a very moderate reduction of about 16% in CD63R 
mRNA levels was observed (Figure 3.22). This reduction was well within the 
standard error of the normalised expression levels (see Figure 3.22). The results 
of this experiment did not allow the null hypothesis to be rejected. With more 
replicates it might be possible to determine, whether the small observed effect 
seen was reproducible or due to chance. Nonetheless, this result is an 
improvement on the previous soaking knockdown where an increase in CD63R 
mRNA levels was observed in the treated sample relative to the negative control. 
 
Figure 3.22: No significant knock-down of CD63 receptor expression was 
observed. RNAi knockdown of CD63 receptor using the ‘electroporation 
method’ was measured relative to the negative control sample (electroporated 
with non-specific dsRNA) using qRT-PCR. PSMD4 was used as internal reference 
gene. The difference in expression was not found to be statistical significant (p = 
0.822). Error bars represent the standard error of the mean.  
 
In the CD63a knockdown experiment, a statistically significant (p = 0.044) 47% 
reduction in CD63a mRNA levels was measured with much smaller standard 
errors measured compared to the CD63R knockdown (see Figure 3.23). In this 
experiment, the knockdown was found to be more successful than the soaking 
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experiment [reduction by ~35% (Figure 3.19)]. Taken together, these results 
suggest that CD63a is targetable by RNAi.  
 
For measuring expression of both CD63R and CD63a, PSMD4 was used as a 
reference gene. The negative controls, that had not been reverse transcribed, 
only showed amplification about seven cycles after the samples suggesting that 
the DNase treatment successfully removed most gDNA contamination (Appendix 
A.26). The no-template controls showed no amplification until about ten cycles 




Figure 3.23: A significant knock-down in CD63 antigen expression was 
observed. RNAi knockdown of CD63 antigen using the ‘electroporation methods’ 
was measured relative to the negative control sample (electroporated with non-
specific dsRNA) using qRT-PCR. PSMD4 was used as internal reference gene. The 
difference in gene expression was statistical significant (p = 0.044). Error bars 





Figure 3.24: The number of laid eggs was reduced significantly in the 
CD63a and CD63R knockdown worms. The number of eggs per female is 
plotted for the knockdown of CD63 antigen, the negative control and the CD63 
receptor; three replicates were available for each condition. The eggs were laid 
during the 48 hours following RNAi electroporation. An ANOVA showed that the 
treatment groups laid significantly fewer eggs compared to the negative control 
(p = 0.0156). The analysis also showed that both, the CD63a and CD63R 
knockdown resulted in a significant reduction of eggs compared to the negative 
control (CD63a: p = 0.00679; CD63R: p = 0.0201). 
 
Again, a reduction in egg laying was observed in both knockdown experiments 
(see Figure 3.24). A 9.6-fold reduction of egg laying was observed in worms with 
knocked down CD63a expression and a 3.2-fold reduction in worms with 
knocked down CD63R expression, relative to the negative control (Figure 3.24). 
Here, three biological replicates were analysed and the observed reduction in 
eggs laid was greater than in the soaking experiment (Figure 3.20). As a result, 
an ANOVA showed that the reduction in eggs laid was found to be statistically 
significant (p = 0.0156) but also that CD63a and CD63R knockdowns 
significantly affected egg production compared to the negative control (CD63a: p 
= 0.00679; CD63R: p = 0.0201). Notably, the number of eggs was overall much 
lower (approximately 10%) compared to the egg counts in the soaking 
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knockdown experiment (compare Figures 3.20 and 3.24), which might be due to 
the effect of electroporation on the females. Although only a moderate reduction 
of mRNA was observed for CD63a, the significant reduction in egg production is 
strongly suggestive of a real effect and not chance. This is especially true, as 
CD63a expression was reduced to a similar extend in the soaking experiment 
where egg laying was also reduced (albeit not statistically significant) and 
therefore showing the same trend (compare Figures 3.20 and 3.24). 
 
CD63R expression, however, was reduced to a much smaller extent (Figure 
3.23), yet a phenotype was measured at the egg laying level (Figure 3.24). This 
was also observed in the soaking experiment, where a (non-significant) 
reduction in egg production was observed (Figure 3.20). At worst, this could 
suggest that the egg laying phenotype is not a suitable phenotype, as egg 
production can be sensitive to many other factors, such as stress and injury 
caused during the perfusion. If this is the case, then a lot of random fluctuations 
should be seen within replicates. To some extent this can be seen, certainly in the 
negative control, but also CD63R (Figure 3.24). However, the egg counts for the 
CD63a were remarkably similar (5, 5 and 3 eggs in each well respectively) and 
much smaller than even the lowest negative control sample (Figure 3.24). A 
similar trend was observed in the soaking experiment, giving me further 
confidence that the observed effect of the CD63a knockdown on egg production 








The aim of this chapter was to perform an analysis of gene expression of the 
developing male and female worms inside the mammalian host. The differential 
expression analysis reproduced many findings in the published literature, 
validating the approach. The analysis of male worms showed clearly that the 
male transcriptome was largely unaffected by pairing, with only a handful of 
genes consistently differentially expressed between males from SS and MS 
infections (Leutner et al., 2013). Females on the other hand are known to mature 
in a pairing dependent manner from the fourth week of infection (Biolchini et al., 
2006), with my RNA-Seq data showing the greatest increase in differentially 
expressed genes between females from SS and MS infections between 21 and 28 
d.p.i. Also, in MS infections, egg laying was observed from 35 d.p.i. onwards in 
addition to egg production related gene expression reaching its peak at 35 and 
38 d.p.i. This includes genes encoding eggshell synthesis domain containing 
proteins, tyrosinases, extracellular superoxide dismutases, as well as genes 
coding for the tetraspanin CD63 antigen and receptor, showing that paired 
female worms reached sexual maturity around this time. Another up-regulated 
gens was TRAP1, a heat shock protein mainly localised to the mitochondria, that 
protects cells from oxidative stress by inhibiting the respiratory complex II and 
protecting the cell from apoptosis (Guzzo et al., 2014). Tyrosinases expressed in 
the vitellaria are essential for proper egg development in schistosomes 
(Fitzpatrick et al., 2007). However, tyrosinase activity is generally thought to 
result in oxidative stress, as it has been shown in other systems such as 
mosquitoes (Christensen et al., 2005). The extracellular superoxide dismutase 
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and TRAP1 may help cells in the vitellaria to cope with the oxidative stress 
resulting from the tyrosinase activity to prevent damage to the tissue and allow a 
high rate of continuous egg production. Together, the results confirmed many 
findings of the published literature (Fitzpatrick & Hoffmann, 2006; Leutner et al., 
2013) but provided a more comprehensive picture of when these sex specific 
genes become differentially expressed.  
 
When comparing male and female worms at different time points, but 
particularly at 38 d.p.i., a significant up-regulation of nicotinic receptors was 
observed in male worms (Table 3.3). Nicotinic receptors represent a group of 
drug targets in many parasitic nematodes which are targeted by anthelmintics 
such as levamisole, pyrantel and oxantel (Williamson et al., 2009). These drugs 
cause the ligand-gated ion channels to open, resulting in “prolonged muscle 
contraction and spastic paralysis of the worms” (Williamson et al., 2009). Such 
receptors have recently also become of interest as a drug targets for S. mansoni 
as described by MacDonald et al. (2014). The authors observed that the S. 
mansoni nicotinic acetylcholine receptors do not exert an excitatory effect on the 
neuromuscular system as in mammals and nematodes, but instead function as 
inhibitory neuromuscular receptors (MacDonald et al., 2014). MacDonald et al. 
(2014) localised two of these proteins to the worm surface as well as in nerves. 
Therefore, the up-regulation of neurotransmitter receptor genes in male worms 
could be the result of the greater surface area as well as greater proportion of 





During the analysis of the juvenile male worm, genes related to the cytochrome 
P450 related drug metabolism were found to be up-regulated. Cytochrome P450-
dependent metabolism plays an important role in processing praziquantel in 
humans (Li et al., 2003) but whether this is true for schistosomes is not clear. 
This pathway was found to contain several differentially expressed genes 
encoding glutathione S transferases, one of which (Smp_102070) has previously 
been shown to bind praziquantel and play an important role in the detoxification 
of S. mansoni (McTigue et al., 1995; Cardoso et al., 2003). Another GST encoding 
gene (Smp_024010) was also found to be down-regulated after 18 d.p.i.. From 
day 18 to 38, its expression decreased 21.9 and 18.2-fold in male and female 
worms respectively, potentially making the worm more susceptible to the effects 
of praziquantel. McTigue et al. (1995) showed that homodimers of GST bind 
praziquantel at the dimer interface, not in their substrate-binding site and 
concluded that praziquantel inhibits GST activity, which leads to a build-up of 
reactive oxygen species and toxic metabolites inside the parasite, in particular 
cytotoxic free radicals. Cardoso et al. (2003), on the other hand, concluded that 
the binding of praziquantel to GST had a protective effect on the worm by 
keeping praziquantel away from its real cellular target [for example voltage 
operated calcium ion channel (Nogi et al., 2009)]. Given the rapid effect of 
praziquantel on schistosomes (Xiao et al., 1985), a build-up of reactive oxygen 
species and toxic metabolites does not seems as plausible as the conclusion of 
Cardoso et al. (2003). However, in either case, a greater expression of GST 
encoding genes such as Smp_102070 and Smp_024010 would confer a protective 




When examining the expression of testes related genes, a number of interesting 
similarities and differences were observed between males from SS and MS 
infections. The comparison between male worms from MS infections at 21 and 
28 d.p.i. revealed that they appear to use a similar mechanism to prevent the 
premature proliferation of prospermatogonia as mammals. Basonuclin 2 
(Smp_138350), a testes specific gene in mammals and S. mansoni, was found to 
be up-regulated in male worms from SS and MS infections prior to pairing at 
around 28 d.p.i. Vanhoutteghem et al. (2014) reported that “basonuclin 2 is 
required for proper mitotic arrest, prevention of premature meiotic initiation 
and meiotic progression” of germ cells. In knock out mice, prospermatogonia 
multiply excessively leading to accumulation of spermatocytes and ultimately 
apoptosis during meiotic prophase (Vanhoutteghem et al., 2014). Adult male 
worms are known to produce sperm in the absence of a female partner 
(Armstrong, 1965); therefore, the role of this gene in schistosomes may be to 
allow male worms to mature sufficiently before investing energy into sperm 
production. However, differential regulation of genes potentially involved in 
sperm production were also observed. Neves et al. (2005) demonstrated 
morphological differences between the testes of males from SS and MS 
infections, despite both producing sperm.  In the male time series analysis, genes 
encoding the FGF receptor activating protein (Smp_035730, adjusted p-value = 
0.0053) and the epidermal growth factor receptor (Smp_152680, adjusted p-
value = 0.0069) were found to be up-regulated in paired males. These genes 
were shown to be expressed in the testes at significantly higher levels than in 
other organs (see Chapter 5). Both FGF and the EGF signalling pathways regulate 
cell proliferation and differentiation (Eswarakumar et al., 2005; Herbst, 2004). 
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This may assist to regulate sperm production in male worms and allow unpaired 
male worms to conserve energy. 
 
In female worms from SS and MS infections, a much larger number of 
differentially expressed genes were observed than in male worms. When 
examining females between 21 and 28 d.p.i. a large proportion of the 
significantly regulated genes were found to encode transcription factors. This 
included approximately a third of the genes up-regulated at day 21 (37/119), 
suggesting that some developmental processes finished then, but also that the 
regulation of the transcriptome is changing significantly around the time pairing 
is thought to occur. Interestingly, a comparison of females from SS and MS 
infections at 28 d.p.i. showed that down-regulation of these genes encoding 
transcription factors occurs independently of pairing at this stage of the worm 
development. Female worms became developmentally arrested around this time 
in the absence of male worms (Figure 3.2), which stimulate further maturation. 
The down-regulation of these genes coding for transcription factors probably 
marks the beginning of this developmental arrest. However, at least six genes 
encoding transcription factors were found to be up-regulated at 28 d.p.i., four of 
which were found to be consistently associated with sexual maturity in female 
worms, with expression being pairing-dependent. Expression of these four genes 
was detected at very low levels in most samples, but a significant increase in 
expression in females from MS infections was measured from 28 d.p.i. onwards. 
Although their precise function remains unknown, their expression patterns 
over the RNA-Seq time course caused them to be clustered with genes expressed 
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predominantly in the vitellaria of mature female worms. This is further evidence 
of a changing regulation of transcription in paired females.  
 
Using two clustering algorithms, MBCluster and Kohonen, a set of 76 female 
specific genes putatively involved in egg production was identified, a subset of 
which has previously been shown to play important roles in female reproduction 
(for example Fitzpatrick et al., 2007; Fitzpatrick & Hoffmann, 2006). Due to their 
functions as cell surface receptors and their potential involvement in signalling, 
the CD63 antigen and tetraspanin CD63 receptor stood out. Further investigation 
with qRT-PCR confirmed the RNA-Seq expression patterns. Both genes were 
expressed in paired females, beginning around 28 d.p.i. To get more insight into 
the role of these genes and add evidence for their role in egg production whole 
mount situ hybridisation (WISH) and RNAi knockdown experiments were 
performed for both genes. The WISH experiments showed that both genes were 
expressed in the vitellarian tissue of the female worms, although the CD63 
receptor was expressed in the outer portions of the vitellarium, whereas the 
CD63 antigen was found to be expressed throughout the vitellarian tissue. 
 
The RNAi knockdown experiment proved challenging. In the first round of 
knockdowns, using a soaking technique, the positive control, TSP-2, worked well 
with a reduction of mRNA to 0.5% of the original expression. However, 
knockdown efficiency for CD63a and CD63R was far less satisfactory. CD63a 
expression had been reduced by 35% whereas expression of CD63R was 
measured to be 53% higher after RNAi treatment compared to the control 
samples. This unexpected result may have been caused by the effects of the in 
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vitro culture. Worms were found to have significantly lower expression of CD63a 
(~14x) and CD63R (~230x) after in vitro culture, compared to freshly perfused 
worms (Figure 3.21). It has previously been shown (Galanti et al., 2012) that 
female worms lose maturity and regress outside their host even in the presence 
of male worms; however, the extent of this effect was greater than expected. In a 
repeat of this experiment, I opted to reduce the length of the in vitro culture after 
RNAi treatment to 48h, instead of 7 days. Furthermore, I chose to use 
electroporation rather than soaking in the second experiment to maximise probe 
penetration, at the expense of worm fitness. This experiment proved to be more 
successful with a measured reduction of CD63R mRNA of 16% (instead of a 
measured increase) and a reduction of CD63a mRNA of 47% (instead of 35%). 
Finally, the number of eggs laid by the RNAi treated worms was significantly 
reduced for both CD63R and CD63a by 3.2 and 9.6-fold respectively, suggesting 
that both genes play a role in the production of eggs. The CD63 antigen is known 
in humans to form complexes with integrins and act as part of signalling 
complexes that regulate cell proliferation and differentiation (Tugues et al., 
2013). For example CD63a is known to interact with syntenin-1 – an adaptor 
protein regulating vesicle formation and TGF-β mediated SMAD activation 
(Hwangbo et al., 2016) – and other adaptor proteins of the clathrin-dependent 
endocytosis pathway (Charrin et al., 2014) as well as the “tissue inhibitor of 
metalloproteinase-1” and integrins (Jung et al., 2006). The interactions with 
syntenin-1 and the adaptor proteins occur at the same location on the CD63a 
protein and are thought to be mutually exclusive (Berditchevski & Odintsova, 
2007). By interacting with syntenin-1, CD63a might play a role in the regulation 
of TGF-β signalling as well as the formation of vesicles, potentially in the 
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vitellocytes of the maturing female. Mature (S4) vitellocytes are known to 
contain a large number of vesicles containing eggshell protein precursors 
(Cogswell et al., 2012). The CD63 receptor, on the other hand, may play a role in 
endocytosis via clathrin-dependant as well as independent pathways 
(Berditchevski & Odintsova, 2007) and may aid in the formation of the vitelline 
cells’ secretory vesicles that will later go on to form the eggshells. Another 
mechanism by which CD63 antigen may regulate vitelline proliferation, namely 











Transcriptome analysis of sexually 





The sexual maturity of female schistosomes is pairing-dependent, a trait of their 
biology that requires close contact to a male partner for the ovaries and vitelline 
tissue of the female to develop fully. Female reproductive tissues regress when 
the male partner is no longer present, and regenerate upon re-pairing.  
 
Galanti et al. (2012) performed a series of experiments in order to examine the 
contribution of pairing on apoptosis and cell proliferation and the resulting 
effect on the growth and shrinkage of the female reproductive system. They 
involved culturing mature female worms ex vivo for up to 11 days either paired 
with a male or in the absence of a mate and recording their size and egg laying. 
They also measured the gene expression of an eggshell protein, p14, the rate of 
mitosis and apoptosis in female worms, which served as a marker of female 
sexual development. The results showed that both paired and single females 
regress sexually in ex vivo culture but, importantly, that paired females undergo 
this regression more slowly, retaining cellularity in their vitelline tissue and 
expressing p14 at higher levels, albeit lower than in vivo. Based on the relative 
amount of TUNEL (for apoptotic cells) and BrdU (for dividing cells) staining 
observed in paired and separated females, Galanti et al. (2012) also concluded 
that growth and shrinkage of the vitelline tissue is primarily regulated by the 
rate of apoptosis, not proliferation, and that unpaired females have more 
apoptotic cells. These results highlighted two things in particular: a pairing-
specific effect on the females that can even be observed during ex vivo culture 
and secondly that in the culture conditions used by Galanti et al. (2012), females 
145 
 
do not retain their mature state independent of the pairing status. In their 
discussion, reference is made to a richer media (Basch, 1988) that better 
supports female fertility, although still not perfectly. 
 
Work described in this chapter examined the changes in gene expression that 
take place in unpaired females compared to those that remain paired over time. 
By examining the mechanism by which female S. mansoni undergo regression of 
their reproductive tissues at the transcriptome level, new avenues for preventing 
or treating schistosomiasis may be uncovered.  
 
Following a series of testes with different culture conditions Basch medium was 
chosen for this experiment to minimise the loss of fertility of females due to ex 
vivo culture. The length of the experiment was set to 8 days, based on qPCR 
results (Galanti et al., 2012). These showed that single females expressed 
significantly lower levels of p14 than paired females from day 7 and that 
expression levels do not fall much further from then until day 11. Worms were 
perfused from mice and sorted by sex. Some males and females were 
immediately placed in separate microcentrifuge tubes containing Trizol (day 0) 
for RNA extractions. The remaining worms were split into three groups and 
maintained ex vivo using modified Basch medium (see methods). The three 
groups consisted of single male, single female and paired worms. After 4 and 8 
days, half of each group was placed in Trizol (paired worms were separated 
beforehand), RNA was extracted from all samples and RNA-Seq libraries were 




Based on the results described in Chapter 3, I expected to find a reduction of the 
expression of fertility related genes in single females when compared to paired 
females but also in paired females when compared to day 0 females. Examples of 
such fertility related genes include eggshell protein (Smp_000430), various 
eggshell synthesis domain containing proteins, major egg antigens and female 
specific genes (Smp_077900 & Smp_000290). Furthermore, based on the results 
by Galanti et al. (2012), I also expected to find evidence for increased levels of 
apoptosis in females cultured in vitro for 8 days  - especially in single females – at 
the transcriptome level.  
 
Previous publications have gathered a list of apoptosis related genes of 
Schistosoma. Peng et al. (2010) discovered and characterised an inhibitor of 
apoptosis (SjIAP) in S. japonicum, which they propose belongs to a conserved 
group of negative regulators of apoptosis with homologues in H. sapiens, C. 
elegans and D. melanogaster. Using both S. japonicum cell lysate and transformed 
human 293T cells, inhibition of apoptosis by SjIAP was demonstrated. Using the 
sequences of human genes regulating apoptosis, namely the Bcl-2 family,  Lee et 
al. (2011) identified eight Bcl-2 related genes in S. mansoni with a variety of 
domain architectures. More recently Lee et al. (2014) published a summary of 
eleven apoptosis regulating genes, including five members of the Bcl-2 family: 
Bcl-2, Bak, Bcl-2 2, BH1 and BH3. They also identified an Apaf1 homologue, four 
caspase homologues and included the S. mansoni ortholog of the SjIAP gene 
characterised by Peng et al. (2010), which they noted shares no relation to other 




Figure 4.1: Apoptosis in S. mansoni. Black arrow – activation; red arrow – 
inhibition; dashed arrow – indirect interaction. The S. mansoni apoptosis 
pathway is similar to that of mammals, including a Fas receptor homologue and 
associated proteins, a caspase cascade, involvement of the mitochondria via 
Bak/Bax and Bcl-2 homologues as well as a cell cycle dependent apoptosis 
regulators  such as PAK. Diagram modified from Lee et al. (2014) and the Kyoto 
Encyclopedia of Genes and Genomes (KEGG) website (2012). Abbreviations: 
FasR, Fas Receptor; FAF, Fas Associated Factor; FBF, Fas Binding Factor; FADD, 
Fas Associated Death Domain; Casp, Caspase; IAP, Inhibitor of Apoptosis Protein; 
APAF1, Apoptotic Protease Activating Factor; CytC, Cytochrome C; Bak, Bcl-2 
homologue antagonist/killer; Bcl, B Cell Lymphoma; BH3, Blc-2 homology 3; 
PAK1, p21 activated kinase 1; PAK1IP, PAK1 Interacting Protein; PPP1R13B, 





Despite these efforts, there are still considerable gaps in our understanding of 
the putative schistosome apoptosis pathway as summarised in Figure 4.1. The 
presence of Bak and Bax homologues in S. mansoni suggests involvement of the 
mitochondria in schistosome apoptosis as their function in other higher 
eukaryotes is to puncture the mitochondrial outer membrane and form pores in 
it (Westphal et al., 2011). Furthermore, the Bcl-2 and BH3 homologues may be 
involved in the regulation of Bak/Bax activity, which leads to permeabilisation of 
the mitochondrial outer membrane and the release of cytochrome C and 
activation of the caspase cascade (Westphal et al., 2011). In S. mansoni four 
caspase homologues have been identified which could be activated by 
cytochrome C via the apoptotic protease activating factor 1 (APAF1). Induction 
of apoptosis can occur either from within the cell, by proteins regulating the cell 
cycle and detecting critical DNA damage or by extracellular signals that stimulate 
the Fas receptor family. There are several apoptosis regulating genes that link 
the S. mansoni cell cycle to its apoptotic machinery including homologues of the 
p21 activating kinase (PAK) and an PAK interacting protein 1 (PAKIP1) as well 
as a p53 apoptosis stimulating factor (PPP1R13B). There is also a pro-apoptotic 
“death receptor”, a homologue of FAS, as well as four homologues of FAS 
receptor interacting proteins including a FAS-Associated protein with Death 
Domain (FADD) homologue, a key mediator of pro-apoptotic signalling, which 
links the Fas receptor to caspase activation in mammals.  
 
The ability of sexually mature female worms to regress to a more juvenile stage 
when unpaired is an intriguing aspect of schistosome biology. The work in this 
chapter aimed to examine how the expression of apoptosis-related genes 
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changes during the regression of female reproductive tissue. To do so, female 
worms were kept either by themselves or with a male worm in vitro for up to 
eight days. Several technical issues were encountered during the data analysis 
for this chapter, so that the focus of the chapter shifted to also examine the effect 
of in vitro culture on gene expression in male and female worms.  
 
4.2 Results 
4.2.1 Optimising culture media 
In order to maintain worms in vitro, different culturing conditions were tested, 
particularly, different media and red blood cell concentrations. The number of 
eggs laid by female worms over the course of 28 days was used as a measure for 
the healthiness of cultured worms. The tests with different culturing conditions 
showed that Basch medium resulted in an approximately 6-fold more eggs being 
laid (see Figure 4.2) compared to a less complex, RPMI-based medium (see 
Chapter 2.1.5). While female worms in Basch medium were found to have laid 
approximately 190 eggs on average, females in the RPMI based media only laid 
around 30 eggs. Using a t-test the average number of eggs for both samples was 





Figure 4.2: Significantly more eggs were laid in Basch media compared to 
RPMI. Box plot of eggs laid per female in RPMI based medium and Basch 
medium after 28 days in in vitro culture. Both groups contained 36 paired 
females. Using a Welch two sample t-test, a significant difference between the 
numbers of eggs laid by both groups was found; p < 2.2E-16.  
Furthermore, the addition of red blood cells (RBC) was shown to increase the 
rate of egg laying. 1% RBC resulted in the highest number of eggs being laid (an 
average of 178 eggs), 0.1% resulted in fewer eggs (an average of 122 eggs) and 
no RBC resulted in the lowest number of eggs being laid (an average of 86 eggs) 
(see Figure 4.3). These differences were found to be statistically significant using 





Figure 4.3: Significantly more eggs were laid in media enriched with 1.0% 
red blood cells compared to 0.0% and 0.1%. Box plot of eggs laid per female 
in Basch medium with varying amounts of red blood cells (by volume) after 28 
days in in vitro culture. All groups contained 24 paired females. Using a Welch 
two sample t-test, significant differences between the numbers of eggs laid by 
the three groups were found.  
 
For the main experiment, testing the effect of unpairing on the female 
transcriptome, the culture conditions with the best egg laying results were 
chosen: Basch medium with a 1% concentration of RBC. In total 100 worms, 50 
female and 50 male, were used in this experiment. RNA-Seq libraries in this 
experiment were obtained from single worms. 10 biological replicates were set 
up for each time point and pairing condition, however due to the small quantities 
of RNA isolated from single worms only 60 out of the 100 libraries were 
completed successfully. While for some samples the RNA extraction failed 
entirely, other samples contained degraded RNA. Overall at least four biological 
replicates were successfully produced for each samples group. At the beginning 
of the experiment (day 0) the selected females were all sexually mature and 
paired. Both groups, paired and unpaired, remained visibly unchanged by day 8, 
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except that in both groups the stomachs of female worms appeared less darkly 
coloured. This suggests that despite the addition of RBC to the Basch medium the 
rate of feeding was lower during in vitro culture.  
 
4.2.2 Apoptosis related genes 
In preparation for the functional interpretation of the differential expression 
analysis, apoptosis related genes were identified. In order to determine whether 
any significant up-regulation of apoptosis occurred in the unpaired females 
when compared to the females that remained paired throughout the 8 days, I 
first compiled a list of apoptosis related genes both from the literature (Lee et al., 
2011, 2014; Peng et al., 2010) as well as by using BLAST to identify other 
homologues of known apoptosis genes in the S. mansoni genome (see Chapter 
2.4.12). In total, 29 genes were found but two were subsequently removed (see 
Appendix B.2-10 for details on the function and domains of the apoptosis related 
genes). These two genes, Smp_041630 and Smp_043360, had been initially 
identified from the literature, but had neither relevant Pfam domains nor 
significant BLAST hits to known apoptosis related genes (Table 4.1) and were 














E value Identity Accession 
         
Smp_002410 14-3-3 protein 
epsilon  
H. sapiens 306 95% 2.00E-103 65% NP_006752.1 
Smp_009760 14-3-3 protein 
zeta/delta  
H. sapiens 301 93% 3.00E-101 64% NP_003397.1 
Smp_034840 14-3-3 protein 
epsilon isoform 
transcript variant 1 
H. sapiens 295 95% 2.00E-99 65% AAX68683.1 
Smp_032000 CED-3, isoform b  C. elegans 143 64% 5.00E-39 33% NP_001255709.1 
Smp_141270 CED-3, isoform b  C. elegans 115 32% 6.00E-28 28% NP_001255709.1 
Smp_028500 CED-3, isoform b  C. elegans 121 79% 9.00E-32 32% NP_001255709.1 
Smp_199580 Chain A, Crystal 
Structure Of Mutant 
Form Of Caspase-7 
H. sapiens 207 77% 4.00E-63 40% 4HQ0_A 
Smp_041630 Microtubule-
associated protein 
1A, isoform CRA_a  
H. sapiens 34.3 28% 1.5 27% EAW92606.1 
Smp_095190 Bak-2 protein  H. sapiens 72 67% 2.00E-14 33% AAA74467.1 
Smp_168470 Apoptosis regulator 
Bcl-2 β isoform  
H. sapiens 46.2 14% 6.00E-05 45% NP_000648.2 
Smp_213250 Chain A, Bak Domain 
Swapped Dimer 
Induced By Bidbh3 
With Chaps 
H. sapiens 90.5 24% 3.00E-19 32% 4U2U_A 
Smp_213250 bcl-2 homologous 
antagonist/killer  
H. sapiens 90.5 24% 6.00E-19 32% NP_001179.1 
Smp_043360 Chain A, Crystal 
Structure Of The 
Nudix Domain Of 
Nudt6 
H. sapiens 29.3 70% 3.4 27% 3H95_A 
Smp_044000 BAX inhibitor 1  H. sapiens 179 83% 2.00E-53 42% AAU29521.1 
Smp_072180 Apoptosis regulator 
BAX isoform delta  
H. sapiens 48.9 41% 1.00E-06 32% NP_620118.1 
Smp_210790 Protein lifeguard 4 
isoform b  
H. sapiens 171 93% 5.00E-51 44% NP_057140.2 
Smp_084610 FAS-associated factor 
2  
H. sapiens 233 87% 4.00E-69 31% NP_055428.1 
Smp_213730 Chain A, Structure Of 
The Variant Histone 
H3.3-h4 Heterodimer 
In Complex With Its 
Chaperone Daxx 
H. sapiens 146 28% 2.00E-38 39% 4HGA_A 
Smp_213730 Death domain-
associated protein 6 
isoform c  
H. sapiens 154 26% 3.00E-38 40% NP_001241646.1 
Smp_077540 FAS-associated factor 
1  
H. sapiens 182 45% 1.00E-29 28% NP_008982.1 
Smp_148130 FAS-binding factor 1  H. sapiens 83.2 53% 3.00E-15 26% NP_001074011.1 
Smp_207000 Anamorsin isoform 1  H. sapiens 122 93% 2.00E-31 31% NP_064709.2 
Smp_013040 Cathepsin D 
preproprotein  
H. sapiens 419 85% 3.00E-142 53% NP_001900.1 
Smp_136730 Cathepsin D 
preproprotein  






protein 1 isoform X1  
H. sapiens 117 53% 2.00E-28 32% XP_011513022.1 
Smp_179800 Serine/threonine-
protein kinase PAK 3 
isoform c  
H. sapiens 506 54% 6.00E-172 75% NP_001121644.1 
Smp_179800 Serine/threonine-
protein kinase PAK 3 
isoform a  
H. sapiens 504 54% 7.00E-172 75% NP_002569.1 
Smp_179800 P21-activated  
kinase 3  
H. sapiens 504 54% 1.00E-171 75% AAF67008.1 
Smp_129670 Apoptosis-
stimulating of p53 
protein 2 isoform X3  
H. sapiens 196 11% 3.00E-50 46% XP_011542572.1 
Smp_137540 Chain A, Crystal 





H. sapiens 254 63% 3.00E-73 32% 4BUR_A 




H. sapiens 253 63% 4.00E-73 32% 1M6I_A 
Smp_197180 Apoptosis inhibitor 5 
isoform b  
H. sapiens 293 98% 1.00E-90 35% NP_006586.1 
Smp_168070 Fas Receptor H. sapiens 60 21% 8.00E-09 33% EAW50150.1 
Smp_140260 Apoptotic peptidase 
activating factor, 
isoform CRA_h  
H. sapiens 147 30% 1.00E-20 22% EAW97610.1 
 
Table 4.1: Summary of Schistosoma mansoni putative apoptosis-related 
genes. This table provides S. mansoni gene IDs, product names and their Homo 
sapiens or Caenorhabditis elegans homologues with BLAST scores, e-value and 
coverage. The total score is the number of sequence matches between the query 
and the subject sequences. Query coverage is the proportion of query sequence 
covered by the subject sequence. The Expected (E) value is a measure of how 
probable the given alignment is by chance. The identity is the extent to which 
query and subject sequences have the same amino acids in the same position, 










4.2.3 Sequencing & sample clustering 
Illumina libraries were prepared from 50ng of total RNA as outlined in Chapter 
2. In total Illumina sequencing produced nearly 2.2 billion reads, with 10.7-75.8 
million reads per sample (average 36.5 million) (see Appendix B.1). Of those 
reads, on average 90% were successfully mapped to the S. mansoni reference 
genome using TopHat2 (see Appendix B.1). The unmapped reads were mostly 
multimers of adapter and PCR primers, which cannot be completely removed 
during the size selection step of library preparation.  
 
A principal component analysis was performed using DESeq2 It showed how 
well samples from each experimental group clustered together and how similar 
the groups were to one another (see Figure 4.4). Male and female samples 
clustered separately and the PCS suggests that the transcriptomes of paired and 
separated worms changed over the course of the 8-day experiment (Fig. 4.4).  
However, many samples did not cluster by treatment. While male worms from 
different time points separated relatively well, paired and separated males at 
each time point did not form discrete groups (Fig 4.4). Overall, the first two 
principal components explained 67% of the variability of samples, most of which 







Figure 4.4: Samples clustered well by gender but separated less well by 
time in vitro and pairing status. Principal component analysis (PCA) plot of 
RNA-Seq samples at 0, 4 and 8 days after perfusion. The RNA-Seq samples 
separated into female (left) and male (right) clusters but samples separate 
poorly by treatment (paired and separated). 
 
4.2.4 Comparison of pairing and separated females at day 8 
The PCA plot (Figure 4.5 B) of paired and separated females at day 8 shows that 
the separated females (blue) showed greater transcriptome variability than 
paired females. However, the groups did not separate well and in fact 
overlapped. Compared to the paired females, the PCA plot showed that separated 
females responded to separation less uniformly and that the treatment 




Figure 4.5: Most differentially expressed genes were up-regulated in 
separated females. Pair-wise comparison of paired and unpaired females at day 
8 after perfusion. A) The Log ratio against mean (MA) plot showed only one 
differentially expressed gene (marked with arrow) was up-regulated in paired 
females, all others in separated females. Blue lines indicate 2-fold expression 
change. B) A principal component analysis of RNA-Seq data from paired and 
separated females. The gene expression data of separated females grouped less 
tightly but overlapped with the data of paired female samples. 
 
Out of a total of 10,828 genes with non-zero read counts, 9464 (92%) were 
removed from the analysis using the DESeq2 independent filtering algorithm, 
and 297 were removed as outliers, based on their Cook cut-offs (Chapter 2.4.4), a 
single gene (Fig 4.6) was found to be up-regulated in paired females but 149 
were up-regulated in single females (see Appendix B.11 for expression data of 
the DEGs of this chapter). Due to the high variability between biological 
replicates (Fig 4.5 B) the RNA-Seq analysis yielded a relatively low number of 
differentially expressed genes when compared to Chapters 3 and 5. Here, the 
default p-value threshold for the DESeq2 package (adjusted p-value < 0.1) was 
used to determine significance. In Chapters 3 and 5, the large number of 
identified DEGs allowed for a more stringent selection to remove a higher 
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proportion of false positive results. To increase the statistical power of this 
analysis, DESeq2 removed a large proportion of genes from this part of the 
analysis based on the independent filtering algorithm, as mentioned above. 
Genes with a smaller average expression than 6350 reads per sample were 
removed from this comparison. This is done to remove genes with low absolute 
expression, which have little chance of being found to be differentially expressed. 
As a result, the p-values of the remaining genes have to be adjusted less harshly 
for multiple hypothesis testing. 
 
The gene found to be up-regulated in paired females codes for the major egg 
antigen (p40) (Smp_049270; 3.7x change, adjusted p-value = 0.046) (Table 4.2). 
Finding reproduction and fertility related genes up-regulated in the paired 
females was expected; however, many of the genes found to be up-regulated in 
the unpaired females were also associated with these aspects of female biology 
(Appendix B.11). These include genes coding for an eggshell protein 
(Smp_000430; 3.6x change, adjusted p-value = 0.089) and a trematode eggshell 
synthesis domain containing protein (Smp_077890; 3.0x change, adjusted p-
value = 0.089). Furthermore, genes found in Chapter 3 to be associated with 
pairing in vivo were found to be expressed at significantly higher levels in the 
single females compared with the paired females, including the genes coding for 
the CD63 receptor (Smp_155310; 3.8x change, adjusted p-value = 0.078) and the 
CD63 antigen (Smp_173150; 3.1x change, adjusted p-value = 0.089) which were 
the 9th and 27th most up-regulated genes in single females respectively 
(Appendix B.11). A striking number of mitochondrial genes (8 out 150 DEGs), 
but even more ribosomal genes (48 out 150 DEGs) was found to be differentially 
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expressed, suggesting that unpaired females have a higher metabolic rate and 
greater rate of protein synthesis, both of which seems contradictory to the 
published literature given that pairing is associated with growth and 
reproduction (Fitzpatrick & Hoffmann, 2006; Sun et al., 2015). None of the 
apoptosis related genes from my gene set were found to be differentially 
expressed (see Appendix B.11).  
 







Smp_074390 7340.6 4.242 0.033 Eukaryotic translation initiation factor binding 
protein 
Smp_131110 177674.7 4.205 0.053 Uncharacterised protein 
Smp_018930 7063.7 4.011 0.053 Uncharacterised protein 
Smp_095980 30236.6 3.838 0.070 Extracellular superoxide dismutase (Cu Zn) 
Smp_155310 8225.5 3.760 0.078 Tetraspanin CD63 receptor 
Smp_023840 12609.0 3.758 0.053 Uncharacterised protein 
Smp_900040 112222.7 3.631 0.064 Uncharacterised protein 
Smp_000430 75350.6 3.607 0.089 Trematode eggshell synthesis protein 
Smp_900100 57478.3 3.603 0.065 NADH dehydrogenase subunit 3 
Smp_202690 15523.4 3.599 0.053 Putative universal stress protein 
Smp_006040 11467.1 3.563 0.053 Uncharacterised protein 
Smp_145370 6960.2 3.540 0.033 Uncharacterised protein 
Smp_090520 9271.9 3.434 0.064 Purine nucleoside phosphorylase 
Smp_241620 82078.6 3.373 0.089 Uncharacterised protein 
Smp_054160 135853.5 3.328 0.053 Glutathione S-transferase 
Smp_900050 227094.7 3.260 0.070 NADH dehydrogenase subunit 5 
Smp_043120 41091.7 3.179 0.065 Universal stress protein 
Smp_058690 20056.6 3.022 0.088 Glutathione peroxidase 
Smp_158110 9316.0 2.257 0.053 Putative thioredoxin peroxidase 
Smp_079770 41164.0 1.642 0.033 Putative disulfide-isomerase ER-60 
Smp_049270 24812.2 0.267 0.045 Major egg antigen (p40) 
 
Table 4.2: The 20 most differentially expressed genes identified in the 
comparison of paired and separated females at day 8 after perfusion. 
Average read counts provide a measure of absolute expression for a given gene. 
The fold changes reflect expression in separated females relative to paired 
females. Notably only a single gene (Smp_049270) was significantly up-regulated 






Figure 4.6: Biological replicates of separated females have great variability 
in gene expression. This is a box whisker plots of normalised read counts, a 
measure for absolute gene expression, for all RNA-Seq samples of paired and 
separated females at day 8 after perfusion. In all genes, with the exception of 
Smp_049270 (coding for the major egg antigen), the expression is less uniform 
and more variable in the separated females compared to paired females.  
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4.2.5 Comparison of pairing and separated males at day 8 
The PCA plot (Figure 4.7 B) of paired and separated males at day 8 shows three 
relative outliers, one from the separated and two from the paired males.  The 
remaining samples there do not separate into two groups but overlap. Given that 
pairing has been shown to have a very limited impact on the male transcriptome 
(Leutner et al., 2013), it was not surprising that separation only had a small 
effect on the transcriptome. Furthermore, as the MA plot (Figure 4.7 A) shows, 




Figure 4.7: The low number of differentially expressed genes between 
separated and paired males has small fold changes. Pair-wise comparison of 
paired and separated males at day 8 after perfusion. A) The log ratio vs mean 
(MA) plot showed that none of the differentially expressed genes have a fold 
change greater than 2 (log2 fold change > 1), indicated by the blue lines. This 
small effect size stood in contrast to the female comparison where much bigger 
fold changes in expression were found. B) Principal component analysis of 
paired and separated males showed outliers in both groups but also that the two 





In the comparison of female samples, differential expression analysis identified 
only 150 DEGs despite there being over 900 genes with greater than two-fold 
change in expression (Figure 4.5), the result of high variance within biological 
replicates (Figure 4.6). In this comparison of male worms on the other hand, 42 
DEGs were identified but not a single gene was found to have a greater than two-
fold change in expression (Table 4.3). 
 
In the comparison of paired and separated male worms at day 8, a total of 18 
genes were found to be up-regulated in paired, and 24 genes up-regulated 
separated males (Fig. 4.7A and Table 4.3). This is out of a total of 10172 genes 
with non-zero read counts, of which 2029 (20%) were removed using the 
independent filtering algorithm of DESeq2. The cut-off used for filtering was a 
mean expression of fewer than 78 reads. The cut-off used to determine 
differential expression was again an adjusted p-value < 0.1, which is the DESeq2 
default. Noticeably, unlike in the female comparison where the median fold 
change of DEGs was 2.5x change, the fold changes for the male DEGs were 
smaller, ranging from 1.8x change in expression to as small as 1.12x change, with 
a median fold change of only 1.3x for DEGs (Table 4.3).  Several genes encoding 
proteins with structural functions were differentially expressed in separated 
males (Table 4.3). These included two actin homologues (Smp_183710 and 
Smp_046600), two tegument allergen-like proteins (Smp_086480 and 
Smp_077310) and two tubulin chains (Smp_103790 and Smp_192110) (Table 
4.3). In contrast, the genes coding for an endothelin 2 homologue (Smp_122030) 











Smp_169090 343.6 1.788 5.81E-04 Solute carrier family 43 
Smp_128010 236.6 1.677 2.91E-03 Uncharacterised protein 
Smp_074710 89.7 1.522 0.025 Putative pleckstrin homologue 
Smp_159370 402.8 1.424 0.046 Endothelin-converting protein 
Smp_151090 871.1 1.379 0.083 Large neutral amino acid transporter 
Smp_005360 602.4 1.367 0.069 Uncharacterised protein 
Smp_181140 2835.8 1.348 0.095 Uncharacterised protein 
Smp_128680 1857.2 1.337 2.91E-03 SN1-specific diacylglycerol lipase β 
Smp_158190 574.9 1.269 0.079 Transmembrane protein 184B 
Smp_155750 2164.2 1.255 2.91E-03 Non-lysosomal glucosylceramidase 
Smp_040720 2188.0 1.228 0.069 Uncharacterised protein 
Smp_141380 1057.2 1.227 5.19E-03 Serine/threonine-protein kinase VRK1 
Smp_162260 2299.6 1.215 0.027 Phosphatidylinositol-binding clathrin 
assembly protein unc-11 
Smp_128300 1414.6 1.196 0.018 Putative ragulator complex protein LAMTOR2 
Smp_008260 2864.2 1.190 0.089 Glycogen synthase kinase-3 
Smp_034940 9109.6 1.179 0.068 Uncharacterised protein 
Smp_122030 2532.3 1.162 0.095 Endophilin A2 
Smp_164210 2893.6 1.151 5.19E-03 Synaptosomal-associated protein 
Smp_085530 11478.5 0.886 0.080 Synapse-associated protein 
Smp_052810 6968.3 0.871 0.052 Glucose-6-phosphate 1-dehydrogenase 
Smp_046600 34020.0 0.819 0.018 Actin 
Smp_073940 5863.5 0.813 0.027 Putative flare homologue 
Smp_183710 48864.4 0.811 0.012 Actin 
Smp_132550 236.0 0.795 0.088 Centrosomal protein POC5 
Smp_128860 1315.1 0.784 0.025 Lysyl oxidase homologue 
Smp_151800 117.0 0.765 0.038 Uncharacterised protein 
Smp_141290 21544.6 0.764 0.079 Innexin unc-9 
Smp_068180 388.4 0.763 0.015 Protein lysine oxidase 
Smp_037900 788.4 0.756 0.033 β-lactamase-like protein 
Smp_089320 4894.3 0.752 0.058 Uncharacterised protein 
Smp_152990 162.3 0.724 0.089 Tetraspanin 
Smp_103790 1076.8 0.722 5.81E-04 Tubulin α-1A chain 
Smp_159090 1206.9 0.707 0.046 Uncharacterised protein 
Smp_192110 1065.9 0.706 5.67E-03 Tubulin β 
Smp_054160 134550.5 0.702 9.56E-03 Glutathione S-Transferase 
Smp_212720 307.8 0.701 0.093 Methylmalonyl-CoA epimerase, mitochondrial 
precursor 
Smp_086480 15779.4 0.701 0.069 Tegument allergen-like protein 
Smp_150150 336.3 0.686 3.59E-03 Uncharacterised protein 
Smp_015100 345.7 0.663 2.91E-03 Uncharacterised protein 
Smp_077310 622.1 0.636 1.76E-03 Tegument allergen-like protein 
Smp_157690 325.1 0.635 0.015 Putative zonadhesin 




Table 4.3: A list of all genes differentially expressed between the RNA-Seq 
samples of paired and separated males at day 8 after perfusion. The average 
read counts provide a measure of absolute expression for a given gene. The fold 
changes reflect expression in separated males relative to paired males. That 
means fold changes greater than 0 are up-regulated separated males, and those 
smaller than 0 are down-regulated in separated males. The p-value has been 
adjusted for multiple hypothesis testing. 
 
 
4.2.6 Time series analysis 
Female Time Series Analysis 
The pairwise comparison of female RNA-Seq samples at day 8 was noisy and 
highly enriched for ribosomal and mitochondrial genes. To overcome this 
problem, I analysed a time-series that combined the data of all female samples 
over the whole time course of day 0, 4 and 8. The aim was to generate a more 
accurate list of differentially expressed genes. This approach should allow for a 
better estimate of variation between biological replicates as well as between 




Figure 4.8: In this Principal component analysis plot female samples 
separate by time, but not pairing status. This is a PCA plot of a time series 
analysis of female samples at 0, 4 and 8 days after perfusion. The PCA shows high 
variance between the separated females at day 8 after perfusion but paired and 
separated samples overlap and do not separate into distinct groups.  
 
By using a likelihood ratio test, genes were identified that were expressed in a 
pairing specific manner (Table 4.4). Paired and separated females at day 0, 
where no differences should be observed, were used to control for differences 
between the groups at the later time points. The day 0 samples are also 
compared against later time points to identify changes in gene expression over 
time. Out of 10439 genes with non-zero read counts, 9848 (94%; mean 
expression cut-off of fewer than 6545 reads) were filtered out by the DESeq2 
independent filtering algorithm, 52 were removed as outliers and in total 103 
DEGs were identified (adjusted p-value > 0.1), one of which was up-regulated in 
paired females. The remaining 102 DEGs were up-regulated in separated females 
(Table 4.4). As in the previously described pair-wise analysis, Smp_049270 












































0.017) but the number of genes up-regulated in separated females was 30% 
smaller compared to the pair-wise comparison (103 compared to 150 DEGs).  
 







Smp_000280 17110.6 3.16 0.017 Trematode eggshell synthesis domain 
containing protein 
Smp_000390 7664.0 3.36 0.017 Trematode eggshell synthesis domain 
containing protein 
Smp_000420 17283.8 3.18 0.017 Uncharacterised protein 
Smp_000430 45222.4 3.61 0.017 Trematode eggshell synthesis domain 
containing protein 
Smp_006040 7682.4 3.56 0.019 Uncharacterised protein 
Smp_009230 103686.8 3.60 0.081 Uncharacterised protein 
Smp_014610 59748.7 3.37 0.017 P48 eggshell protein 
Smp_023840 9114.0 3.76 0.017 Uncharacterised protein 
Smp_049270 17664.8 0.267 0.017 Major egg antigen 
Smp_054160 88898.5 3.33 0.025 Glutathione S-Transferase 
Smp_058690 15222.5 3.02 0.025 Glutathione peroxidase 
Smp_071000 6733.1 2.98 0.047 Proteasome subunit 
Smp_077890 8954.8 2.97 0.025 Uncharacterised protein 
Smp_087760 13520.1 3.06 0.071 Ferritin heavy chain 
Smp_090520 7336.1 3.43 0.025 Purine nucleoside phosphorylase 
Smp_095980 19016.7 3.84 0.017 Extracellular superoxide dismutase 
Smp_131110 108668.3 4.21 0.017 Uncharacterised protein 
Smp_138570 7169.2 3.36 0.017 Uncharacterised protein 
Smp_173150 7836.9 3.11 0.024 Tetraspanin CD63 antigen 
Smp_191910 53312.1 3.24 0.017 Uncharacterised protein 
Smp_202690 10689.7 3.60 0.039 Uncharacterised protein 
Smp_202770 9022.0 3.00 0.076 Uncharacterised protein 
Smp_203090 23497.7 3.60 0.076 Uncharacterised protein 
Smp_900040 67182.0 3.63 0.017 Uncharacterised protein 
Smp_900100 34224.6 3.60 0.019 NADH dehydrogenase subunit 3 
 
Table 4.4: Table of the 25 most differentially expressed genes identified in 
the female time series analysis. The average read counts provide a measure of 
absolute expression for a given gene. The fold changes provided are expression 
at day 8 in separated females relative to paired females. That means fold changes 
greater than 0 are up-regulated separated females, and those smaller than 0 are 







The DEGs up-regulated in separated females still included a large number of 
fertility-related genes, such as genes coding for trematode eggshell synthesis 
domain containing proteins and an extracellular superoxide dismutase (Table 
4.4). Furthermore, many ribosomal and mitochondrial genes were up-regulated 
in separated females compared to paired females. This resembles the results 
from earlier comparison of paired and separated females at day 8 (Chapter 
4.2.4). The greatest factor influencing the transcriptome of these worms is 
certainly the time spent in vitro, as indicated by the results in Chapter 3.2.11 as 
well as the PCA plot (Figure 4.4). Together with the great variability in gene 
expression found in the separated females (see Figure 4.6), this may explain 
these unexpected results to some extent.  
 
Male Time Series Analysis 
The PCA plot (Figure 4.9) revealed that the variability of the biological replicates 
increased over time. Out of 10336 genes with non-zero read counts, none were 
filtered out by the DESeq2 independent filtering algorithm, compared to the 94% 
of genes filtered out in the female time series analysis (94%) as a result of lower 
overall variability across biological replicates. No genes were identified to be 
outliers based on the Cook cut-off. Using the same threshold for significance as 
for the female samples (adjusted p-value < 0.1) 23 genes were significantly up-
regulated in separated males and 25 up-regulated in paired males.  
 
Among the up-regulated DEGs in paired males was a genes coding for the 
serine:threonine kinase VRK1 (Smp_141380, 1.2x change, adjusted p-value = 
0.084) (Table 4.5), which is known to be involved in regulating proliferation of 
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reproductive tissues in schistosomes (Vanderstraete et al., 2014). Also, up-
regulated were genes coding for a tyrosine phosphatase receptor (Smp_156870, 
1.34x change, adjusted p-value = 0.004) as well as a DPY-30 homologue 
(Smp_026440, 1.8x change, adjusted p-value = 0.025) (Table 4.5).  
 
 
Figure 4.9: In this Principal component analysis male RNA-Seq samples do 
not separate by pairing status. This is a PCA plot of the time series analysis of 
male samples at 0, 4 and 8 days after perfusion. The PCA shows more variance 
between samples at day 4 and especially day 8 when compared to the day 0 
samples.  
 
Genes expressed significantly higher in separated males included genes coding 
for a tetraspanin (Smp_152990, 1.69x change, 0.024) and a spermatogenesis 
associated protein homologue (Smp_145360, 1.93x change, 0.030) (Table 4.5), a 
protein that in humans is needed for production of healthy spermatocytes 
(Bornstein et al., 2011). Furthermore, two signalling related genes were found 


















































(Smp_245810, 1.6x change, adjusted p-value = 0.030), a group of heparin 
sulphate proteoglycans that regulate developmental pathways including Wnt 
(Filmus et al., 2008), and a delta-like protein D homologue (Smp_135370, 3.3x 
change, adjusted p-value = 0.089), which is a member of the Notch signalling 
pathway (Gray et al., 1999). The Notch and Wnt signalling pathways both play 
crucial roles in the regulation of cell fate determination in animal development 





























Smp_077610 70.4 1.33E-03 3.57E-12 Uncharacterised protein 
Smp_128680 1850.3 0.84 6.63E-07 Putative SN1-specific diacylglycerol lipase β 
Smp_159370 296.7 0.89 1.80E-04 Endothelin converting enzyme 1 
Smp_130500 96.6 0.49 4.60E-04 Uncharacterised protein 
Smp_155750 1925.7 0.79 3.40E-03 Putative non-lysosomal glucosylceramidase 
Smp_156870 467.0 0.74 4.03E-03 Tyrosine phosphatase receptor 
Smp_042210 528.5 2.60 1.21E-02 Origin recognition complex subunit 
Smp_041700 174.8 0.50 1.21E-02 Uncharacterised protein 
Smp_144380 98.9 1.69 2.24E-02 Homeobox protein 
Smp_152990 123.0 2.01 2.24E-02 Tetraspanin 
Smp_078640 1996.0 0.78 2.24E-02 Like-sM3, small nuclear ribonucleoprotein 
Smp_076540 777.6 0.91 2.24E-02 Dynein regulatory complex subunit 
Smp_026440 210.5 0.54 2.49E-02 DYP-30 protein 
Smp_103790 883.2 1.38 2.56E-02 Tubulin-α chain 
Smp_194720 1872.6 2.22 2.56E-02 Uncharacterised protein 
Smp_245810 176.2 1.93 2.96E-02 Putative glypican homologue 
Smp_145360 349.1 3.04 2.96E-02 Spermatogenesis associated protein  
Smp_034940 7930.4 0.72 2.96E-02 Uncharacterised protein 
Smp_187190 550.0 0.81 2.96E-02 Innexin unc 9 
Smp_212110 99.1 1.14 2.98E-02 Uncharacterised protein 
Smp_202120 40.9 0.96 3.78E-02 Hox class homeodomain protein 
Smp_125070 1778.4 1.12 4.75E-02 Cystathionine-β synthase 
Smp_037900 683.3 1.26 4.75E-02 β-lactamase domain containing protein 
Smp_143300 323.3 0.91 5.42E-02 Neurogenic locus Notch homologue 
Smp_063500 1304.9 1.11 7.71E-02 Uncharacterised protein 
 
Table 4.5: The 25 most differentially expressed genes of the male time 
series analysis of paired and separated males at 0, 4 and 8 days after 
perfusion. The average read counts provide a measure of absolute expression 
for a given gene. The fold changes are provided for the expression in separated 
males relative to paired males. That means fold changes greater than 0 are up-
regulated separated males, and those smaller than 0 are down-regulated in 
separated males. The p-value has been adjusted for multiple hypothesis testing. 
 
 
I decided to also include in my thesis an analysis of the transcriptome changes 
that take place in male and female worms over the course of 8 days, grown in 
vitro, and how these changes relate to sexual regression, nutrient metabolism 
and other aspects of worm biology affected by the in vitro culture. For this 
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comparison samples of paired females at day 8 were used as they were shown to 
have relatively less variability across biological replicates compared to separated 
females (see Figure 4.5). 
 
4.2.7 Comparison of females before and after in vitro culture 
After 8 days, females in in vitro culture differentially expressed hundreds of 
genes compared to their day 0 counterparts, which were placed in Trizol 
immediately after perfusion and thus did not experience in vitro culture. Out of 
10498 genes with non-zero read counts, DESeq2 filtered out 472 (4.5%) genes 
with a mean expression of fewer than 1.1 reads and 105 outliers were identified 
using the default Cook cut-off of DESeq2 and subsequently removed from the 
analysis. This reflects the relatively lower variability in these samples compared 
to the separated females (D8FS) where 94% of genes were filtered out. Of the 
remaining genes 696 (6.4%) were significantly down-regulated and 778 (7.2%) 







Figure 4.10: In vitro culture of Schistosoma mansoni induces a great 
magnitude of changes in gene expression in female worms. Pair-wise 
comparison of female worms at day 0 and day 8 after perfusion. A) A plot of the 
log ratio against the mean expression showed a large numbers of genes 
significantly up-regulated (red) in both groups with large fold changes. Triangles 
indicate genes outside the boundaries of the plots; like other genes, they are red 
if they are statistically significant, grey if they are not. B) The principal 
component analysis shows that females samples separate well into two groups 
based on principal component 1 (57% of observed variance). These results 
demonstrate the significant effect of in vitro culture on the female transcriptome.  
 
Among the most down-regulated genes were several coding for proteins that are 
important for digestion, in particular lysosomes, such as saposin-related 
proteins, a lysosomal Pro-X carboxypeptidase and cathepsin B (Table 4.6). These 
proteins help to break down macromolecules such as proteins and lipids taken 
up in autophagic or phagocytic vacuoles to make these nutrients available to the 
cell metabolism (Luzio et al., 2007). Other down-regulated genes included those 
coding for the transmembrane protein 60, 2 zinc finger proteins, a nogo B 




Both CD63 genes that were found to be significantly up-regulated in mature, 
paired females in the previous chapter – Smp_173150 & Smp_155310 – were 
found to be significantly down-regulated in females after in vitro culture. 
Smp_173150 was 5.35x down-regulated (adjusted p-value = 9.21E-11) and 
Smp_155310 was 6.27x down-regulated (adjusted p-value = 0.00026) (Table 
4.6). These results are similar to those from the RNAi experiment in Chapter 3 
where in vitro culturing was found to lead to a significant down-regulation of the 
CD63 receptor and antigen transcripts. The lower p-value of Smp_155310 
compared to Smp_173150 is the result of lower expression levels of Smp_155310 
(~40% of the expression level of Smp_173150; see Table 4.6).  
 
KEGG pathway enrichment analysis showed that the lysosome (smm04142) was 
the most significantly down-regulated of 14 pathways involving the metabolism 
of different amino acids, lipids and carbohydrates (Table 4.7). The second most 
significantly down-regulated pathway was sphingolipid metabolism 
(smm00600; p-value = 0.002): the genes coding for ceramide synthase 
(Smp_042440) and ceramide kinase (Smp_130110) were down-regulated 2.54x 
(adjusted p-value = 1.03E-06) and 2.06x (adjusted p-value = 2.91E-10) 
respectively (Table 4.6).  
 
Pfam domain enrichment (Table 4.8) revealed a striking down-regulation of 
genes coding for proteins with trematode eggshell synthesis domains, with 10 
out of 11 genes containing such a domain being down-regulated after eight days 
outside the host (p-value = 2.05E-11), which is consistent with a decline of egg 
being laid in vitro and a reduction in the expression of associated genes that has 
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been observed before (Galanti et al., 2012). Smp_000430, the only gene of this 
group not to be down-regulated significantly, fell narrowly short of the 
significance threshold (adjusted p-value = 0.013) despite a 3.7x reduction of 
expression (Table 4.6). Across all of the differentially expressed genes found in 
this comparison of females before and after 8 days in in vitro culture, the down-
regulation of genes coding for trematode egg shell synthesis domain-containing 
genes (Table 4.7) is the most compelling evidence that reproductive activity is 



























Smp_181070 25744.6 11.15 1.24E-35 Uncharacterised protein 
Smp_137700 2087.4 10.19 3.24E-19 Zinc finger, C2H2 type domain containing protein 
Smp_137720 8610.1 10.15 2.64E-23 Saposin B domain containing protein 
Smp_016490 38084.7 10.10 5.52E-35 Saposin B domain containing protein 
Smp_146180 1081.7 9.87 1.72E-16 Sterol esterase 2 
Smp_139160 29285.6 9.74 3.13E-16 Cathepsin L 
Smp_000500 40.4 9.48 2.47E-13 Uncharacterised protein 
Smp_153070 2421.8 9.22 7.66E-29 Uncharacterised protein 
Smp_136730 17432.3 9.16 1.61E-15 Streptomycin 3-adenylyltransferase 1 
Smp_194910 168333.1 9.11 3.81E-23 Saposin B domain containing protein 
Smp_130100 56762.1 9.08 1.67E-16 Saposin domain containing protein 
Smp_105450 86662.2 8.85 6.73E-18 Saposin domain containing protein 
Smp_202610 10354.1 8.34 2.44E-13 Uncharacterised protein 
Smp_028870 28335.4 8.30 2.50E-17 Zinc finger, C2H2 type domain containing protein 
Smp_139240 16693.6 8.17 1.03E-12 Cathepsin S 
Smp_085180 1027.4 7.85 9.75E-13 Cathepsin B 
Smp_002600 21358.8 7.67 7.59E-25 Lysosomal Pro X carboxypeptidase 
Smp_158150 584.4 7.42 1.98E-07 Reticulocalbin 2 
Smp_187140 17722.6 7.42 2.95E-11 Cathepsin L proteinase 
Smp_131500 3612.4 6.14 7.47E-20 Transmembrane protein 60 
Smp_126340 122.6 6.12 2.37E-07 Uncharacterised protein 
Smp_170560 173.9 6.07 4.27E-16 Parathyroid hormone 2 receptor 
Smp_155310 1513.5 5.30 2.58E-04 Tetraspanin CD63 receptor 
Smp_173150 3910.5 4.84 9.21E-11 CD63 antigen 
Smp_038330 1601.7 3.40 6.86E-17 Nogo B receptor 
Smp_042440 1457.1 2.68 1.03E-06 Ceramide synthase 
Smp_130110 1423.8 2.09 2.91E-10 Ceramide kinase 
 
Table 4.6: A selection of significantly down-regulated genes from the 
comparison of female Schistosoma mansoni at day 8 compared to day 0 in 
vitro. This table contains the 20 most significantly down-regulated genes as well 
as those specifically mentioned in the results. The average read counts provide a 
measure of absolute expression for a given gene. The fold changes are the gene 

















smm04142 Lysosome 15 47 1.66E-05 
smm00600 Sphingolipid metabolism 6 15 1.72E-03 
smm00330 Arginine and proline metabolism 6 18 4.69E-03 
smm00531 Glycosaminoglycan degradation 2 2 9.64E-03 
smm00630 Glyoxylate and dicarboxylate metabolism 4 10 1.04E-02 
smm00561 Glycerolipid metabolism 5 17 1.62E-02 
smm00920 Sulfur metabolism 3 7 2.19E-02 
smm00604 Glycosphingolipid biosynthesis - ganglio series 2 3 2.61E-02 
smm00830 Retinol metabolism 2 3 2.61E-02 
smm00511 Other glycan degradation 3 8 3.16E-02 
smm00480 Glutathione metabolism 4 14 3.30E-02 
smm00350 Tyrosine metabolism 3 9 4.27E-02 
smm00053 Ascorbate and aldarate metabolism 2 4 4.71E-02 
smm00360 Phenylalanine metabolism 2 4 4.71E-02 
 
Table 4.7: KEGG pathways enriched amongst the significantly down-
regulated genes in females at day 8 after perfusion compared to females at 
day 0 females. The column “Significant Genes” provides the number of genes in 
a given pathway that were down-regulated in day 8 females; “Total Genes” is the 
total number of genes in the pathway. 
 





PF08034 Trematode eggshell synthesis protein 10 11 2.05E-11 
PF00112 Papain family cysteine protease 9 16 2.09E-07 
PF00255 Glutathione peroxidase 3 3 3.15E-04 
PF01008 Initiation factor 2 subunit family 3 3 3.15E-04 
PF03982 Diacylglycerol acyltransferase 3 3 3.15E-04 
PF04261 Dyp-type peroxidase family 3 3 3.15E-04 
PF03062 MBOAT, membrane-bound O-acyltransferase 
family 
4 8 1.13E-03 
PF08127 Peptidase family C1 propeptide 3 4 1.17E-03 
PF00106 Short chain dehydrogenase 7 27 1.45E-03 
PF00789 UBX domain 3 5 2.74E-03 
 
Table 4.8: A table of the 10 Pfam domains found to be most significantly 
enriched among the genes which were down-regulated in females on day 8 
after perfusion compared to females at day 0. The column “Significant Genes” 
provides the number of genes encoding a given domain that were down-
regulated in day 8 females; “Total Genes” is the total number of S. mansoni genes 
containing the domain. 
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Among the most up-regulated DEGs (Table 4.9) were several genes coding for 
proteins with proteolysis related functions such as E3 ubiquitin protein ligase 
and the peptidase inhibitor 16.  Another gene, coding for an S9 family non-
peptidase homologue, was also found up-regulated although, as the name 
suggests, it does not have peptidase activity. Furthermore, genes coding for a DC 
STAMP domain protein, otopetrin, and sortilin were up-regulated as well as 
many cell adhesion related proteins including innexin and protocadherin 1. 
 
An analysis of KEGG pathways showed extracellular matrix (ECM) receptor 
interactions to be the most significantly up-regulated pathway after 8 days (p-
value = 0.00013). The analysis also showed that many genes coding for protein 
domains associated with the ECM were expressed at higher frequency than 
expected by chance. This included genes coding for proteins with the following 
domains: cadherin (p-value = 1.38E-13), laminin N-terminal (p-value = 0.0053), 
laminin G (p-value = 0.013), annexin (p-value = 0.017), and fibronectin type III 
(p-value = 0.024). The above pathways are summarised in Table 4.10. 
 
Pathway analysis further showed up-regulation of developmental signalling 
pathways, such as the Jak-STAT, Wnt, Notch, mTOR, FoxO and Hedgehog 
signalling pathway as well as neuroactive ligand-receptor interactions after 8 
day in vitro (Table 4.10). Neural processes are involved in the maintenance of the 
female germline (Collins et al., 2010) and their differential expression in this 
experiment may be further evidence for that function. Furthermore, the analysis 
of Pfam domains showed that genes coding for proteins with several closely 
related epidermal growth factor (EGF) domains were up-regulated at a higher 
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frequency than expected by chance. These included a total of 16 genes (Table 
4.11). Up-regulation of growth factors was unexpected because these females 
were thought to be in the process of reducing their reproductive capacity, 
particularly egg production. Out of the 16 up-regulated genes with EGF domains, 
eight are involved in extracellular matrix receptor interactions, the pathway 
most significantly enriched with genes up-regulated in day 8 females (Table 
4.10). These protein products of these genes play an important role in tissue 
remodelling and the regulation of cell survival (Gray et al., 1999). Of the 
remaining eight genes, five code for neurogenic locus notch proteins, members of 
the significantly up-regulated notch signalling pathway (Table 4.10). Notch 
proteins are a group of proteins thought to be essential for maintenance of 
neuronal progenitor cells as well as neurogenesis (Zhou et al., 2010). In total 
eight neurogenic locus notch proteins are annotated in the Schistosoma genome, 
five of them are differentially up-regulated after 8 days in vitro and the 
remaining 3 are not differentially expressed (Table 4.9). The Pfam domain 
enrichment analysis revealed another group of genes with neural related 
functions called semaphorins to be up-regulated significantly (Smp_159050, 
1.89x change, adjusted p-value = 0.00053; Smp_158550, 1.4x change, adjusted p-
value = 0.028; Smp_132520, 6.97x change, adjusted p-value = 1.22E-07) (Table 
4.9). These genes encode proteins that are either membrane bound or secreted 
and act as inhibitors of axon growth, thus helping to regulate neurone 
development (Bashaw & Klein, 2010). In addition to the semaphorin genes a 
homologue of the SLIT gene was up-regulated in these female worms 
(Smp_147470, 2.30x change, adjusted p-value = 0.0013) (Table 4.9), which also 
regulates axon growth in D. melanogaster and H. sapiens (Bashaw & Klein, 2010). 
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Two genes coding for homologues of slit-interacting protein (Smp_132540, 3.57x 
change, adjusted p-value = 2.89E-08; Smp_028030, 1.88x change, adjusted p-
value = 7.21E-05) were also up-regulated. Furthermore, the significantly up-
regulated Wnt signalling pathway (Table 4.10), is known to help establish a 
growth axis within developing axons (Mulligan & Cheyette, 2012).  
 
 
Figure 4.11: Many genes involved in axon development became up-
regulated in vitro. Heatmap of neurogenesis related genes in female worms at 
day 0 (three replicates: D0 F1-3) and day 8 (four replicates: D8 F1-4).  Colours 
represent a Z score of log transformed normalised read counts scaled by row, 
giving relative measures of gene expression in each sample. Average normalised 
read counts for each gene are in the row on the right on a logarithmic scale as a 




Several other groups of genes involved in the regulation of axon development 
were found to be expressed differently at day 8, including genes coding for 
netrins, netrin receptors, a plexin homologue, ephrins and their receptors, a slit 
robo homologue and a catenin delta homologue (Fig. 4.11), which play important 
roles in the guidance, pruning and deletion of axons, in some case regulated by 
the Wnt pathway (Bashaw & Klein, 2010; Vanderhaeghen & Cheng, 2010). In the 
heat map of neurogenesis related genes, samples clustered well by treatment but 
also revealed variability between biological samples (Fig. 4.11). Overall Fig. 4.11 
shows a trend of genes coding for proteins involved in the processes of axon 
guidance and axon pruning to be expressed at higher levels at day 8 (for example 
ephrin and the ephrin receptors, netrins and their receptors, slit and ROBO as 
well as semaphorins, plexins and neurophilins (Bashaw & Klein, 2010)). In 
contrast, several genes known to be critical for neuron survival, such as survival 
of motor neuron 1 and fragile X mental retardation protein 1 as well as proteins 
interacting with them can be seen to be down-regulated at day 8 in Fig. 4.11.  
 
Work by Galanti et al. (2012) showed that females begin to regress to a sexually 
immature state once removed from the mammalian host and that the rate of 
apoptosis increases, resulting in the reduction of reproductive tissue, especially 
in the vitellarium. A small number of the apoptosis related genes discussed at the 
beginning of this chapter were found to be differentially expressed in the female 
worms. Two genes coding for the Bcl-2 domain containing protein 
(Smp_043360) and the FAS associated factor 2 (Smp_084610) were found to be 
down-regulated after day 8 (Table 4.9). In contrast, two genes were found to be 
up-regulated in females after in vitro culture (Table 4.9): the genes coded for the 
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FAS associated factor 1 (Smp_077540), and the FAS binding factor 1 
(Smp_148130).  However, overall there was no clear pattern of up- or down-
regulation of apoptosis related genes, one of the samples of female worms at day 
0 did not even cluster with the other day 0 samples (Fig. 4.12). 
 
Figure 4.12: No clear trend was found in the expression of pro- and anti-
apoptotic genes. Heatmap of apoptosis related genes in females Schistosoma 
mansoni at day 0 (three replicates: D0 F1-3) and day 8 (four replicates: D8 F1-4). 
Colours represent a Z score of log transformed normalised read counts scaled by 
row, giving relative measures of gene expression in each sample. The “+” and “-“ 
to the right of the heat map indicate putative pro- and anti-apoptotic function; 





Although a heat map of the apoptosis related genes and their expression in 
females at day 0 and 8 showed some consistent patterns, one of the day 0 
females did not cluster with the others nor did a trend for pro- or anti-apoptotic 
genes to be expressed in either group become apparent (Fig. 4.12).  
 







Smp_141520 593.9 4.32 1.61E-15 E3 ubiquitin protein ligase PDZRN3 
Smp_134210 2229.9 4.21 3.66E-12 Peptidase inhibitor 16 
Smp_141510 1025.4 4.98 6.58E-15 Family S9 non peptidase 
Smp_152940 1372.9 5.99 6.66E-08 Otopetrin 
Smp_162520 707.6 3.78 0.000185833 Protocadherin fat 4 
Smp_141290 17226.1 2.72 3.87E-13 Innexin 
Smp_179360 5635.2 3.09 5.44E-12 Sortilin 
Smp_154790 634.8 12.87 2.47E-24 DC STAMP domain containing protein 2 
Smp_105360 258.4 1.78 0.006098043 Neurogenic locus notch protein 
Smp_140800 1165.0 2.37 6.34E-06 Neurogenic locus notch protein 2 
Smp_128230 6954.8 1.96 0.000729261 Neurogenic locus notch protein 
Smp_128220 1619.0 3.29 6.95E-05 Neurogenic locus notch protein 
Smp_050520 3444.3 2.77 0.000747004 Neurogenic locus notch protein 
Smp_159050 3041.2 1.89 0.000534464 Semaphorin 5B 
Smp_158550 2399.4 1.42 0.028126836 Semaphorin 5A 
Smp_132520 24.8 6.97 1.22E-07 Semaphorin 1A 
Smp_147470 2426.8 2.30 0.001325385 Slit 
Smp_132540 275.8 3.57 2.89E-08 Slit interacting protein 
Smp_028030 3251.6 1.88 7.21E-05 Slit interacting protein 
 
Table 4.9: Up-regulated genes of females at day 8 after perfusion compared 
to females at day 0. The average read counts provide a measure of absolute 
expression for a given gene. The fold changes represent changes in gene 














smm04512 ECM-receptor interaction 4 9 1.25E-04 
smm04630 Jak-STAT signalling pathway 4 11 3.08E-04 
smm04142 Lysosome 6 47 3.41E-03 
smm04310 Wnt signalling pathway 5 35 4.61E-03 
smm04330 Notch signalling pathway 3 13 7.47E-03 
smm00500 Starch and sucrose metabolism 3 14 9.20E-03 
smm04080 Neuroactive ligand-receptor interaction 3 15 1.11E-02 
smm00563 Glycosylphosphatidylinositol(GPI)-anchor 
biosynthesis 
3 17 1.56E-02 
smm04150 mTOR signalling pathway 3 20 2.36E-02 
smm02010 ABC transporters 2 8 2.55E-02 
smm04068 FoxO signalling pathway 4 38 2.85E-02 
smm04340 Hedgehog signalling pathway 2 9 3.17E-02 
smm04144 Endocytosis 5 64 4.22E-02 
 
Table 4.10: KEGG pathways significantly enriched amongst the genes up-
regulated in females at day 8 after perfusion compared to females a day 0. 
The column “Significant Genes” provides the number of genes in a given pathway 
that were up-regulated in day 8 females; “Total Genes” is the total number of 
genes in the pathway. 
 





PF00028 Cadherin domain 23 45 1.38E-13 
PF00008 EGF-like domain 8 15 1.01E-05 
PF07645 Calcium-binding EGF domain 5 7 8.24E-05 
PF12661 Human growth factor-like EGF 5 7 8.24E-05 
PF07679 Immunoglobulin I-set domain 12 45 2.36E-04 
PF01414 Delta serrate ligand (Notch ligands) 4 6 6.87E-04 
PF00053 Laminin EGF-like (Domains III and V) 4 7 1.46E-03 
PF00503 G-protein α subunit 5 12 1.99E-03 
PF00864 ATP P2X receptor 3 4 2.33E-03 
PF01403 Sema domain 3 4 2.33E-03 
 
Table 4.11: Pfam domains which were significantly enriched amongst the 
genes up-regulated in females at day 8 after perfusion compared to females 
at day 0. The column “Significant Genes” provides the number of genes encoding 
a given domain that were up-regulated in day 8 females; “Total Genes” is the 






4.2.8 Comparison of males before and after in vitro culture 
The comparison of day 0 and day 8 was performed for male worms as well, 
revealing transcriptome changes of a similar magnitude as in the female 
comparison. After removing 962 (9.2%) genes with low read counts and 105 
(1%) outliers it was found that 493 (4.6%) genes were down-regulated and 717 
(6.6%) genes up-regulated after 8 days in culture (adjusted p-value < 0.01) 
(Figure 4.13 A). As the MA plot revealed, the fold changes observed in males 
were relatively small compared to those in females (compare Figure 4.10 A and 
4.13 A). The first two principal components, shown in the PCA plot, explain 72% 
of variability measured across the samples (Figure 4.13 B). 
 
 
Figure 4.13: In vitro culture induced large changes in gene expression in 
male worms. Pair-wise comparison of male worms at day 0 and day 8 after 
perfusion. A) The log ratio against mean (MA) plot shows large numbers of genes 
significantly up-regulated (red) in both groups with large fold changes. Triangles 
indicate genes outside the boundaries of the plots; like other genes, they are red 
if they are statistically significant, grey if they are not. B) Principal component 
analysis shows that males samples also separate well into two groups based on 
principal component 1 (53% of observed variance). These results demonstrate a 
significant effect of in vitro culture on the male transcriptome. 
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Of the 717 genes up-regulated at day 8, the most significantly differentially 
expressed gene coded for a homologue of the interferon-related developmental 
regulator (Smp_004680; 2.13x change; adjusted p-value = 4.60E-17) (Table 
4.12). Also differentially expressed were genes coding for a phenylalanyl-tRNA 
synthase β (Smp_094060; 1.41x change; adjusted p-value = 4.69E-17), a heat 
shock 70 protein (Smp_106930; 2.91x change; adjusted p-value = 4.21E-14)) and 
a γ-secretase subunit APH (Smp_050110;1.83x change; adjusted p-value = 4.31E-
13) as well as many proteins with unknown function (Table 4.12). 
 
After 8 days four pathways were significantly down-regulated in male worms (p-
value < 0.05) compared to males at day 0 (Table 4.13). Down-regulation of RNA 
transport (smm03013; p = 0.0049), mRNA surveillance (smm03015; p = 0.028), 
and protein processing in endoplasmic reticulum (smm04141; p = 0.039) 
suggested a down-regulation of transcription. Also down-regulated was N-
Glycan biosynthesis (smm00510; p = 0.034), which plays a role in the post-
translation modification of glycoproteins (Bieberich, 2014). Furthermore, the 
Pfam domain enrichment analysis (Table 4.14) suggested that in addition to RNA 
processing, many genes coding for proteins with DNA replication and cell cycle 
control related function were down-regulated after 8 days outside the host. 
These relevant domains include MIF4G domain (PF02854; p = 0.0010), which 
forms part of translation initiation factors (Virgili et al., 2013); Rad17 cell cycle 
checkpoint domain (PF03215; p = 0.0024), involved in cell cycle control (Post et 
al., 2003); and BRCA1 C Terminus domain (PF00533; p = 0.0072), which occurs 
in proteins that help to regulate the cell cycle in response to DNA damage (Deng, 
2006).  Also, significantly down-regulated were genes coding for several heat 
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shock protein associated domains, including Hsp20 crystalline family (PF00011; 
p = 1.69E-07), DnaJ central domain (PF00684; p = 0.0024), DnaJ C terminal 
domain (PF01556; p = 0.013) and Hsp70 domain (PF00012; p = 0.039). Finally, 
GO term enrichment analysis showed, among others (Table 4.15), DNA 
replication (GO:0006260, p-value = 5.30E-05), cell division (GO:0051301, p-
value = 0.0020), meiotic nuclear division (GO:0007126, p-value = 0.0056) and 
cell cycle (GO:0006269, p-value = 0.012) down-regulated, suggestion a reduction 
in sperm production as well as somatic cell division.   
 
Gene ID Average 
Read Count 
Fold Change p-value Product 
Smp_196900 92.7 0.087 6.63E-11 Uncharacterised protein 
Smp_144740 173.9 0.112 1.42E-11 Uncharacterised protein 
Smp_144730 166.2 0.115 6.77E-13 DnaJ protein 
Smp_106930 162521.3 0.344 4.21E-14 Heat shock protein 70 
Smp_124030 893.9 0.386 2.50E-11 Uncharacterised protein 
Smp_004680 8356.1 0.469 4.60E-17 Interferon-related developmental 
regulator 
Smp_168130 727.3 0.471 4.25E-11 Phosphatase and actin regulator 1 
Smp_176490 693.6 0.491 4.60E-16 Uncharacterised protein 
Smp_050110 3076.6 0.546 4.31E-13 γ-Secretase subunit APH 
Smp_094060 3055.4 0.710 4.69E-17 Phenylalanyl-tRNA synthetase β 
 
Table 4.12: The 10 genes most significantly down-regulated in males at day 
8 after perfusion compared to males at day 0. Average read counts provide a 
measure of absolute expression for a given gene. Fold changes represent gene 
expression at day 8 after perfusion relative to day 0. The p-value has been 














smm03013 RNA transport 14 103 4.86E-03 
smm03015 mRNA surveillance pathway 8 60 2.83E-02 
smm00510 N-Glycan biosynthesis 5 30 3.43E-02 
smm04141 Protein processing in endoplasmic 
reticulum 
10 89 3.90E-02 
 
Table 4.13: KEGG pathways significantly enriched amongst the genes 
down-regulated genes in males at day 8 after perfusion compared to males 
at day 0. The column “Significant Genes” provides the number of genes in a 
given pathway that were down-regulated in day 8 males; “Total Genes” is the 
total number of genes in the pathway. 
 
 





PF00011 Hsp20 crystallin family 7 11 1.69E-07 
PF00400 WD domain, G-β repeat 18 141 1.09E-04 
PF02854 MIF4G domain 3 5 1.04E-03 
PF00684 DnaJ central domain 2 2 2.37E-03 
PF03215 Rad17 cell cycle checkpoint protein 2 2 2.37E-03 
PF06584 DIRP 2 2 2.37E-03 
PF06682 Protein of unknown function (DUF1183) 2 2 2.37E-03 
PF09668 Aspartyl protease 2 2 2.37E-03 
PF11461 Rab interacting lysosomal protein 2 2 2.37E-03 
PF13481 AAA domain 2 2 2.37E-03 
 
Table 4.14: Pfam domains enriched amongst the significantly down-
regulated genes in males at day 8 after perfusion compared to males at day 
0. The column “Significant Genes” provides the number of genes encoding a 
given domain that were down-regulated in day 8 males; “Total Genes” is the total 
















GO:0006260 DNA replication 161 21 5.30E-05 
GO:0009408 Response to heat 26 6 0.0014 
GO:0051301 Cell division 123 15 0.002 
GO:0007126 Meiotic nuclear division 8 3 0.0056 
GO:0016070 RNA metabolic process 1303 76 0.0071 
GO:0006457 Protein folding 85 10 0.0088 
GO:0007049 Cell cycle 207 24 0.0098 
GO:0000184 Nuclear-transcribed mRNA catabolic 
process 
39 6 0.0115 
GO:0007067 Mitotic nuclear division 88 9 0.0249 
GO:0006269 DNA replication, synthesis of RNA primer 6 2 0.0321 
GO:0031119 tRNA pseudouridine synthesis 6 2 0.0321 
GO:0006506 GPI anchor biosynthetic process 25 4 0.0327 
GO:0006879 Cellular iron ion homeostasis 7 2 0.0435 
GO:0016485 Protein processing 17 3 0.0488 
GO:0051168 Nuclear export 7 2 0.0494 
 
Table 4.15: GO terms which were significantly enriched amongst the down-
regulated genes in males at day 8 after perfusion compared to males at day 
0. The column “Significant Genes” provides the number of genes associated with 
a given GO term that were down-regulated in males at day 8; “Expected Genes” 
provides the number of up-regulated genes annotated with the GO term as 
expected by chance. The GO terms are all in the “Biological Process” category. 
 
The most up-regulated genes (Table 4.16) included several genes coding for 
proteins with neural function. This included a netrin homologue (Smp_146840, 
5.62x change, adjusted p-value = 1.67E-20), and a catenin delta-2 homologue 
(Smp_042340, 3.04x change, adjusted p-value = 1.64E-13), both of which are 
thought to play important roles in neural development (Bashaw & Klein, 2010). 
Also up-regulated were genes coding for a stomatin homologue (Smp_003440, 
5.72x change, adjusted p-value = 1.97E-16), a neurogenic locus Notch protein 
homologue (Smp_143300, 7.58x change, adjusted p-value 2.12E-16) and a 
calcium binding protein that confers elasticity to the ECM (Handford, 2000). 
Another up-regulated gene codes for a RNA polymerase associated factor 1 
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homologue (Smp_045940, 2.15x change, 2.52E-13), which is a component of the 
PAF1 complex that is thought to regulate development and maintenance of 
embryonic stem cell pluripotency in humans (Ding et al., 2009). Also, among the 
ten most differentially expressed genes are three genes with unknown function 
(Table 4.16). 
 
Gene ID Mean Read 
Count 
Fold change Adjusted  
p-value 
Product 
Smp_175390 1144.8 9.19 2.07E-32 Uncharacterised protein 
Smp_137300 51.7 8.54 1.96E-17 Amine GPCR 
Smp_143300 220.8 7.58 2.12E-16 Fibrillin 1 
Smp_084780 540.2 6.98 6.47E-15 Uncharacterised protein 
Smp_003440 1455.0 5.73 1.97E-16 Stomatin 
Smp_146840 584.5 5.62 1.67E-20 Netrin 
Smp_162500 341.6 4.31 2.52E-13 Drug efflux protein 
Smp_042340 783.0 3.05 1.64E-13 Catenin delta 2 
Smp_045940 7329.6 2.16 2.52E-13 RNA polymerase II associated 
factor 1 
Smp_060080 2182.4 1.81 3.56E-14 Uncharacterised protein 
Smp_140800 1165.0 1.63 6.48E-03 Neurogenic locus notch protein  
Smp_155050 3126.2 2.27 1.83E-05 Agrin 
Smp_123860 798.8 2.75 7.61E-04 Neurexin-2 homologue 
Smp_157620 553.2 3.26 3.24E-09 Netrin receptor DDC 
Smp_172470 90.6 2.25 8.39E-05 Netrin receptor 
Smp_165440 1102.1 2.12 4.57E-08 Netrin receptor unc 5 
Smp_132540 275.8 1.97 1.43E-03 Slit 
Smp_159050 3041.2 2.09 2.98E-06 Semaphorin 
 
Table 4.16: Selection of the genes significantly up-regulated in males at day 
8 after perfusion compared to males at day 0. Average read counts provide a 
measure of absolute expression for a given gene. Fold changes represent the 
gene expression in males at day 8 after perfusion relative to day 0. The p-value 






After 8 days in vitro the up-regulated genes were enriched for pathways such as 
citrate cycle (smm00020; p = 0.00086), neuroactive ligand-receptor interaction 
(smm04080; p = 0.0044), wnt signalling pathway (smm04310; p = 0.0049), ECM-
receptor interaction (smm04512; p = 0.0072), as well as two amino acid 
metabolism pathways (smm00330; p = 0.0084 & smm00250; p = 0.024) (Table 
4.19). Three out of the six significantly up-regulated pathways in male worms 
were also up-regulated in female worms after 8 days: the neuroactive ligand-
receptor interaction, the wnt signalling pathway and the ECM-receptor 
interaction (Tables 4.10 and 4.19). 
 
After 8 days in culture, the up-regulated DEGs were enriched with genes coding 
for domains such as the neurotransmitter-gated ion-channel ligand binding 
domain (PF02931; p = 0.00021), the neurotransmitter-gated ion-channel 
transmembrane region (PF02932; p = 0.00068) and several EGF-related 
domains (as observed in the female worms; Table 4.11), including the calcium-
binding EGF domain (PF07645; p = 0.0016), EGF-like domain (PF00008; p = 
0.0064) and laminin EGF-like (Domains III and V) (PF00053; p = 0.017), in total 
ten genes with EGF domains (Table 4.17). Many of the genes up-regulated in 
males were involved in neural processes (Table 4.16). The annotation of the 
following genes was confirmed by checking for relevant PFAM domains as well 
as significant BLAST hits (data not shown here). They include a genes coding for 
a neurogenic locus notch protein (Smp_140800, 1.63x change, adjusted p-value = 
0.0065), thought to be involved in neural cell progenitor maintenance (Louvi & 
Artavanis-Tsakonas, 2006), two homologues of netrin (Smp_146840, 5.62x 
change, adjusted p-value = 3.53E-24; Smp_151310, 3.37x change, adjusted p-
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value = 5.01E-05), a gene involved axon guidance (Bashaw & Klein, 2010), and 
agrin (Smp_155050, 2.27x change, adjusted p-value = 1.83E-05), a large 
proteoglycan thought to play a role in the development of neuromuscular 
junctions (Bolliger et al., 2010) and finally genes coding for a homolog of 
neurexin-2 (Smp_123860, 2.75x change, adjusted p-value = 0.00076) and a 
neuronal cell surface protein that mediates the assembly of presynaptic 
terminals (Dean et al., 2003). In addition to the genes of both netrin homologues 
in the S. mansoni genome being up-regulated in male worms after 8 days, all 
three genes coding for homologues of the netrin receptor were also up-regulated 
in these worms (Smp_157620, 3.26x change, adjusted p-value = 3.24E-09; 
Smp_172470, 2.25x change, adjusted p-value = 8.39E-05; Smp_165440, 2.12x 
change, adjusted p-value = 4.57E-08). One other gene annotated as a netrin 
receptor homologue on GeneDB, Smp_080870, was found not to contain any 
conserved domains nor to have BLAST hits to relevant proteins and was 
excluded from this analysis. The gene coding for slit (Smp_132540, 1.97x change, 
p = 0.0014), another regulator of axon guidance (Bashaw & Klein, 2010), was 
also up-regulated in the male worms after 8 days, as was the gene of a 
semaphorin homologue (Smp_159050, 2.08x change, adjusted p-value = 2.98E-
06) (Table 4.16). 
 
GO term enrichment (Table 4.18) showed GO terms related to cell adhesion to be 
most significantly enriched (G0:0007155, p-value = 1.90E-17; GO:0007156, p-
value = 2.00E-13), but also several development and regulatory GO terms to be 
up-regulated. These include G-protein coupled receptor signalling (GO:0007186, 
p-value = 5.20E-06), multicellular organismal development (GO:0007275, p-
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value = 0.00031), negative regulation of cell differentiation (GO:0045596, p-
value = 0.00043) and negative regulation of BMP signalling (GO:0030514, p-
value = 0.00043) (Table 4.18). Furthermore, two pathways implicated in the 
development and growth of axons were found up-regulated. The first, Wnt 
signalling (GO:0016055, p-value = 0.0175), helps to establish the body’s axes in 
developing organisms including Schmidtea mediterranea (Gurley et al., 2010). 
Also up-regulated was gamma-aminobutyric acid (GABA) signalling 
(GO:0007214, p-value = 0.0162), which has been shown to play a role in axon 
pruning in mice (Wu et al., 2012). The heat map of neurogenesis related genes 
(Figure 4.14) contains genes identified from the differential expression analysis 
as well as from the literature by including differentially expressed homologues of 
genes discussed by Bashaw & Klein (2010) and Vanderhaeghen & Cheng (2010). 
It showed that both male and female worms exhibited similar trends in gene 
expression (Figure 4.11). Genes coding for netrin and netrin receptor genes, as 
well as slit, ephrin receptor, semaphorin and plexin genes were up-regulated 
after 8 days in vitro. On the other hand, neuron survival genes such as genes 
coding for FXMR, SMN as well as most catenin genes were not differentially 
expressed, or even slightly down-regulated (Figure 4.14). Although this overall 
trend held true, and samples clustered well by treatment, variability within 




Figure 4.14: Axon proning-related genes became up-regulated in vitro. 
Heatmap of neurogenesis related genes in males worms at day 0 (five replicates: 
D0 M1-5) and day 8 (seven replicates: D8 M1-7). Colours represent a Z score of 
log transformed normalised read counts scaled by row, giving relative measures 
of gene expression in each sample. Average normalised read counts for each 
gene are in the row on the right on a logarithmic scale as a measure of absolute 
expression levels. 
 
Unlike in female worms, no large changes in the set of apoptosis related genes 
were expected, as male worms are generally thought to remain sexually mature 
in the absence of a partner (Basch, 1991). The heat map of apoptosis related 
genes in male worms (see Figure 4.15) suggested that only small changes in the 
transcription of these genes took place between day 0 and 8 in culture, but no 
clear pattern of differential expression of pro- or anti-apoptotic genes emerged. 
194 
 
In total, nine out of 27 genes were differentially expressed (Table 4.20). This 
included four genes – two pro-apoptotic and two with unknown effect – down-
regulated after 8 days and five genes up-regulated – three anti-apoptotic and two 
pro-apoptotic genes.  
 
However, the fold changes were relatively small  (Table 4.20). These data 
suggested that there is regulation of apoptosis at the transcriptome level. 
However, it did not conclusively indicate apoptosis being up-regulated during in 
vitro culture. Apoptosis after 8 days was expected to take place at a lower rate 
compared with females due to regression of the reproductive tissues taking 
place in females (Galanti et al., 2012). However, due to high levels of variability, 






Figure 4.15: Expression of apoptosis-related genes does not show clear 
trends before and after in vitro cultrue. No Heatmap of apoptosis related 
genes in males worms at day 0 (five replicates: D0 M1-5) and day 8 (seven 
replicates: D8 M1-7). Colours represent a Z score of log transformed normalised 
read counts scaled by row, giving relative measures of gene expression in each 
sample. The “+” and “-“ to the right of the heat map indicate putative pro- and 
anti-apoptotic function; apoptosis related genes whose exact role could not be 















PF00028 Cadherin domain 21 45 2.49E-11 
PF07679 Immunoglobulin I-set domain 18 45 1.33E-08 
PF01410 Fibrillar collagen C-terminal domain 5 5 5.35E-06 
PF00041 Fibronectin type III domain 11 29 1.61E-05 
PF01391 Collagen triple helix repeat (20 copies) 7 12 2.06E-05 
PF13895 Immunoglobulin domain 10 27 4.93E-05 
PF00027 Cyclic nucleotide-binding domain 10 28 7.00E-05 
PF00520 Ion transport protein 12 43 1.91E-04 
PF02931 Neurotransmitter-gated ion-channel ligand 
binding domain 
7 16 2.07E-04 
PF00858 Amiloride-sensitive sodium channel 6 12 2.50E-04 
 
Table 4.17: Pfam domains significantly enriched amongst the up-regulated 
genes in males at day 8 after perfusion compared to males at day 0. The 
column “Significant Genes” provides the number of genes coding for a given 
domain that were up-regulated in males at day 8; “Total Genes” is the total 























GO:0007155 Cell adhesion 226 73 1.90E-17 
GO:0007156 Homophilic cell adhesion via plasma 
membrane 
60 25 2.00E-13 
GO:0006817 Phosphate ion transport 19 12 9.20E-10 
GO:0007165 Signal transduction 547 91 2.60E-08 
GO:0006811 Ion transport 389 75 9.20E-07 
GO:0007186 G-protein coupled receptor signalling 
pathway 
161 32 5.20E-06 
GO:0006813 Potassium ion transport 77 17 4.30E-05 
GO:0051216 Cartilage development 5 4 0.00015 
GO:0006814 Sodium ion transport 64 14 0.00023 
GO:0007275 Multicellular organismal development 286 41 0.00031 
GO:0045596 Negative regulation of cell differentiation 3 3 0.00043 
GO:0030514 Negative regulation of BMP signalling 
pathway 
3 3 0.00043 
GO:0050896 Response to stimulus 808 106 0.00112 
GO:0010646 Regulation of cell communication 77 8 0.00568 
GO:0023051 Regulation of signalling 77 8 0.00568 
GO:0006163 Purine nucleotide metabolic process 101 10 0.0119 
GO:0055114 Oxidation-reduction process 127 18 0.0159 
GO:0006855 Drug transmembrane transport 3 2 0.01621 
GO:0009098 Leucine biosynthetic process 3 2 0.01621 
GO:0007214 γ-aminobutyric acid signalling pathway 3 2 0.01621 
GO:0016055 Wnt signalling pathway 27 7 0.01749 
GO:0006821 Chloride transport 8 3 0.01797 
GO:0030154 Cell differentiation 78 14 0.02305 
GO:0006108 Malate metabolic process 4 2 0.03081 
GO:0005977 Glycogen metabolic process 24 4 0.0447 
 
Table 4.18: GO terms which were significantly enriched amongst the genes 
up-regulated in males at day 8 after perfusion compared to males at day 0. 
The column “Significant Genes” provides the number of genes associated with a 
given GO term that were up-regulated in males at day 8; “Expected Genes” 
provides the number of up-regulated genes with the GO term as expected by 













smm00020 Citrate cycle (TCA cycle) 6 25 8.62E-04 
smm04080 Neuroactive ligand-receptor interaction 4 15 4.36E-03 
smm04310 Wnt signalling pathway 6 35 4.89E-03 
smm04512 ECM-receptor interaction 3 9 7.16E-03 
smm00330 Arginine and proline metabolism 4 18 8.45E-03 
smm00250 Alanine, aspartate and glutamate 
metabolism 
3 14 2.43E-02 
 
Table 4.19: KEGG pathways which were significantly enriched amongst the 
gene up-regulated in males at day 8 after perfusion compared to males at 
day 0. The column “Significant Genes” provides the number of genes in a given 
pathway that were up-regulated in males at day 8; “Total Genes” is the total 







































Smp_043360 97.2 1.64 0.022 sBH3-1 
Smp_213730 1741.5 1.38 0.010 FDD associated protein 
Smp_136730 17432.3 1.21 0.739 Cathepsin D 
Smp_213250 3527.9 1.19 0.003 Bcl 2 antagonist:killer 
Smp_084610 2237.6 1.18 0.002 FAS associated factor 2 
Smp_197180 3314.5 1.14 0.053 Apoptosis inhibitor 5 
Smp_041630 708.6 1.07 0.753 BCL2 apoptosis inhibitor 
Smp_013040 45112.2 1.06 0.834 Cathepsin D 
Smp_022110 2100.3 1.06 0.763 p21 APK interacting protein 
Smp_044000 27649.2 1.05 0.713 Bax inhibitor 1 
Smp_072180 2661.2 1.05 0.752 Apoptosis regulator BAX 
Smp_168470 421.4 1.02 0.942 BCL2 apoptosis inhibitor 
Smp_196040 4717.2 1.01 0.918 Shc-transformig protein 3 
Smp_077540 2452.7 1.00 0.981 FAS associated factor 1 
Smp_095190 512.4 0.99 0.961 Bcl 2 antagonist:killer 
Smp_032000 555.9 0.95 0.713 Caspase 
Smp_028500 395.6 0.94 0.666 sCasp3 
Smp_141270 431.4 0.92 0.900 Caspase 8 
Smp_148130 686.1 0.92 0.765 FAS binding factor 1 
Smp_002410 12906.3 0.90 0.446 14-3-3 epsilon 2 
Smp_210790 4704.8 0.88 0.367 Transmembrane BAX inhibitor 
Smp_179800 824.4 0.86 0.465 p21 activated protein kinase 1 
Smp_137540 2569.7 0.84 0.011 Apoptosis inducing factor 1 
Smp_207000 1143.3 0.75 0.028 Anamorsin homolog 
Smp_009760 50176.7 0.73 0.073 14-3-3 protein homolog 1 
Smp_034840 44878.7 0.72 0.001 14-3-3 protein epsilon 
Smp_129670 966.7 0.69 0.071 Apoptosis stimulating protein of P53 
 
Table 4.20: Table of apoptosis-related gene expression in the comparison 
of male Schistosoma mansoni after 8 days in vitro. Average read counts 
provide a measure of absolute expression for a given gene. Fold changes express 
the gene expression at day 8 relative to day 0. The p-value has been adjusted for 














Pairing-specific changes in gene expression are obscured by the effect of in 
vitro cultivation on the transcriptome 
Maintenance of S. mansoni in vitro has been noted in the past to have adverse 
effects on female fertility (Basch, 1991) and regression of female reproductive 
tissue has been observed in the presence and absence of male worms (Galanti et 
al., 2012). To optimally support female fertility in in vitro culture, Basch medium 
was tested here for the maintenance of S. mansoni in vitro. It was found to 
support female fertility to a significantly greater extent than a less rich medium. 
Overall females were found to lay six times as many eggs over four weeks in 
Basch medium. Supplementation of the growth media with red blood cells was 
also shown to have a significant effect on fertility, resulting in a 2-fold increase of 
egg production in media supplemented with 1% RBC compared to media 
without RBC. 
 
The next challenge was the isolation of sufficient total RNA from single worms to 
prepare cDNA libraries. Using an extraction protocol that I had optimised  
(Chapter 2.2.3) at least 50 ng of total RNA could be isolated from 60 single worm 
samples. From the generated RNA-Seq data, 150 genes were identified to be 
differentially expressed between paired and separated females after 8 days in 
culture and 42 in between paired and separated males. Even more genes were 
identified to be differentially expressed in comparisons of worms before and 




A considerable problem in this analysis was the large variability in gene 
expression between biological replicates, particularly of female worms. This 
made it very difficult to examine the effect of treatment, i.e., the pairing or 
separation of pairs. The magnitude of variability increased over the course of the 
experiment. The PCA plot of all samples (Figure 4.4) as well as the PCA plots of 
the time series analysis (Figure 4.8 and Figure 4.9) suggested that the effect of in 
vitro culture on the transcriptome was greater than of the treatment itself, 
despite the optimisation efforts. The in vitro culture of worms is a long 
established technique but one that has been noted to have significant draw backs 
and weaknesses, most notably the decline of female fertility but also slow or 
absent maturation of immature worms (Galanti et al., 2012). The variability 
within the biological replicates reduced the statistical power to detect 
differentially expressed genes and obscured the effect of unpairing on the 
transcriptome of worms, especially for genes with moderate to low expression. 
As a result, fewer than expected differentially expressed genes, 150 DEGs in 
total, could be identified between paired and separated females. Furthermore, 
these results included several unexpected genes, including those coding for 
putative fertility-related proteins (eggshell protein, Smp_000430; and eggshell 
synthesis domain containing protein, Smp_077890) being up-regulated in 
separated females compared to their paired counter parts at day 8. Had the 
effects of in vitro culture been smaller, more subtle effects could have been 
identified in the separated females. The process of sexual regression that female 
worms undergo when removed from their mate should ideally be studied in vivo 
to ensure proper host condition. This could be achieved by perfusing worms 
from mixed sex infections, isolating mature females and reimplanting them into a 
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new host before perfusing them again after a few days or weeks to extract the 
RNA of these separated worms from in vivo conditions. This method of 
reimplanting worms into a host surgically has been used in the past (e.g. Basch 
1990). However, this would be an invasive procedure that could cause injury and 
stress to the female worms, and likely impact their transcriptomes. 
 
In male worms, only 42 DEGs were identified, all of which had relatively small 
fold changes, ranging from 1.8x to 1.12x with a median fold change of 1.3x. These 
fold changes are consistent with small changes in expression in the male worms 
but could also have resulted from larger fold changes in particular tissues. Such 
changes would become masked by measuring the average expression across 
whole male worms. The fact that DEGs were identified by DESeq2 in the 
comparison of male worms, despite the overall small fold changes, could indicate 
that the relatively low number of DEGs in the female comparison could be due to 
high levels of variability across biological replicates. In male worms on the other 
hand, there seems to be genuinely low levels of differentially expressed genes. 
 
Down-regulation of genes coding for two actin homologues, two tegument 
allergen-like proteins and two tubulin genes, would indicate a reduction of the 
size of the tegument and muscle tissue. The up-regulation of a gene coding for an 
endothelin 2 homologue as well as an endothelin-converting protein suggests an 
involvement of this peptide hormone in the response of male S. mansoni to being 
separated from their partner. In humans, endothelin primarily plays a role in the 
regulation of blood pressure and has also been shown stimulate the nervous 
system (Bruno et al., 2011). 
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Differential expression of apoptosis related genes does not conclusively 
show up or down-regulation  
To study the role of apoptosis in regression of female reproductive tissues I 
carefully curated a list of 27 putative apoptosis-related genes, making sure that 
their gene models were supported by RNA-Seq evidence and that they had 
sufficient homology to known apoptosis effectors. The function as well as 
domain structure of these apoptosis-related genes is described in more detail in 
Appendix B. I was expecting to find pro-apoptotic genes to be up-regulated in 
separated females compared to paired females. However, the comparison 
between paired and separated females did not provide conclusive evidence for 
up-regulation of apoptotic genes nor did the comparison of worms from day 0 
and day 8, although some differential regulation of apoptosis-related genes was 
observed. Again, this may to have been due to the high degree of variability 
between biological replicates introduced by in vitro culture. Notably, 
sphingolipid metabolism-related genes were found to be differentially expressed 
at a higher than expected rate. Sphingolipids are important components of 
membranes and help cells to withstand stress (Futerman & Hannun, 2004). They 
can also be involved in signalling as is the case with ceramide. Ceramide is a 
sphingolipid and an important positive regulator of apoptosis (Thomas D Mullen 
& Obeid, 2012; Tirodkar & Voelkel-Johnson, 2012). Two genes have been shown 
to be of particular importance for controlling ceramide levels in cells: Ceramide 
kinase that phosphorylates ceramide, greatly diminishing its pro-apoptotic 
effect, and ceramide synthase that helps to synthesis ceramide and has a pro-
apoptotic effect (Jensen et al., 2014). However, both genes coding for these 
protein were significantly down-regulated after in vitro culture. However, both 
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ceramide kinase and ceramide synthase were found to be down-regulated after 
in vitro culture. It was therefore not possible to reliably assess, whether the 
down-regulation of the sphingolipid metabolism pathway had a pro- or anti-
apoptotic effect. Overall, differential expression of apoptosis-related genes in a 
manner consistent with my pro- and anti-apoptotic classification could not be 
demonstrated although several of these genes were found to be differentially 
expressed.  
 
Neurogenesis related genes in male and female worms 
One of the 42 DEGs in the comparison of paired and unpaired males was the gene 
coding for DYP-30 which was up-regulated in paired males. DPY proteins are 
involved in dosage compensation, but not sex determination, in C. elegans (Hsu & 
Meyer, 1994) and the protein DPY-30 has recently been shown to be critical for 
neural lineage differentiation of mouse embryonic stem cells by regulating 
histone methylation (Jiang et al., 2011). Being located on the Z/W chromosome 
(Uniprot – G4VT64; https://www.uniprot.org/uniprot/G4VT64), it may play a 
similar role development of neural cells in S. mansoni. 
 
However, the most striking finding was the differential expression of 
neurogenesis related genes in male and female worms, that suggested a 
regression of the nervous system during in vitro culture. As discussed in the 
introduction to this chapter, most of the genes involved in the process of neural 
development can function in several roles. In particular the ligand:receptor pairs 
known to control axon guidance, namely semaphorins and their plexin and 
neuropilin receptors, netrins and the DCC and UNC receptors, slit and its robo 
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receptors as well as ephrin and its receptors have also all been implicated in the 
pruning of axons and neural cell death (Vanderhaeghen & Cheng, 2010). Notably, 
S. mansoni homologues of all of these genes were found to be differentially 
expressed after in vitro culture. Given the context of this data set and the well 
documented regression observed in worms outside the mammalian host, it 
seems most likely that the sudden up-regulation of these neural genes is 
correlated to a regression of parts of the schistosome nervous system. First and 
foremost, several neuron survival genes are down-regulated at day 8 as can be 
seen from the heatmaps of both male and female worms (Figure 4.11 & 4.14). 
Secondly several further pieces of evidence point to this also, including the up-
regulation of GABA signalling in male worms at D8, which has been implicated in 
axon pruning, as well as the GO terms such as negative regulation of cell 
differentiation as well as the up-regulation of genes coding for neurogenic locus 
notch proteins in both male and female worms, a group of proteins thought to be 
essential for maintenance of neuronal progenitor cells. Combined, this evidence 
suggests that parts of the worm nervous system regresses by axon pruning and 
neural cell death and that neural progenitor cells are maintained in an 
undifferentiated form.  
This process may be similar to the regression of reproductive tissues observed in 
female worms after they become separated from the male (Galanti et al., 2012). 
However, it was shown to be independent of worm gender as transcriptome 
changes consistent with neural regression were found in both males and females. 
As worms could not have evolved a response to in vitro culture, it seems likely 
that the regression was a response to the lack of a host factor. The host immune 
system is a plausible candidate, as schistosome development is known to be 
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modulated by B and T cells (Davies et al., 2001; Tang et al., 2013). Davies et al. 
(2001) found schistosomes derived from mice without B and T cells were 
smaller, uniform and undifferentiated at 26 days post infection compared to 
worms from wild type mice and remained significantly smaller and stunted at 42 
and 56 days after infection. Similar observations were made by Tang et al. 
(2013). The authors suggest that this may be a mechanism to ensure host and 
thus worm survival. Davies et al. (2001) speculated that by arresting worm 
development and thus temporarily preventing reproduction, host survival might 
be ensured, until the host is healthy enough again to sustain egg production. An 
important part of the S. mansoni nervous system is made up of the 
neuromuscular system. It allows the worms to control their movement, but also 
plays a role in digestion and excretion as well as other body functions (Ribeiro & 
Patocka, 2013). During the process of regression any loss of muscle tissue would 
therefore likely be accompanied by a loss of neural cells involved on the 
neuromuscular processes. Like female worms regressing after becoming 
unpaired from the male worm, the neural regression observed here could be 















Schistosomes are a rare exception within the platyhelminths having evolved to 
be dioecious with distinct male and female individuals, however the sexual 
biology of schistosomes is not only of evolutionary interest but also a rich area of 
research. This is due to its potential as an intervention target in the Schistosoma 
life cycle as sexual reproduction is obligatory for schistosome reproduction but 
and because the eggs are essential for transmission and responsible most of the 
pathology caused by schistosomes (Gryseels, 2012). Few tissues play such a 
prominent role in reproduction as the testes and ovaries as they are responsible 
for generating the spermatocytes and oocytes required for fertilisation and the 
formation of embryos. 
 
The gonads are highly specialised tissues in which cytokinesis takes place at a 
high rate and in which cells undergo meiosis (Beckmann et al., 2010). But not 
only are the tissues themselves specialised, they also produce specialised cells, 
the spermatocytes and oocytes. So, it is to be expected that many genes will be 
uniquely expressed in the gonads or at least expressed differentially as 
compared to whole worms. In both genders the gonads make up a relatively 
small portion of the total organism, whereas the somatic worm tissues are 
comprised mostly of tegument, gut and muscle (especially in the male) and 
vitellarian tissue [in the female (Basch, 1990)].  
 
The transcriptomes of both these organs have been examined in the past both in 
S. mansoni (Nawaratna et al., 2011) and S. japonicum (Gobert et al., 2009) using a 
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combination of laser micro dissection microscopy (LMM) and cDNA microarrays. 
These studies were great steps towards an improved understanding of the 
schistosome gonads but left room for improvement. The authors had to rely on 
less complete sequencing data as well as less up-to-date genome annotation for 
the construction of the microarrays. The study also lacked biological replicates 
and did not correct for multiple hypothesis testing. Nawaratna et al. (2011) 
found 1989 genes (4450 probes) to have at least 2-fold higher expression in 
ovaries of mature females compared to a whole females, whereas 1188 genes 
(2171 probes) were found to have at least 2-fold higher expression in the testes 
of males from MS infections compared to control samples from whole MS males 
(Nawaratna et al., 2011). To explore the functional relationship between these 
genes, GO term enrichment analysis was performed. This gave a broad overview 
of the different groups of genes involved in processes such as “binding”, 
“catalytic activity”, “cellular process” and “metabolic process”. However, as the 
annotation of the S. mansoni genome has been steadily improved since 2011 
(Protasio et al., 2012), including the GO term annotation of genes, it is now 
possible to perform more in-depth enrichment analysis to yield greater insight 
into the underlying biological processes of sets of up- or down-regulated genes 
than was achieved previously. 
 
Another aspect of gonad biology that so far has remained relatively unexplored 
is the transcriptome changes induced by pairing. Hahnel et al. (2013) developed 
a new method for the isolation of whole organs from S. mansoni using an 
approach that used both detergent and proteases to dissolve the outer layers of 
tegument and muscle to gain access to the worm gonads. This approach allowed 
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isolation of those tissues at a greater scale than previously feasible by micro 
dissection and thus made it possible to gather enough material for RNA 
sequencing. The team could demonstrate that cells could be isolated intact and 
with high quality RNA (Hahnel et al., 2013; Hahnel et al., 2014) and measured 
differential genes expression between the ovaries and testes of worms from 
mixed sex (MS) and single sex (SS), worms by qRT-PCR. Six genes putatively 
influenced by pairing based on transcriptomic evidence published in previous 
studies (Collins et al., 2013; Leutner et al., 2013; Zamanian et al., 2011) were 
chosen for closer examination: two genes coding for homologues of the 
fibroblast growth factor receptor (FGFR-A/B), and genes coding for one 
homologue each of frizzled (Fz1), membrane progestin receptor component 1 
(PMRC1), notch and the RNA binding protein musashi. Most of the analysed 
genes were found to have up-regulated transcription upon pairing, supporting 
the hypothesis that these genes are regulated by pairing and play a role in the 
sexual maturation of females. While the authors demonstrated that high quality 
RNA can be extracted from the isolated gonads of S. mansoni, they did not show 
how the process of organ extraction effects the transcriptome (Hahnel et al., 
2014).  
 
The signalling network that regulates female fertility (see Figure 5.1) has been 
studied intensively (Beckmann et al., 2010; Knobloch et al., 2007; LoVerde et al., 
2009; Andrade et al., 2014) and is described in Chapter 1.5. It comprises over 40 
known genes, many of which have been characterised using in silico approaches, 
RNAi, in situ hybridisation, yeast-two-hybrid screens or using inhibitors such as 





Figure 5.1: Representation of the MAPK, Rho and TGF-β signalling pathway 
inside a maturing oocyte from cell surface receptor to transcription 
regulators in the nucleus. Adapted from Knobloch et al. (2007). Dotted arrows 
indicate indirect interactions, solid arrows indicate direct interaction. Red 
arrows indicate inhibition and black arrows activation of the target. 
 
Galanti et al. (2012) studied another aspect of schistosome reproductive biology: 
the female developmental regression by apoptosis, when separated from the 
male partner. The authors described the effect of pairing and un-pairing on gene 
expression in female worms in vitro and compared the rate of cell proliferation 
and apoptosis between females from single and mixed sex infections. Apoptosis 
was found to be responsible for the regression of the vitellarium as part of the 
developmental regression that the females undergoes in response to separation 
from their partner (Galanti et al., 2012). Curiously, they also observed that the 
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rate of proliferation of the vitellarian tissue in females from SS and MS infections 
is very similar in vivo, but that the expansion of the vitellarium in SS females is 
prevented by a higher rate of apoptosis than in MS females (Galanti et al., 2012). 
Like the vitellarium, the ovary also undergoes growth and development once 
induced by stable pairing of the female with a male. Therefore, it would be 
interesting to examine whether the transcriptome of ovaries from SS females 
reveals higher expression of pro-apoptotic genes compared to the ovaries from 
MS females. Apoptosis in Schistosoma has been previously studied by Lee et al. 
(2011, 2014) and Peng et al. (2010) who identified homologues of apoptosis 
related genes in the S. mansoni and S. japonicum genomes, respectively. Their 
results, as well as my efforts to identify other apoptosis related genes In the S. 
mansoni genome are discussed in detail in Chapter 4.2.  
 
This work was a collaborative effort between our group and that of Prof. Dr. 
Christoph Grevelding. RNA was isolated from the gonads of worms from MS and 
SS infections as well as whole worm controls and provided to me. I used the RNA 
to synthesise stranded cDNA libraries for sequencing on Illumina HiSeq 
machines. Independent analyses of this data set (Lu et al., 2016), as well as a 
gene expression atlas (Lu et al., 2017) were recently published by both groups. 
The analysis placed greater emphasis on the evolutionary aspects of the gender 
interplay and examined the molecular mechanisms inducing sexual maturation. 
Since this experiment was conducted, our collaborators have also published a 
paper about the role of integrins and Venus Kinase Receptor 1 in the regulation 
of apoptosis in the ovaries (Gelmedin et al., 2017). The following analysis aims to 
define a set of ovary and testes expressed genes, as well as examining the 
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changes that take place in both gonads in response to pairing. To give proper 
context to these differentially expressed genes, I used several functional 
genomics approaches to show how groups of genes with similar biological 
functions are expressed in the gonads of S. mansoni and whole worms. 
 
5.2 Results 
5.2.1 Sequencing and sample clustering 
In total, over 1.5 billion sequencing reads were produced, on average 63 million 
per sample (ranging from 42 million to 110 million), 84% of which could be 
mapped to the S. mansoni genome v5.2 (on average) (Appendix C.1). 
 
During the initial analysis, one sample (single sex ovary 3, sO3) was identified 
which had apparently been mishandled and appeared to be whole male RNA 
instead of an ovary sample. This became apparent on a PCA plot (Figure 5.2) and 
was confirmed by examining expression of known male specific transcripts 
(Fitzpatrick et al., 2005) (see Figure 5.3) such as those coding for the tegument 
allergen like (TAL) proteins (Smp_045200, Smp_086480 and Smp_195090) and 











Figure 5.2: Samples cluster by type, male samples from mixed sex and 
single sex infection cluster together. The samples are either from single sex 
(SS) or mixed sex (MS) infections. In this principal component analysis of RNA-
Seq samples, 86% of the variation among all samples is explained by the two 
most important principal components. The PCA plot is based on the 500 most 
variable genes in the data set, which contains three replicates per condition. 
Notably one of the SS ovary samples (sO3) clustered with the whole male 






Figure 5.3: Single sex (SS) ovary replicate 3 was more similar to SS male 
replicates 1-3 than other SS ovary replicates (1-2). Here the sex-biased 
expression of genes is used to examine an outlier. Normalised read counts of SS 
male and SS ovary replicates were plotted for four transcripts with known male-
biased expression patterns.  
 
The principal component analysis based on the 500 genes with the greatest 
variance showed that samples from tight clusters. As expected, male and female 
samples formed discrete clusters and, as observed in Chapter 3.2, females from 
MS and SS infections form separate clusters reflecting the transcriptomic (and 
physiological differences) between sexually mature and immature females. 
Again, unsurprisingly, both males from MS as well as SS infections clustered very 
closely, despite a small number of consistently differentially expressed genes. 
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Furthermore, the clusters of gonad samples resembled those of the whole worms 
with ovaries of MS and SS females clustering away from one another, whereas 
both groups of testes showed very similar transcriptomes (Figure 5.2). 
Generally, the organ samples clustered less tightly and showed more variation 
within groups than those of whole worms (Figure 5.2). This could be due to 
differences in RNA quality caused by the procedure used for organ extraction, 
although apart from lower RNA concentrations no signs of low quality were 
observed (Appendix C.2). 
 
5.2.2 Comparing RNA-Seq to published microarray & qPCR data 
To examine how the gonad RNA-Seq data compared to similar data sets in the 
literature, I compared the present results to the most recent large scale effort to 
define the S. mansoni testes and ovary transcriptome (Nawaratna et al., 2011). In 
their paper, Nawaratna et al. (2011) use a powerful combination of laser 
microdissection and a small oligonucleotide microarray to isolate tissue from the 
testes and ovary of sexually mature worms from MS infections. They then 
compared the expression levels of “39342 probes representing 19907 putative 
genes” (Nawaratna et al., 2011) in the gonads with whole worm controls, 
defining genes expressed 2-fold higher in the gonads as compared with the 
whole worm control as “testes” and/or “ovary” genes. 
 
To compare this data set with my RNA-Seq data the probe sequences were 
mapped to the S. mansoni reference genome v5.2 to find regions that uniquely 
corresponded to each probe. Splicing had to be taken into account, therefore 
Tophat2 was used for this process. Having determined the positions of the 
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probes in the genome allowed me to count RNA-Seq reads overlapping the 
position of these mapped probe sequences as described in the methods (Chapter 
2.4.5). RNA-Seq data and microarray data are expected not to correlate linearly 
as RNA-Seq is expected to be more accurate at the lower and higher ends of 
expression (Zhao et al., 2014) as discussed in the introduction (Chapter 1.6.3). 
Therefore, I chose Spearman’s rank correlation coefficient to measure the 
correlation between RNA-Seq and microarray expression and found there was a 
weak positive correlation across all samples (r=0.46 to r=0.54), both whole 
worms and gonads (Figure 5.4). 
 
In a previous analysis of the correlation between S. mansoni RNA-Seq to 
microarray results Protasio (2011) found that the results produced by both 
methods correlated well, with the correlation coefficient r ranging from 0.66-
0.69. Therefore, a slightly higher correlation was anticipated in the present 
study, but there are several possible contributing factors to explain the lower 
correlation that I observed (see Figure 5.4). First, it is possible that the method of 
obtaining the organs, laser microdissection and protease/detergent treatment, 
had an impact on the transcriptome. However, this is unlikely as the correlation 
between whole worm samples was as low as the correlation of the gonad 
samples. Some of the variation between samples can be explained by the use of 
different parasite strains; Nawaratna et al. (2012) used the Puerto Rican strain of 
S. mansoni, whereas the strain used in our experiment on the gonad 
transcriptome originated in Liberia. Another reason could be differences in the 
quality of the RNA used in the two experiments, but there is no way to directly 




Figure 5.4: RNA-Seq and microarray data are moderately correlated. RNA-
Seq counts were plotted against normalised intensity values of the microarray 
data sets (Nawaratna et al., 2011); local regression line was plotted in red. A) 
Correlation of whole MS female samples. B) Correlation of ovaries from MS 
females. C) Correlation of whole MS males. D) Correlation of testes from MS 
males. 
 
RNA-Seq counts were plotted against signal intensity of the microarray probes 
(see Figure 5.4). A local regression line (red) was fit onto the plots showing a 
weak correlation and the correlation coefficient was close to r=0.5 for all four 
samples Figure 5.4). In all cases, no signal was detected for a large number of 
probes using one or both methods of expression analysis (Figure 5.4). Another 
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publication that examined gene expression in the testes and ovaries of S. mansoni 
by Hahnel et al. (2014) used qRT-PCR to measure the expression of six genes 
coding for the following proteins: Frizzled (Smp_173940), FGFR-A 
(Smp_175590), FGFR-B (Smp_157300), PMRC1 (Smp_093700), Notch 
(Smp_050520), Musashi (Smp_157750) using actin (Smp_161930) as a reference 
gene. Next, the published qRT-PCR fold changes were comparable to the fold 
changes measured by RNA-Seq (Appendix C.3). 
 
The initial comparison revealed striking differences in the ratio of expression 
(mature ovary gene expression divided by immature ovary gene expression) 
(Figure 5.5). 
 
Figure 5.5: Comparison of qRT-PCR and RNA-Seq reveals systematic 
differences. Expression ratio in ovaries (expression in mixed sex ovaries 
divided by expression in single sex ovaries) as measured by qRT-PCR and RNA-
seq. Generally, RNA-Seq ratios were all much lower suggesting less expression in 
paired ovaries to be lower than measured by qRT-PCR, although the trend is the 




When examining expression of the reference gene (actin) however, the RNA-Seq 
data suggested significant differential expression of actin between ovaries from 
MS and SS infections (8.1-fold higher expression in SS ovaries than in MS ovaries; 
adjusted p-value 6.33E-14). Eleven other published qRT-PCR reference genes 
(Liu et al., 2012) were examined to see whether they displayed a similar 
behaviour in the RNA-Seq data which would indicate of a problem with the 
normalisation of expression across samples. However, the other reference genes 
were not found to be differentially expressed and had smaller fold changes (1.3-
fold change on average) (Appendix C3). When taking into account the 8.1-fold 
expression change of the qRT-PCR reference gene in the comparison of gene 
expression between the two methods, the “adjusted” expression ratios were 
much closer to those reported by Hahnel et al. (2014) (Figure 5.6) and therefore 
provide excellent validation of the results discussed in the following sections. 
 
Actin was not found to be expressed differentially to such large degrees in any 
other comparison of samples from SS versus MS infection but was still found to 
be significant (2.2-fold down-regulation in MS females; adjusted p value = 2.16E-






Figure 5.6: RNA-Seq data showed good agreement with qRT-PCR after 
adjustment for differential expression of qRT-PCR reference gene. 
Expression ratio in ovaries (expression in MS ovaries divided by expression in SS 




5.2.3 Testes Transcriptome 
“Testes genes” were identified using a pair-wise comparison of gene expression 
in testes of MS males and whole MS males using DESeq2. To be considered as 
“testes gene” a gene had to be differentially expressed using an adjusted p-value 
cut-off smaller than 0.01 and be at least 2-fold more highly expressed in testes 
from MS infections than the whole male control. This threshold was used 
throughout this chapter to identify DEGs. 10270 out of 10828 transcripts were 
found to be expressed (i.e. non-zero read counts), of which 512 (5%) were 
filtered out due to low expression levels using the DESeq2 independent filtering 
algorithm. 1949 transcripts passed the criteria to be considered “testes genes” 





Figure 5.6: The testis transcriptome differs considerably from that of whole 
males. A) Log ratio against mean (MA) plot of the testis-whole male comparison. 
Genes with an adjusted p-value of < 0.01 are high-lighted in red; genes with a 
log-fold change of > 1 (fold-change of > 2) and adjusted p-value of < 0.01 were 
called as differentially expressed “testis genes”. B) PCA plot of testes of paired 
males and whole male control samples.  
 
When plotting the mean expression (A) of genes against their log fold change (M) 
(Figure 5.6 A), a large number of genes have large fold changes, especially those 
up-regulated in whole males. This is because genes expressed exclusively outside 
the testes should be completely absent from the testes samples, unlike the 
testes-specific genes, which also appear as expressed in the whole males. 99% of 
variation of the RNA-Seq count data between whole male and testes samples is 
explained by the first two principal components, most notably, the first principal 
component that separates the male from the testes samples explains 98% of the 
total variation (Figure 5.6 B). This suggests that there are large differences in 
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gene expression between whole male worms and testes samples and that the 
expression data has relatively little noise.  
 
Amongst the most differentially expressed testes genes (adjusted p-value < 
1.30E-186; Table 5.1) were DEGs coding for a cyclin dependent kinase 
(Smp_080730), a RNA helicase (Smp_172150), HORMA domain containing 
protein (Smp_169930), which is involved in DNA replication and recognition of 
damaged DNA (Muniyappa et al., 2014), a DNA primase subunit (Smp_079050) 
and a hormone receptor 4 (Smp_041540). As expected, this list suggests that the 
transcriptome of the testes is dominated by factors involved in mitosis. Also, a 
“testis expressed protein” (Smp_131630) was found to be expressed more 
strongly in testes than whole male. Another interesting gene found to be 
differentially expressed codes for the transcription factor boule (Smp_144860), 
which is expressed in the gonads of other Platyhelminthes, such as free-living 
Macrostomum lignano (Kuales et al., 2011). The transcription factor boule is also 
widely conserved across other animals including mammals due to its importance 
in the regulation of meiosis (Shah et al., 2010). I performed a whole mount in situ 
hybridisation to examine the specificity of boule expression in 20 male worms 
and detected a robust signal in the testes of all worms but no other tissues of the 
worm, except in the ventral sucker of four worms which are common sites of 





Figure 5.7: In situ hybridisation targeting mRNA of transcription factor 
boule demonstrated expression in the testes of male worms. Four out of 
twenty worms stained for boule also exhibited staining in the ventral sucker 
(left). Sense transcript of boule was used as negative control (right). Even after 
prolonged development no distinct expression signal was noticeable in the 
testes. OS – Oral Sucker; VS – Ventral Sucker; T – Testes. 
 
A GO term enrichment analysis was performed using topGO (Alexa et al., 2006) 
in order to get a more comprehensive picture of the function of testes genes. By 
testing for statistically significant (p-value < 0.01) enrichment of GO terms I 
aimed to get a more comprehensive picture of the biological processes taking 
place in the testes. The testes genes were significantly enriched with DEGs from a 
total of 32 GO terms (Table 5.2), whereas genes up-regulated in whole males 
were enriched with genes from 37 GO terms (Appendix C.4). Notably, the list of 
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testes GO terms was dominated by mitosis related processes such as “DNA 
replication initiation”, “spermatogenesis”, “DNA repair”, “cell cycle”, “mitotic 
nuclear division” and “miss match repair”, all reflecting the primary function of 
testes, the production of sperm. Furthermore, “microtubule-based movement” 
and “striated muscle contraction” were found to be up-regulated significantly in 
testes (Table 5.2). Spermatocytes are known to rely on microtubules for 
locomotion; in human sperm cells eleven microtubules are arranged into an 
axoneme which forms the central part of the sperm flagellum (Kierszenbaum, 
2002). Furthermore, microtubules play an important role in the separation of 
chromosomes during meiosis and mitosis, which are expected to occur at a high 
rate in the testes. Striated muscle, on the other hand, has been observed to 
surround the testes of D. melanogaster and mammals (Kuckwa et al., 2016). 
“Protein glycosylation” (GO:0006486) and “protein refolding” (GO:0042026) 
were also significant GO terms (Table 5.2). The latter includes several genes 
coding for chaperone proteins such as heat shock protein 70, which in mice plays 
an essential role in spermatogenesis by allowing Cdc2 and cyclin B1 to form a 
complex without which the developing spermatocytes become arrested at the 
G2-M-phase transition and undergo apoptosis (Eddy, 1999) 
 
A KEGG pathway was performed, aimed at identifying pathways significantly 
enriched in testes-specific genes, including metabolic and signalling pathways 
among others (Chapter 2.4.10). It showed that DNA replication, mismatch repair 
and homologous recombination but also the Fanconi anaemia (FA) pathway play 
an important role in the testicular tissue (Table 5.3). The FA pathway is 
necessary to allow the repair of damaged DNA, especially interstrand cross-links, 
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which are recognised by the FA core complex, which in turn activates various 
DNA repair proteins (Rodríguez & D’Andrea, 2017). Additionally, ribosomes, 
ribosome biogenesis and tRNA biosynthesis were up-regulated in testes 
compared to whole worms (Table 5.3). Together with mitosis-related GO terms 
and KEGG pathways, these biological processes such as ribosome and protein 
production are also indicative of rapid cell proliferation in the testes. 
 
The mitotic activity of testes is also evident in an analysis of over-represented 
protein domains in the testes transcriptome; for instance, out of 75 genes coding 
for helicase C-terminal domains, more than half are expressed at higher levels in 
testes than the whole male control (only three are expressed at higher levels in 
the whole male control) and 27 out of 55 genes coding for DEAD/DEAH box 
helicase domain containing proteins are up-regulated in testes (compared with 3 
in whole males) (Table 5.4). Furthermore, all 10 genes coding for mini-
chromosome maintenance domains are up-regulated in the testes, as are all 
genes coding for proteins with MutS domain II, III, IV and V (all involved in DNA 
mismatch repair) (Table 5.4). Many of proteins with these domains play an 





Figure 5.8: Most annotated S. mansoni homologues of DNA replication 
machinery genes are up-regulated in testes. Genes with a Schistosoma 
mansoni homologue are coloured in green, “testes genes” are highlighted in red. 
Most DNA replication genes are up-regulated in the testes transcriptome. This 
list highlights the important role played by many proteins with minichromosome 
maintenance (MCM) and helicase domains.  Figure adapted from KEGG 
(https://www.genome.jp/dbget-bin/www_bget?hsa03030). 
 
Notably absent from the testes genes but instead over represented in the whole 
male transcriptome were genes mapped to the following KEGG pathways: 
lysosomes, phagosome and endocytosis as well as various metabolic pathways 
including starch, sucrose, galactose, glucose, glycerophospholipid and amino acid 
metabolism (Appendix C.5), all of which are responsible for core physiology of 
the parasite. The whole male transcriptome was also enriched for various 
signalling pathways including Wnt, FoxO and hedgehog signalling (Appendix C.5) 
which play important roles during development of many organisms 
(Eijkelenboom & Burgering, 2013; Ingham et al., 2011; Nusse & Varmus, 1992; 
Nusse & Varmus, 2012). This is probably caused by the whole worms containing 
a wide variety of tissues and being more complex, including at the transcriptome 




Gene ID Description Average 
Read Count 
Fold Change adjusted  
p-value 
Smp_169930 HORMA domain containing protein 5313.73 34.78 4.14E-215 
Smp_131630 Testis expressed protein 1452.24 34.07 1.27E-146 
Smp_172150 Putative ATP-dependent RNA 
helicase 
4062.9 32.22 2.67E-223 
Smp_041540 Hormone receptor 4 (dHR4) 7395.01 31.12 2.39E-205 
Smp_144860 Boule 4169.81 27.19 2.61E-166 
Smp_079050 DNA primase large subunit 3908.09 24.93 1.27E-210 
Smp_080730 Cyclin dependent kinase 4902.06 22.78 1.64E-233 
 
Table 5.1: List of differentially expressed genes with testes-specific 
expression (see above). Average read counts are a measure of absolute gene 
expression; they are the average of normalised read counts across all samples. 
The fold changes reflect expression in the testes relative to whole male worms. 
The p-value has been adjusted for multiple hypothesis testing. See Appendix C.6 
for an expanded list. 
 
GO term Description Total Genes DEGs Expected p-value 
GO:0007018 Microtubule-based 
movement 
60 36 9.32 3.40E-15 
GO:0006941 Striated muscle 
contraction 
145 59 22.52 1.20E-13 
GO:0006270 DNA replication initiation 15 13 2.33 2.20E-09 
GO:0007283 Spermatogenesis 10 9 1.55 4.40E-07 
GO:0006281 DNA repair 122 46 18.95 7.00E-07 
GO:0007049 Cell cycle 207 78 32.15 2.40E-06 
GO:0007067 Mitotic nuclear division 88 37 13.67 3.50E-06 
GO:0006260 DNA replication 161 64 25.01 7.50E-05 
GO:0007126 Meiotic nuclear division 8 6 1.24 0.00029 
GO:0006298 Mismatch repair 11 7 1.71 0.0004 
GO:0006486 Protein glycosylation 58 15 9.01 0.00897 
GO:0042026 Protein refolding 8 4 1.24 0.024 
 
Table 5.2: List of GO terms enriched in testes genes (see above). The column 
“Total Genes” provides the number of genes associated with a particular GO 
term. “DEGs” provides the number of genes associated with a given GO term that 
had significantly higher expression in testes than whole males; “Expected Genes” 
provides the number of differentially expressed genes associated with a given 
GO term that are expected by chance. The GO terms are all in the “Biological 






Pathway Description Total Genes DEGs Expected p-value 
smm03030 DNA replication 30 24 7 5.80E-11 
smm03430 Mismatch repair 18 16 4.2 5.93E-09 
smm03440 Homologous recombination 18 15 4.2 1.07E-07 
smm03010 Ribosome 110 47 25.68 1.88E-06 
smm03460 Fanconi anaemia pathway 27 17 6.3 9.39E-06 
smm03008 Ribosome biogenesis in 
eukaryotes 
62 22 14.47 9.86E-03 
smm00970 Aminoacyl-tRNA biosynthesis 34 13 7.94 2.09E-02 
 
Table 5.3: List of pathways enriched amongst the testes expressed genes 
(see above). The column “Total Genes” provides the number of genes in the 
KEGG pathway; “DEGs” provides the number of differentially expressed genes in 
that pathway; “Expected Genes” provides the number of differentially expressed 






DEGs Expected p-value 
PF00271 
Helicase conserved C-terminal 
domain 
75 38 17.68 2.03E-07 
PF00270 DEAD/DEAH box helicase 55 27 12.97 2.19E-05 
PF00493 MCM2/3/5 family 10 10 2.36 5.20E-07 
PF00488 MutS domain V 4 4 0.94 3.08E-03 
PF05188 MutS domain II 3 3 0.71 1.31E-02 
PF05190 MutS family domain IV 3 3 0.71 1.31E-02 
PF05192 MutS domain III 3 3 0.71 1.31E-02 
 
Table 5.4: List of domains enriched amongst testes expressed genes 
discussed above. The column “Total Genes” provides the number of genes with 
a given Pfam domain; “DEGs” provides the number of differentially expressed 
genes with that domain; “Expected” provides the number of differentially 
expressed genes encoding a given domain that is expected by chance. See 
Appendix C.9 for an expanded list. 
 
 
5.2.4 Ovary Transcriptome 
“Ovary genes” were identified using the same method as testes genes, by doing a 
pair-wise comparison between ovaries of MS females and whole paired females 
using DESeq2. “Ovary genes” had to be differentially expressed using the same 
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adjusted p-value cut-off (< 0.01) and also have at least two-fold higher 
expression in ovaries than in the whole female control. Out of 10828 transcripts, 
10213 were found to be expressed (i.e. non-zero read counts), of which 509 
(5%) were filtered out due to low levels of expression using the DESeq2 
independent filtering algorithm. 1272 transcripts passed the criteria to be 
considered “ovary genes” (Figure 5.9A). 
 
 
Figure 5.9: 1272 genes were identified as ovary-specific genes. A) Log ratio 
against mean (MA) plot of the ovary-whole female comparison. Genes with an 
adjusted p-value of < 0.01 are high-lighted in red; genes with a log-fold change of 
> 1 (fold-change of > 2) and adjusted p-value of < 0.01 were called as 
differentially expressed “ovary genes”. B) PCA plot of ovaries of paired females 
and whole female control samples.  
 
Similar to the testes vs whole male comparison, the comparison of ovaries vs 
whole female shows a pattern, where genes up-regulated in whole females have 
greater fold changes than those up-regulated in ovaries (Figure 5.9B). Similarly 
to the testes genes, the most differentially expressed ovary genes contain genes 
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coding for proteins related to DNA replication and repair such as cytospin-A, as 
well as cell cycle controlling transcripts such as cyclins (Table 5.5) which 
promotes the anaphase stage of the cell cycle (Yuan & O’Farrell, 2015). The gene 
boule was also found to be differentially expressed in ovaries as compared to 
whole worms, indicating that - like its homologue in hermaphroditic flatworms – 
it is expressed in both testes and ovaries (Kuales et al., 2011). A “testis expressed 
protein” gene (Smp_131630) was found to be up-regulated in the ovaries as well 
(Table 5.5). In mice it contributes to the formation of intercellular bridges, 
making it essential for spermatogenesis. It plays the same role in the 
development of oocytes, although knock-outs of testis expressed gene 14 does 
not lead to sterility in females (Greenbaum et al., 2009). 
 
The results of the GO term analysis of ovary genes (Table 5.6) were very similar 
to that of the testes genes (Table 5.2). The ovary genes are enriched for 36 GO 
terms, 20 of which are shared with the GO terms enriched in the testes genes and 
include: “DNA replication initiation” and “DNA repair”, “mitotic nuclear division”, 
“miss-match repair” and “protein glycosylation”. Other GO terms enriched in the 
testes and ovary genes include cell cycle control and regulation of cell 
proliferation: “cell proliferation”, “negative regulation of cell proliferation”, “cell 
cycle” and “meiotic nuclear division”.  Unlike testes genes, which are not over-
represented in GO terms for signalling, the ovary genes are over-represented in 
“regulation of Rho protein signal transduction”. Almost four times more ovary 
genes associated with that GP-term are up-regulated significantly when 
compared to the expected number of such genes (23 up-regulated, 6 expected). 




The KEGG pathway analysis also highlighted the importance of DNA replication, 
the FA pathway and mismatch repair pathway, which were significantly up-
regulated in the ovary transcriptome (Table 5.7). Additionally, the analysis 
indicated a high rate of protein synthesis in this tissue, with ovary genes being 
over represented in Ribosome, Ribosome Biogenesis and other related pathways 
(Table 5.7).  
 
Even more so than in the testes genes, the ovary genes were significantly 
enriched with genes coding for helicase (both C-terminal helicase domains and 
DEAD/DEAH box helicase domains) and MCM domains (both the N-terminal 
domain and the MCM2/3/5 family domain). These were the three most 
significantly enriched domains, with between 77-100% (compared to 30% 
expected by chance) of genes coding for such domains being expressed at 
significantly higher levels in ovaries compared to whole females (Table 5.8). 
Another significant domain was the BRCA1 C Terminus domain (BRCT), 
belonging to a group of genes involved in DNA repair and is most known for its 
role in breast cancer (Friedenson, 2007). All nine S. mansoni genes coding for 
this domain had at least 2-fold higher expression in the ovaries than whole 
females (Table 5.8). 
 
Genes with noticeably low expression in the ovaries included those involved in 
digestion and metabolism of nutrients (in particular KEGG pathways such as 
lysosome, phagosome and endocytosis as well as amino acid and sugar 
metabolism) (Appendix C.10. Other pathways which were also expressed at low 
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levels in ovaries were signalling pathways such as FoxO (smm04068), hedgehog 
(smm04340) and neuroactive ligand-receptor interactions (smm04080). These 
results were found to be similar to those of the testes transcriptome, reflecting 
the function of germ cell production common to both gonad tissues.  
 
Gene ID Product Average Read 
Count 
Fold Change adjusted 
p-value 
Smp_144860 Boule 1998.21 16.06 1.34E-147 
Smp_131630 Testis expressed protein 1524.23 15.04 7.49E-162 
Smp_018010 Cytospin-A 9979.58 8.34 2.59E-211 
Smp_047620 Cyclin 6150.25 8.05 5.09E-162 
 
Table 5.5: Differentially expressed ovary-genes (see above). Average read 
counts provide a measure of absolute expression for a given gene. The fold 
changes reflect expression in ovaries relative to whole females. The p-value has 




GO term Description Total 
Genes 
DEGs Expected p-value 
GO:0006281 DNA repair 122 45 14.67 2.500E-10 
GO:0006270 DNA replication initiation 15 12 1.8 2.700E-09 
GO:0007049 Cell cycle 207 71 24.89 8.700E-08 
GO:0006260 DNA replication 161 57 19.36 1.500E-07 
GO:0007067 Mitotic nuclear division 88 33 10.58 1.300E-06 
GO:0007126 Meiotic nuclear division 8 6 0.96 6.700E-05 
GO:0006298 Mismatch repair 11 6 1.32 8.000E-04 
GO:0008285 Negative regulation of cell proliferation 5 3 0.6 1.436E-02 
GO:0006486 Protein glycosylation 58 11 6.98 4.348E-02 
GO:0035023 Regulation of Rho protein signal 
transduction 
23 6 2.77 4.972E-02 
 
Table 5.6: GO terms enriched amongst genes up regulated in the ovaries of 
paired females (see above). The column “Total Genes” provides the number of 
genes associated with a particular GO term; “DEGs” provides the number of 
genes associated with a given GO term that had significantly higher expression in 
ovaries; “Expected Genes” provides the number of differentially expressed genes 
associated with a given GO term that are expected by chance. The GO terms are 




Pathways Description Total 
Genes 
DEGs Expected p-value 
smm03008 Ribosome biogenesis in eukaryotes 62 48 20.60 5.076E-13 
smm03030 DNA replication 30 25 9.97 1.650E-08 
smm03010 Ribosome 110 62 36.55 1.712E-07 
smm03460 Fanconi anaemia pathway 27 21 8.97 2.040E-06 
smm03430 Mismatch repair 18 15 5.98 1.495E-05 
 
Table 5.7: KEGG pathways enriched amongst the genes up-regulated in the 
ovaries of paired females (see above). The column “Total Genes” provides the 
number of genes in the KEGG pathway; “DEGs” provides the number 
differentially expressed genes in that pathway; “Expected Genes” provides the 
number of differentially expressed genes in a given pathway that is expected by 
chance. See Appendix C.13 for the complete list. 
 
 
Domain Description Total 
Genes 
DEGs Expected p-value 
PF00271 Helicase conserved C-terminal domain 75 58 22.29 1.360E-17 
PF00270 DEAD/DEAH box helicase 55 43 16.35 1.126E-13 
PF00493 MCM2/3/5 family 10 10 2.97 5.309E-06 
PF00533 BRCA1 C Terminus (BRCT) domain 9 9 2.68 1.791E-05 
PF14551 MCM N-terminal domain 6 6 1.78 6.865E-04 
 
Table 5.8: Pfam domains enriched amongst the genes up-regulated in the 
ovaries of paired females (see above). The column “Total Genes” provides the 
number of genes encoding the Pfam domain; “DEGs” provides the number of 
differentially expressed genes coding for the domain; “Expected” provides the 
number of differentially expressed genes coding for the domain that is expected 
by chance. See Appendix C.14 for an expanded list. 
 
 
5.2.5 Comparing the Testes and Ovary Transcriptomes 
To identify genes that serve common function in the testes and ovary of S. 
mansoni, I examined the intersection between the sets of “testes genes” and 
“ovary genes”.  Out of 1949 testes genes and 1272 ovary genes, 715 were shared 
(Figure 5.10). The 715 DEGs were over-represented in many mentioned GO 
terms discussed in Chapters 5.2.3 and 5.2.4. This includes DNA repair and 
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replication, both mitotic and meiotic nuclear division, striated muscle 
contraction and microtubule based movement (Figure 5.10). However, there are 
interesting differences when looking at the genes expressed in ovaries and 
testes. While “testes genes” showed an expected enrichment for 
spermatogenesis, the “ovary genes” included an enrichment for genes of the 
Notch signalling pathway (Figure 5.10) which is known to be interconnected 
with Rho signalling and is a highly conserved pathway found in all metazoans 
(Boureux et al., 2007; Schwartz, 2004). The Notch signalling pathway 
(GO:0007219) was represented by 22 genes (4 expected, p = 0.033) (Appendices 
C.15-16).  
 
Fewer genes had ovary-specific expression compared to the testes (Figure 5.10). 
In the differential expression analysis, ovary-expressed genes were found to 
have a lower median fold-change than testes genes (6.51 and 14.03-fold change 
respectively). As a result, more testes genes had a fold-change above the 






Figure 5.10: More testes-specific than ovary-specific genes were identified 
with distinct functions in the two groups of genes. The numbers indicate the 
testes and ovary “specific” genes as well as genes shared by both. A selection of 
significantly enriched GO terms is given for each category. The 715 shared genes 
were found to be strongly enriched for DNA replication related functions. This 
included repair and chromosome maintenance. The genes expressed in testes 
contained many spermatogenesis-specific genes whereas the genes expressed in 
ovaries included genes that regulate multicellular organismal development and 









5.2.6 Effect of pairing on testes transcriptome 
The effect of pairing on the testes transcriptome is, like the effect of pairing on 
the male overall, relatively small. The aim was to identify pairing-related 
transcriptome changes in the testes. By excluding all non-testes specific 
transcripts, small transcriptome changes in the testes should be more easily 
detected, allowing more differentially expressed testes-specific genes to be 
identified. Genes differentially expressed between testes of males from MS and 
SS infections were identified by doing a pair-wise comparison using DESeq2. 
 
 
Figure 5.11 Few differentially expressed genes s were identified in 
comparison of testes from single sex (SS) and mixed sex (MS) infections. A) 
Log ratio vs mean (MA) plot of the SS testes – MS testes comparison. Genes with 
an adjusted p-value of < 0.01 are high-lighted in red; triangles indicate genes 
outside the boundaries of the plots; like other genes, they are red if they are 
statistically significant, grey if they are not. Genes with a log-fold change of > 1 
(fold-change of > 2) and adjusted p-value of < 0.01 were called as differentially 
expressed “testes genes”. B) PCA plot of testes of MS males and testes of SS 




10348 out of 10828 transcripts were found to be expressed (i.e. non-zero read 
counts), of which 2555 (25%) were filtered out due to low levels of expression 
using the DESeq2 independent filtering algorithm (Figure 5.11). 17 transcripts 
were found to be significantly up-regulated in testes of MS worms (Table 5.9), 
whereas only 3 were found to be down-regulated (Table 5.10). None of these 
genes had been found to be differentially expressed in the comparison of whole 
males from MS and SS infections. 
 






Smp_179370 Putative low-density lipoprotein 
receptor 
298.44 3.94 9.67E-13 
Smp_105420 Uncharacterised protein 298.24 2.39 7.07E-06 
Smp_075800 Legumain preprotein 433.98 2.43 1.20E-05 
Smp_103610 Cathepsin B-like cysteine proteinase 718.52 2.33 2.06E-05 
Smp_179170 Legumain preprotein 125.36 2.43 7.15E-05 
Smp_191250 Uncharacterised protein 412.72 2.19 9.85E-05 
Smp_198240 Anosmin-1 193.43 2.01 1.09E-04 
Smp_067060 Cathepsin B-like cysteine proteinase 770.84 2.14 3.75E-04 
Smp_179970 Uncharacterised protein 111.34 2.28 4.49E-04 
Smp_162070 Uncharacterised protein 562.93 2.04 4.84E-04 
Smp_084450 Asteroid-like protein 260.89 2.14 4.84E-04 
Smp_169920 Translation machinery associated 
protein 
6312.85 2.13 5.20E-04 
Smp_199790 α-(1,3)-fucosyltransferase 262.87 2.14 7.52E-04 
Smp_004530 Uncharacterised protein 68.27 2.14 2.09E-03 
Smp_014570 Saposin-like protein 104.84 2.10 2.09E-03 
Smp_139530 Tumour protein p63 89.43 2.08 2.40E-03 
Smp_053520 Homeobox protein aristaless-like 61.39 2.03 5.27E-03 
 
Table 5.9: Differentially expressed genes up-regulated in testes of males 
from mixed sex infections. Average read counts provide a measure of absolute 
expression for a given gene. The fold changes reflect expression in testes of 
males from mixed sex infections compared to testes of males from single sex 












Smp_166530 Phospholipase A 431.09 2.23 4.45E-05 
Smp_130280 Uncharacterised protein 59.57 2.08 2.72E-03 
Smp_018170 Krupple-like zinc finger protein 42.67 2.04 4.12E-03 
 
Table 5.10: Genes up-regulated in testes of males from single sex 
infections. Average read counts provide a measure of absolute expression for a 
given gene. The fold changes reflect expression in testes of males from single sex 
infections compared to testes of males from mixed sex infections. The p-value 
has been adjusted for multiple hypothesis testing. 
 
For this comparison the number of differentially expressed genes was so low 
that no reliable results could be obtained from the enrichment analysis. All three 
types of analysis, GO term, KEGG pathway and Pfam domain enrichment, 
returned statistically significant results for both MS and SS testes, but often these 
were based on as few as a single gene so that the results were not convincing 
from a biological point of view. 
 
Follistatin - SmFst 
Leutner et al. (2013) suggested in their paper on pairing experienced, i.e. MS, and 
inexperienced, i.e. SS, males that follistatin or SmFst (Smp_123300) might play a 
regulatory role in the testes of adult S. mansoni. This was based on the 
observation that SmFst was consistently up-regulated in SS males when 
compared to MS males (an effect that was replicated in this data set also (2.3x 
expression in SS males compared to MS males; adjusted p-vale = 1.50E-08), as 
well as an in situ hybridisation experiment suggesting a testes-specific pattern of 
SmFst expression (Leutner et al., 2013). However, the testes-specific nature of 
SmFst expression could not be detected using RNA-Seq, instead our data 
suggested an almost 10-fold higher expression of SmFst outside the testes 
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(adjusted p-value = 4.29E-11) (Appendix C.17). Furthermore, our data revealed 
that SmFst expression is not limited to male worms but is similarly down-
regulated in MS females (12-fold decrease in MS females; adjusted p-value = 
9.46E-31) and ovaries of MS and SS females (9-fold decrease in ovaries from MS 
worms; adjusted p-value = 8.58E-12) (Appendix C.18).  
 
 
5.2.7 Effect of pairing on ovary transcriptome 
Unlike the small transcriptome changes found in the testes, in ovaries the 
changes induced by pairing are of a much greater magnitude.  Out of 10828 
examined genes, 10217 had non-zero read counts of which 1019 genes were 
filtered out due to low read counts using the DESeq2 independent filtering 








Figure 5.12 Over 2700 DEGs were identified in comparison of ovaries from 
single sex (SS) and mixed sex (MS) infections. A) Log ratio against mean (MA) 
plot of the SS ovaries – MS ovaries comparison. Genes with an adjusted p-value of 
< 0.01 are highlighted in red; triangles indicate genes outside the boundaries of 
the plots; like other genes, they are red if they are statistically significant, grey if 
they are not. Genes with a log-fold change of > 1 (fold-change of > 2) and 
adjusted p-value of < 0.01 were called as differentially expressed “ovary genes”. 
B) PCA plot of ovaries of MS and SS females. 93% of variation across samples is 
explained by the experimental conditions in this PCA.  
 
 
Of the remaining genes, 2769 were found to be differentially expressed in 
response to pairing (966 up-regulated in MS ovaries and 1803 up in ovaries of SS 
females) (Figure 5.12A). Many of the genes differentially expressed between the 
ovaries of MS and SS females had not been identified as “ovary genes” in Chapter 
5.2.4. Instead they were expressed in the rest of the female worm as well. Out of 
the 2769 DEGs in this comparison, 574 were “ovary genes”. It shows that pairing 
dependant regulation of gene expression is not limited to “ovary genes” but also 
affects many genes expressed throughout the body of female worm. Particular 
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the vitellarian tissue undergoes significant growth and cell proliferation though 
at an even larger scale than the ovaries. 
 
Initially, I examined the genes up-regulated in MS ovaries (summaries in Table 
5.11). The list of GO term these genes were enriched with was dominated by all 
aspects of translation, but also included “cell-matrix adhesion”, “integrin-
mediated signalling pathway” and “neurotransmitter transport” (Table 5.12 and 
Appendix C.19). Female maturation is linked to a neural signal, neuropeptide-Y 8 
(Collins & Newmark, 2013) and cell proliferation of oogonia is thought to be 
stimulated by integrin signalling among others (Beckmann et al., 2012).  
 
Genes up-regulated in MS ovaries coded for proteins that for part of the KEGG 
pathways responsible for gene expression and protein production: “RNA 
transport”, “RNA polymerase” and “pyrimidine metabolism” indicated a high rate 
of transcription whereas “ribosome”, “ribosome biogenesis” and functionally 
related pathways such as “aminoacyl-tRNA biosynthesis” represented the 
translational activity of the mature ovaries, all of which is fuelled by a more 
highly transcribed “oxidative phosphorylation” pathway (Table 5.13). 
 
When examining enriched protein domains, these same processes were found to 
be enriched (Table 5.14). Amongst genes up-regulated in MS ovaries were many 
coding for proteins with domains such as helicase domains and RNA polymerase 
Rpb2 domains as well as RNA recognition motifs, 50S ribosome-binding GTPase 
domains, tRNA synthetase class I domains and different ribosomal protein 
domains (Table 5.14). Additionally, mitochondrial specific domains were 
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significantly enriched, including ATP synthase subunit C and mitochondrial 
carrier protein (Table 5.14). Highlighting the mitogenic activity within the 
mature ovaries, genes coding for proteins with cyclin domains were 
differentially expressed at higher levels than expected by chance in the MS 
ovaries. Cyclins play a key role in regulating the cell cycle by controlling the 
progression from one stage to the next (Sclafani & Holzen, 2007). Comparing the 
expression levels of all genes annotated as cyclin, cyclin dependant kinases 
(CDK), or cell division cycle protein (CDC), there were a total of 38 genes that 
formed two distinct clusters based on their expression (Figure 5.13). This 






Figure 5.13: Many genes involved in cell cycle regulation, including cyclin, 
CDK and CDC genes are up-regulated in mix sex ovary samples. Three RNA-
seq replicates of mixed sex (MS) ovary (MS ovary 1-3) and two replicates of 
single sex (SS) ovary (SS ovary 1-2) were used to generate this figure.  Colours 
represent a Z-score of log transformed normalised read counts scaled by row, 
providing relative measures of gene expression in each sample (measured in 
standard deviations from the mean). Average normalised read counts for each 
gene are in the row on the right on a logarithmic scale as a measure of absolute 






The MAPK, Rho and TGF-β signalling pathways have been examined closely and 
are known to play an important role in the development of the female sexual 
maturity (Andrade et al., 2014; Osman et al., 2006; Santos et al., 2002). To 
examine the processes that lead to the initiation of the MAPK pathway in the 
cells of the ovaries and induce maturation of the tissue I compiled a list of the 
well-established S. mansoni genes involved in the signalling network that 
transmits the male stimulus to the nuclei of ovary cells (Andrade et al., 2014; 
Beckmann et al., 2010; Knobloch et al., 2007; Oliveira et al., 2012; Osman et al., 
2006) and created a heat map of normalised read counts for the ovary samples 
(Figure 5.14).  This set of genes was also clustered into two expression groups, 
one up-regulated in the ovaries of MS females and one down-regulated when 
compared to ovaries of female worms from SS infections (Figure 5.14). The 
signalling network features over 40 members with different regulatory function 
that, in response to pairing, drive the cell cycle towards DNA replication and the 






Figure 5.14: Many genes of the MAPK, Rho and TGF-β signalling pathways 
are differentially expressed in the mixed sex (MS) and single sex (SS) ovary 
samples. Three RNA-seq replicates of MS ovary (MS ovary 1-3) and two 
replicates of SS ovary (SS ovary 1-2) were used to generate this figure.  Colours 
represent a Z-score of log transformed normalised read counts scaled by row, 
giving relative measures of gene expression in each sample. Average normalised 
read counts for each gene are in the row on the right on a logarithmic scale as a 
measure of absolute expression levels. See Appendix C.21 for a description of 






Unlike in Figure 5.13, where the expression of genes coding for cyclins, CDCs and 
CDKs was compared, the picture emerging from a comparison of genes coding 
for proteins involved in MAPK, TGFβ and integrin signalling was less clear. 
Although a large number of these genes were up-regulated in the MS ovaries, a 
similar number of genes had greater expression in the ovaries of SS females 
(Figure 5.14). Up-regulation of genes in the SS ovaries was by no means limited 
to genes coding for proteins with inhibitory functions but included genes coding 
for some of the key regulators of the MAPK signalling pathway such as 
homologues of Rho, Ras-guanine nucleotide exchange factor, Raf and Erk (Figure 
5.15). Others, such as genes coding for growth factor receptor-bound protein 2 
and Ras, showed no differentially expression (Figure 5.15). In contrast, the genes 
coding for SMAD2 and 4 as well as Transforming Growth Factor-β Receptor II, 
Ras-GAP and Scr-cytoplasmic tyrosine kinase homologues were found to be up-
regulated in MS ovaries (Figure 5.15). Ultimately however, the induction of cell 
proliferation is dependent on receiving specific extracellular stimuli provided by 
pairing as well as host factors to initiate signalling and mitogenic activity and cell 







Figure 5.15: Many members of the MAPK, Rho and TGF-β signalling 
pathway are differentially expressed in ovaries. Adapted from Knobloch et al. 
(2007). Dotted arrows indicate indirect interactions, solid arrows indicate direct 
interaction. Red arrows indicate inhibition and black arrows activation of the 
target. Red coloured genes are up-regulated in the ovaries of MS females, blue 
coloured genes are up-regulated in the ovaries of SS females, grey coloured 

















Smp_095350 Zinc finger protein 16607.90 985.26 0 
Smp_070360 Cytoplasmic polyadenylation element-binding 
protein 
3765.62 576.03 4.63E-153 
Smp_145490 Putative poly-rC-binding protein 7793.72 557.04 2.12E-298 
Smp_148390 Uncharacterised protein 13636.61 220.84 0 
Smp_164140 Uncharacterised protein 428.29 191.09 2.49E-43 
Smp_129920 Sodium- and chloride-dependent transporter 624.76 163.98 1.97E-59 
Smp_141570 Potassium channel of the TWiK family 278.68 154.52 5.77E-34 
Smp_013540 Tyrosinase 1012.14 138.29 2.77E-96 
Smp_172980 Uncharacterised protein 6231.87 112.03 0 
Smp_176940 Permease solute carrier 1183.57 98.93 1.48E-125 
Smp_134490 Thyroid receptor α 395.32 96.86 1.47E-49 
Smp_129960 Uncharacterised protein 14093.01 87.57 0 
Smp_080360 Uncharacterised protein 3841.06 82.10 0 
Smp_154390 Uncharacterised protein 2326.47 75.57 2.65E-221 
Smp_145400 Putative Rcd1-domain protein 730.32 72.26 6.68E-88 
 
Table 5.11: Most differentially expressed genes up-regulated in the ovaries 
of females from mixed sex infections compared to ovaries from single sex 
infections. Average read counts provide a measure of absolute expression for a 
given gene. The fold changes reflect expression in ovaries of females from mixed 
sex infections compared to ovaries of females from single sex infections. The p-
value has been adjusted for multiple hypothesis testing. Some p-values were 
calculated to be equal to 0, highlighting how statistically significant the 














GO term Description Total 
Genes 
DEGs Expected p-value 
GO:0006412 Translation 393 83 41.42 2.000E-09 
GO:0042254 Ribosome biogenesis 137 31 14.44 5.900E-06 
GO:0006414 Translational elongation 27 10 2.85 4.600E-04 
GO:0007160 Cell-matrix adhesion 8 4 0.84 6.040E-03 
GO:0006446 Regulation of translational 
initiation 
5 3 0.53 9.890E-03 
GO:0007229 Integrin-mediated signalling 
pathway 
9 4 0.95 9.980E-03 
GO:0006836 Neurotransmitter transport 30 8 3.16 1.038E-02 
GO:0006413 Translational initiation 37 11 3.9 1.510E-02 
GO:0006364 rRNA processing 108 19 11.38 2.259E-02 
GO:0008033 tRNA processing 61 10 6.43 2.631E-02 
GO:0006633 Fatty acid biosynthetic process 51 10 5.37 3.746E-02 
 
Table 5.12: GO terms enriched amongst the genes up-regulated in ovaries 
of females from mixed sex (MS) infections compared to ovaries from single 
sex infections (see above). The column “Total Genes” provides the number of 
genes associated with a particular GO term. “DEGs” provides the number of 
genes associated with a given GO term that had significantly higher expression in 
ovaries of MS females; “Expected Genes” provides the number of differentially 
expressed genes associated with a given GO term that are expected by chance. 
The GO terms are all in the “Biological Process” category. See Appendix C.19 for 
the complete list. 
 
Pathway Description Total 
Genes 
DEGs Expected p-value 
smm03010 Ribosome 110 91 55.90 7.516E-13 
smm03008 Ribosome biogenesis in eukaryotes 62 57 31.51 1.798E-12 
smm03013 RNA transport 103 73 52.34 1.118E-05 
smm00190 Oxidative phosphorylation 69 52 35.06 1.377E-05 
smm03020 RNA polymerase 24 20 12.20 7.794E-04 
smm00970 Aminoacyl-tRNA biosynthesis 34 23 17.28 1.972E-02 
smm00240 Pyrimidine metabolism 59 35 29.98 4.411E-02 
 
Table 5.13: KEGG pathways enriched amongst the genes up-regulated in 
the ovaries of females from mixed sex infections compared to ovaries from 
single sex infections (see above). The column “Total Genes” provides the 
number of genes in the KEGG pathway. “DEGs” provides the number 
differentially expressed genes (DEGs) in that pathway; “Expected Genes” 
provides the number of DEGs in a given pathway that is expected by chance. See 





Domain Description Total Genes DEGs Expected p-value 
PF00270 DEAD/DEAH box helicase 55 33 18.16 2.375E-05 
PF14259 RNA recognition motif (a.k.a. RRM, RBD, 
or RNP domain) 
29 19 9.57 2.547E-04 
PF00153 Mitochondrial carrier protein 26 16 8.58 1.896E-03 
PF00271 Helicase conserved C-terminal domain 75 35 24.76 4.477E-03 
PF13893 RNA recognition motif. (a.k.a. RRM, 
RBD, or RNP domain) 
13 9 4.29 6.669E-03 
PF01926 50S ribosome-binding GTPase 11 8 3.63 6.965E-03 
PF00137 ATP synthase subunit C 4 4 1.32 1.186E-02 
PF00579 tRNA synthetases class I (W and Y) 4 4 1.32 1.186E-02 
PF00134 Cyclin, N-terminal domain 13 8 4.29 2.442E-02 
PF00004 ATPase family associated with various 
cellular activities (AAA) 
34 16 11.22 3.222E-02 
PF00164 Ribosomal protein S12/S23 3 3 0.99 3.595E-02 
PF00380 Ribosomal protein S9/S16 3 3 0.99 3.595E-02 
PF00562 RNA polymerase Rpb2, domain 6 3 3 0.99 3.595E-02 
 
Table 5.14 Pfam domains enriched amongst the genes up-regulated in 
ovaries the of females from mixed sex infections compared to ovaries from 
single sex infections (see above). The column “Total Genes” provides the 
number of genes with a given Pfam domain. “DEGs” provides the number of 
differentially expressed genes with that domain; “Expected” provides the 
number of DEGs with a given domain that is expected by chance. See Appendix 
C.23 for an expanded list. 
 
 
Next, I examined the genes upregulated in SS ovaries, the most differentially 
expressed of which are summarised in Table 5.15. Genes up-regulated in the 
ovaries of SS females were enriched for a total of 38 GO terms (Table 5.16). 
Interestingly these GO terms included “spermatogenesis” and “male sex 
determination” (Table 5.16), two biological processes that intuitively are 
associated with testes rather than ovaries. In the case of the “male sex 
determination” the genes in question included negative regulators of 
transcription (Logan-Klumpler et al., 2012) via the MAPK signalling pathway 
such as a capicua (Smp_142600) and a SOX family transcription factor 
homologue (Smp_148110) (Hargrave et al., 2000; Jimenez et al., 2012) as well as 
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two members of the Wnt signalling pathway (Logan-Klumpler et al., 2012) 
responsible for regulating embryogenesis in D. melanogaster, a pangolin 
(Smp_131260) and transcription factor 7-like-2 (Smp_148190) homologue (Jin & 
Liu, 2008; Ravindranath & Cadigan, 2014) which also play a role in the ovaries. 
The “spermatogenesis” genes include three homologues of the gene coding for 
the “spermatogenesis associated proteins” (Logan-Klumpler et al., 2012) but 
their function is not necessarily involved exclusively in spermatogenesis; they 
fulfil varied roles, such as apoptosis regulation and degradation of mitochondrial 
proteins (Jiang et al., Wang, 2013; Puri et al., 2011). Additionally, two nanos 
homologues (Smp_051920, Smp_055740) are included (Logan-Klumpler et al., 
2012), which play an important role in spermatogenesis but were also shown to 
be involved in oocyte development by maintaining the adult germlines in D. 
melanogaster (Bhat, 1999). Furthermore the “spermatogenesis” GO term 
included two lin54 protein homologues (Smp_022870, Smp_178740) (Logan-
Klumpler et al., 2012), which are both involved in the regulation of the cell cycle. 
They are components of the DREAM complex, which regulates gene expression 
at various points throughout the cell cycle (Schmit et al., 2009). Other interesting 
GO terms included the “Wnt signalling pathway”, “cell cycle arrest”, and “cell 
differentiation” (Table 5.16). These GO terms were further evidence for the strict 
control of cell proliferation in the ovaries of SS females.  Finally, a significant 
proportion of genes annotated with the GO terms “Fatty acid biosynthetic 
process” and “Sphingolipid metabolism” were up-regulated (Table 5.16). 
 
Next, a pathway analysis was performed using the KEGG reference pathways for 
S. mansoni. The aim was to identify any pathways containing more up-regulated 
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genes than expected by chance. The pathway analysis of the SS ovary genes 
revealed 14 pathways to be significantly up-regulated (Table 5.17). Metabolic 
pathways, including amino acid metabolism, carbohydrate metabolism and lipid 
metabolism notably including “sphingolipid metabolism” were found to be 
enriched with DEGs (Table 5.17). Several developmental signalling pathways 
were also found to be over-represented among the DEGs, such as Wnt signalling 
and dorsal-ventral axis formation, similar to the GO terms found up-regulated in 
the SS ovaries (Table 5.17). The SS ovary genes were also examined for Pfam 
domain enrichment with 77 different domains found to be enriched (Table 5.18).  
Among them were genes coding for domains that control apoptosis, such as the 
Bcl-2 domain and growth factor domains, such as Calcium-binding EGF domains, 
complement clr-like EGF-like domains and growth factor receptor domain IV 
(Table 5.18). 
 
Since Galanti et al. (2012) observed apoptosis to be occurring at a higher rate in 
the vitellarian tissue of SS females compared to MS females, I examined whether 
similar activity could be detected in the ovary transcriptome. I first noted that all 
four genes known to code for Bcl-2 domains were up-regulated in ovaries of SS 
females (Table 5.18). Furthermore, ceramide, one of the central metabolites of 
the sphingolipid metabolism pathway that was significantly up-regulated in the 
ovaries of SS females (Table 5.17), is also an important regulator of apoptosis 
(Bose et al., 1995; Jensen et al., 2014; Separovic et al., 2012). Bose et al. (1995) 
showed that ceramide synthase mediates an alternative pathway of apoptosis 
activation. Sparovic et al. (2012) showed that human cells became more 
resistant to apoptosis when ceramide synthase was knocked down using RNAi. 
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Finally, Jensen et al. (2014) discovered that a member of the Bcl-2 family, a 
group of apoptosis regulating protein, can inhibit ceramide synthase. The 
mitochondria associated protein Bcl-2-like 13 blocks apoptosis by inhibiting 
ceramide synthase, thereby linking sphingolipid metabolism and the Bcl-2 
regulated apoptosis machinery (Jensen et al., 2014). In the ovaries of SS females, 
a homologue of ceramide synthase (Smp_042440) was 2.5-fold up-regulated 
(adjusted p value = 1.74E-07) (Table 5.15) and as can be seen in Figure 5.16, 
several other genes involved in the biosynthesis of ceramide were up-regulated 




Figure 5.16: Many genes involved in sphingolipid metabolism are 
differentially expressed in ovaries from single sex (SS) and mixed sex (MS) 
infections. The genes encoding red coloured enzymes are up-regulated in 
ovaries of SS females, genes coding for blue coloured enzymes are down-
regulated in the ovaries of SS females. Arrows indicate the catalysed reaction. 






I used the list of 28 putative apoptosis-related genes from Chapter 4.2.2 to 
examine the apoptosis in the ovaries. These genes had been identified using a 
combination of previously published literature (Lee et al., 2011, Lee et al., 2014; 
Peng et al., 2010) as well as Interpro Scan, Pfam and BLAST comparison (see 
Chapter 2.4.12 for method; see Appendix B2-10 for more details). Several groups 
of genes, such as cytochrome C genes (21 genes in total), known to be involved in 
apoptosis were excluded from this heat map due to the size of these gene 
families and due to their role in many other cellular processes. In total, six out of 
13 putative pro-apoptotic factors were significantly up-regulated in the ovaries 
of SS females, whereas only one was significantly up-regulated in the ovaries of 
MS females (six not significantly differentially expressed) (Appendix C.24). In 
contrast, six out of nine putative anti-apoptotic genes were significantly up-
regulated in the ovaries of MS females and only one in the ovaries of SS females 
(two were not significantly differentially expressed) (Appendix C.24). Of the six 
genes for which it was unknown whether they are pro- or anti-apoptotic two – 
Smp_168470 & Smp_148130 – were significantly up-regulated in the ovaries of 
SS females and four – Smp_043360, Smp_022110, Smp_084610 & Smp_196040 – 
were up-regulated in the ovaries of MS females. If the assumption that pro-
apoptotic genes are up-regulated in SS ovaries and anti-apoptotic genes are 
down-regulated is correct, Smp_043360 (sBH3), Smp_022110 (p21 activated 
protein kinase interacting protein), Smp_084610 (FAS associated factor 2) and 
Smp_196040 (SHC transforming protein 3) may have anti-apoptotic activity, 
whereas Smp_168470 (Bcl-2 family protein) and Smp_148130 (FAS binding 
factor) could have pro-apoptotic functions (see Figure 5.17). However, to 
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confirm or dismiss these predictions careful characterisation of these genes 
using RNAi or other methods should to be performed. 
 
Figure 5.17 Expression of apoptosis-related genes points to higher levels of 
apoptosis in the ovaries of females from single sex (SS) infections than 
those of females form mixed sex (MS) infections. Three RNA-seq samples of 
MS ovary (MS ovary 1-3) and two SS ovary (SS ovary 1-2) were used to generate 
this figure. Colours represent a Z-score of log transformed normalised read 
counts scaled by row, giving relative measures of gene expression in each 
sample. Average normalised read counts for each gene are in the row on the 
right on a logarithmic scale as a measure of absolute expression levels. Samples 
were clustered by similarity of expression patterns, forming the expected groups 
of single sex and mixed sex ovaries. Genes were also clustered by expression.  
Genes were either categorised as pro-apoptotic (+), anti-apoptotic (-) or with 
unknown regulatory function (?).See Appendix C.24 for a description of these 
putative apoptosis-related genes and their expression in ovaries. 
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Smp_079970 Tubulin-β chain 31.51 44.38 5.27E-16 
Smp_079960 Tubulin-β chain 41.05 37.93 2.23E-17 
Smp_135500 Phosphodiesterase 387.74 36.16 9.33E-101 
Smp_127170 Putative potassium channel 147.33 35.77 6.53E-51 
Smp_038730 Uncharacterised protein 4801.90 34.18 3.69E-30 
Smp_184180 Uncharacterised protein 213.38 32.46 2.69E-33 
Smp_022480 Putative transient receptor cation channel 32.34 32.29 8.95E-14 
Smp_133900 Indoleamine 2,3-dioxygenase 91.77 30.77 6.21E-31 
Smp_168610 Putative suppression of tumorigenicity 
protein 
73.08 30.49 9.33E-26 
Smp_182770 Putative neuroblast differentiation 
associated protein 
5961.91 28.93 1.00E-44 
Smp_173070 Invasolysin-like protease 247.08 28.56 5.82E-62 
Smp_162190 Cystein and glycine-rich protein 61.27 28.34 3.58E-19 
Smp_180890 Rho/GAP domain-containing protein 237.53 28.33 2.78E-41 
Smp_128250 Uncharacterised protein 158.60 27.06 4.93E-45 
Smp_174340 Frizzled protein 82.08 26.62 9.44E-22 
Smp_042440 Ceramide synthase 151.44 2.56 1.74E-07 
 
Table 5.15: Most differentially expressed genes up-regulated in the ovaries 
of females from single sex (SS) infections compared to ovaries from mixed 
sex (MS) infections. Average read counts provide a measure of absolute 
expression for a given gene. The fold changes reflect expression in ovaries of SS 
females compared to ovaries of MS females. The p-value has been adjusted for 
multiple hypothesis testing. 
 
GO ID Description Total Genes DEGs Expected p-value 
GO:0030154 Cell differentiation 78 29 11.89 2.000E-06 
GO:0007283 Spermatogenesis 10 5 1.52 1.053E-02 
GO:0016055 Wnt signalling pathway 27 9 4.12 3.073E-02 
GO:0007050 Cell cycle arrest 6 3 0.91 4.934E-02 
GO:0030238 Male sex determination 6 3 0.91 4.934E-02 
 
Table 5.16 GO terms enriched in genes up-regulated in ovaries of ovaries of 
females from single sex (SS) infections compared to ovaries from mixed sex 
(MS) infections (see above). The column “Total Genes” provides the number of 
genes associated with a particular GO term. “DEGs” provides the number of 
genes associated with a given GO term that had significantly higher expression in 
ovaries of SS females; “Expected Genes” provides the number of differentially 
expressed genes associated with a given GO term that are expected by chance. 
The GO terms are all in the “Biological Process” category. See Appendix C.25 for 




Pathway Description Total 
Genes 
DEGs Expected p-value 
smm00330 Arginine and proline 
metabolism 
18 9 2.84 5.943E-04 
smm00052 Galactose metabolism 14 6 2.21 1.152E-02 
smm00600 Sphingolipid metabolism 15 6 2.37 1.621E-02 
smm04320 Dorso-ventral axis formation 8 4 1.26 2.164E-02 
smm04310 Wnt signalling pathway 35 10 5.52 2.345E-02 
smm00561 Glycerolipid metabolism 17 6 2.68 2.854E-02 
smm00500 Starch and sucrose 
metabolism 
14 5 2.21 4.143E-02 
smm00062 Fatty acid elongation 6 3 0.95 4.675E-02 
smm00564 Glycerophospholipid 
metabolism 
35 9 5.52 4.878E-02 
 
Table 5.17: KEGG pathways enriched for in genes up-regulated in ovaries of 
females from single sex infections compared to ovaries from mixed sex 
infections (see above). The column “Total Genes” provides the number of genes 
in the KEGG pathway. “DEGs” provides the number differentially expressed 
genes in that pathway; “Expected Genes” provides the number of differentially 
expressed genes in a given pathway that is expected by chance. See Appendix 
C.26 for the complete list. 
 
Domain Description Total 
Genes 
DEGs Expected p-value 
PF07645 Calcium-binding EGF domain 7 6 1.94 2.310E-03 
PF13405 EF-hand domain 12 8 3.33 4.741E-03 
PF00452 Apoptosis regulator proteins, Bcl-2 
family 
4 4 1.11 5.938E-03 
PF14843 Growth factor receptor domain IV 3 3 0.83 2.140E-02 
PF12662 Complement Clr-like EGF-like 3 3 0.83 2.14E-02 
 
Table 5.18 Pfam domains enriched amongst the in genes up-regulated in 
ovaries of females from single sex infections compared to ovaries from 
mixed sex infections (see above). The column “Total Genes” provides the 
number of genes encoding a given Pfam domain. “DEGs” provides the number of 
differentially expressed genes with that domain; “Expected” provides the 
number of differentially expressed genes encoding a given domain that is 







5.3 Discussion  
When examining the published results (Hahnel et al., 2014) on differential 
expression in mature (MS) and immature (SS) gonads, differences emerged both 
in terms of direction and magnitude of the observed changes. These 
discrepancies could be resolved by taking into account changes in the expression 
of the reference gene, actin, which was shown to be distinctly differentially 
expressed across mature and immature ovaries. After applying this calibration, 
both sets of data agreed well, not only in terms of the direction of differential 
expression but also the magnitude of the changes measured, strengthening the 
confidence that can be placed in this data set as well as highlighting the 
importance of choosing appropriate internal reference genes for qPCR analysis.  
There are several papers discussing the role of pairing-induced signalling 
through various pathways on actin and its role in the remodelling of the cell 
cytoskeleton (Beckmann et al., 2010; Faix & Grosse, 2006; Knobloch et al., 2007; 
Olson, 2003; Wallar & Alberts, 2003). As a result, differential expression of actin 
between ovaries of SS and those of MS females is not entirely unexpected, 
although the magnitude of the change was surprising. This analysis suggests that 
actin should be used very carefully as a reference gene for qRT-PCR. Instead a 
more rational choice of internal reference gene, such PSMD4, another gene 
recommended by Liu et al. (2012), may more suitable, especially when 
comparing samples from different life cycle stages, different genders or different 




Comparing the number genes identified to be gonad specific by Nawaratna et al. 
(2011) to this analysis several differences become apparent. Nawaratna et al. 
(2011) identified 2141 probes, corresponding to 1188 genes, to be testes-
specific and 4352 probes, 1989 genes, to be ovary-specific. In the present study, 
1949 testes-specific and 1272 ovary-specific genes were found, despite using the 
same threshold for gonad specificity (a two-fold higher expression in the gonads 
compared to the whole worm control). In this context it is interesting to note 
that Nawaratna et al. (2011) had two biological replicates for testes, but only one 
sample for ovaries (and only single sample for both male and female whole 
worm controls). This may explain some of the discrepancy between the 
microarray and RNA-Seq results.  
 
The transcriptome analysis of ovaries and testes reflected their known biological 
functions closely with both highly enriched for genes involved in DNA replication 
and cell proliferation/division genes as suggested by GO term, KEGG pathway 
and Pfam domain enrichment analysis. The domain enrichment analysis 
highlighted a significant enrichment of genes involved in faithful DNA replication 
compared to the whole worm transcriptome, showing all genes with MutS and 
BRCA domains being expressed at higher levels in the gonads than the whole 
worm controls. These findings do not come as a great surprise, given that germ 
cell maintenance as well as spermatocyte and oocyte production are the main 
function of the testes and ovaries respectively. Similar to Nawaratna et al. 
(2011), this analysis showed cyclins, CDCs and CDKs to be expressed at higher 




Few changes in gene expression were found in the testes in response to pairing. 
This is in good agreement with the literature that suggests little change except a 
small shrinkage of testes, which was observed in MS male worms. Follistatin, 
which was hypothesised by Leutner et al. (2013) to be testes specific, was not 
found to be expressed at higher levels in the testes than whole males nor was it 
found to be differentially expressed in the testes of MS and SS males. Nonetheless 
a down-regulation of follistatin in MS males was observed in this experiment, as 
had been previously reported by Leutner et al. (2013). This suggests that SmFst 
plays a role in the response of male worms to pairing that is unrelated to the 
testes. Rather its function appears to take place in the somatic tissues of male 
worms, which was unexpected.  
 
 
The small transcriptome changes in testes stood in stark contrast to those in the 
ovaries. In the ovaries of MS females, clear up-regulation of cell cycle regulating 
genes was seen, including cyclins, CDCs and CDKs, which play a pivotal in the 
tight control of DNA replication and repair in eukaryotes (Sclafani & Holzen, 
2007) to allow for successful mitosis and meiosis. The higher expression of those 
genes in MS females emphasised the higher rate of cell division and proliferation 
in females worms from MS infections compared to female worms from SS 
infections, as expected from our current knowledge of the effect of pairing on the 
ovaries.  
 
In addition to the cell cycle regulating proteins, many genes involved in Rho and 
MAPK signalling pathway - known to regulate proliferation and maturation of 
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ovaries in response to pairing (Beckmann et al., 2010) - were differentially 
regulated between SS and MS ovaries. Although no clear pattern of up- or down- 
regulation of this group of genes emerged, the large, statistically significant 
proportion of these genes expressed differentially between immature and 
mature ovaries, reinforces the key role that the MAPK pathway plays in 
regulating ovary growth. As discussed in the introduction, Rho is thought to be 
an important member of the group of genes regulating cell proliferation in the 
ovaries in response to pairing (Beckmann et al., 2010). Rho signalling allows 
cells to respond to a variety of extracellular signals, including growth factors, 
cytokines and hormones (Schwartz, 2004). This could be part of the mechanism 
that regulates the pairing-induced fertility in female worms. 
 
 
The changes that took place in the ovary transcriptome in response to pairing 
were also highly suggestive of apoptosis playing an important role in controlling 
ovary maturation before pairing. Two important aspects of this process are the 
sphingolipid metabolism (Tirodkar & Voelkel-Johnson, 2012) and secondly a set 
of proteins including Bcl-2 domain containing proteins, caspases, BAX domain 
containing proteins and apoptosis inhibitors (Lee et al., 2011). The sphingolipid 
metabolism pathway was significantly up-regulated in SS females, with ceramide 
synthase, a known positive regulator of apoptosis in human cells (Separovic et 
al., 2012), being 2.5-fold more expressed in SS ovaries than MS ones. On the 
other hand, neutral ceramidase, known to have a protective effect on cells in rat 
cells (Zhu et al., 2008), was also up-regulated, suggesting that proliferation and 




Further evidence of the important role apoptosis plays in the regulation of ovary 
proliferation before pairing was based on classification of apoptosis genes in 
schistosomes by Lee et al. (2014) as well as BLAST and Pfam evidence. Many 
putative pro-apoptotic genes were found to be expressed in the ovaries of SS 
females in contrast to the high level of expression of putative anti-apoptotic 
genes in the ovaries of MS females. These findings were consistent with the high 
levels of apoptosis reported in vitellarian tissue of SS females by Galanti et al. 
(2012) and point to a common regulatory mechanism for the proliferation of 















Sexual maturation of female schistosomes is critically dependant on stimulation 
by a male partner, as is well established (Basch, 1991). In the absence of a male 
stimulus, the female worms remain developmentally stunted without mature 
ovaries and vitellaria on which egg production depends. While the differences 
between fully mature females and immature females had already been explored 
extensively [for example Fitzpatrick & Hoffmann (2006) and Waisberg et al. 
(2007)] when I started working on this thesis, a time course of gene expression, 
measured using RNA-Seq, over the course of female development was not 
available. This time course revealed the changes in gene expression as they 
occurred over time after pairing commenced, rather than just the gene 
expression of fully mature females. Many studies have examined the signalling 
cascade that leads to the proliferation of cells in the female reproductive organs 
(see Chapter 1.5) and there was already evidence for the involvement of 
neuropeptides (Collins et al., 2010) as well as apoptosis (Galanti et al., 2012) 
playing an important role in female development, and particularly regulating cell 
proliferation in female reproductive organs. 
 
Recently, several papers examined the changes in genes expression over the 
course of schistosome maturation (Cai et al., 2016; Wang et al., 2017). One of 
their aims was to discover the precise stimulus used by male worms to induce 
maturation in females. The nature of this stimulus has been the subject to 
research and speculation of years but has remained elusive (Chapter 1.4). Wang 
et al. (2017) used their expression data to identify genes whose expression was 
correlated with paring or vitelline development. Wang et al. (2017) hypothesised 
that an aromatic-L-amino acid decarboxylase (AADC) gene, which they showed 
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to be expressed in the gynecophoral canal of male worms using WISH, was 
responsible for the stimulation of female worms. The authors did not present 
RNAi evidence showing that knock down of AADC prevented female maturation 
as they did for another gene in the same paper. Thus, the evidence for AADC 
inducing female fertility seems somewhat circumstantial at this point, as it 
appears to be based on a correlation of AADC expression with female fertility, as 
well as the expression in the gynecophoral canal. Furthermore, data from 
Chapter 3 showed that the S. mansoni homologue of AADC is expressed in a 
paring-dependant manner. However, that would raise the question of how male 
worms are stimulated to express AADC. More concrete evidence, such as RNAi 
experiments, similar to that provided for the allatostatin receptor in the same 
publication (Wang et al., 2017), would greatly strengthen this hypothesis. 
 
This thesis examined the events leading to maturation of female worms starting 
with pairing and the male-female interaction. This is an important aspect of 
schistosome biology for many reasons. In particular, if untreated, adult 
schistosomes survive for years inside the mammalian host, and their egg 
production is responsible for much of the pathology associated with 
schistosomiasis as well as its transmission.  Hopefully the information gathered 
here can help to identify new avenues in the search for novel drug targets and 
therapies. Praziquantel, the current drug of choice for the treatment of 
schistosomiasis, is not effective against developing parasites and also faces the 





Divergent development of males and females 
In Chapter 3, the development of male and female worms was examined at the 
transcriptome level, to determine when changes in gene expression take place 
and how they differ in worms from mixed sex and single sex infections. Male and 
female S. mansoni are still highly similar at the transcriptome level at 18 d.p.i. 
with only 38 DEGs identified between them. As pairing commences, their 
differences increase to 173 DEGs at 28 d.p.i. and continues to 2194 DEGs at 35 
d.p.i. when sexual maturation of the female worms has significantly progressed. 
Both male and female worms expressed genes involved in the cytochrome P450-
dependent drug metabolism pathway at higher levels at 18 d.p.i. than at later 
time points. Of these genes, glutathione S transferases (including Smp_024010 
and Smp_102070) in particular are thought to play a key role in the mediation of 
xenobiotic metabolism in schistosomes, and have been shown to bind 
praziquantel at a non-substrate site (Cardoso et al., 2003). Their high expression 
levels at the earliest point during the time course suggests that these glutathione 
S transferases may be responsible for the resistance of immature worms to 
praziquantel. Expression of genes involved in spermatocyte production such as 
the testes expressed transcription factors boule (Smp_144860) and basonuclin 2 
(Smp_138350) was found to change from 18 d.p.i. onwards in male worms. The 
expression of boule, which in Schmidtea mediterranea is responsible for meiotic 
progression of male germ cells, rose significantly over the following time points. 
In contrast, the expression of basonuclin 2, which prevents premature 
maturation of spermatocytes in mammals, was found to decline significantly 




Relatively few differences were found between males of mixed sex and single sex 
infections during their development. A notable exception to this was an 
aromatic-L-amino acid decarboxylase (AADC) described by Wang et al. (2017) 
(see above). Female worms are well known to up-regulate fertility related genes 
such as eggshell proteins and tyrosinases once paired, and this was observed 
consistently from 28 to 38 d.p.i. in mixed sex infections. A large number of 
transcription factors became down-regulated around the time pairing 
commences in females from both mixed sex as well as single sex infections. This 
is interesting because it showed that the down-regulation occurs in a pairing-
independent fashion (Chapter 3.2.5). After an approximately three week period 
of maturation the female worms become developmentally arrested, which 
coincides with this down-regulation of transcription factors. Only after pairing, 
three zinc-finger transcription factors (Smp_166560, Smp_087320 and 
Smp_095350) became up-regulated. Their homologues in D. melanogaster 
regulate expression of neuropeptides (Vogler & Urban, 2008) and the response 
to stimuli such as growth factors (Baou et al., 2009). If this function were 
conserved in schistosomes it would potentially allow them to regulate the 
development of female schistosomes to reach sexual maturity.  
 
In vitro culture has significant effects on neural genes 
Having examined the process of maturation in Chapter 3, Chapter 4 aimed to 
examine the opposite: regression of female worms in the absence of a male 
partner. However, when comparing RNA-Seq data of paired and single worm, it 
became apparent that in vitro culture has an extensive effect on gene expression. 
Changes due to in vitro culture, especially of fertility related genes, had been 
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expected in female worms as reported in the literature (Galanti et al., 2012). 
However, the changes in gene expression measured here were neither limited to 
fertility related genes nor to female worms. Using RNA-Seq the whole 
transcriptome could be examined rather than being limited to small numbers of 
genes as in previous studies. As a result, a large group of neural genes involved in 
regulating the development of the nervous system was found to be up-regulated 
in vitro. These genes, such as semaphorins and their plexin and neuropilin 
receptors, netrins and the DCC and UNC5 receptors, slit and its robo receptors as 
well as ephrin and its receptors, have all been implicated in the pruning of axons 
and controlled neural cell death (Vanderhaeghen & Cheng, 2010). On the other 
hand, neuron survival genes, such as those coding for motor neuron 1 and fragile 
X mental retardation protein 1, were found to be down-regulated. Together these 
expression results suggested that parts of the worm nervous system regressed 
together with the reproductive tissues. This may be of particular interest as the 
nervous system is thought to be involved in the regulation of female fertility 
(Collins et al., 2010; Wang et al., 2017). 
 
The role of CD63 receptor and antigen in female fertility 
The analysis of RNA-Seq data revealed the up-regulation of two tetraspanins in 
females from mixed sex infections from 28 d.p.i.: CD63 receptor, previously 
reported by Fitzpatrick et al. (2009), and CD63 antigen. Using RNA-Seq and qRT-
PCR data, mature paired females were shown to express the CD63 receptor and 
antigen at 800- and 50-fold higher levels than male worms as well as at over 
190- and 39-fold higher levels than females from single sex infections. Also, both 
genes were found to be depleted in the ovaries of paired females, compared to 
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whole worms and the in situ experiments showed expression predominantly in 
the vitellarian tissue. Furthermore, in Chapter 3, both genes clustered with 
several well-known fertility related genes strongly suggesting a role in the 
development or maintenance of female fertility. RNAi provided some evidence of 
a RNA knock down affecting egg production. However, the RNAi experiment was 
performed in vitro and was therefore confounded by the associated problems of 
reduced fertility in the negative control. Female fertility is particular difficult to 
study in vitro, as regression of female reproductive tissues occurs quickly outside 
the host although Galanti et al. (2012) showed that this process is slowed in the 
presence of male worms. Although only a moderate reduction of expression was 
achieved for the CD63 antigen and no significant reduction for the CD63 
receptor, both knockdowns were found to result in a significantly reduced 
production of eggs (CD63 antigen: 9.6-fold; CR63 receptor: 3.2-fold), compared 
to the negative control.   
 
Given this evidence, a role of both CD63 receptor and antigen in egg production 
seems near certain. However, their exact function in this process is unclear. In 
humans the CD63 receptor is involved in forming signalling complexes of 
integrins and growth factors and thereby regulating downstream gene 
expression and cell proliferation. If the schistosome homologues performed 
similar functions, such a role could be crucial to regulate the development of 
vitellarian tissue in paired female worms. Furthermore, both the CD63 receptor 
and antigen have been implicated in the regulation of cell survival by down-
regulating integrin-β signalling and consequently down-regulating apoptosis in 
human cell lines. Up-regulation of these two genes in paired females could allow 
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for proliferation of vitellocytes by reducing the rate of apoptosis in this tissue. 
The CD63 receptor has also been associated with intracellular vesicles and 
regulation of protein transport in and out of such vesicles. During their 
maturation vitellocytes become filled with intracellular vesicles in which 
precursors of the egg shell proteins are stored. This could mean that CD63 
receptors play a role in the formation of such vesicles.  
 
To further explore the role of CD63 receptor and antigen it would be useful to 
study their interactions with other proteins or maybe even with one another. 
This might be possible by using a yeast two-hybrid assay which has been used 
identify other protein interactions in S. mansoni (Vanderstraete et al., 2014). 
Another possible method might be the use of fluorescence resonance energy 
transfer to observe co-localisation of CD63R and CD63a, however this would 
require the availability of antibodies with binding specificity to the schistosome 
genes. A similar approach has been used successfully before to study the 
interaction of tetraspanins with other proteins (Termini and Gillette, 2017). 
 
Apoptosis in S. mansoni 
Finally, in Chapter 5, gene expression in the gonads of worms from mixed and 
single sex infections was examined. This enabled a set of genes to be produced 
with ovary- and testes-biased expression and the effect of pairing in the worm 
gonads to be analysed, which had previously been obscured by the somatic 
tissue. Several apoptosis genes have been identified in schistosomes previously 
and apoptosis has been shown to play an important role in regulating the growth 
of vitellarian tissue. In Chapter 2, many genes were examined for their sequence 
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homology and the presence of appropriate domains in particular, to expand the 
list of schistosome apoptosis genes. Among the 15 identified genes were 
homologues of the FAS associated factors 1 and 2, a homologue of the tumour 
necrosis factor receptor as well as two Bax inhibitors, adding considerable detail 
to how apoptosis potentially functions in S. mansoni. Having divided these genes 
in to pro- and anti-apoptotic genes based on the reported functions of orthologs, 
the expression of such genes was observed in several experiments. No consistent 
pattern of apoptosis related genes was found in vitro (see Chapter 4). However, a 
significant down-regulation of putative pro-apoptotic genes and, vice versa, an 
up-regulation of putative anti-apoptotic genes was observed in the ovaries of 
females from mixed sex infections, compared to ovaries from single sex 
infections (see Figure 5.17). This further strengthened my confidence that these 
genes are involved in the regulation of apoptosis in S. mansoni.  
 
The limitations of bulk RNA-Seq  
RNA-Seq is a powerful method to study gene expression, making it possible to 
measure changes in mRNA levels for all genes at once. And as discussed in the 
introduction (see Chapter 1.6.3), RNA-Seq offers some significant advantages 
over other methods used to measure gene expression. However, there are also 
some limitations to RNA-Seq as used in this thesis. For one, studies by 
Schwanhaeusser et al. (2011) and Vogel et al. (2010) found the steady-state 
mRNA concentrations to only explain between one and two thirds of the 
variation in observed protein levels. However, work by Li et al. (2014) showed 
that due to problems with the normalisation of proteomics data in the 
aforementioned studies, mRNA may explain around 84% of protein abundances. 
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Furthermore, the correlation of mRNA and protein abundance were shown to 
correlate strongly when specifically looking at changes in gene expression, 
meaning that the mRNA abundance of differentially expressed genes is in fact 
very well correlated to their protein products (Koussounadis et al. 2015).  
 
Another limitation is the use of RNA-Seq on mRNA extracted from whole worms, 
rather than individual organs or even single cells, although this was done to 
some extent in Chapter 5 of this thesis. When examining genes that are only or 
predominantly expressed in a subset of organs, changes in gene expression may 
be more difficult to detect. This is because in a sample derived from a whole 
worm, the mRNA of such organ-specific genes will make up a lower proportion 
of total reads. Another variation of this problem occurs when comparing samples 
from different developmental stages. As organs such as the vitellarium develop, 
they start to make up an increasingly large share of the sequenced mRNA. Due to 
this, it may appear that certain genes in these female worms have become down-
regulated, when in reality the absolute expression has not changed but the gene’s 
mRNA now makes up a relatively smaller proportion of the total mRNA pool. For 
instance, in Chapter 3.2.8, the reads from just 27 genes, most of which are known 
to be expressed in vitellarian cells, made up >14% of the transcriptome of 
mature females. As a result, many other genes appeared to be expressed at lower 
levels in mature females compared to females from single sex infections. Lastly, 
when performing RNA-Seq on whole worms, in essence the average gene 
expression across all tissues is measured, despite there potentially being 
considerable variation in expression in organs or even adjacent cells. In such 
samples the average of gene expression in all tissues may show a different 
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qualitative trend than when all tissues had been measured individually, an effect 
known as Simpson’s paradox (Trapnell et al., 2014). Although RNA-Seq data 
from different tissues or even single cells would provide an even better and set 
of data with greater resolution of schistosome transcriptome, RNA-Seq data 
derived from whole worms still holds a wealth of information. Arguably, for 
genes expression in a single tissue, such as many genes expressed in the 
reproductive organs, there must be a very strong change in expression for it to 
be detected as significantly expressed. 
 
As the above summary of results shows, the work in this thesis succeeded in 
generating high quality RNA-Seq data that illuminate the changes in gene 
expression that result in female maturation, following their development from 
approximately one week before pairing occurs to sexual maturity. The data 
generated here also covered transcriptome changes in vitro as well as gene 
expression in the gonads of male and female worms. The analysis presented in 
this thesis also showed numerous examples of differences between male and 
female schistosomes during their development as well as the changes induced by 
the male-female interaction. 
 
In the future, the use of single cell RNA sequencing (scRNA-Seq) could address 
some of the shortcomings of bulk RNA-seq. Most importantly, it would provide a 
finer resolution of gene expression, not providing transcriptome data of whole 
worms or individual organs but of single cells. With this technology, it could be 
possible to detect and quantify the abundance of mRNAs coding for the CD63 
receptor and antigen in different subpopulations of vitellocytes. The vitelline 
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tissue could be dissociated using a collagenases or dispases (Freshney, 1987) 
and fluorescence activated cell sorting (FACS) could be used to sort cells by their 
granularity (Basu et al., 2010). This may allow vitelline S1, S2, S3 and S4 cells to 
be separated as they contain increasing numbers of vesicles (Erasmus, 1975), 
with S4 cells being most densely packed with eggshell protein containing vesicle 
(Köster et al., 1988). With this method the localisation of CD63R to particular 
portion of the vitellaria could potentially be confirmed. Also, very small 
subpopulations of cells could potentially be examined, such as stem cells, which 
have previously been observed (Collins et al., 2013), and could play a role in the 
ability of S. mansoni to regenerate reproductive tissues after losing it. Similarly, 
scRNA-Seq could provide unprecedented resolution of the development of cells 
in the ovary and testes. This may make it possible to better understand the role 
of apoptosis in the development of ovarian tissue. 
 
However, not all of the goals of this thesis could be met. In particular, examining 
the regression of sexually mature females as a result of separation from male 
worms in Chapter 4 proved challenging. Despite several biological replicates, the 
number of differentially expressed genes found between treatment groups was 
low. This most likely resulted from the large magnitude of transcriptome 
changes brought on by in vitro culture, which was shown to have extensive 
effects on the transcriptome of male and female worms. Due to this, the focus of 
the chapter changed to examining the effects of in vitro culture on gene 
expression, especially neural and apoptosis-related genes. The transcriptome 
changes observed in Chapter 4, most likely brought on by a lack of host factors, 
highlights the need for a better in vitro culturing system. Alternatively, worms 
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could have been re-implanted into mice (Basch & Humbert, 1981) after 
separation from their partner, to provide a host environment for the rest of the 
experiment. However, this method would have required more mice to be 
subjected to invasive procedures, moreover it would expose the worms 
themselves to considerable stress, which might have interfered with gene 
expression. Another improvement could have been to perform the RNAi 
experiment described in Chapter 3 in vivo, as described by (Wang et al., 2017). As 
described above, the in vitro conditions caused changes in gene expression that 
made it difficult to detect the changes in gene expression brought on by the 
dsRNA treatment compared to the control. Performing RNAi in vivo circumvents 
that problem by making in vitro culture during or after exposure to dsRNA 
unnecessary.  
 
The results in this thesis, including a better understanding of the male-female 
interaction as well as how apoptosis functions in schistosomes, will hopefully 
prove valuable for the development of therapeutics in the future. For example, in 
addition to GST28 (Smp_054160), a long-standing vaccine target, other 
glutathione S transferases, such as Smp_024010, may also be suitable 
therapeutic targets. Also, an improved understanding of how schistosomes 
regulate apoptosis could make it possible to exploit differences between 
schistosome and mammalian apoptosis to kill worms. The data generated for 
Chapter 5, in collaboration with Professor Grevelding’s group, has also been 
made available to the research community as a resource for gene expression 




To further investigate apoptosis in the ovaries, but also the vitelline tissue, a 
number of approached could be taken in the future.  
 
To determine how much apoptosis is taking place in the ovaries of females from 
MS and SS infections, terminal deoxynucleotidyl transferase dUTP nick end 
labelling (TUNEL) staining could be used, as Galanti et al. (2012) did to detect 
apoptosis in the vitelline tissue. TUNEL staining is a method that detects the DNA 
fragmentation that occurs during apoptosis (Kyrylkova et al., 2012). This is done 
by using the terminal deoxynucleotidyl transferase to conjugate labelled 
nucleotides, for example with a bromodeoxyuridine (BrdU) label. In the next 
step, these nucleotides can then be detected with a method appropriate for the 
chosen label (Kyrylkova et al., 2012). In the case of BrdU, this can be done with 
antibodies with conjugated alkaline phosphatase, allowing BrdU detection using 
a method like that used in WISH (Chapter 2.2.7). Another method which could be 
used to study apoptosis is an assay for caspase 3 activity (Galanti et al., 2012). 
 
In Chapter 5, differences in the expression of gene coding for proteins of the 
sphingolipid metabolite pathway were observed in the ovaries of females of SS 
and MS infections. Two important enzymes regulating the abundance of 
ceramide in cells are ceramide synthase and ceramidase (Levy & Futerman, 
2010; Mullen et al., 2012). Inhibitors of these enzymes could be used to 
investigate if these enzymes also play a role in regulating apoptosis in S. mansoni, 
as they do in mammalian cells (Separovic et al., 2012; Zhu et al., 2008). 
Fumonisin B, a fungal toxin, has been shown to inhibit ceramide synthase and 
reduce apoptosis in human cells (Boppana et al., 2014), whereas carmofur is a 
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potent ceramidase inhibitor (Realini et al., 2013). Using TUNEL staining, it may 
be possible to examine, if an effect on apoptosis can be observed in females from 
SS and MS infections when exposed to these inhibitors. Treatment of females 
from SS infections may prevent apoptosis of vitellarian cells and allow 
maturation of the organ. On the other hand, treatment of females from MS 
infections with carmofur, may result in higher levels of apoptosis and lead to a 
shrinkage of the vitellarian tissue. 
 
There are also fluorescence-based assays available to measure the activity of 
ceramide synthase (Kim et al., 2012) and ceramidase (Bedia et al., 2010), which 
could be used to confirm the specificity of the inhibitors to the schistosome 
homologues of these genes.  
 
By addressing the limitations discussed above, new insights can be gained. Single 
cell RNA-Seq especially will open up new avenues for characterising gene 
expression at much greater resolution and improve our understanding of 
schistosome biology. Secondly improving the available in vitro culture methods 









































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Gene ID Product Fold Change Adjusted  
p-value 
Smp_070540 Uncharacterised protein 5.58 1.62E-06 
Smp_213480 Muts protein 6.54 9.36E-06 
Smp_124750 Uncharacterised protein 8.53 3.93E-05 
Smp_135290 Macrophage expressed gene 1 protein 3.30 3.93E-05 
Smp_191690 Tumour susceptibility gene 101 protein 8.96 3.93E-05 
Smp_082420 Uridine phosphorylase 2.98 3.63E-04 
Smp_147320 Camp dependent protein kinase regulatory 
chain 
5.11 5.22E-04 
Smp_174530 Aminopeptidase PILS (M01 family) 5.74 5.22E-04 
Smp_007760 Alanine aminotransferase 2 2.20 6.61E-04 
Smp_172340 Uncharacterised protein 3.48 1.09E-03 
Smp_151840 Uncharacterised protein 5.33 1.13E-03 
Smp_032980 Calmodulin protein 6.17 1.49E-03 
Smp_015100 Uncharacterised protein 2.32 1.60E-03 
Smp_178780 Single minded 4.78 1.60E-03 
Smp_042150 Tegument-allergen-like protein 3.52 1.79E-03 
Smp_162840 Uncharacterised protein 3.37 1.79E-03 
Smp_163170 Sodium:potassium dependent ATPase beta 
subunit 
3.61 2.31E-03 
Smp_153070 Uncharacterised protein 3.43 2.32E-03 
Smp_118960 Jun protein 6.60 2.60E-03 
Smp_158150 Reticulocalbin 2 4.95 5.31E-03 
Smp_141810 Uncharacterised protein 2.76 7.79E-03 
Smp_141250 Protein jagged 1 2.59 8.74E-03 
 
Appendix A.2: List of the most differentially expressed genes upregulated 
in females compared to male worms from mixed sex infections at 21 days 
post infection.  Fold changes measure expression in female relative to male 

















Gene ID Product Fold Change Adjusted  
p-value 
Smp_211240 Beta 1,4 N acetylgalactosaminyltransferase 13.37 1.64E-07 
Smp_160360 Sodium:chloride dependent 
neurotransmitter 
3.54 3.36E-07 
Smp_074560 Uncharacterised protein 3.59 9.85E-07 
Smp_129960 Uncharacterised protein 5.07 3.52E-05 
Smp_195090 Tegument-allergen-like protein 6.09 7.41E-05 
Smp_084270 Rhodopsin orphan GPCR 2.92 2.28E-04 
Smp_153930 Invadolysin (M08 family) 4.84 3.35E-04 
Smp_168730 Carbonic anhydrase 2.35 3.63E-04 
Smp_105780 Uro adherence factor A 6.74 8.16E-04 
Smp_120020 Uncharacterised protein 6.44 1.13E-03 
Smp_212180 Glucose dehydrogenase (acceptor) 5.03 1.19E-03 
Smp_056280 Zinc finger CCCH domain containing protein 
31 
4.96 1.39E-03 
Smp_091210 Uncharacterised protein 6.12 1.49E-03 
Smp_151660 Uncharacterised protein 3.32 2.60E-03 
Smp_161190 Uncharacterised protein 2.44 4.58E-03 
Smp_071810 Uncharacterised protein 2.11 7.11E-03 
 
Appendix A.3: List of the most differentially expressed genes upregulated 
in males compared to female worms from mixed sex infections at 21 days 
post infection.  Fold changes measure expression in male relative to female 
worms. The p-value has been adjusted for multiple hypothesis testing. 
 
 
Gene ID Product Fold Change Adjusted  
p-value 
Smp_147670 Receptor kinase I-interacting protein SIP 6.49 6.85E-36 
Smp_159510 Uncharacterised protein 6.98 1.14E-35 
Smp_017610 amiloride sensitive amine oxidase 66.88 5.87E-33 
Smp_075280 Uncharacterised protein 3.78 1.77E-31 
Smp_175090 long-chain-fatty-acid--CoA ligase 5.63 3.41E-31 
Smp_170020 tachykinin receptor protein like 9.10 2.54E-30 
Smp_125940 Uncharacterised protein 10.53 9.28E-28 
Smp_168730 carbonic anhydrase 9.29 4.26E-27 
Smp_169570 glycerol 3 phosphate dehydrogenase 14.15 1.24E-26 
Smp_161030 Uncharacterised protein 14.02 2.02E-26 
Smp_093210 FMRFamide activated amiloride sensitive sodium 4.92 2.45E-26 
Smp_059570 Uncharacterised protein 7.04 3.15E-26 
Smp_139380 Spindle assembly checkpoint component MAD1 55.18 5.20E-26 
Smp_034550 Alpha actinin 6.54 1.93E-25 
Smp_167160 Dynamin binding protein 2.91 4.29E-25 
Smp_089670 Alpha 2 macroglobulin 4.54 6.92E-25 
Smp_197860 Gelsolin 11.28 4.05E-24 
Smp_134710 Uncharacterized MFS type transporter C19orf28 16.55 4.12E-24 
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Smp_104890 Glutamate-gated chloride channel subunit 3 6.03 7.84E-24 
Smp_198930 Uncharacterised protein 6.54 1.13E-23 
Smp_028670 Carbonic anhydrase II 4.23 1.14E-23 
Smp_146200 Zyxin:trip6 2.88 1.61E-23 
Smp_153780 Glutamate receptor, ionotropic kainate 3 6.68 1.89E-23 
Smp_168980 Adenylate cyclase 4.06 2.09E-23 
Smp_134130 Ring canal kelch 5.60 3.63E-23 
Smp_068280 Prolyl 4 hydroxylase subunit alpha 2 3.99 4.79E-23 
Smp_194050 Clumping factor A 5.09 6.12E-23 
Smp_160360 Sodium:chloride dependent neurotransmitter 9.63 9.19E-23 
Smp_006860 PDZ and LIM domain protein Zasp 4.66 9.42E-23 
Smp_059170 Troponin i 7.43 1.07E-22 
Smp_155410 Coiled coil domain containing protein 102A 4.80 1.22E-22 
Smp_074560 Uncharacterised protein 10.69 1.26E-22 
Smp_136930 Uncharacterised protein 3.58 1.42E-22 
Smp_053560 MAP kinase activated protein kinase 2 3.15 2.44E-22 
Smp_016230 Protocadherin 17 12.59 4.94E-22 
Smp_164240 Junctophilin 2 5.43 6.27E-22 
Smp_000170 KV channel interacting protein 2 (KChIP2) 15.56 6.44E-22 
Smp_022340 PDZ and LIM domain protein Zasp 5.83 6.54E-22 
Smp_126360 Uncharacterised protein 10.50 8.02E-22 
Smp_166920 PDZ and LIM domain protein Zasp 7.50 8.16E-22 
Smp_214190 Calpain 3.03 2.08E-21 
Smp_121190 Voltage gated potassium channel 7.48 2.44E-21 
Smp_133550 Neuropeptide receptor type; neuropeptide ff 
receptor 
7.09 2.79E-21 
Smp_072450 Rhodopsin orphan GPCR 10.11 2.95E-21 
Smp_126320 D glucuronyl C5 epimerase 2.41 3.34E-21 
Smp_174870 Uncharacterised protein 5.16 4.25E-21 
Smp_046640 Twik family of potassium channels 6.67 4.77E-21 
Smp_164960 Phosphatidylinositol 4,5 bisphosphate 3 kinase 1.84 5.65E-21 
Smp_151100 cGMP dependent protein kinase 5.43 7.80E-21 
Smp_163090 Voltage gated potassium channel 5.45 9.67E-21 
 
Appendix A.4: List of the most differentially expressed genes upregulated 
in male worms compared to female worms from mixed sex infections at 38 
days post infection.  Fold changes measure expression in male relative to 










Gene ID Product Fold Change Adjusted  
p-value 
Smp_212820 Zinc finger protein 20.55 7.07E-67 
Smp_038030 Adenylosuccinate lyase 6.35 3.02E-63 
Smp_179710 Maternal Effect Lethal family member 32.86 4.82E-62 
Smp_159920 Protocadherin 11 41.35 4.03E-49 
Smp_090520 Purine nucleoside phosphorylase 18.90 2.20E-47 
Smp_126210 Uncharacterised protein 20.18 7.25E-41 
Smp_160160 Solute carrier family 17 13.56 7.68E-41 
Smp_212090 Calcium dependent activator protein 13.74 3.75E-40 
Smp_042700 Protein FAM81B 13.50 1.96E-39 
Smp_002080 S adenosylmethionine synthetase 3.03 1.28E-38 
Smp_210370 Ormdl protein 2.95 1.67E-38 
Smp_148770 Ribose 5 phosphate isomerase 6.94 6.99E-36 
Smp_173150 CD63 antigen 34.92 1.03E-35 
Smp_041540 Hormone receptor 4 13.98 1.18E-35 
Smp_080730 Cyclin dependent kinase 1 6.84 1.18E-35 
Smp_056700 Membrane associated RING finger protein 36.62 1.14E-34 
Smp_048430 Thioredoxin glutathione reductase 3.05 1.59E-33 
Smp_092390 N acetylglucosamine kinase 5.33 5.87E-33 
Smp_026400 Thyrotroph embryonic factor 23.27 7.70E-33 
Smp_077900 Female specific protein 800 82.82 1.00E-32 
Smp_155740 TNF receptor associated protein 1 2.22 1.79E-32 
Smp_075870 Translocation associated membrane protein 1 3.65 2.47E-32 
Smp_000290 Female-specific protein 800  84.02 6.32E-32 
Smp_021070 Guanine nucleotide binding protein 3.79 7.89E-32 
Smp_035470 Dolichyl diphosphooligosaccharide protein 3.36 7.89E-32 
Smp_055800 Pescadillo 3.57 7.89E-32 
Smp_146480 Uncharacterised protein 60.43 7.89E-32 
Smp_198170 Protein FAM81B 13.66 1.05E-31 
Smp_105680 Dolichyl diphosphooligosaccharide protein 2.97 3.41E-31 
Smp_171150 Protein arginine N methyltransferase 5 3.75 5.04E-31 
Smp_209060 Alpha 1,3 fucosyltransferase B 10.74 2.70E-30 
Smp_148390 Uncharacterised protein 193.90 3.22E-30 
Smp_142760 Centrosomal protein of 95 kDa 5.04 5.55E-30 
Smp_011870 Uncharacterised protein 139.19 5.80E-30 
Smp_075330 Uncharacterised protein 13.02 6.68E-30 
Smp_135840 Uncharacterised protein 5.07 7.55E-30 
Smp_082490 G2:mitotic specific cyclin B2 7.21 1.25E-29 
Smp_062070 Sulfide quinone reductase 3.58 1.56E-29 
Smp_175560 Beta site APP cleaving enzyme 1 60.07 2.12E-29 
Smp_169970 Kinetochore protein ndc80 5.18 4.08E-29 
Smp_076320 Uncharacterised protein 70.01 4.83E-29 
Smp_083770 Anoctamin 7 14.31 6.92E-29 
Smp_054010 Y+L amino acid transporter 2 35.13 2.94E-28 
Smp_199540 Inositol type trisphosphate receptor 40.29 3.73E-28 
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Smp_058240 Reticulon 4 (Neurite outgrowth inhibitor) 3.74 4.33E-28 
Smp_141160 E3 ubiquitin protein ligase RNF168 11.23 5.97E-28 
Smp_048660 Nucleolar protein 56 3.27 1.02E-27 
Smp_013970 Uncharacterised protein 6.43 1.06E-27 
Smp_199830 Leucine rich repeat protein 7.36 1.25E-27 
Smp_031730 Signal peptidase 18 kDa subunit 3.43 1.34E-27 
 
Appendix A.5: List of the most differentially expressed genes upregulated 
in females compared to male worms from mixed sex infections at 38 days 
post infection. Fold changes measure expression in female relative to male 
worms. The p-value has been adjusted for multiple hypothesis testing. 
 
 
Gene ID  Product Average 
read count 
Fold change Adjusted 
p-value 
Smp_015630 Glutamate-gated chloride channel 
subunit 
353.74 1.07 0.929 
Smp_104890 Glutamate-gated chloride channel 
subunit 
244.18 0.41 5.58E-08 
Smp_099500 Glutamate-gated chloride channel 
subunit 
38.57 2.17 3.45E-02 
Smp_031680 Nicotinic acetylcholine receptor 176.02 0.95 0.948 
Smp_012000 Nicotinic acetylcholine receptor 92.58 1.18 0.779 
Smp_132070 Nicotinic acetylcholine receptor subunit 3562.48 1.02 0.937 
Smp_180570 Nicotinic acetylcholine receptor 132.26 1.08 0.900 
Smp_139330 Nicotinic acetylcholine receptor non α 811.23 0.72 0.106 
Smp_157790 Nicotinic acetylcholine receptor subunit 121.98 2.32 4.21E-03 
Smp_176310 Nicotinic acetylcholine receptor subunit 699.76 1.23 0.637 
Smp_101990 Acetylcholine receptor subunit α 23.03 0.27 9.56E-05 
Smp_037960 Neuronal acetylcholine receptor 
subunit α 
1308.18 1.33 0.387 
Smp_096480 Glycine receptor subunit β 520.33 1.03 0.951 
Smp_142690 Neuronal acetylcholine receptor 
subunit α 
1875.19 1.33 5.15E-03 
Smp_175110 Neurotransmitter gated ion channel 0 1.00 N/A 
Smp_197600 Nicotinic acetylcholine receptor subunit 0.68 0.78 0.819 
 
Appendix A.6: Expression of genes encoding neurotransmitters in females 
compared to males from single sex infections at 38 days post infection. Fold 
changes measure expression in male relative to female worms; that mean genes 
with a fold change of > 1 are up regulated in males. The p-value has been 







Pathway Description Total 
Genes 
DEGs Expected p-value 
smm03010 Ribosome 110 88 22.49 1.66E-43 
smm00190 Oxidative phosphorylation 69 38 14.11 9.48E-11 
smm03030 DNA replication 30 14 6.13 7.75E-04 
smm03020 RNA polymerase 24 12 4.91 8.73E-04 
smm00240 Pyrimidine metabolism 59 21 12.06 2.64E-03 
smm03040 Spliceosome 105 32 21.47 3.93E-03 
smm03050 Proteasome 32 12 6.54 1.20E-02 
smm03060 Protein export 19 8 3.88 1.83E-02 
smm00982 Drug metabolism - cytochrome 
P450 
4 3 0.82 2.71E-02 
smm03008 Ribosome biogenesis in 
eukaryotes 
62 18 12.68 3.00E-02 
smm04122 Sulfur relay system 7 4 1.43 3.06E-02 
 
Appendix A.7: KEGG pathways which are significantly enriched amongst the 
genes up regulated in males from single sex infections at 18 days post infection 
compared to males at 21 days post infection. “Total genes” is the number of 
genes in the given pathway. “DEGs” provides the number of differentially 
expressed genes in that pathway. “Expected” provides the number of genes 
expected by chance to be differentially expressed in each pathway. 
 
 
Comparison Fold change Adjusted p-value 
Expression in male worms at 18 d.p.i. 
compared to males at 21 d.p.i.  
5.10 6.45E-06 
Expression in male worms at 18 d.p.i. 
compared to males at 38 d.p.i.  
21.95 1.34E-14 
Expression in female worms at 18 d.p.i. 
compared to females at 38 d.p.i. 
18.16 1.30E-11 
 
Appendix A.8: Expression of the gene encoding the microsomal glutathion S 
transferase (Smp_024010) in different gene expression comparisons of 
male and females worms at different time points. The fold change provides 
the gene expression in the first condition relative to the second condition in each 
comparison. Smp_024010 was found up-regulated in male or female worms at 
18 days post infection (d.p.i.) compared to later time points in all the 













Smp_139380 Spindle assembly checkpoint component 
MAD1 
14.15 2.35E-14 
Smp_136100 Kelch protein 10 8.63 3.13E-09 
Smp_155570 Endoglycoceramidase 2.78 3.18E-08 
Smp_074570 Uncharacterised protein 4.85 3.43E-07 
Smp_042160 Fructose-bisphosphate aldolase 2.10 1.55E-05 
Smp_105410 Glucose transport protein 3.14 1.55E-05 
Smp_169090 Solute carrier family 43 3.59 1.55E-05 
Smp_201700 Uncharacterised protein 2.68 3.77E-05 
Smp_017610 Amiloride sensitive amine oxidase 4.95 5.81E-05 
Smp_133970 Uncharacterised protein 5.26 7.10E-05 
Smp_142970 Palmitoyl protein thioesterase 1 2.01 7.10E-05 
Smp_134710 Uncharacterized MFS type transporter 
C19orf28 
3.20 7.58E-05 
Smp_056460 Uncharacterised protein 6.61 1.04E-04 
Smp_154800 DC STAMP domain containing protein 2 6.54 1.23E-04 
Smp_128510 Uncharacterised protein 7.51 1.56E-04 
Smp_144440 Replication A protein 6.92 1.99E-04 
Smp_123300 Follistatin 2.35 2.67E-04 
Smp_046790 Solute carrier family 2 facilitated glucose 3.34 2.72E-04 
Smp_127880 Uncharacterised protein 3.43 2.72E-04 
Smp_143590 Uncharacterised protein 2.30 2.79E-04 
Smp_005470 Dynein light chain 4.89 2.80E-04 
Smp_084270 Rhodopsin orphan GPCR 2.80 2.80E-04 
Smp_169570 Glycerol 3 phosphate dehydrogenase 2.86 2.80E-04 
Smp_104450 Uncharacterised protein 4.83 3.09E-04 
Smp_084440 Uncharacterised protein 2.32 3.23E-04 
Smp_045490 Annexin 2.96 3.31E-04 
Smp_017620 Uncharacterised protein 5.13 4.21E-04 
Smp_013040 Cathepsin D 2.06 4.36E-04 
Smp_194950 ELAV protein 2 3.57 5.00E-04 
Smp_212180 Glucose dehydrogenase 5.23 5.43E-04 
Smp_091460 Glutamine synthetase 2.45 5.61E-04 
Smp_128470 Cation transporting ATPase worm 2.37 5.61E-04 
Smp_034550 Alpha actinin 2.09 6.04E-04 
Smp_152200 Cdc25 6.03 6.11E-04 
Smp_161240 Uncharacterised protein 3.94 6.25E-04 
Smp_042910 Uncharacterised protein 2.08 6.41E-04 
Smp_091210 Uncharacterised protein 5.55 6.78E-04 
Smp_153930 Invadolysin (M08 family) 4.32 7.48E-04 
Smp_163360 Dystrophin 2.35 7.55E-04 
Smp_048030 Uncharacterised protein 3.05 8.06E-04 
Smp_007760 Alanine aminotransferase 2 2.19 8.84E-04 
Smp_148030 DC STAMP domain containing protein 1 4.24 8.84E-04 
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Smp_161220 Adipocyte plasma membrane associated 
protein 
2.42 9.68E-04 
Smp_172960 Serine type protease inhibitor 3.84 9.88E-04 
Smp_129960 Uncharacterised protein 3.67 1.00E-03 
Smp_145900 Sphingolipid delta(4) desaturase:C4 
hydroxylase 
2.96 1.03E-03 
Smp_071610 Lysosomal Pro X carboxypeptidase 2.13 1.48E-03 
Smp_151920 Paladin 3.80 1.51E-03 
Smp_191910 Stress protein DDR48 5.82 1.52E-03 
Smp_033250 Uncharacterised protein 5.98 1.57E-03 
 
Appendix A.9: Genes up-regulated in males from from mixed sex infections 
at 28 days post infection (d.p.i.) compared to males at 21 d.p.i. Fold changes 
provide gene expression in males at 28 d.p.i.  compared to males at 21 d.p.i. The 
p-value has been adjusted for multiple hypothesis testing. 
 
 
Gene ID Product Fold Change Adjusted  
p-value 
Smp_185130 Uncharacterised protein 5.46 2.19E-03 
Smp_199670 Cation transporting ATPase 5.09 9.85E-04 
Smp_141740 Protocadherin 11 4.49 2.51E-04 
Smp_165240 Uncharacterised protein 4.43 8.32E-03 
Smp_022740 Tumour necrosis factor alpha induced 
protein 
4.41 5.41E-03 
Smp_164080 Bromodomain testis specific protein 4.09 4.78E-04 
Smp_135630 Protocadherin gamma a10 4.07 1.97E-03 
Smp_137820 Uncharacterised protein 3.80 2.89E-03 
Smp_012000 Nicotinic acetylcholine receptor 3.55 6.18E-04 
Smp_198650 Ankyrin :unc 3.46 6.05E-03 
Smp_187740 Forkhead box protein j1 b 3.38 2.06E-03 
Smp_170270 Uncharacterised protein 3.28 9.72E-03 
Smp_012950 Cytoplasmic polyadenylation element 
binding 
3.23 2.85E-03 
Smp_160590 Uncharacterised protein 3.20 3.74E-07 
Smp_163790 Nuclear receptor 2DBD gamma 3.20 2.12E-03 
Smp_124600 Uncharacterised protein 3.15 2.10E-03 
Smp_193630 Endoglycoceramidase 3.10 3.73E-03 
Smp_177020 Phospholipase C Like family member (pll 1) 3.09 8.88E-03 
Smp_183130 Liprin alpha 2 2.97 2.10E-03 
Smp_161640 Transient receptor potential cation 
channel 
2.84 1.43E-03 
Smp_203940 Short chain dehydrogenase 2.81 2.06E-03 
Smp_126290 Uncharacterised protein 2.70 5.06E-03 
Smp_142940 Paired box protein pax 2.54 7.61E-03 
Smp_123300 Follistatin 2.39 8.16E-04 
Smp_168650 Microtubule actin cross linking factor 1 2.26 2.71E-03 
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Smp_170620 Rhodopsin orphan GPCR 2.26 4.44E-03 
Smp_174340 Frizzled 9 2.22 5.41E-03 
Smp_158720 Protein kinase 2.21 4.77E-03 
Smp_173450 Chromosome associated kinesin KIF4A 2.19 8.60E-03 
 
Appendix A.10: Genes up-regulated in males from from mixed sex 
infections at 28 days post infection (d.p.i.) compared to males at 35 d.p.i. 
Fold changes provide gene expression in males at 28 d.p.i.  compared to males at 
35 d.p.i. The p-value has been adjusted for multiple hypothesis testing. 
 
 
Comparison Fold change Adjusted  
p-value 
Males from single sex infections at 38 d.p.i. compared 
to Males from single sex infections at 18 d.p.i. 
7.54 2.26E-06 
Males from mixed sex infections at 35 d.p.i. compared 
to males from single sex infections at 35 d.p.i. 
7.45 1.23E-03 
Males from mixed sex infections at 38 d.p.i. compared 
to males from single sex infections at 38 d.p.i. 
5.33 1.99E-03 
 
Appendix A.11: Expression of the gene encoding the aromatic-L-amino acid 
decarboxylase (Smp_135230) in different gene expression comparisons of 
male worms at different time points. The fold change provides the gene 
expression in the first condition relative to the second condition in each 
comparison. The p-value has been adjusted for multiple hypothesis testing. 
 
 
Gene ID Product Fold Change Adjusted  
p-value 
Smp_191910 Stress protein DDR48 165.06 1.85E-33 
Smp_144440 Replication A protein 118.44 2.30E-33 
Smp_033250 Uncharacterised protein 135.80 3.73E-30 
Smp_014610 Serine:threonine kinase 1 141.61 8.74E-30 
Smp_129960 Uncharacterised protein 27.58 2.90E-27 
Smp_000420 Pro His rich protein 116.10 3.56E-27 
Smp_131110 Uncharacterised protein 116.50 5.99E-27 
Smp_077900 Female specific protein 800 41.86 2.52E-26 
Smp_165360 Histone acetyltransferase myst4 118.07 2.52E-26 
Smp_151150 Arabinogalactan protein 57.98 1.06E-25 
Smp_169090 Solute carrier family 43 10.13 6.27E-25 
Smp_076320 Uncharacterised protein 39.53 1.16E-24 
Smp_000290 Female-specific protein 800 36.61 1.32E-23 
Smp_130970 G2:mitotic specific cyclin B3 40.30 2.40E-23 
Smp_000410 Trematode Eggshell Synthesis domain containing protein 64.17 2.91E-23 
Smp_050750 Uncharacterised protein 52.20 4.24E-23 
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Smp_138570 Spore germination protein 84.73 2.53E-22 
Smp_077890 Trematode Eggshell Synthesis domain containing protein 71.24 8.35E-22 
Smp_151160 Stress protein DDR48 54.68 9.80E-22 
Smp_192220 Uncharacterised protein 59.23 1.23E-21 
Smp_000430 Eggshell protein 75.11 5.84E-21 
Smp_050270 Tyrosinase 75.26 7.31E-21 
Smp_175560 Beta site APP cleaving enzyme 1 21.44 2.76E-19 
Smp_137460 Cytoplasmic polyadenylation element binding 46.34 7.38E-19 
Smp_202830 Uncharacterised protein 52.80 1.01E-18 
Smp_095980 Extracellular superoxide dismutase (Cu Zn) 59.48 1.72E-18 
Smp_000400 Uncharacterised protein 58.60 1.83E-18 
Smp_143970 Kelch protein 10 38.47 1.87E-18 
Smp_000270 Uncharacterised protein 56.03 2.51E-18 
Smp_013540 Tyrosinase 53.82 3.17E-18 
Smp_155310 Tetraspanin CD63 receptor 56.65 1.23E-17 
Smp_000280 Uncharacterised protein 54.16 1.55E-17 
Smp_056700 Membrane associated RING finger protein 9.84 2.75E-17 
Smp_095350 Acetyl coenzyme A carboxylase; methylcrotonyl CoA 44.73 1.00E-16 
Smp_125740 Uncharacterised protein 3.02 1.61E-16 
Smp_195090 Tegument-allergen-like protein 19.98 1.61E-16 
Smp_074710 Def8 protein 11.41 6.55E-16 
Smp_007670 Uncharacterised protein 5.83 1.36E-15 
Smp_058160 Uncharacterised protein 24.34 1.43E-15 
Smp_112450 Trematode Eggshell Synthesis domain containing protein 41.41 2.01E-15 
Smp_145490 Poly(rC) binding protein 2:3:4 39.76 3.52E-15 
Smp_077920 Uncharacterised protein 40.27 9.28E-15 
Smp_159920 Protocadherin 11 6.03 1.57E-14 
Smp_211240 Beta 1,4 N acetylgalactosaminyltransferase 23.57 3.77E-14 
Smp_196950 One cut domain family member 14.57 4.00E-14 
Smp_136100 Kelch protein 10 17.81 6.25E-14 
Smp_130780 Monocarboxylate transporter 30.67 9.01E-14 
Smp_065530 Acrosin 29.09 9.98E-14 
Smp_132800 STARP antigen 18.57 1.89E-13 
Smp_199540 Type inositol trisphosphate receptor; inositol 
trisphosphate receptor type 
10.61 2.28E-13 
Smp_173150 CD63 antigen 6.33 5.24E-12 
 
Appendix A.12: The most differentially expressed genes in female worms 
from mixed sex infections at 28 days post infection (d.p.i.) compared to 
females at 21 d.p.i. The fold change provides a measure of expression in 
females at 28 d.p.i. relative to females at 21 d.p.i. The p-value has been adjusted 










Smp_131110 Uncharacterised protein 616.92 5.50E-48 
Smp_077900 Female specific protein 800 504.95 4.69E-65 
Smp_000290 Female-specific protein 800 463.72 5.79E-61 
Smp_191910 Stress protein DDR48 431.31 3.31E-46 
Smp_014610 Serine:threonine kinase 1 427.38 1.30E-43 
Smp_000430 Eggshell protein 374.21 5.91E-39 
Smp_151150 Arabinogalactan protein 362.41 8.12E-50 
Smp_013540 Tyrosinase 353.16 1.35E-38 
Smp_077890 Trematode Eggshell Synthesis domain containing 
protein 
351.06 4.31E-40 
Smp_192220 Uncharacterised protein 350.92 1.63E-40 
Smp_095980 Extracellular superoxide dismutase (Cu Zn) 323.47 9.38E-37 
Smp_202830 Uncharacterised protein 293.50 2.46E-37 
Smp_050750 Uncharacterised protein 265.17 1.30E-43 
Smp_000280 Uncharacterised protein 262.95 5.31E-34 
Smp_138570 Spore germination protein 261.01 1.15E-34 
Smp_000400 Uncharacterised protein 252.51 7.23E-34 
Smp_000270 Uncharacterised protein 243.96 8.24E-34 
Smp_050270 Tyrosinase 243.54 1.61E-33 
Smp_151160 Stress protein DDR48 230.02 1.82E-38 
Smp_000420 Pro His rich protein 214.78 3.81E-34 
Smp_155310 Tetraspanin CD63 receptor 190.75 5.98E-30 
Smp_165360 Histone acetyltransferase myst4 175.53 1.24E-30 
Smp_144440 Replication A protein 169.70 2.82E-37 
Smp_000370 Uncharacterised protein 152.97 5.61E-30 
Smp_000410 Trematode Eggshell Synthesis domain containing 
protein 
146.36 2.85E-32 
Smp_175560 Beta site APP cleaving enzyme 1 138.39 4.93E-45 
Smp_058160 Uncharacterised protein 112.56 8.89E-33 
Smp_143970 Kelch protein 10 109.35 2.49E-30 
Smp_129960 Uncharacterised protein 101.63 2.15E-48 
Smp_199540 Inositol type trisphosphate receptor 50.27 1.72E-34 
Smp_074710 Def8 protein 38.78 5.84E-33 
Smp_173150 CD63 antigen 38.76 1.62E-42 
Smp_054010 Y+L amino acid transporter 2 37.52 1.66E-32 
Smp_159920 Protocadherin 11 30.49 5.42E-47 
Smp_169090 Solute carrier family 43 30.16 5.37E-49 
Smp_212820 Zinc finger protein 19.90 1.63E-74 
Smp_075330 Uncharacterised protein 19.25 4.86E-44 
Smp_179710 Maternal Effect Lethal family member (mel 32) 14.46 5.02E-42 
Smp_129610 Malate dehydrogenase 10.57 8.24E-34 
Smp_209060 Alpha 1,3 fucosyltransferase B 9.25 1.90E-30 
Smp_199830 Leucine rich repeat protein 7.03 5.61E-30 
Smp_148770 Ribose 5 phosphate isomerase 6.93 4.35E-41 
Smp_038030 Adenylosuccinate lyase 5.45 5.79E-61 
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Smp_135840 Uncharacterised protein 5.22 3.63E-35 
Smp_062070 Sulfide quinone reductase 4.44 9.54E-46 
Smp_058240 Reticulon 4 (Neurite outgrowth inhibitor) 4.00 3.24E-35 
Smp_011960 Inositol pentakisphosphate 2 kinase 3.78 1.46E-33 
Smp_075870 Translocation associated membrane protein 1 3.49 1.52E-34 
Smp_031730 Signal peptidase 18 kDa subunit 3.36 2.02E-30 
Smp_035470 Dolichyl diphosphooligosaccharide protein 3.33 7.22E-36 
Smp_056760 Protein disulfide isomerase 3.26 1.46E-33 
Smp_075470 Cysteine desulfurase, mitochondrial 3.21 2.74E-41 
Smp_048660 Nucleolar protein 56 3.17 5.78E-30 
Smp_048430 Thioredoxin glutathione reductase 2.70 1.08E-30 
Smp_210370 Ormdl protein 2.63 1.48E-35 
 
Appendix A.13: The most differentially expressed genes in female worms 
from mixed sex infections at 38 days post infection (d.p.i.) compared to 
females from single sex infections. The fold change provides a measure of 
expression in females from mixed sex infections relative to females from single 
sex infections. The p-value has been adjusted for multiple hypothesis testing. 
 
 
Gene ID Product Fold Change Adjusted  
p-value 
Smp_185340 Uncharacterised protein 8.98 7.08E-06 
Smp_121070 Uncharacterised protein 8.82 2.08E-05 
Smp_172340 Uncharacterised protein 6.87 7.56E-07 
Smp_141840 Uncharacterised protein 6.74 8.37E-07 
Smp_144860 Protein boule 6.61 6.34E-05 
Smp_012660 Sushi:SCR:CCP,domain containing protein 6.15 6.52E-06 
Smp_191250 Reverse transcriptase 6.15 6.09E-05 
Smp_124870 Uncharacterised protein 5.99 5.42E-05 
Smp_145580 Progesterone induced blocking factor 5.55 3.33E-06 
Smp_164590 Fibrillar collagen chain FAp1 alpha 5.54 3.96E-11 
Smp_196840 Collagen alpha 1(II) chain 5.21 1.06E-19 
Smp_123830 Collagen alpha (xi) chain 4.90 3.96E-11 
Smp_197370 Uncharacterised protein 4.66 3.96E-11 
Smp_135560 Collagen alpha 2(I) chain 4.60 1.49E-14 
Smp_110280 Nucleolar phosphoprotein p130 4.42 4.00E-09 
Smp_043390 Beta D xylosidase 2 4.29 6.94E-06 
Smp_050520 Neurogenic locus notch protein 3.97 1.14E-10 
Smp_166540 Serine:threonine protein kinase Nek11 3.85 7.08E-06 
Smp_124040 FMRFamide activated amiloride sensitive 
sodium 
3.72 2.10E-06 
Smp_062720 e1b 55 kDA associated protein 3.42 1.10E-06 
Smp_128470 Cation transporting ATPase worm 3.39 2.08E-05 
Smp_165040 Tbc1 domain family member 3.36 2.08E-05 
Smp_133340 Uncharacterised protein 3.35 1.54E-05 
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Smp_137550 Dynein heavy chain 3.27 1.40E-07 
Smp_168590 Pema SRCR protein 3.23 5.15E-07 
Smp_188670 Uncharacterised protein 3.23 1.14E-10 
Smp_062120 Serine protease inhibitors serpins 3.08 7.32E-10 
Smp_143910 Coiled coil and C2 domain containing protein 
2A 
2.98 3.33E-06 
Smp_164000 Uncharacterised protein 2.94 3.50E-05 
Smp_123010 High affinity cationic amino acid transporter 1 2.79 9.13E-06 
Smp_068720 Formin Homology 2 Domain containing 
protein 
2.76 4.83E-08 
Smp_213300 Putative transcription elongation regulator 1 2.66 7.56E-07 
Smp_091820 Bestrophin 3 2.50 4.15E-10 
Smp_136850 Centrin 1 2.50 5.09E-05 
Smp_120320 Splicing factor 3A subunit 1 2.43 2.34E-09 
Smp_189850 Uncharacterised protein 2.39 2.33E-06 
Smp_025130 RNA binding motif protein 22 2.37 4.31E-06 
Smp_151730 Rhabdoid tumour deletion region protein 1 2.35 9.33E-09 
Smp_013860 Glutamate cysteine ligase catalytic subunit 2.34 5.25E-08 
Smp_105950 Armadillo repeat containing protein 3 2.33 5.36E-07 
Smp_021540 Zinc finger protein 2.28 3.34E-05 
Smp_134660 Radial spoke head protein 4 A 2.25 3.62E-06 
Smp_131890 Sodium:chloride dependent transporter 2.25 2.02E-06 
Smp_156080 Dynein heavy chain 2.24 1.48E-05 
Smp_175090 Long-chain-fatty-acid--CoA ligase 2.20 2.19E-05 
Smp_180810 Papilin 2.18 1.22E-05 
Smp_001160 Sperm associated antigen 16 protein 2.18 2.08E-05 
Smp_005860 Heterogeneous nuclear ribonucleoprotein k 2.16 2.19E-05 
Smp_165060 Uncharacterised protein 2.16 1.04E-05 
Smp_136550 Tyrosine protein kinase transmembrane 
receptor 
2.08 4.83E-08 
Smp_067420 Splicing factor 3b subunit 4 2.07 2.14E-05 
Smp_007640 Uncharacterised protein 2.03 3.50E-05 
 
Appendix A.14: The most differentially expressed genes in female worms 
from mixed sex infections at 21 days post infection (d.p.i.) compared to 
females at 18 d.p.i. The fold change provides a measure of expression in 
females at 21 d.p.i. relative to females at 18 d.p.i. The p-value has been adjusted 











Gene ID Product Fold Change Adjusted  
p-value 
Smp_150630 Dissatisfaction (Dsf) 8.56 1.43E-04 
Smp_180330 MEG 2 (ESP15) family 5.90 1.74E-03 
Smp_134100 G protein coupled receptor fragment 4.54 4.01E-03 
Smp_138350 Zinc finger protein basonuclin 2 4.32 1.61E-04 
Smp_083880 G protein coupled receptor No9 3.89 5.00E-08 
Smp_128710 G protein coupled receptor 3.86 3.85E-04 
Smp_167140 WNT 3.07 6.70E-03 
Smp_177670 Placental protein 11 2.79 4.84E-04 
Smp_062080 Serine protease inhibitors serpins 2.75 5.57E-08 
Smp_196930 WNT 2.49 2.72E-03 
Smp_167400 Transcription factor sum 1 2.36 1.52E-03 
Smp_062560 Secreted frizzled protein 2.21 6.67E-03 
Smp_041700 G protein coupled receptor fragment 2.08 6.48E-03 




Appendix A.15: The most differentially expressed genes in female worms at 
18 days post infection (d.p.i.) compared to females from mixed sex 
infections at 21 d.p.i. The fold change provides a measure of expression in 
females at 18 d.p.i. relative to females at 21 d.p.i. The p-value has been adjusted 





























Smp_062620 12.61 1.73E-07 Uncharacterised protein 
Smp_138350 5.43 1.86E-05 Zinc finger protein basonuclin 2 
Smp_000620 5.13 2.15E-04 Class E basic helix loop helix protein 23 
Smp_136830 4.90 3.09E-04 Subfamily A1A unassigned peptidase (A01 
family) 
Smp_203270 4.61 3.23E-04 Twist protein 
Smp_158480 3.43 4.75E-04 AMP dependent ligase 
Smp_119140 3.32 1.72E-06 Uncharacterised protein 
Smp_203660 2.76 3.69E-06 Uncharacterised protein 
Smp_174320 2.70 3.10E-05 Protein lozenge 
Smp_201920 2.66 1.04E-04 Uncharacterised protein 
Smp_124300 2.42 1.23E-04 Lamin B receptor (ERG24) 
Smp_026670 2.40 1.54E-05 Transmembrane protein 26 
Smp_157370 2.32 4.82E-05 Ribosomal protein s kinase alpha 
Smp_202620 2.32 1.56E-04 Uncharacterised protein 
Smp_202400 2.29 9.58E-06 Uncharacterised protein 
Smp_130870 2.20 2.56E-04 ETS domain containing protein Elk 4 
Smp_130050 2.18 5.61E-04 PDZ domain containing RING finger protein 
Smp_135730 2.15 2.67E-04 Protocadherin alpha 7 
Smp_086220 2.12 3.60E-04 Uncharacterised protein 
Smp_137110 2.02 4.50E-05 Uncharacterised protein 
 
Appendix A.16: The most differentially expressed genes in male worms at 
28 days post infection (d.p.i.) compared to males from mixed sex infections 
at 21 d.p.i. The fold change provides a measure of expression in males at 28 
























Smp_000620 Class E basic helix loop helix protein 23 3.89 0.000546398 
Smp_001980 Barh 2 homeobox protein 3.98 0.000461429 
Smp_009020 Zinc finger protein 2.07 0.006630352 
Smp_009040 POU domain, class 4, transcription factor 2 3.16 7.04E-05 
Smp_027990 Homeobox protein NK 2 2.70 0.008565627 
Smp_035650 Dorsal root ganglia homeobox protein 2.73 0.001246198 
Smp_045470 Prospero homeobox protein 2 9.87 1.12E-06 
Smp_049160 Zinc finger protein 2.17 0.000610056 
Smp_051130 ERG transcription factor 2.52 2.27E-06 
Smp_060220 Lipopolysaccharide induced tumour necrosis 3.73 0.002346011 
Smp_072470 Neurogenic differentiation factor 2.40 0.001806143 
Smp_075230 B cell lymphoma/leukaemia 11B 5.04 3.13E-05 
Smp_076600 Transcription factor SOX 14 2.33 0.000577322 
Smp_124090 Uncharacterised protein 2.53 0.002649938 
Smp_124600 Uncharacterised protein 3.67 1.25E-06 
Smp_125400 Neurogenic differentiation 6 5.89 0.001685335 
Smp_126560 OTP paired class homeobox protein 9.09 3.52E-07 
Smp_130870 ETS domain containing protein Elk 4 2.12 2.78E-05 
Smp_134690 EMX homeobox protein 3.45 0.00905731 
Smp_136120 N twist 4.37 0.009792167 
Smp_136900 Homeobox protein distal less dlx 7.42 8.67E-06 
Smp_138230 Doublesex and mab-3 related transcription factor 
1 
3.23 2.04E-05 
Smp_138350 Zinc finger protein basonuclin 2 7.81 7.45E-11 
Smp_140980 MDS1 and evi1 complex locus protein evi1 2.35 0.004593848 
Smp_142120 Achaete scute transcription factor 9.13 4.22E-06 
Smp_148110 Transcription factor SOX 14 3.50 0.008318475 
Smp_153850 Zinc finger ch type domain containing protein 2.17 5.83E-05 
Smp_155690 Sox family of transcription factor 3.71 0.003879486 
Smp_162760 Homeobox protein prospero 3.13 4.79E-06 
Smp_165410 LIM class homeodomain transcription factor 2.78 0.001109032 
Smp_168600 Aryl hydrocarbon receptor 2.42 0.002250422 
Smp_170750 Paired box protein pax 6 5.27 4.30E-07 
Smp_171130 Glial cells missing 10.95 8.12E-07 
Smp_174320 Protein lozenge 3.02 1.02E-08 
Smp_175410 Zinc finger protein 398 4.26 6.23E-05 
Smp_189380 Homeobox protein distal less 4.44 0.006044648 
Smp_203270 Twist protein 4.33 4.67E-05 
 
Appendix A.17: List of genes involved in the regulation of transcription 
(annotated with GO term G0:0006355) which were up-regulated in females from 
mixed sex infections at 21 days post infection (d.p.i.) compared to females at 28 
d.p.i. The fold change provides a measure of expression in females at 21 d.p.i. 





Gene ID Product Fold change Adjusted p-
value 
Smp_000620 Class E basic helix loop helix protein 23 1.90 0.114 
Smp_001980 Barh 2 homeobox protein 2.72 0.020 
Smp_009020 Zinc finger protein 1.23 0.604 
Smp_009040 POU domain, class 4, transcription factor 2 1.87 0.066 
Smp_027990 Homeobox protein NK 2 2.13 0.059 
Smp_035650 Dorsal root ganglia homeobox protein 2.13 0.025 
Smp_045470 Prospero homeobox protein 2 4.50 3.67E-03 
Smp_049160 Zinc finger protein 1.74 0.026 
Smp_051130 ERG transcription factor 1.90 3.68E-03 
Smp_060220 Lipopolysaccharide induced tumour necrosis 4.00 1.40E-03 
Smp_072470 Neurogenic differentiation factor 3.18 5.47E-05 
Smp_075230 B cell lymphoma/leukaemia 11B 3.70 1.87E-03 
Smp_076600 Transcription factor SOX 14 2.75 5.01E-05 
Smp_124090 Uncharacterised protein 1.63 0.187 
Smp_124600 Uncharacterised protein 2.47 2.60E-03 
Smp_125400 Neurogenic differentiation 6 7.92 1.11E-04 
Smp_126560 OTP paired class homeobox protein 1.62 0.416 
Smp_130870 ETS domain containing protein Elk 4 1.24 0.419 
Smp_134690 EMX homeobox protein 4.15 2.58E-03 
Smp_136120 N twist 0.66 0.645 
Smp_136900 Homeobox protein distal less dlx 3.96 3.50E-03 
Smp_138230 Doublesex and mab-3 related transcription 
factor 1 
2.37 4.14E-03 
Smp_138350 Zinc finger protein basonuclin 2 7.94 3.98E-10 
Smp_140980 MDS1 and evi1 complex locus protein evi1 1.58 0.209 
Smp_142120 Achaete scute transcription factor 5.21 1.37E-03 
Smp_148110 Transcription factor SOX 14 2.55 0.064 
Smp_153850 Zinc finger ch type domain containing protein 1.87 2.91E-03 
Smp_155690 Sox family of transcription factor 1.80 0.285 
Smp_162760 Homeobox protein prospero 2.56 5.44E-04 
Smp_165410 LIM class homeodomain transcription factor 2.38 8.69E-03 
Smp_168600 Aryl hydrocarbon receptor 1.56 0.203 
Smp_170750 Paired box protein pax 6 1.76 0.148 
Smp_171130 Glial cells missing 3.05 0.051 
Smp_174320 Protein lozenge 3.75 8.37E-11 
Smp_175410 Zinc finger protein 398 2.84 8.82E-03 
Smp_189380 Homeobox protein distal less 1.36 0.694 
Smp_203270 Twist protein 2.30 0.041 
 
Appendix A.18: List of genes from Appendix A.17 expressed in female worms 
from single sex infections at 21 days post infection (d.p.i.) compared to females at 
28 d.p.i. These genes are involved in the regulation of transcription (annotated 
with GO term G0:0006355). The fold change provides a measure of gene 
expression in females from single sex infections at 21 d.p.i. compared to females 




Gene ID Product Fold change Adjusted  
p-value 
Smp_191910 Stress protein DDR48 455.30 1.26E-41 
Smp_131110 Uncharacterised protein 387.32 3.95E-38 
Smp_202830 Uncharacterised protein 331.05 4.34E-31 
Smp_050750 Uncharacterised protein 315.19 1.52E-39 
Smp_144440 Replication A protein 281.18 2.53E-38 
Smp_151150 Arabinogalactan protein 266.26 2.97E-39 
Smp_014610 Uncharacterised protein 246.64 5.15E-33 
Smp_033250 Uncharacterised protein 243.38 1.78E-33 
Smp_077890 Trematode Eggshell Synthesis domain 
containing protein 
224.72 8.07E-32 
Smp_095980 Extracellular superoxide dismutase 213.90 1.57E-30 
Smp_000410 Trematode Eggshell Synthesis domain 
containing protein 
203.71 2.72E-32 
Smp_151160 Stress protein DDR48 203.06 1.98E-32 
Smp_000420 Pro His rich protein 199.29 1.57E-30 
Smp_000430 Eggshell protein 197.15 1.05E-29 
Smp_192220 Uncharacterised protein 178.59 1.66E-30 
Smp_076320 Uncharacterised protein 173.56 6.66E-37 
Smp_050270 Tyrosinase 172.20 3.14E-28 
Smp_165360 Histone acetyltransferase myst4 170.11 2.15E-28 
Smp_077900 Female specific protein 800 (fs800) 168.73 4.01E-38 
Smp_138570 Spore germination protein 167.61 5.00E-28 
Smp_013540 Tyrosinase 165.63 4.89E-28 
Smp_000280 Uncharacterised protein 155.70 4.07E-27 
Smp_000270 Uncharacterised protein 147.29 9.32E-27 
Smp_000400 Uncharacterised protein 143.08 2.21E-26 
Smp_155310 Tetraspanin CD63 receptor 140.39 4.62E-26 
Smp_148390 Uncharacterised protein 140.06 1.87E-26 
Smp_000290 Female-specific protein 800 (fs800) 139.81 1.37E-34 
Smp_095350 Tis11 zinc finger protein 46.36 2.34E-16 
Smp_087320 TPA induced protein 11B mouse 37.10 8.14E-18 
Smp_166560 Zinc finger homeobox protein 1 12.20 1.13E-10 
 
Appendix A.19: The most differentially expressed genes in females from 
mixed sex infections at 38 days post infection (d.p.i.) compared to females 
at 18 d.p.i. Three putative transcription factor genes (Smp_095350, 
Smp_087320 and Smp_166560) were added to this list despite ranking lower on 
the list of most differentially expressed genes but are in the 100 most 
differentially expressed genes. Fold changes provide a measure of gene 
expression in females at 38 d.p.i. compared to females at 18 d.p.i. The p-value has 










Product Rank Eggshell 
synthesis 
domain 
Smp_000270 243.96 8.24E-34 Uncharacterised protein 17 Yes 
Smp_000280 262.95 5.31E-34 Uncharacterised protein 14 Yes 
Smp_000290 463.72 5.79E-61 Female-specific protein 800 3 Yes 
Smp_000390 142.88 3.93E-26 Uncharacterised protein 28 Yes 
Smp_000400 252.51 7.23E-34 Uncharacterised protein 16  
Smp_000410 146.36 2.85E-32 Trematode Eggshell Synthesis 
domain containing protein 
27 Yes 
Smp_000420 214.78 3.81E-34 Pro His rich protein 20  
Smp_000430 374.21 5.91E-39 Eggshell protein 6 Yes 
Smp_013540 353.16 1.35E-38 Tyrosinase 8  
Smp_014610 427.38 1.30E-43 Serine:threonine kinase 1 5  
Smp_050270 243.54 1.61E-33 Tyrosinase 18  
Smp_050750 265.17 1.30E-43 Uncharacterised protein 13  
Smp_077890 351.06 4.31E-40 Trematode Eggshell Synthesis 
domain containing protein 
9 Yes 
Smp_077900 504.95 4.69E-65 Female specific protein 800 2 Yes 
Smp_077920 183.03 2.02E-29 Uncharacterised protein 22 Yes 
Smp_095980 323.47 9.38E-37 Extracellular superoxide 
dismutase (Cu Zn) 
11  
Smp_112450 179.17 9.08E-30 Trematode Eggshell Synthesis 
domain containing protein 
23 Yes 
Smp_131110 616.92 5.50E-48 Uncharacterised protein 1  
Smp_138570 261.01 1.15E-34 Spore germination protein 15  
Smp_144440 169.70 2.82E-37 Replication A protein 25  
Smp_151150 362.41 8.12E-50 Arabinogalactan protein 7  
Smp_151160 230.02 1.82E-38 Stress protein DDR48 19  
Smp_155310 190.75 5.98E-30 Tetraspanin CD63 receptor 21  
Smp_165360 175.53 1.24E-30 Histone acetyltransferase myst4 24  
Smp_191910 431.31 3.31E-46 Stress protein DDR48 4 Yes 
Smp_033250 96.72 4.80E-26 Uncharacterised protein 36  
Smp_152150 93.32 2.47E-22 Uncharacterised protein 38  
 
Appendix A.20: Expression of genes of Cluster 13 from the Kohonen 
analysis in the comparison of female worms from mixed sex infections to 
males worms at 38 days post infection. Fold changes provide a measure of 
gene expression in females worms relative to male worms. The p-value has been 
adjusted for multiple hypothesis testing. The Rank provides the position of the 
gene within the list of differentially expressed gene when ordered by fold 
change. All genes in Cluster 13 where amongts the 40 most differentially 
expressed genes. The final column indicates the presence or absence of a 






Gene ID Reads in females 
from mixed sex 
infections at 38 d.p.i. 
Reads in females 
from single sex 
infections at 38 d.p.i. 
Smp_000270 24679 14 
Smp_000280 143373 49 
Smp_000290 13081 17 
Smp_000390 67711 14 
Smp_000400 26606 14 
Smp_000410 128053 501 
Smp_000420 208495 299 
Smp_000430 483455 97 
Smp_013540 31888 8 
Smp_014610 1045457 415 
Smp_033250 66492 416 
Smp_050270 92273 61 
Smp_050750 39007 75 
Smp_077890 44949 23 
Smp_077900 16593 20 
Smp_077920 18893 4 
Smp_095980 204041 87 
Smp_112450 16580 12 
Smp_131110 3988553 1125 
Smp_138570 229180 122 
Smp_144440 129993 498 
Smp_151150 5309 6 
Smp_151160 44898 92 
Smp_152150 10866 25 
Smp_155310 84156 60 
Smp_165360 50134 77 
Smp_191910 1321831 1072 
Sum of fertility  
gene reads 
8536546 5203 
Total of all  
gene reads 
59621509 84076361 
Percentage of reads 14.31% 0.0062% 
 
Appendix A.21: Numbers of reads in females from mixed and single sex 
infections at 38 days post infection for the 27 genes in Cluster 13 of the 









Smp_000950 Smp_075330 Smp_136870 Smp_152310 Smp_185440 
Smp_005710 Smp_078200 Smp_137700 Smp_152910 Smp_186940 
Smp_007670 Smp_083770 Smp_139700 Smp_154030 Smp_187360 
Smp_011180 Smp_084890 Smp_139720 Smp_154830 Smp_194840 
Smp_011960 Smp_085180 Smp_140570 Smp_154900 Smp_198170 
Smp_012930 Smp_087760 Smp_141340 Smp_156250 Smp_198260 
Smp_020840 Smp_089840 Smp_141900 Smp_158120 Smp_198900 
Smp_025830 Smp_095360 Smp_142020 Smp_158360 Smp_199830 
Smp_026400 Smp_101100 Smp_142620 Smp_158510 Smp_200150 
Smp_029930 Smp_121070 Smp_142680 Smp_158520 Smp_200310 
Smp_034680 Smp_125060 Smp_144270 Smp_159470 Smp_202450 
Smp_036660 Smp_125740 Smp_145240 Smp_160160 Smp_202690 
Smp_038030 Smp_126210 Smp_145290 Smp_163060 Smp_203200 
Smp_038970 Smp_127130 Smp_145760 Smp_164140 Smp_204130 
Smp_041540 Smp_128190 Smp_146180 Smp_170320 Smp_204250 
Smp_042700 Smp_128480 Smp_146810 Smp_172830 Smp_205410 
Smp_056290 Smp_129920 Smp_148770 Smp_172980 Smp_206250 
Smp_058690 Smp_132660 Smp_149610 Smp_173520 Smp_206290 
Smp_058700 Smp_135020 Smp_149780 Smp_175310 Smp_209060 
Smp_061100 Smp_135840 Smp_151660 Smp_179710 Smp_212090 
Smp_062070 Smp_136730 Smp_151860 Smp_181390 Smp_212820 
Smp_063520     
 





Smp_000500 Smp_056680 Smp_123880 Smp_141460 Smp_165500 
Smp_000850 Smp_058380 Smp_124070 Smp_142490 Smp_167000 
Smp_001410 Smp_059980 Smp_125070 Smp_143540 Smp_167960 
Smp_004420 Smp_063530 Smp_125190 Smp_144260 Smp_169020 
Smp_011270 Smp_063630 Smp_125250 Smp_144770 Smp_170560 
Smp_012560 Smp_073990 Smp_126230 Smp_147450 Smp_171270 
Smp_016490 Smp_074000 Smp_126820 Smp_148680 Smp_171290 
Smp_018870 Smp_074570 Smp_128110 Smp_151120 Smp_172740 
Smp_019030 Smp_075800 Smp_128300 Smp_153070 Smp_174500 
Smp_026810 Smp_077610 Smp_128350 Smp_155510 Smp_177540 
Smp_027340 Smp_089240 Smp_129270 Smp_155570 Smp_179170 
Smp_030000 Smp_089290 Smp_130100 Smp_155900 Smp_181060 
Smp_033930 Smp_090010 Smp_131410 Smp_157080 Smp_181070 
Smp_037720 Smp_090110 Smp_131470 Smp_158620 Smp_181470 
Smp_042140 Smp_091750 Smp_132800 Smp_161240 Smp_187140 
Smp_042910 Smp_094500 Smp_133170 Smp_162320 Smp_191970 
Smp_043120 Smp_096290 Smp_134590 Smp_162390 Smp_195070 
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Smp_043290 Smp_096840 Smp_137720 Smp_163310 Smp_197730 
Smp_049150 Smp_102430 Smp_139160 Smp_163380 Smp_199290 
Smp_052470 Smp_105420 Smp_139240 Smp_163700 Smp_201330 
Smp_054620 Smp_105450 Smp_140460 Smp_163720 Smp_203910 
Smp_055740 Smp_121930 Smp_140840 Smp_164320 Smp_900040 
Smp_055990 Smp_123720    
 




Gene ID Average 
read count 
Fold change  Gene ID Average 
read count 
Fold change 
Smp_000270 1098.89 243.96  Smp_129960 414.79 101.63 
Smp_000280 5844.21 262.95  Smp_130370 143.49 24.89 
Smp_000290 520.85 463.72  Smp_130780 22.76 94.63 
Smp_000370 40.72 152.97  Smp_131110 146222.11 616.92 
Smp_000390 2812.64 142.88  Smp_137460 167.86 35.98 
Smp_000400 1056.45 252.51  Smp_138570 10245.16 261.01 
Smp_000410 5371.41 146.36  Smp_140720 336.99 22.60 
Smp_000420 9619.11 214.78  Smp_141450 104.15 98.45 
Smp_000430 20613.88 374.21  Smp_144440 6322.04 169.70 
Smp_011870 222.98 47.15  Smp_145020 135.79 23.62 
Smp_013540 1311.58 353.16  Smp_145490 63.19 113.36 
Smp_014610 49190.98 427.38  Smp_146480 99.57 17.68 
Smp_029620 4.49 10.18  Smp_148390 317.14 71.70 
Smp_033250 2959.04 96.72  Smp_151150 237.48 362.41 
Smp_041880 56.69 30.47  Smp_151160 1990.40 230.02 
Smp_050270 3936.38 243.54  Smp_151850 85.29 28.57 
Smp_050750 1575.47 265.17  Smp_152150 443.42 93.32 
Smp_054010 876.51 37.52  Smp_154390 30.35 20.51 
Smp_055260 226.77 22.05  Smp_155310 3646.08 190.75 
Smp_056280 82.41 5.48  Smp_157730 9.54 24.66 
Smp_056700 1482.19 17.68  Smp_159480 57.64 28.80 
Smp_058160 199.83 112.56  Smp_159920 1085.76 30.49 
Smp_065530 107.12 69.46  Smp_164400 424.85 40.10 
Smp_070360 30.37 14.18  Smp_165360 2524.98 175.53 
Smp_074710 246.16 38.78  Smp_166560 217.40 29.12 
Smp_076320 648.59 25.03  Smp_167830 28.59 17.07 
Smp_077890 2068.34 351.06  Smp_169090 551.51 30.16 
Smp_077900 675.45 504.95  Smp_170770 11.19 21.11 
Smp_077920 916.91 183.03  Smp_170840 47.48 19.16 
Smp_078720 58.79 22.57  Smp_173150 3694.12 38.76 
Smp_080360 54.01 41.78  Smp_175560 457.47 138.39 
Smp_087320 75.30 15.68  Smp_191910 54945.48 431.31 
Smp_095350 151.74 13.84  Smp_194060 6.05 4.10 
307 
 
Smp_095980 7743.79 323.47  Smp_194750 137.24 86.72 
Smp_105780 68.84 1.99  Smp_195090 551.03 3.99 
Smp_112450 827.17 179.17  Smp_196950 203.53 7.69 
Smp_122280 66.19 44.71  Smp_199540 163.74 50.27 
Smp_124510 92.96 43.69  Smp_202840 40.55 113.42 
 
Appendix A.24: Summary of the 76 genes in Cluster 7 generated by 
MBCluster. The column “Average read count” provides a measure of absolute 
expression, the average number of reads mapped to the gene across all RNA-Seq 
samples used in Chapter 3. The fold changes provided reflect expression in 
females from mixed sex infections compared to females from single sex 




GO term Description Annotated Significant Expected p-value 
GO:0006570 Tyrosine metabolic process 4 2 0.02 1.40E-04 
GO:0046189 Phenol-containing compound 
biosynthetic process 
4 2 0.02 1.40E-04 
GO:0044550 Secondary metabolite biosynthetic 
process 
7 2 0.03 5.00E-04 
GO:0006875 Cellular metal ion homeostasis 10 2 0.05 1.05E-03 
GO:0046148 Pigment biosynthetic process 11 2 0.05 1.28E-03 
 
Appendix A.25: Significantly enriched GO terms amongst the genes in 
Cluster 7 of the MBCluster analysis. “Annotated” provides the total number of 
genes in the genome annotated with a given GO term. “Significant” provides the 
number of genes annotated with that GO term in Cluster 9. “Expected” provides 
the number of genes with that GO term expected by chance. The significance cut-













































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Table B.1: Summary of sequencing statistics for sequnced RNA-Seq 
samples. Total reads is the number of all reads sequenced. Mapped is the total 
number of reads mapped to the S. mansoni reference genome v5.2. ‘Prop. Paired’ 
refers to the total number of reads mapped together with a mate-paired read in 
close proximity and in the correct orientation. Unmapped is the total number of 




14-3-3 proteins play an important role in relaying apoptosis signals within cells 
and exert pro-apoptotic effects at different points of the apoptosis pathway 
(Rosenquist, 2003). Three 14-3-3 proteins have been annotated in S. mansoni all 
of which were found to contain a 14-3-3 Pfam domain as well as significant 
BLAST hits (Table 4.1) against 14-3-3 proteins of model organisms.  
 
The next group of genes I examined are caspases which are key mediators of 
apoptosis as they form the apoptotic protease cascade that lead to controlled cell 
death (McIlwain et al., 2013). Four caspase homologues have been identified in S. 
mansoni, which all contain a caspase domain. Blast results suggest caspase-3, -7 
and -8  homologues are represented in the S. mansoni genome. Three of these 
caspases (Smp_028500, Smp_141270 & Smp_032000) were previously described 
by Lee et al. (2014). 
313 
 
Figure B.2: Diagram of 14-3-3 family members showing length and presence of 
PFAM domains. 
 
Figure B.3: Diagram of caspase family members showing length and presence of 
PFAM domains. 
 
Another group of proteins that function as regulators of apoptosis, in both pro- 
and anti-apoptotic roles are Bcl-2 domain containing proteins. Four Bcl-2 
domain containing proteins were identified by InterProScan, a further two were 
found to be annotated as Bcl-2 proteins, one in the genome (Smp_041630) 


























(Protasio et al., 2012) and the other by Lee et al. (2011) (Smp_043360). 
However, InterProScan did not identify Bcl-2 domains in the latter two, nor did 
BLAST find significant homology to such proteins (Table B.5), which is why I 
decided to exclude them from the down-stream work flow of my analysis. One of 
the genes identified by InterProScan showed significant homology to apoptosis 
regulator Bax, also known as Bcl-2-like protein 4, a known pro-apoptotic 
member of the bcl-2 like family (Pawlowski & Kraft, 2000). Five of the Bcl-2 
family proteins (Smp_043360, Smp_072180, Smp_095190, Smp_213250 & 
Smp_168470) were described previously (Lee et al., 2014). 
 
Figure B.4: Diagram of Bcl-2 domain containing protein showing length and 
presence of PFAM domains. Two genes, marked with ‘X’, failed the quality 
control and were excluded from the following analysis. 
 
















Bcl-2 domain proteins Bcl-2
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Two genes were found to contain Bax-Inhibition domains. Bax is known to have 
an important pro-apoptotic domain and its activity is tightly regulated by 
proteins such as Bax inhibitor 1. This group of proteins was first identified as an 
inhibitor of Bax but was later recognised to inhibit apoptosis through 
interactions with several other pro-apoptotic processes as well (Robinson et al., 
2011). 
 
Figure B.5: Diagram of BAX interacting proteins showing length and presence of 
PFAM domains. 
 
The Fas ligand:receptor interaction was one of the first aspects of the pro-
apoptotic signalling cascade to be studied (Nagata, 1997, 1999). A homologue of 
the Fas receptor as well as several homologues of Fas associated proteins with 
putative roles in the regulation of apoptosis have been identified. Determining 
whether these genes should be assigned putative pro- or anti-apoptotic function 
based on domains was difficult as two of the genes did not contain known 
domains (see Figure B.7) so that their function could only be inferred by 
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homology to genes of model organisms. However, the function of the human fas 
binding factor 1 (FAB1) and fas associated factor 2 (FAF2) are only poorly 
understood. FAF2 is thought to confer resistance to apoptosis to T cells in 
patients with atopic dermatitis (Koelsch et al., 2013). FAB1 on the other hand 
was first described in 2000 but no definitive function has yet been assigned 
(Schmidt et al., 2000). 
Figure B.6: Diagram of Fas receptor and associated proteins, showing length and 
presence of PFAM domains. 
 
Figure B.7: Diagram of inhibitor of apoptosis protein, showing length and 
presence of PFAM domains. 
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The schistosome homologue of the Inhibitor of Apoptosis protein (IAP) was 
identified by Peng et al. (2010) and contains two overlapping “cytokine induced 
apoptosis inhibitor 1” domains, but lacks the Baculo virus IAP repeat (BIR) 
domain which is a hallmark of the family of IAPs. Rather than a member of the 
IAP family, Smp_207000 shares greater sequence similarity with the human 
anamorsin gene, a cytokine induced inhibitor of apoptosis. Given that the 
schistosome homologue was shown to inhibit caspases and thus apoptosis both 
in human cells as well as schistosome lysate (Peng et al., 2010) it can be 
classified confidently as an anti-apoptotic gene.  
 
Figure B.8: Diagram of cathepsin D homologues, showing length and presence of 
PFAM domains. 
 
Cathepsin D is a lysosomal protease that besides its role in digestion also plays a 
regulatory function in apoptosis. When activated, for example by ceramide 
(Heinrich et al., 1999), cathepsin D mediates oxidative stress induced apoptosis 
by translocation to the cytoplasm (Watchorn et al., 2001) as well as mediation of 
cytochrome C release and caspase activation (Conus et al., 2008; Johansson et al., 











2003). Both cathepsin D homologues in S. mansoni contain aspartate protease 
domains as expected from cathepsins.  
 
p21 is a cyclin dependent kinase (CDK) inhibitor and an important regulator of 
cell fate, controlling both division and apoptosis depending on the cell state and 
extracellular signals.  By impeding CDKs it can arrest the cell cycle and is 
considered an important proliferation inhibitor (Gartel & Tyner, 2002). Despite 
this, p21 is a negative regulator of p53-dependent apoptosis. p21-activated 
kinase 1 (PAK1) are serine/threonine protein kinases serving as mediators of 
Rac and Cdc42 GTPase function as well as Ras-driven tumorigenesis by 
protecting cells from apoptosis (Ong et al., 2011). As the schistosome homologue 
of PAK1 has a protein kinase domain as well as significant sequence similarity to 
the human PAK1, I assigned it a putative anti-apoptotic function. The PAK1 
interacting protein (PAK1IP) homologue on the other hand contains a conserved 
WD40 repeat, as does the human PAK1IP.  PAK1IP is a negative regulator of 
PAK1, binding to the N-terminal region of PAK1 to inactivate it, thus acting in a 




Figure B.9: Diagram of PAK1 and PAK1IP, showing length and presence of PFAM 
domains. 
 
Five other S. mansoni genes were found to be homologous to apoptosis 
regulating genes of humans and C. elegans. These did not form a related group of 
genes and thus contain a range of different, unrelated protein domains, such as 
WD40, SH2 and Sh3 domains. The apoptotic protease activating factor (APAF1) 
like gene (Smp_140260) contains several WD domains that allow its human and 
C. elegans homologues to bind to caspase proteins and activate them, thereby 
promoting apoptosis (Qin et al., 1999; Yakovlev et al., 2001). The schistosome 
homologue of APAF1 (Smp_140260) was first described by Lee et al. (2014). 
 
Almost the entire length of the schistosome homologue of apoptosis inhibitor 5 
(AIP5) is made up of a conserved apoptosis inhibitory protein 5 domain, which, 
together with the sequence homology to human AIP5 suggests that it has an anti-
apoptotic effect, acting as a suppressor of E2-promoter binding factor dependent 
apoptosis (Morris et al., 2006). 













In humans, the apoptosis inducing factor 1 is associated with the mitochondria 
and involved in a caspase independent activation of apoptosis (Joza et al., 2001; 
Susin et al., 1999). The schistosome homologue (Smp_137540) shares a “C-
terminal mitochondrion-associated apoptosis-inducing factor”-domain as well as 
a pyridine nucleotide-disulphide oxidoreductase domain.  
 
Like the human apoptosis-stimulating of p53 protein (PPP1R13B), the 
schistosome homologue has two domains near its C-terminus: an ankyrin repeat 
and a SH3 domain. In humans, these domains allow PPP1R13B to interact with 
p53/TP53 and regulate it by enhancing the DNA binding and transactivation 
function of TP53 on the promoters of pro-apoptotic genes in vivo, thereby 




Figure B.10: Diagram of miscellaneous apoptosis related proteins, showing 

































































Smp_107750 11120.5 4.764 0.033 Uncharacterised protein 
Smp_108010 7839.4 4.696 0.033 Uncharacterised protein 
Smp_116960 7850.2 4.665 0.033 Uncharacterised protein 
Smp_100450 7759.5 4.605 0.033 Uncharacterised protein 
Smp_074390 7340.6 4.242 0.033 Eukaryotic translation initiation factor 
Smp_145370 6960.2 3.540 0.033 Uncharacterised protein 
Smp_079770 41164.0 1.642 0.033 Probable protein disulfide-isomerase ER-60 
Smp_049270 24812.2 0.267 0.045 Major egg antigen (p40) 
Smp_131110 177674.7 4.205 0.053 Uncharacterised protein 
Smp_018930 7063.7 4.011 0.053 Uncharacterised protein 
Smp_023840 12609.0 3.758 0.053 Uncharacterised protein 
Smp_202690 15523.4 3.599 0.053 Universal stress protein 
Smp_006040 11467.1 3.563 0.053 Uncharacterised protein 
Smp_054160 135853.5 3.328 0.053 Glutathione S-transferase class-mu 28 kDa isozyme 
Smp_158110 9316.0 2.257 0.053 Thioredoxin peroxidase 
Smp_900040 112222.7 3.631 0.064 NADH dehydrogenase subunit 2 
Smp_090520 9271.9 3.434 0.064 Purine nucleoside phosphorylase 
Smp_900100 57478.3 3.603 0.065 NADH dehydrogenase subunit 3 
Smp_043120 41091.7 3.179 0.065 Universal stress protein 
Smp_900050 227094.7 3.260 0.070 NADH dehydrogenase subunit 5 
Smp_095980 30236.6 3.838 0.070 Extracellular superoxide dismutase (Cu Zn) 
Smp_155310 8225.5 3.760 0.078 Tetraspanin CD63 receptor 
Smp_058690 20056.6 3.022 0.088 Glutathione peroxidase 
Smp_000430 75350.6 3.607 0.089 Eggshell protein 
Smp_014610 82078.6 3.373 0.089 Serine:threonine kinase 1 
Smp_138570 9976.6 3.364 0.089 Spore germination protein 
Smp_000390 9269.4 3.361 0.089 Uncharacterised protein 
Smp_191910 66486.1 3.244 0.089 Stress protein DDR48 
Smp_000420 22883.9 3.184 0.089 Pro His rich protein 
Smp_000280 24250.8 3.163 0.089 Uncharacterised protein 
Smp_173150 7196.8 3.111 0.089 CD63 antigen 
Smp_087760 15931.7 3.059 0.089 Ferritin 1 heavy chain 
Smp_080920 48931.4 3.050 0.089 Uncharacterised protein 
Smp_008360 21077.1 3.020 0.089 Adenosine kinase 
Smp_033610 8093.4 3.007 0.089 NADH dehydrogenase (ubiquinone) 1 beta 
Smp_202770 15844.8 3.002 0.089 Uncharacterised protein 
Smp_071000 9542.5 2.977 0.089 26 proteasome complex subunit DSS1 
Smp_016490 8570.6 2.970 0.089 Saposin B domain containing protein 
Smp_900020 123222.9 2.967 0.089 NADH dehydrogenase subunit 6 
Smp_077890 11865.3 2.966 0.089 Trematode Eggshell Synthesis domain containing protein 
Smp_036940 8638.4 2.944 0.089 Protein transport protein Sec61 subunit 
Smp_135740 8509.8 2.918 0.089 Splicing factor 3B subunit 5 
Smp_900000 316106.4 2.876 0.089 Cytochrome c oxidase subunit I 
Smp_066590 7573.6 2.875 0.089 LYR motif containing protein 4 
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Smp_105450 25570.2 2.857 0.089 Saposin containing protein 
Smp_158910 6850.8 2.835 0.089 Cyclin dependent protein kinase CDC28 regulatory 
Smp_028190 9228.7 2.816 0.089 Methylthioadenosine phosphorylase 
Smp_053390 32861.4 2.813 0.089 Histone H4 
Smp_033400 21383.4 2.755 0.089 Uncharacterised protein 
Smp_079270 8197.8 2.741 0.089 LIM, zinc binding domain containing protein 
Smp_079230 21402.5 2.717 0.089 Immunophilin FK506 binding protein FKBP12, putative 
Smp_004940 26544.0 2.708 0.089 60S ribosomal protein L35 
Smp_036220 19780.6 2.707 0.089 Histone H2B 
Smp_900110 82393.2 2.706 0.089 NADH dehydrogenase subunit 1 
Smp_019060 10298.8 2.699 0.089 Sec61 beta subunit 
Smp_179460 9344.1 2.683 0.089 Uncharacterised protein 
Smp_007900 32378.3 2.676 0.089 Large subunit ribosomal protein 23 
Smp_029820 35411.7 2.645 0.089 Ribosomal protein, large P2 
Smp_205570 15821.5 2.640 0.089 Small nuclear ribonucleoprotein e 
Smp_050280 25043.2 2.637 0.089 Ribosomal protein L31 
Smp_066990 31353.8 2.631 0.089 40S rRNA protein homolog 
Smp_146190 20760.2 2.627 0.089 40S ribosomal protein S21 
Smp_035790 32243.6 2.623 0.089 60S ribosomal protein L44 
Smp_074780 24348.9 2.614 0.089 Ribosomal protein S18 
Smp_089570 17532.3 2.586 0.089 Stress associated endoplasmic reticulum protein 
Smp_075560 12705.4 2.583 0.089 Small nuclear ribonucleoprotein Sm D2 
Smp_059930 6598.7 2.568 0.089 Cytochrome b c1 complex subunit 6 
Smp_035800 23949.4 2.566 0.089 60S ribosomal protein L37 
Smp_041650 18343.7 2.563 0.089 Ribosomal protein S27 
Smp_091640 28194.6 2.553 0.089 Ribosomal protein S24 
Smp_031310 25869.9 2.553 0.089 Ribosomal protein, Small subunit 
Smp_014650 20471.8 2.544 0.089 Small subunit ribosomal protein s30e 
Smp_210630 8450.9 2.535 0.089 histone H2A 
Smp_032060 8096.4 2.532 0.089 14 kDA subunit splicing factor 3b 
Smp_039400 44213.9 2.518 0.089 Eukaryotic translation initiation factor 5A 
Smp_089430 30223.8 2.518 0.089 Ubiquitin (ribosomal protein L40) 
Smp_113620 14145.9 2.500 0.089 Splicing factor, arginine:serine rich 2 
Smp_176200 13488.6 2.484 0.089 Superoxide dismutase [Cu-Zn] 
Smp_058700 8579.6 2.480 0.089 Glutathione peroxidase 
Smp_001830 27123.9 2.456 0.089 Ribosomal protein L24 
Smp_087550 11928.4 2.452 0.089 Uncharacterised protein 
Smp_022560 15102.5 2.451 0.089 60S ribosomal protein L21 
Smp_900090 167743.1 2.444 0.089 NADH dehydrogenase subunit 4 
Smp_050940 24957.3 2.442 0.089 60S ribosomal protein L11 
Smp_063350 23711.0 2.428 0.089 Ribosomal protein L27 
Smp_054780 45354.7 2.410 0.089 40S ribosomal protein S8 
Smp_060910 7628.8 2.406 0.089 Small nuclear ribonucleoprotein f 
Smp_074470 26940.0 2.406 0.089 Ribosomal protein, Small subunit 
Smp_019440 8101.0 2.405 0.089 Protein translation factor sui1 
Smp_097380 15244.8 2.378 0.089 Heat shock 10 kDa protein 1 
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Smp_151810 6755.1 2.340 0.089 Potassium voltage gated channel subfamily H 
Smp_068420 7552.8 2.287 0.089 Small nuclear ribonucleoprotein sm d3 
Smp_210310 18054.2 2.265 0.089 Ribosomal protein l7a 
Smp_055210 9659.2 2.221 0.089 Microsomal glutathione S transferase 3 
Smp_018020 6429.4 2.211 0.089 NADH dehydrogenase (ubiquinone) iron sulfur 
Smp_020770 7586.2 2.095 0.089 Dolichyl diphosphooligosaccharide protein 
Smp_074000 36900.7 1.742 0.089 Uncharacterised protein 
Smp_049550 33633.6 1.454 0.089 78 kDa glucose regulated protein 
Smp_054560 8523.3 2.363 0.089 Huntingtin interacting protein K 
Smp_175740 35702.1 2.351 0.091 Ribosomal protein L14 
Smp_061200 27528.7 2.469 0.092 Ribosomal protein L35A 
Smp_130100 7798.6 2.830 0.092 Saposin containing protein 
Smp_105320 16857.7 2.532 0.092 60S ribosomal protein L37a 
Smp_213130 31795.4 2.436 0.092 Ribosomal protein S25 
Smp_044580 24381.9 2.423 0.092 Ribosomal protein L30 
Smp_098960 35400.1 2.408 0.092 60S ribosomal protein L26 
Smp_032760 16458.3 2.369 0.092 Ribosomal protein S11 
Smp_012750 39845.5 2.348 0.092 60S ribosomal protein L12 
Smp_053830 29481.0 2.347 0.092 40S ribosomal protein S14 
Smp_098330 6356.7 2.229 0.092 H:ACA ribonucleoprotein complex subunit 2 
Smp_054240 35052.9 2.217 0.092 Translationally-controlled tumour protein homolog 
Smp_082240 19731.3 2.210 0.092 Histone H3 
Smp_002180 11152.9 2.068 0.092 Basic transcription factor 3 4 
Smp_042400 6909.0 1.929 0.092 Arginine rich, mutated in early stage tumours 
Smp_030690 16512.0 2.426 0.093 Eukaryotic translation elongation factor 1 beta 
Smp_174950 28022.6 2.367 0.093 Ribosomal protein S19e 
Smp_027610 32304.2 2.335 0.093 Ribosomal protein S3 
Smp_022640 39721.0 2.334 0.093 60S ribosomal protein L13 
Smp_036400 9180.3 2.199 0.093 NADH dehydrogenase (ubiquinone) 1 beta 
Smp_027880 8201.2 2.153 0.093 Prefoldin subunit 6 
Smp_138210 10112.2 2.691 0.094 Uncharacterised protein 
Smp_055050 24033.0 2.372 0.094 40S ribosomal protein S17 
Smp_211250 25308.8 2.343 0.094 Ribosomal protein L34a 
Smp_085300 16087.7 2.260 0.094 Ribosomal protein L22 
Smp_098890 6376.0 2.120 0.094 Arginine:serine rich splicing factor 
Smp_079430 29778.5 1.970 0.094 GTP binding nuclear protein Ran 
Smp_900030 29615.6 2.412 0.095 ATP synthase F0 subunit 6 
Smp_076740 21127.7 2.344 0.095 Ribosomal protein saa; ribosomal protein rpsa 
Smp_096750 14596.0 2.338 0.095 40S ribosomal protein S13 
Smp_018990 24725.4 2.313 0.095 Ribosomal protein L9 
Smp_194840 41848.5 2.263 0.095 Niemann Pick C2 protein 
Smp_119920 21711.9 2.259 0.095 Ribosomal protein S16 
Smp_037700 8014.7 2.254 0.095 Nuclear transport factor 2 
Smp_066890 23966.5 2.120 0.095 40S ribosomal protein S10 
Smp_055900 8220.4 2.101 0.095 Leptin receptor overlapping transcript 
Smp_179650 9467.6 2.008 0.095 Chromobox protein 
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Smp_066940 10628.5 2.290 0.096 60S ribosomal protein L29 
Smp_011570 27137.1 2.138 0.096 Ribosomal protein S4 
Smp_092380 6836.2 2.042 0.096 Protein bud31 
Smp_046020 10706.6 1.941 0.097 Protein phosphatase 1 regulatory subunit 7 
Smp_179300 14257.1 1.915 0.097 Cellular nuclear acid binding protein 
Smp_058240 6942.3 1.902 0.098 Reticulon 4 (Neurite outgrowth inhibitor) 
Smp_082030 15560.6 2.169 0.098 Uncharacterised protein 
Smp_041500 7421.3 2.265 0.099 Mitogen activated protein kinase 
Smp_130850 43065.9 2.257 0.099 40S ribosomal protein S15 
Smp_008070 27008.4 2.221 0.099 Thioredoxin 
Smp_089290 15876.3 2.286 0.100 Alpha galactosidase:alpha n 
Smp_132300 32382.5 2.225 0.100 Kinesin protein KIF3A like 
Smp_024850 26420.3 2.176 0.100 60S ribosomal protein L17 
Smp_038560 20226.0 2.159 0.100 Prothymosin alpha B 
 
Appendix B11: All 150 genes found to be differentially expressed between 
paired and separated females 8 days after perfusion. Genes are ranked by 
adjusted p-value, from smallest to largest. Average read count provides a 
measure of absolute expression. The fold change is expression in separated 




















































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































































Appendix C.1: Summary of sequencing statistics for sequnced RNA-Seq 
samples. Samples are named as follows: Sample type (Males – M; Female – F; 
Testes – T; Ovaries – O), replicate number (1 to 3) and infection status (Mixed 
sex infections – MS; Single sex infection – SS). Total reads is the number of all 
reads sequenced. Mapped is the total number of reads mapped to the 
Schistosoma mansoni reference genome v5.2. ‘Prop. Paired’ refers to the total 
number of reads mapped together with a mate-paired read in close proximity 
and in the correct orientation. ‘Singletons’ refers to the total number of reads 
with a correctly mapped mate but themselves unmapped. Unmapped is the total 
number of reads that could not be mapped to the reference by Tophat2. Mapped 
to feature is the total number of reads mapped to exons of annotated genes in the 




Appendix C.2: Bioanalyzer data shows that ovary and whole male worm 
samples form single sex infections had good quality total RNA. RNA was 
extracted from whole worms and isolated organs and the quality examined as 
described in Chapter 2.2.3. All samples showed a single, sharp ribosomal RNA 















Gene ID Description Average Gene Count Fold Change Adjusted p-value 
Smp_173940 Frizzled 636.07 1.08 4.38E-01 
Smp_175590 FGFR-A 977.81 0.16 9.34E-70 
Smp_157300 FGFR-B 1537.22 0.27 2.23E-47 
Smp_093700 PMRC1 1974.06 1.46 4.15E-09 
Smp_050520 Notch 286.33 0.45 1.29E-06 
Smp_157750 Musashi 799.75 0.73 2.66E-04 
Smp_161930 Actin 2205.63 0.12 6.33E-14 
Smp_156670 EIF4E 8964.66 0.92 3.27E-01 
Smp_069770 NDUFV2 3069.44 1.13 1.33E-01 
Smp_000740 PSMD4 7314.60 1.02 7.34E-01 
Smp_047200 RPL3 46765.34 2.19 3.09E-32 
Smp_091740 TPC2L 1194.72 1.30 8.45E-03 
Smp_090120 TUBA 40164.97 0.85 5.61E-03 
Smp_023160 ATPF 1261.13 1.08 3.68E-01 
Smp_056970 GAPDH 28090.64 1.96 8.25E-45 
Smp_003770 HID 21443.85 0.42 1.42E-44 
Smp_007630 PABP2 3694.28 2.14 2.76E-36 
Smp_002180 BTF3L4 9920.43 2.15 1.14E-54 
 
Appendix C.3: List of genes examined in Chapter 5.2.2. Expression data is 
provided for the comparison of ovaries from females from single sex (SS) 
infections compared to the ovaries from mixed sex (MS) infections. Average read 
counts provide a measure of absolute expression for a given gene. The fold 
changes reflect expression in ovaries from SS females relative to ovaries of MS 
females. The p-value has been adjusted for multiple hypothesis testing. 
 
 
GO term Description Total 
Genes 
DEGs Expected topGO 
GO:0007155 Cell adhesion 226 128 55.92 2.50E-14 
GO:0007156 Homophilic cell adhesion 60 40 14.85 6.90E-12 
GO:0007186 G-protein coupled receptor signalling 
pathway 
161 73 39.84 2.50E-09 
GO:0006811 Ion transport 389 167 96.25 2.00E-05 
GO:0007165 Signal transduction 581 242 143.76 3.90E-05 
GO:0006810 Transport 1184 391 292.96 0.00011 
GO:0007264 Small GTPase mediated signal transduction 168 65 41.57 0.00012 
GO:0006813 Potassium ion transport 77 34 19.05 0.00014 
GO:0006817 Phosphate ion transport 19 12 4.7 0.00043 
GO:0006897 Endocytosis 52 24 12.87 0.0006 
GO:0006865 Amino acid transport 22 13 5.44 0.00061 
GO:0006120 Mitochondrial electron transport 9 7 2.23 0.00124 
GO:0007229 Integrin-mediated signalling pathway 9 7 2.23 0.00124 
GO:0007017 Microtubule-based process 101 24 24.99 0.00196 
GO:0008203 Cholesterol metabolic process 18 9 4.45 0.00257 
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GO:0006814 Sodium ion transport 64 26 15.84 0.00355 
GO:0007160 Cell-matrix adhesion 8 6 1.98 0.00397 
GO:0050790 Regulation of catalytic activity 60 18 14.85 0.0044 
GO:0006629 Lipid metabolic process 241 83 59.63 0.00476 
GO:0006508 Proteolysis 318 85 78.68 0.0055 
GO:0006493 Protein O-linked glycosylation 12 7 2.97 0.00941 
GO:0051216 Cartilage development 5 4 1.24 0.01499 
GO:0046165 Alcohol biosynthetic process 13 6 3.22 0.01511 
GO:0031032 Actomyosin structure organization 3 3 0.74 0.01512 
GO:0045596 Negative regulation of cell differentiation 3 3 0.74 0.01512 
GO:0030514 Negative regulation of BMP signalling 
pathway 
3 3 0.74 0.01512 
GO:0030301 Cholesterol transport 3 3 0.74 0.01512 
GO:0006855 Drug transmembrane transport 3 3 0.74 0.01512 
GO:0015904 tetracycline transport 8 5 1.98 0.02604 
GO:0007169 Transmembrane receptor protein tyrosine 
signalling 
31 13 7.67 0.02627 
GO:0022904 Respiratory electron transport chain 19 12 4.7 0.03574 
GO:0006665 Sphingolipid metabolic process 9 6 2.23 0.03606 
GO:0007223 Wnt signalling pathway, calcium 
modulating 
6 4 1.48 0.03618 
GO:0035023 Regulation of Rho protein signal 
transduction 
23 10 5.69 0.03787 
GO:0042632 Cholesterol homeostasis 4 3 0.99 0.04929 
GO:0001503 Ossification 4 3 0.99 0.04929 
GO:0006518 Peptide metabolic process 13 5 3.22 0.04931 
 
Appendix C.4: Expanded list of GO terms enriched amongst genes 
expressed more strongly in whole male, compared to testes. The column 
“Total Genes” provides the number of genes associated with a particular GO 
term. “DEGs” provides the number of genes associated with a given GO term that 
had significantly higher expression in testes; “Expected Genes” provides the 
number of differentially expressed genes associated with a given GO term that 


















Pathway Description Total 
Genes 
DEGs Expected p-value 
smm04142 Lysosome 47 37 14.25 5.41E-12 
smm04144 Endocytosis 64 38 19.41 7.10E-07 
smm00564 Glycerophospholipid metabolism 35 21 10.61 1.74E-04 
smm00500 Starch and sucrose metabolism 14 11 4.25 2.35E-04 
smm00010 Glycolysis / Gluconeogenesis 27 17 8.19 3.28E-04 
smm00565 Ether lipid metabolism 9 8 2.73 4.37E-04 
smm04145 Phagosome 38 21 11.52 7.45E-04 
smm00561 Glycerolipid metabolism 17 11 5.16 2.74E-03 
smm00520 Amino sugar and nucleotide sugar 
metabolism 
24 14 7.28 2.83E-03 
smm04070 Phosphatidylinositol signalling system 32 17 9.70 3.71E-03 
smm04512 ECM-receptor interaction 9 7 2.73 4.06E-03 
smm04310 Wnt signalling pathway 35 18 10.61 4.37E-03 
smm00562 Inositol phosphate metabolism 26 14 7.88 6.81E-03 
smm00052 Galactose metabolism 14 9 4.25 7.00E-03 
smm04141 Protein processing in endoplasmic 
reticulum 
89 36 26.99 1.04E-02 
smm00511 Other glycan degradation 8 6 2.43 1.05E-02 
smm04068 FoxO signalling pathway 38 18 11.52 1.11E-02 
smm04080 Neuroactive ligand-receptor interaction 15 9 4.55 1.22E-02 
smm00330 Arginine and proline metabolism 18 10 5.46 1.57E-02 
smm00620 Pyruvate metabolism 21 11 6.37 1.87E-02 
smm04340 Hedgehog signalling pathway 9 6 2.73 2.19E-02 
smm00020 Citrate cycle (TCA cycle) 25 12 7.58 2.83E-02 
smm00340 Histidine metabolism 5 4 1.52 2.93E-02 
smm00190 Oxidative phosphorylation 69 26 20.93 4.18E-02 
smm04320 Dorso-ventral axis formation 8 5 2.43 4.84E-02 
 
Appendix C.5: Complete list of KEGG pathways enriched amongst the genes 
up regulated the wholes males compared to testes. The column “Total Genes” 
provides the number of genes in the KEGG pathway. “DEGs” provides the number 
differentially expressed genes (DEGs) in that pathway; “Expected Genes” 
provides the number of DEGs in a given pathway that is expected by chance. 
 
 






Smp_202140 Uncharacterised protein 14.69 149.01 2.68E-06 
Smp_184400 Uncharacterised protein 34.97 126.87 8.23E-12 
Smp_130450 RNA-binding protein bicaudal C 500.41 111.34 1.26E-105 
Smp_015190 Uncharacterised protein 10050.53 108.74 1.43E-105 
Smp_205500 Uncharacterised protein 10.22 106.35 2.19E-05 
Smp_193990 Uncharacterised protein 18.90 101.49 1.49E-07 
Smp_138560 Uncharacterised protein 178.30 89.95 3.31E-42 
Smp_194950 Putative ELAV-like RNA-binding protein 4441.96 87.64 1.93E-109 
Smp_145730 Putative EGF-domain containing protein 575.65 79.13 5.22E-68 
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Smp_135030 Uncharacterised protein 97.10 78.96 3.48E-24 
Smp_154260 Putative glioma pathogenesis-related protein 35.79 78.74 1.72E-13 
Smp_125190 Uncharacterised protein 1628.78 77.56 7.55E-110 
Smp_166570 Zinc finger protein 229.83 73.38 5.82E-50 
Smp_152310 Uncharacterised protein 527.06 68.84 1.19E-92 
Smp_202660 Uncharacterised protein 6.07 67.51 2.51E-04 
Smp_134110 Voltage-gated hydrogen channel 12.18 67.26 3.98E-06 
Smp_185360 Uncharacterised protein 14.76 65.70 8.63E-06 
Smp_161840 Uncharacterised protein 5577.64 64.96 7.27E-106 
Smp_027290 Uncharacterised protein 1467.26 64.13 2.82E-58 
Smp_142240 Uncharacterised protein 266.80 63.42 2.37E-64 
Smp_062490 Putative heart- and neural crest derivatives-
expressed protein 
421.89 60.19 1.14E-95 
Smp_182990 Uncharacterised protein 5.84 59.98 4.56E-04 
Smp_123970 Uncharacterised protein 103.54 59.58 1.21E-26 
Smp_185830 Uncharacterised protein 18.29 59.28 1.07E-06 
Smp_205410 Uncharacterised protein 7080.46 59.11 1.59E-94 
Smp_128140 Putative ATP-dependant DNA helicase 94.14 57.69 9.08E-31 
Smp_203270 Twist-related protein 11.16 57.14 2.55E-05 
Smp_168440 Uncharacterised protein 16.07 56.10 4.87E-07 
Smp_061400 Uncharacterised protein 20.61 55.82 1.46E-08 
Smp_161060 Uncharacterised protein 1305.71 55.33 3.75E-83 
Smp_155350 Putative coiled-coil domain containing protein 482.40 54.92 9.27E-69 
Smp_131240 Uncharacterised protein 222.27 54.09 2.28E-32 
Smp_205470 Uncharacterised protein 28.75 52.86 9.76E-08 
Smp_054680 Archipelago-like protein 28.81 52.24 1.55E-11 
Smp_203840 Uncharacterised protein 19.99 52.04 1.96E-07 
Smp_143940 Cytoplasmic dynein-1 light intermediate chain 66.98 50.90 1.30E-17 
Smp_142220 APOBEC1 complementation factor-like RNA-
binding protein 
1999.21 50.66 1.15E-96 
Smp_028130 Uncharacterised protein 425.61 50.49 4.11E-54 
Smp_123300 Follistatin 99.62 109.80 4.29E-11 
 
Appendix C.6: Expanded list of DEGs with testes-biased expression 
compared to whole males. Average read counts are a measure of absolute gene 
expression; they are the average of normalised read counts across all RNA-Seq 
samples used in Chapter 5. The fold changes reflect expression in the testes 












GO term Description Total 
Genes 
DEGs Expected topGO 
GO:0007018 Microtubule-based movement 60 36 9.32 3.40E-15 
GO:0006941 Striated muscle contraction 145 59 22.52 1.20E-13 
GO:0006270 DNA replication initiation 15 13 2.33 2.20E-09 
GO:0007283 Spermatogenesis 10 9 1.55 4.40E-07 
GO:0006281 DNA repair 122 46 18.95 7.00E-07 
GO:0007049 Cell cycle 207 78 32.15 2.40E-06 
GO:0007067 Mitotic nuclear division 88 37 13.67 3.50E-06 
GO:0006260 DNA replication 161 64 25.01 7.50E-05 
GO:0007126 Meiotic nuclear division 8 6 1.24 2.90E-04 
GO:0006298 Mismatch repair 11 7 1.71 4.00E-04 
GO:0030030 Cell projection organization 9 5 1.4 5.80E-04 
GO:0000226 Microtubule cytoskeleton 
organization 
17 7 2.64 1.65E-03 
GO:0008285 Negative regulation of cell 
proliferation 
5 4 0.78 2.54E-03 
GO:0007064 Mitotic sister chromatid cohesion 3 3 0.47 3.74E-03 
GO:0007076 Mitotic chromosome condensation 9 5 1.4 6.52E-03 
GO:0006278 RNA-dependent DNA replication 32 11 4.97 6.67E-03 
GO:0006183 GTP biosynthetic process 6 4 0.93 6.67E-03 
GO:0006269 DNA replication, synthesis of RNA 
primer 
6 4 0.93 6.67E-03 
GO:0006228 UTP biosynthetic process 6 4 0.93 6.67E-03 
GO:0006241 CTP biosynthetic process 6 4 0.93 6.67E-03 
GO:0006486 Protein glycosylation 58 15 9.01 8.97E-03 
GO:0007601 Visual perception 10 5 1.55 0.011 
GO:0006310 DNA recombination 39 12 6.06 0.012 
GO:0009809 Lignin biosynthetic process 4 3 0.62 0.013 
GO:0006268 DNA unwinding involved in DNA 
replication 
11 5 1.71 0.018 
GO:0042026 Protein refolding 8 4 1.24 0.024 
GO:0042592 Homeostatic process 58 9 9.01 0.024 
GO:0016568 Chromatin modification 111 24 17.24 0.028 
GO:0007059 Chromosome segregation 18 12 2.8 0.029 
GO:0006955 Immune response 11 5 1.71 0.029 
GO:0018298 Protein-chromophore linkage 9 4 1.4 0.038 
GO:0006261 DNA-dependent DNA replication 42 24 6.52 0.050 
 
Appendix C.7: Expanded list of GO terms enriched amongst the testes 
genes. The column “Total Genes” provides the number of genes associated with 
a particular GO term. “DEGs” provides the number of genes associated with a 
given GO term that had significantly higher expression in testes; “Expected 
Genes” provides the number of differentially expressed genes associated with a 






Pathway Description Total Genes DEGs Expected p-value 
smm03030 DNA replication 30 24 7.00 5.80E-11 
smm03430 Mismatch repair 18 16 4.20 5.93E-09 
smm03440 Homologous recombination 18 15 4.20 1.07E-07 
smm03010 Ribosome 110 47 25.68 1.88E-06 
smm03420 Nucleotide excision repair 32 19 7.47 9.28E-06 
smm03460 Fanconi anaemia pathway 27 17 6.30 9.39E-06 
smm03410 Base excision repair 20 12 4.67 3.71E-04 
smm00230 Purine metabolism 82 30 19.14 2.15E-03 
smm00240 Pyrimidine metabolism 59 23 13.77 2.70E-03 
smm03008 Ribosome biogenesis in 
eukaryotes 
62 22 14.47 9.86E-03 
smm03040 Spliceosome 105 33 24.51 0.013 
smm00970 Aminoacyl-tRNA biosynthesis 34 13 7.94 0.021 
 
Appendix C.8: Complete list of KEGG pathways enriched amongst the testes 
expressed genes. The column “Total Genes” provides the number of genes in 
the KEGG pathway. “DEGs” provides the number differentially expressed genes 
in that pathway; “Expected Genes” provides the number of differentially 































Domain Description Total 
Genes 
DEGs Expected p-value 
PF00271 Helicase conserved C-terminal domain 75 38 17.68 2.03E-07 
PF00493 MCM2/3/5 family 10 10 2.36 5.20E-07 
PF00270 DEAD/DEAH box helicase 55 27 12.97 2.19E-05 
PF00225 Kinesin motor domain 19 13 4.48 3.67E-05 
PF08393 Dynein heavy chain, N-terminal region 2 13 10 3.06 6.67E-05 
PF05186 Dpy-30 motif 6 6 1.41 1.71E-04 
PF14551 MCM N-terminal domain 6 6 1.41 1.71E-04 
PF13414 TPR repeat 40 20 9.43 1.73E-04 
PF00852 Glycosyltransferase family 10 
(fucosyltransferase) 
12 9 2.83 2.18E-04 
PF03028 Dynein heavy chain and region D6 of 
dynein motor 
12 9 2.83 2.18E-04 
PF12774 Hydrolytic ATP binding site of dynein 
motor region D1 
12 9 2.83 2.18E-04 
PF12775 P-loop containing dynein motor region 
D3 
12 9 2.83 2.18E-04 
PF12777 Microtubule-binding stalk of dynein 
motor 
12 9 2.83 2.18E-04 
PF12780 P-loop containing dynein motor region 
D4 
12 9 2.83 2.18E-04 
PF12781 ATP-binding dynein motor region D5 12 9 2.83 2.18E-04 
PF00533 BRCA1 C Terminus (BRCT) domain 9 7 2.12 8.45E-04 
PF00929 Exonuclease 7 6 1.65 9.14E-04 
PF00077 Retroviral aspartyl protease 14 9 3.30 1.16E-03 
PF12799 Leucine Rich repeats (2 copies) 20 11 4.72 1.85E-03 
PF00400 WD domain, G-beta repeat 141 47 33.24 2.15E-03 
PF07728 AAA domain (dynein-related subfamily) 10 7 2.36 2.15E-03 
PF02493 MORN repeat 8 6 1.89 2.79E-03 
PF00488 MutS domain V 4 4 0.94 3.08E-03 
PF06220 U1 zinc finger 4 4 0.94 3.08E-03 
PF08542 Replication factor C C-terminal domain 4 4 0.94 3.08E-03 
PF00612 IQ calmodulin-binding motif 9 6 2.12 6.41E-03 
PF03133 Tubulin-tyrosine ligase family 9 6 2.12 6.41E-03 
PF03148 Tektin family 7 5 1.65 8.91E-03 
PF00078 Reverse transcriptase (RNA-dependent 
DNA polymerase) 
24 11 5.66 9.40E-03 
PF00334 Nucleoside diphosphate kinase 5 4 1.18 0.012 
PF01798 Putative snoRNA binding domain 5 4 1.18 0.012 
PF02463 RecF/RecN/SMC N terminal domain 5 4 1.18 0.012 
PF13181 Tetratricopeptide repeat 5 4 1.18 0.012 
PF00385 Chromo (Chromatin Organisation 
Modifier) domain 
10 6 2.36 0.012 
 
Appendix C.9: Expanded list of Pfam domains enriched amongst the testes 
expressed genes. The column “Total Genes” provides the number of genes with 
a given Pfam domain. “DEGs” provides the number of differentially expressed 
genes with that domain; “Expected” provides the number of differentially 
expressed genes encoding a given domain that is expected by chance. 
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smm04142 Lysosome 47 39 13.59 9.79E-15 
smm04141 Protein processing in endoplasmic reticulum 89 48 25.74 2.65E-07 
smm04145 Phagosome 38 26 10.99 3.48E-07 
smm04144 Endocytosis 64 35 18.51 7.26E-06 
smm00520 Amino sugar and nucleotide sugar 
metabolism 
24 17 6.94 1.98E-05 
smm00510 N-Glycan biosynthesis 30 19 8.68 6.65E-05 
smm00052 Galactose metabolism 14 11 4.05 1.48E-04 
smm00500 Starch and sucrose metabolism 14 11 4.05 1.48E-04 
smm00010 Glycolysis / Gluconeogenesis 27 16 7.81 6.85E-04 
smm00511 Other glycan degradation 8 7 2.31 9.43E-04 
smm00600 Sphingolipid metabolism 15 10 4.34 2.17E-03 
smm04512 ECM-receptor interaction 9 7 2.60 3.03E-03 
smm00051 Fructose and mannose metabolism 14 9 4.05 5.03E-03 
smm04130 SNARE interactions in vesicular transport 14 9 4.05 5.03E-03 
smm04320 Dorso-ventral axis formation 8 6 2.31 8.18E-03 
smm00562 Inositol phosphate metabolism 26 13 7.52 1.19E-02 
smm00564 Glycerophospholipid metabolism 35 16 10.12 1.44E-02 
smm03060 Protein export 19 10 5.50 1.72E-02 
smm04340 Hedgehog signalling pathway 9 6 2.60 1.75E-02 
smm00250 Alanine, aspartate and glutamate 
metabolism 
14 8 4.05 1.87E-02 
smm04140 Regulation of autophagy 14 8 4.05 1.87E-02 
smm00604 Glycosphingolipid biosynthesis - ganglio 
series 
3 3 0.87 2.41E-02 
smm00740 Riboflavin metabolism 5 4 1.45 2.47E-02 
smm04070 Phosphatidylinositol signalling system 32 14 9.25 2.85E-02 
smm04080 Neuroactive ligand-receptor interaction 15 8 4.34 2.86E-02 
smm04068 FoxO signalling pathway 38 16 10.99 2.87E-02 
smm00020 Citrate cycle (TCA cycle) 25 11 7.23 4.40E-02 
 
Appendix C.10: Complete list of KEGG pathways enriched amongst the 
genes up-regulated in whole females compared to ovaries from mixed sex 
infections. The column “Total Genes” provides the number of genes in the KEGG 
pathway. “DEGs” provides the number differentially expressed genes in that 
pathway; “Expected Genes” provides the number of differentially expressed in a 


















Smp_054430 Scratch-family zinc finger protein 37.84 46.88 1.66E-10 
Smp_136900 Homeobox protein DLX 9.77 36.34 5.04E-05 
Smp_198590 Kinesin-like protein 54.56 30.95 4.24E-14 
Smp_032970 Calmodium-like protein 15.05 29.95 3.45E-06 
Smp_126070 Uncharacterised protein 45.96 28.29 1.16E-12 
Smp_204040 Uncharacterised protein 14.31 28.25 4.59E-06 
Smp_082410 Uncharacterised protein 64.87 27.36 1.36E-14 
Smp_134490 Thyroid hormone receptor 265.72 26.97 4.95E-48 
Smp_143820 Uncharacterised protein 6.90 26.82 3.24E-04 
Smp_154860 Zinc finger CW-type protein 358.40 26.30 3.17E-42 
Smp_196000 Aquaporin 20.93 26.14 2.11E-07 
Smp_147880 Rootletin 41.89 24.34 2.60E-11 
Smp_078590 Uncharacterised protein 5.91 22.28 9.25E-04 
Smp_032990 Calmodulin-like protein 24.19 21.25 6.62E-07 
Smp_145230 T-box transcription factor 108.28 19.67 1.41E-14 
Smp_145570 Uncharacterised protein 418.42 19.32 9.13E-60 
Smp_036660 Uncharacterised protein 2385.46 18.72 1.29E-76 
Smp_193990 Uncharacterised protein 5.18 18.41 2.47E-03 
Smp_043430 Uncharacterised protein 788.64 17.21 6.06E-89 
Smp_160590 Uncharacterised protein 2797.25 16.88 1.09E-100 
Smp_203840 Uncharacterised protein 5.71 16.71 4.25E-03 
Smp_161050 Uncharacterised protein 187.69 16.44 2.26E-41 
Smp_152490 E3 ubiquitin-protein ligase 301.44 16.37 3.48E-58 
Smp_165230 Location of vulva defective-like protein 65.10 16.10 1.78E-18 
Smp_144860 Boule-like protein 1998.21 16.06 1.34E-147 
Smp_145280 NACHT and WD repeat domain-containing 
protein 
223.85 15.80 1.71E-42 
Smp_172150 Putative ATP-dependant RNA helicase 975.82 15.78 1.29E-136 
Smp_170960 Uncharacterised protein 709.57 15.77 2.35E-117 
Smp_141570 TWiK family potassium channel 192.15 15.34 6.45E-44 
Smp_145580 Uncharacterised protein 1351.25 15.31 6.99E-58 
Smp_131630 Testes expressed protein-like serine/threonine-
protein kinase 
1524.23 15.04 7.49E-162 
Smp_132660 Rho guanine nucleotide exchange factor 
(RhoGEF) 
2296.39 14.95 1.42E-79 
Smp_165430 Sperm-tail PG-rich repeat-containing protein 81.11 14.82 2.12E-21 
Smp_185360 Uncharacterised protein 3.88 14.69 6.27E-03 
Smp_162740 Meiosis-specific with OB domain-containing 
protein 
190.11 14.44 2.21E-24 
Smp_129750 α-(1,3)-fucosyltransferase 3.70 14.35 6.92E-03 
 
Appendix C.11: Expanded list of differentially expressed ovary-genes 
compared to whole females from mixed sex infections. Average read counts 
provide a measure of absolute expression across all RNA-Seq samples used in 
Chapter 5 for a given gene. The fold changes reflect expression in ovaries relative 
to whole females. The p-value has been adjusted for multiple hypothesis testing. 
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GO term Description Total 
Genes 
DEGs Expected p-value 
GO:0006412 Translation 393 83 41.42 2.00E-09 
GO:0042254 Ribosome biogenesis 137 31 14.44 5.90E-06 
GO:0006414 Translational elongation 27 10 2.85 4.60E-04 
GO:0006839 Mitochondrial transport 16 7 1.69 1.11E-03 
GO:0016246 RNA interference 3 3 0.32 1.17E-03 
GO:0006465 Signal peptide processing 4 3 0.42 4.29E-03 
GO:0007160 Cell-matrix adhesion 8 4 0.84 6.04E-03 
GO:0006446 Regulation of translational 
initiation 
5 3 0.53 9.89E-03 
GO:0007229 Integrin-mediated signalling 
pathway 
9 4 0.95 9.98E-03 
GO:0006836 Neurotransmitter transport 30 8 3.16 0.010 
GO:0005975 carbohydrate metabolic process 246 30 25.92 0.011 
GO:0006875 Cellular metal ion homeostasis 10 3 1.05 0.011 
GO:0006413 Translational initiation 37 11 3.9 0.015 
GO:0006401 RNA catabolic process 59 9 6.22 0.018 
GO:0019321 Pentose metabolic process 6 3 0.63 0.018 
GO:0006364 rRNA processing 108 19 11.38 0.023 
GO:0008033 tRNA processing 61 10 6.43 0.026 
GO:0006098 Pentose-phosphate shunt 7 3 0.74 0.029 
GO:0006637 Acyl-CoA metabolic process 3 2 0.32 0.031 
GO:0006855 Drug transmembrane transport 3 2 0.32 0.031 
GO:0008612 Peptidyl-lysine modification to 
peptidyl-hypusine 
3 2 0.32 0.031 
GO:0006633 Fatty acid biosynthetic process 51 10 5.37 0.037 
GO:0042026 Protein refolding 8 3 0.84 0.044 
GO:0006821 Chloride transport 8 3 0.84 0.044 
GO:0006534 Cysteine metabolic process 8 3 0.84 0.044 
 
Appendix C.12: Expanded list of GO terms enriched amongst the genes up-
regulated in ovaries of females from mixed sex infections compared to 
whole females. The column “Total Genes” provides the number of genes 
associated with a particular GO term. “DEGs” provides the number of genes 
associated with a given GO term that had significantly higher expression in 
ovaries of females from mixed sex infections; “Expected Genes” provides the 
number of differentially expressed genes associated with a given GO term that 













Pathway Description Total Genes DEGs Expected p-value 
smm03008 Ribosome biogenesis in 
eukaryotes 
62 48 20.60 5.08E-13 
smm03030 DNA replication 30 25 9.97 1.65E-08 
smm03013 RNA transport 103 60 34.22 5.56E-08 
smm03010 Ribosome 110 62 36.55 1.71E-07 
smm03460 Fanconi anaemia pathway 27 21 8.97 2.04E-06 
smm03430 Mismatch repair 18 15 5.98 1.50E-05 
smm00970 Aminoacyl-tRNA biosynthesis 34 23 11.30 2.92E-05 
smm03420 Nucleotide excision repair 32 22 10.63 2.99E-05 
smm03040 Spliceosome 105 53 34.89 7.50E-05 
smm00240 Pyrimidine metabolism 59 33 19.60 1.49E-04 
smm03440 Homologous recombination 18 13 5.98 6.55E-04 
smm03020 RNA polymerase 24 15 7.97 2.20E-03 
smm03018 RNA degradation 38 21 12.63 2.52E-03 
smm03410 Base excision repair 20 12 6.65 8.81E-03 
smm00230 Purine metabolism 82 34 27.25 0.026 
smm03450 Non-homologous end-joining 5 4 1.66 0.041 
 
Appendix C.13: Complete list of KEGG pathways enriched amongst the 
genes upregulated in the ovaries of females from mixed sex infections 
compared to whole females. The column “Total Genes” provides the number of 
genes in the KEGG pathway. “DEGs” provides the number differentially 
expressed genes in that pathway; “Expected Genes” provides the number of 
differentially expressed genes in a given pathway that is expected by chance. 
 
 
Domain Description Total 
Genes 
DEGs Expected p-value 
PF00271 Helicase conserved C-terminal domain 75 58 22.29 1.36E-17 
PF00270 DEAD/DEAH box helicase 55 43 16.35 1.13E-13 
PF00493 MCM2/3/5 family 10 10 2.97 5.31E-06 
PF00533 BRCA1 C Terminus (BRCT) domain 9 9 2.68 1.79E-05 
PF00176 SNF2 family N-terminal domain 19 14 5.65 8.21E-05 
PF00400 WD domain, G-beta repeat 141 62 41.91 1.02E-04 
PF00856 SET domain 19 13 5.65 4.55E-04 
PF00481 Protein phosphatase 2C 6 6 1.78 6.87E-04 
PF14551 MCM N-terminal domain 6 6 1.78 6.87E-04 
PF00852 Glycosyltransferase family 10 
(fucosyltransferase) 
12 9 3.57 1.37E-03 
PF00679 Elongation factor G C-terminus 5 5 1.49 2.31E-03 
PF00752 XPG N-terminal domain 5 5 1.49 2.31E-03 
PF02463 RecF/RecN/SMC N terminal domain 5 5 1.49 2.31E-03 
PF08389 Exportin 1-like protein 5 5 1.49 2.31E-03 
PF13589 Histidine kinase-, DNA gyrase B-, and 
HSP90-like ATPase 
5 5 1.49 2.31E-03 
PF00929 Exonuclease 7 6 2.08 3.38E-03 
PF01926 50S ribosome-binding GTPase 11 8 3.27 3.47E-03 
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PF03144 Elongation factor Tu domain 2 11 8 3.27 3.47E-03 
PF00076 RNA recognition motif. (a.k.a. RRM, RBD, 
or RNP domain) 
84 35 24.97 5.80E-03 
PF14259 RNA recognition motif (a.k.a. RRM, RBD, or 
RNP domain) 
29 15 8.62 6.87E-03 
PF00136 DNA polymerase family B 4 4 1.19 7.79E-03 
PF00383 Cytidine and deoxycytidylate deaminase 
zinc-binding region 
4 4 1.19 7.79E-03 
PF00488 MutS domain V 4 4 1.19 7.79E-03 
PF00867 XPG I-region 4 4 1.19 7.79E-03 
PF02984 Cyclin, C-terminal domain 4 4 1.19 7.79E-03 
PF03104 DNA polymerase family B, exonuclease 
domain 
4 4 1.19 7.79E-03 
PF06470 SMC proteins Flexible Hinge Domain 4 4 1.19 7.79E-03 
PF08542 Replication factor C C-terminal domain 4 4 1.19 7.79E-03 
PF13959 Domain of unknown function (DUF4217) 4 4 1.19 7.79E-03 
PF01336 OB-fold nucleic acid binding domain 8 6 2.38 9.51E-03 
PF01398 JAB1/Mov34/MPN/PAD-1 ubiquitin 
protease 
8 6 2.38 9.51E-03 
PF00133 tRNA synthetases class I (I, L, M and V) 6 5 1.78 9.76E-03 
PF05383 La domain 6 5 1.78 9.76E-03 
PF08264 Anticodon-binding domain of tRNA 6 5 1.78 9.76E-03 
 
Appendix C.14: Expanded list of Pfam domains enriched amongst the genes 
up-regulated in the ovaries of females from mixed sex infections compared 
to whole females. The column “Total Genes” provides the number of genes 
encoding a given Pfam domain. “DEGs” provides the number of differentially 
expressed genes with that domain; “Expected” provides the number of 























GO ID Term Annotated Significant Expected p-value 
GO:0007018 Microtubule-based movement 60 24 5.52 1.20E-10 
GO:0006941 Striated muscle contraction 145 32 13.33 1.80E-06 
GO:0007283 Spermatogenesis 10 7 0.92 5.00E-06 
GO:0030030 Cell projection organization 9 5 0.83 7.00E-05 
GO:0006183 GTP biosynthetic process 6 4 0.55 9.10E-04 
GO:0006228 UTP biosynthetic process 6 4 0.55 9.10E-04 
GO:0006241 CTP biosynthetic process 6 4 0.55 9.10E-04 
GO:0000226 Microtubule cytoskeleton 
organization 
17 6 1.56 1.09E-03 
GO:0009809 Lignin biosynthetic process 4 3 0.37 2.88E-03 
GO:0006955 Immune response 11 4 1.01 6.69E-03 
GO:0007275 Multicellular organismal 
development 
286 37 26.29 8.21E-03 
GO:0007602 Phototransduction 6 3 0.55 1.25E-02 
GO:0006278 RNA-dependent DNA replication 32 7 2.94 2.35E-02 
GO:0042026 Protein refolding 8 3 0.74 3.04E-02 
GO:0006334 Nucleosome assembly 34 7 3.13 3.21E-02 
GO:0015074 DNA integration 28 6 2.57 3.85E-02 
GO:0018298 Protein-chromophore linkage 9 3 0.83 4.26E-02 
GO:0006108 Malate metabolic process 4 2 0.37 4.46E-02 
GO:0009073 Aromatic amino acid family 
biosynthetic ... 
4 2 0.37 4.46E-02 
GO:0006563 L-serine metabolic process 4 2 0.37 4.46E-02 
 
Appendix C.15: Expanded list of GO terms enriched amongst the genes up-
regulated in testes compared to ovaries. The column “Total Genes” provides 
the number of genes associated with a particular GO term. “DEGs” provides the 
number of genes associated with a given GO term that had significantly higher 
expression in testes compared to ovaries; “Expected Genes” provides the number 
of differentially expressed genes associated with a given GO term that are 



















GO ID Term Annotated Significant Expected p-value 
GO:0006364 rRNA processing 108 18 6.14 3.10E-05 
GO:0042254 ribosome biogenesis 137 26 7.79 1.10E-04 
GO:0009086 methionine biosynthetic process 5 3 0.28 1.67E-03 
GO:0006468 protein phosphorylation 337 30 19.16 8.79E-03 
GO:0001682 tRNA 5'-leader removal 3 2 0.17 9.30E-03 
GO:0006996 organelle organization 328 32 18.65 1.07E-02 
GO:0007420 brain development 4 2 0.23 1.79E-02 
GO:0006338 chromatin remodelling 4 2 0.23 1.79E-02 
GO:0006333 chromatin assembly or disassembly 63 7 3.58 2.21E-02 
GO:0007275 multicellular organismal 
development 
286 26 16.26 3.23E-02 
GO:0007219 Notch signalling pathway 22 4 1.25 3.33E-02 
GO:0051028 mRNA transport 84 10 4.78 3.37E-02 
GO:0007050 cell cycle arrest 6 2 0.34 4.15E-02 
GO:0016485 protein processing 15 3 0.85 4.98E-02 
 
Appendix C.16: Expanded list of GO terms enriched in genes up-regulated 
in ovaries compared to testes. The column “Total Genes” provides the number 
of genes associated with a particular GO term. “DEGs” provides the number of 
genes associated with a given GO term that had significantly higher expression in 
ovaries compared to the testes; “Expected Genes” provides the number of 




























Gene ID Description Average 
Gene Count 
Fold Change Adjusted p-
value 
Smp_075370 Uncharacterised protein 2546.97 281.45 3.20E-161 
Smp_123830 Collagen alpha (xi) chain 12391.26 247.02 1.23E-204 
Smp_214190 Calpain 7468.55 223.17 1.28E-194 
Smp_161790 Uncharacterised protein 2177.89 170.65 8.69E-168 
Smp_130280 Neurogenic locus notch protein 2542.52 165.81 2.54E-157 
Smp_084090 Uncharacterised protein 2213.81 158.02 1.07E-155 
Smp_018250 Troponin i 12126.92 129.72 2.78E-215 
Smp_045200 Tegument-allergen-like protein 7170.98 107.84 6.62E-286 
Smp_144910 Collagen type I:II:III:V:XI alpha 9835.41 105.69 2.09E-187 
Smp_006860 PDZ and LIM domain protein 
Zasp 
3301.43 72.02 1.59E-193 
Smp_074560 Uncharacterised protein 2562.52 70.69 9.58E-160 
Smp_144280 Tensin 3376.96 67.30 4.93E-190 
Smp_156960 Nardilysin (M16 family) 4146.65 66.18 1.13E-187 
Smp_020070 Uncharacterised protein 6841.37 65.49 4.86E-219 
Smp_045550 Annexin 3514.23 49.80 5.55E-182 
Smp_196250 Supervillin 4252.86 47.39 2.39E-194 
Smp_179810 Oncosphere protein tso22e 17872.05 44.39 0 
Smp_085540 Myosin heavy chain, putative 77964.61 43.45 1.65E-185 
Smp_086330 Myophilin 5101.28 37.76 2.37E-184 
Smp_171780 SPARC protein 2760.33 31.76 7.19E-189 
Smp_049270 Major egg antigen (p40) 6759.56 31.12 2.09E-227 
Smp_037230 Fimbrin 7826.62 24.88 2.47E-215 
Smp_087250 Muscle LIM protein 2504.41 24.05 9.54E-158 
Smp_044010 Tropomyosin 17835.33 17.14 2.26E-159 
Smp_123300 Follistatin 99.62 9.67 4.29E-11 
 
Appendix C.17: Genes up-regulated in whole males from mixed sex 
infections compared to testes. Average read counts are a measure of absolute 
expression across all samples, and fold changes provided a measure pf gene 
expression in whole males relative to testes. The p-value has been adjusted for 
multiple hypothesis testing. 
 
 
Comparison Fold Change Adjusted p-value 
Expression in ovaries from single sex infections 
compared to ovaries from mixed sex infections 
9.07 8.58E-12 
Expression in females from single sex infections 
compared to females from mixed sex infections 
12.34 9.46E-31 
 
Appendix C.18: Expression of the gene encoding follistatin (Smp_122300) 
in female worms and their ovaries. The first column specifies the samples in 
which expression of Smp_122300 was compared. The fold change provides a 
measure of gene expression in the first sample compared to the second. 
Smp_122300 expression was up regulated in the single sex sample in both cases. 
The p-value has been adjusted for multiple hypothesis testing. 
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GO term Description Total 
Genes 
DEGs Expected p-value 
GO:0006281 DNA repair 122 45 14.67 2.50E-10 
GO:0006270 DNA replication initiation 15 12 1.8 2.70E-09 
GO:0007049 Cell cycle 207 71 24.89 8.70E-08 
GO:0006260 DNA replication 161 57 19.36 1.50E-07 
GO:0007067 Mitotic nuclear division 88 33 10.58 1.30E-06 
GO:0007126 Meiotic nuclear division 8 6 0.96 6.70E-05 
GO:0006941 Striated muscle contraction 145 34 17.44 7.50E-05 
GO:0006364 rRNA processing 108 26 12.99 3.30E-04 
GO:0006298 Mismatch repair 11 6 1.32 8.00E-04 
GO:0007059 Chromosome segregation 18 12 2.16 9.00E-04 
GO:0009086 Methionine biosynthetic process 5 4 0.6 9.40E-04 
GO:0042254 Ribosome biogenesis 137 36 16.48 1.19E-03 
GO:0051276 Chromosome organization 168 39 20.2 1.61E-03 
GO:0007064 Mitotic sister chromatid cohesion 3 3 0.36 1.73E-03 
GO:0007018 Microtubule-based movement 60 15 7.22 4.00E-03 
GO:0006268 DNA unwinding involved in DNA 
replication 
11 5 1.32 6.15E-03 
GO:0008285 Negative regulation of cell 
proliferation 
5 3 0.6 0.014 
GO:0006547 Histidine metabolic process 6 3 0.72 0.014 
GO:0000184 Nuclear-transcribed mRNA 
catabolic process 
39 10 4.69 0.015 
GO:0006310 DNA recombination 39 10 4.69 0.015 
GO:0042592 Homeostatic process 58 5 6.98 0.015 
GO:0016568 Chromatin modification 111 23 13.35 0.015 
GO:0007076 Mitotic chromosome condensation 9 4 1.08 0.016 
GO:0006333 Chromatin assembly or 
disassembly 
63 12 7.58 0.018 
GO:0006261 DNA-dependent DNA replication 42 22 5.05 0.018 
GO:0006269 DNA replication, synthesis of RNA 
primer 
6 3 0.72 0.026 
GO:0030212 Hyaluronan metabolic process 6 3 0.72 0.026 
GO:0006435 Threonyl-tRNA aminoacylation 6 3 0.72 0.026 
GO:0008283 Cell proliferation 11 6 1.32 0.040 
GO:0031570 DNA integrity checkpoint 3 2 0.36 0.040 
GO:0001682 tRNA 5'-leader removal 3 2 0.36 0.040 
GO:0006529 Asparagine biosynthetic process 3 2 0.36 0.040 
GO:0006486 Protein glycosylation 58 11 6.98 0.043 
 
Appendix C.19: Expanded list of GO terms enriched amongst the gene up 
regulated in the ovaries of females from mixed sex infections compared to 
those from single sex infections. The column “Total Genes” provides the 
number of genes associated with a particular GO term. “DEGs” provides the 
number of genes associated with a given GO term that had significantly higher 
expression in ovaries; “Expected Genes” provides the number of differentially 




Gene ID Description 
Smp_130980 Cyclin k 
Smp_163380 Cyclin dependent kinase 2 
Smp_076560 Cyclin t1 
Smp_124130 Cyclin dependent kinase 1 
Smp_073340 Cyclin dependent kinase 5 
Smp_152760 Cyclin protein FAM58A 
Smp_137370 Cyclin dependent kinase 16 
Smp_090980 Cyclin dependent kinase 20 
Smp_172050 Cyclin y 
Smp_103950 Cyclin dependent kinase 10 
Smp_172700 Cyclin dependent kinase 6 
Smp_127600 Cyclin y 
Smp_176620 Cyclin dependent kinase 11 
Smp_129360 Cyclin G2 
Smp_150040 Cyclin dependent kinase 7 
Smp_153920 Cyclin G2 
Smp_003000 Cyclin dependent kinase 9 
Smp_041820 Cyclin dependent kinase 16 
Smp_102650 Cyclin dependent kinase 
Smp_157240 Cyclin dependent kinase 1 
Smp_156990 Cyclin dependent kinase 19 
Smp_080730 Cyclin dependent kinase 1 
Smp_094760 Cyclin dependent kinase 9 
Smp_047190 Cyclin g associated kinase 
Smp_039670 Cyclin L1 
Smp_212930 Cyclin h 
Smp_155330 Cyclin dependent kinase 14 
Smp_167410 Cell division cycle protein 123 
Smp_004060 Cell division cycle 20 
Smp_134020 Cell division cycle protein 27 
Smp_070690 Cell division cycle 16 
Smp_208070 CDC16 cell division cycle 16 
Smp_007510 Cell division cycle 2 protein kinase 5 
Smp_177120 Cell division cycle 7 protein 
Smp_129320 Cell division cycle 5 protein 
Smp_193440 Cell division cycle and apoptosis regulator 
Smp_132020 Cell division cycle 20 protein 1 cofactor 
Smp_037400 Cell division cycle protein 23 
 



























Smp_073470 Nuclear receptor 
Smp_153500 Tyrosine Kinase 




















Smp_146810 Diaphanous 2 
 





Pathway Description Total 
Genes 
DEGs Expected p-value 
smm03010 Ribosome 110 91 55.90 7.52E-13 
smm03008 Ribosome biogenesis in eukaryotes 62 57 31.51 1.80E-12 
smm03050 Proteasome 32 29 16.26 1.52E-06 
smm03013 RNA transport 103 73 52.34 1.12E-05 
smm00190 Oxidative phosphorylation 69 52 35.06 1.38E-05 
smm03020 RNA polymerase 24 20 12.20 7.79E-04 
smm03060 Protein export 19 15 9.66 8.63E-03 
smm00970 Aminoacyl-tRNA biosynthesis 34 23 17.28 0.020 
smm04141 Protein processing in endoplasmic 
reticulum 
89 51 45.23 0.040 
smm00240 Pyrimidine metabolism 59 35 29.98 0.044 
 
Appendix C.22: Complete list of KEGG pathways enriched amongst the 
genes up-regulated in ovaries of females mixed sex infections compared to 
those of single sex infections. The column “Total Genes” provides the number 
of genes in the KEGG pathway. “DEGs” provides the number differentially 
expressed genes in that pathway; “Expected Genes” provides the number of 
































Domain Description Total 
Genes 
DEGs Expected p-value 
PF00227 Proteasome subunit 14 14 4.62 1.781E-07 
PF00400 WD domain, G-beta repeat 141 72 46.55 3.273E-06 
PF00270 DEAD/DEAH box helicase 55 33 18.16 2.375E-05 
PF03357 Snf7 9 9 2.97 4.612E-05 
PF00179 Ubiquitin-conjugating enzyme 26 18 8.58 1.341E-04 
PF01398 JAB1/Mov34/MPN/PAD-1 ubiquitin protease 8 8 2.64 1.400E-04 
PF14259 RNA recognition motif (a.k.a. RRM, RBD, or 
RNP domain) 
29 19 9.57 2.547E-04 
PF10584 Proteasome subunit A N-terminal signature 7 7 2.31 4.249E-04 
PF01399 PCI domain 14 11 4.62 5.494E-04 
PF03144 Elongation factor Tu domain 2 11 9 3.63 1.141E-03 
PF00009 Elongation factor Tu GTP binding domain 17 12 5.61 1.384E-03 
PF00153 Mitochondrial carrier protein 26 16 8.58 1.896E-03 
PF00085 Thioredoxin 16 11 5.28 2.966E-03 
PF00467 KOW motif 5 5 1.65 3.910E-03 
PF00679 Elongation factor G C-terminus 5 5 1.65 3.910E-03 
PF05193 Peptidase M16 inactive domain 5 5 1.65 3.910E-03 
PF08389 Exportin 1-like protein 5 5 1.65 3.910E-03 
PF00271 Helicase conserved C-terminal domain 75 35 24.76 4.477E-03 
PF00753 Metallo-beta-lactamase superfamily 7 6 2.31 6.050E-03 
PF13893 RNA recognition motif. (a.k.a. RRM, RBD, or 
RNP domain) 
13 9 4.29 6.669E-03 
PF00118 TCP-1/cpn60 chaperonin family 11 8 3.63 6.965E-03 
PF01926 50S ribosome-binding GTPase 11 8 3.63 6.965E-03 
PF00076 RNA recognition motif. (a.k.a. RRM, RBD, or 
RNP domain) 
84 37 27.73 9.403E-03 
PF00137 ATP synthase subunit C 4 4 1.32 0.012 
PF00383 Cytidine and deoxycytidylate deaminase 
zinc-binding region 
4 4 1.32 0.012 
PF00579 tRNA synthetases class I (W and Y) 4 4 1.32 0.012 
PF00613 Phosphoinositide 3-kinase family, accessory 
domain (PIK domain) 
4 4 1.32 0.012 
PF01237 Oxysterol-binding protein 4 4 1.32 0.012 
PF03129 Anticodon binding domain 4 4 1.32 0.012 
PF01423 LSM domain 14 9 4.62 0.013 
PF00443 Ubiquitin carboxyl-terminal hydrolase 21 12 6.93 0.013 
PF00133 tRNA synthetases class I (I, L, M and V) 6 5 1.98 0.016 
PF08264 Anticodon-binding domain of tRNA 6 5 1.98 0.016 
PF00675 Insulinase (Peptidase family M16) 8 6 2.64 0.016 
 
Appendix C.23: Expanded list of Pfam domains enriched amongst the genes 
up-regulated in ovaries of females from mixed sex infections compared to 
those of single sex infections. The column “Total Genes” provides the number 
of genes encoding a given Pfam domain. “DEGs” provides the number of 
differentially expressed genes with that domain; “Expected” provides the 




Gene ID Description Fold Change Adjusted  
p-value 
Smp_210790 Transmembrane BAX inhibitor motif 
containing 
1.18 1.05E-01 
Smp_136730 Cathepsin D 1.66 2.73E-02 
Smp_179800 p21 activated protein kinase 1 Dpak1 2.01 1.09E-13 
Smp_043360 sBH3-1 4.49 3.77E-04 
Smp_207000 Anamorsin homologue 1.84 4.99E-08 
Smp_028500 Caspase 3 1.35 2.69E-02 
Smp_197180 Apoptosis inhibitor 5 1.51 2.51E-09 
Smp_022110 p21 activated protein kinase interacting 
protein 
1.95 1.50E-28 
Smp_084610 FAS associated factor 2 2.01 5.71E-29 
Smp_196040 Uncharacterised protein 2.67 3.71E-48 
Smp_002410 14-3-3 epsilon 2 1.85 6.72E-42 
Smp_137540 Apoptosis inducing factor 1, mitochondrial 2.29 5.03E-29 
Smp_009760 14-3-3 protein homolog 1 1.45 1.12E-11 
Smp_044000 Bax inhibitor 1 1.34 5.66E-08 
Smp_172010 Caspase 7 0.95 9.41E-01 
Smp_077540 FAS associated factor 1 1.20 2.46E-02 
Smp_032000 Caspase 0.97 8.35E-01 
Smp_148130 FAS binding factor 0.32 1.23E-39 
Smp_213250 Bcl 2 ous antagonist:killer 0.85 6.12E-03 
Smp_213730 FAS death associated protein 0.83 5.69E-03 
Smp_013040 Cathepsin D 0.77 9.99E-08 
Smp_034840 14-3-3 epsilon 0.81 1.08E-04 
Smp_072180 Apoptosis regulator BAX 0.70 1.87E-05 
Smp_141270 Caspase 8 0.82 6.50E-03 
Smp_095190 Bcl 2 ous antagonist:killer 0.53 2.40E-05 
Smp_129670 Apoptosis stimulating of P53 0.97 7.51E-01 
Smp_041630 BCL2 apoptosis inhibitor domain 
containing protein 
0.86 8.99E-02 




Appendix C.24: Expression of putative apoptosis related genes in the 
ovaries of females from single sex infections, compared to ovaries from 
mixed sex infections. The fold change provides a measure of expression in the 
ovaries of ovaries from single sex infections compared to those from mixed sex 
infections (That means fold changes greater than 1 indicate an up regulation in 
the ovaries from single sex infections). The p-value has been adjusted for 








GO term Description Total 
Genes 
DEGs Expected p-value 
GO:0007155 Cell adhesion 226 91 34.46 3.80E-17 
GO:0006278 RNA-dependent DNA replication 32 19 4.88 1.20E-08 
GO:0030154 Cell differentiation 78 29 11.89 2.00E-06 
GO:0006941 Striated muscle contraction 145 44 22.11 2.40E-06 
GO:0007156 Homophilic cell adhesion 60 22 9.15 3.60E-05 
GO:0007165 Signal transduction 581 128 88.6 4.00E-05 
GO:0007169 Transmembrane receptor protein 
tyrosine kinase signalling pathway 
31 14 4.73 6.90E-05 
GO:0006813 Potassium ion transport 77 24 11.74 3.00E-04 
GO:0006811 Ion transport 389 103 59.32 3.30E-04 
GO:0015074 DNA integration 28 12 4.27 4.20E-04 
GO:0006814 Sodium ion transport 64 20 9.76 9.20E-04 
GO:0006816 Calcium ion transport 49 16 7.47 1.75E-03 
GO:0007018 Microtubule-based movement 60 18 9.15 2.71E-03 
GO:0006537 Glutamate biosynthetic process 3 3 0.46 3.54E-03 
GO:0006508 Proteolysis 318 58 48.49 4.19E-03 
GO:0007017 Microtubule-based process 101 32 15.4 5.89E-03 
GO:0007283 Spermatogenesis 10 5 1.52 0.011 
GO:0007601 visual perception 10 5 1.52 0.011 
GO:0009073 Aromatic amino acid family 
biosynthetic process 
4 3 0.61 0.013 
GO:0009809 Lignin biosynthetic process 4 3 0.61 0.013 
GO:0006879 Cellular iron ion homeostasis 7 4 1.07 0.013 
GO:0006826 Iron ion transport 11 5 1.68 0.017 
GO:0042278 Purine nucleoside metabolic 
process 
128 21 19.52 0.023 
GO:0007517 Muscle organ development 12 3 1.83 0.023 
GO:0009060 Aerobic respiration 20 3 3.05 0.023 
GO:0009154 Purine ribonucleotide catabolic 
process 
44 5 6.71 0.023 
GO:0007275 Multicellular organismal 
development 
286 62 43.61 0.025 
GO:0009165 Nucleotide biosynthetic process 115 18 17.54 0.026 
GO:0006013 Mannose metabolic process 5 3 0.76 0.028 
GO:0016055 Wnt signalling pathway 27 9 4.12 0.031 
GO:0016042 Lipid catabolic process 26 8 3.96 0.031 
GO:0006754 ATP biosynthetic process 50 8 7.62 0.032 
GO:0006120 Mitochondrial electron transport, 
NADH to ubiquinone 
9 4 1.37 0.036 
 
Appendix C.25: Expanded list of GO terms enriched amongst the genes up-
regulated in ovaries of female single sex infections compared to those from 
mixed sex infections. The column “Total Genes” provides the number of genes 
associated with a particular GO term. “DEGs” provides the number of genes 
associated with a given GO term that had significantly higher expression in 
ovaries of SS females; “Expected Genes” provides the number of differentially 
expressed genes associated with a given GO term that are expected by chance. 
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Pathway Description Total 
Genes 
DEGs Expected p-value 
smm04142 Lysosome 47 20 7.41 6.70E-06 
smm00330 Arginine and proline metabolism 18 9 2.84 5.94E-04 
smm00760 Nicotinate and nicotinamide 
metabolism 
10 6 1.58 1.59E-03 
smm00511 Other glycan degradation 8 5 1.26 3.21E-03 
smm04512 ECM-receptor interaction 9 5 1.42 6.10E-03 
smm00052 Galactose metabolism 14 6 2.21 0.012 
smm00600 Sphingolipid metabolism 15 6 2.37 0.016 
smm02010 ABC transporters 8 4 1.26 0.022 
smm04320 Dorso-ventral axis formation 8 4 1.26 0.022 
smm04310 Wnt signalling pathway 35 10 5.52 0.023 
smm00561 Glycerolipid metabolism 17 6 2.68 0.029 
smm00500 Starch and sucrose metabolism 14 5 2.21 0.041 
smm00062 Fatty acid elongation 6 3 0.95 0.047 
smm00564 Glycerophospholipid metabolism 35 9 5.52 0.049 
 
Appendix C.26: Complete list of KEGG pathways enriched amongst the 
genes up-regulated in ovaries of females from single sex infections 
compared to those of mixed sex infections. The column “Total Genes” 
provides the number of genes in the KEGG pathway. “DEGs” provides the number 
differentially expressed genes in that pathway; “Expected Genes” provides the 




Domain Description Total 
Genes 
DEGs Expected p-value 
PF00078 Reverse transcriptase (RNA-dependent 
DNA polymerase) 
24 21 6.67 1.480E-09 
PF00665 Integrase core domain 13 13 3.61 5.693E-08 
PF00041 Fibronectin type III domain 29 22 8.05 8.660E-08 
PF00077 Retroviral aspartyl protease 14 13 3.89 5.767E-07 
PF13895 Immunoglobulin domain 27 19 7.50 4.238E-06 
PF07679 Immunoglobulin I-set domain 45 25 12.50 5.559E-05 
PF00011 Hsp20/alpha crystallin family 11 9 3.06 2.792E-04 
PF09380 FERM C-terminal PH-like domain 13 10 3.61 2.908E-04 
PF13499 EF-hand domain pair 66 31 18.33 3.916E-04 
PF07686 Immunoglobulin V-set domain 8 7 2.22 7.318E-04 
PF07645 Calcium-binding EGF domain 7 6 1.94 2.310E-03 
PF13405 EF-hand domain 12 8 3.33 4.741E-03 
PF00452 Apoptosis regulator proteins, Bcl-2 family 4 4 1.11 5.938E-03 
PF01413 C-terminal tandem repeated domain in 
type 4 procollagen 
4 4 1.11 5.938E-03 
PF11901 Protein of unknown function (DUF3421) 8 6 2.22 6.679E-03 
PF00008 EGF-like domain 15 9 4.17 6.944E-03 
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PF00595 PDZ domain (Also known as DHR or GLGF) 54 23 15.00 7.106E-03 
PF01048 Phosphorylase superfamily 6 5 1.67 7.141E-03 
PF01392 Fz domain 6 5 1.67 7.141E-03 
PF13927 Immunoglobulin domain 6 5 1.67 7.141E-03 
PF01221 Dynein light chain type 1 31 15 8.61 7.360E-03 
PF00520 Ion transport protein 43 19 11.94 8.619E-03 
PF09379 FERM N-terminal domain 16 9 4.44 0.011 
PF00373 FERM central domain 19 10 5.28 0.013 
PF00617 RasGEF domain 9 6 2.50 0.014 
PF03133 Tubulin-tyrosine ligase family 9 6 2.50 0.014 
PF07714 Protein tyrosine kinase 46 19 12.78 0.017 
PF07690 Major Facilitator Superfamily 43 18 11.94 0.017 
PF00754 F5/8 type C domain 7 5 1.94 0.018 
PF00501 AMP-binding enzyme 12 7 3.33 0.020 
PF01391 Collagen triple helix repeat (20 copies) 12 7 3.33 0.020 
PF00036 EF hand 3 3 0.83 0.021 
PF00992 Troponin 3 3 0.83 0.021 
PF01596 O-methyltransferase 3 3 0.83 0.021 
PF03188 Eukaryotic cytochrome b561 3 3 0.83 0.021 
PF04434 SWIM zinc finger 3 3 0.83 0.021 
PF04712 Radial spokehead-like protein 3 3 0.83 0.021 
 
Appendix C.27: Expanded list of Pfam domains enriched amongst the genes 
up-regulated in ovaries of females from single sex infections compared to 
those of mixed sex infections. The column “Total Genes” provides the number 
of genes encoding a given Pfam domain. “DEGs” provides the number of 
differentially expressed genes with that domain; “Expected” provides the 
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